{
  "experiment_metadata": {
    "model": "qwen3-32b",
    "experiment": "e3_page_window_distract",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000
  },
  "results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for LMT's nonqualified defined benefit pension plans increased slightly from $1.0 billion as of December 31, 2023, to $905 million as of December 31, 2024. Additionally, the actuarial losses and unrecognized prior service credits related to these plans decreased from $347 million at the end of 2023 to $303 million at the end of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49302,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12545,
        "completion_tokens": 91,
        "total_tokens": 12636
      }
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "General Motors' long-term rate of return assumptions on U.S. pension plan assets increased from 5.4% at December 31, 2022, to 6.5% at December 31, 2024. This upward adjustment indicates a strategic shift in asset mix, with a higher allocation to alternative investments (29%) and a reduced emphasis on debt (60%) in 2024 compared to 2022, reflecting a focus on diversification and potentially higher-yielding assets to improve funded positions and manage risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 63855,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16197,
        "completion_tokens": 115,
        "total_tokens": 16312
      }
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly between 2023 and 2024, as PDC was acquired by Chevron in a business combination during 2023. In 2024, this acquisition contributed to increased U.S. upstream earnings by $3.5 billion, driven by higher sales volumes from legacy PDC assets and the absence of decommissioning charges related to previously divested Gulf of America assets. Operationally, the acquisition added approximately 250,000 barrels per day to net oil-equivalent production, primarily due to the full-year inclusion of PDC's production and growth in the Permian Basin.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 109716,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 27653,
        "completion_tokens": 149,
        "total_tokens": 27803
      }
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "Between 2022 and 2024, Southern Company's treatment and valuation of energy-related derivatives remained largely consistent in terms of accounting methods (regulatory hedges, cash flow hedges, and not designated hedges), but the presentation and magnitude of unrealized gains (losses) changed. In 2022, unrealized gains (losses) from energy-related derivatives designated as regulatory hedges were deferred in regulatory assets and liabilities, with a total of $155 million in gains at year-end. By 2024, the presentation shifted to a more detailed breakdown of derivative balances by current and non-current classifications, with a net liability position of $554 million for Southern Company, reflecting a significant unrealized loss position compared to the net asset position in 2022. The change highlights a shift from regulatory deferrals to a more direct balance sheet presentation of derivative fair values.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 324,
          "pages": [
            322,
            323,
            324,
            325,
            326
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 283,
          "pages": [
            281,
            282,
            283,
            284,
            285
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53912,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13716,
        "completion_tokens": 228,
        "total_tokens": 13944
      }
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "Chevron's investment carrying value in Tengizchevroil increased from $23,727 in 2021 to $27,368 in 2024, reflecting a $3,641 increase over the period. Additionally, Chevron's equity earnings from Tengizchevroil declined from $4,386 in 2022 to $3,033 in 2024, indicating a reduction in profitability from this joint venture during the specified timeframe.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58866,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14942,
        "completion_tokens": 88,
        "total_tokens": 15030
      }
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart acquired a 100% ownership stake in Alert Innovation during fiscal 2023 by completing a $0.4 billion acquisition. This entity was previously consolidated as a variable interest entity. However, it was subsequently sold and deconsolidated in fiscal 2025, meaning Walmart no longer held any ownership stake in Alert Innovation by the end of fiscal 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59308,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15056,
        "completion_tokens": 89,
        "total_tokens": 15145
      }
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "Starbucks' foreign currency - other derivative asset positions increased significantly from $1,009 million in fiscal 2022 to $1,164 million in fiscal 2023, while liability positions remained relatively stable. This indicates an expanded use of hedging instruments to manage foreign currency exposure, reflecting the company's proactive strategy to mitigate risks arising from currency fluctuations in its international operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64541,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16369,
        "completion_tokens": 107,
        "total_tokens": 16477
      }
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "Between fiscal years 2022 and 2024, Medtronic's A Preferred Shares were consistently not issued or outstanding. In 2022, the company redeemed the previously outstanding 1,872 A Preferred Shares for $0.075 million, leaving no A Preferred Shares outstanding as of April 29, 2022. This status remained unchanged through fiscal year 2024, with no A Preferred Shares issued or outstanding as of April 26, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48394,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12322,
        "completion_tokens": 101,
        "total_tokens": 12424
      }
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Comcast's financial relationship with Atairos evolved significantly between 2022 and 2023 in terms of equity income (losses) driven by fair value adjustments on underlying investments. In 2022, Atairos contributed a loss of $434 million, while in 2023, it generated income of $1.1 billion, reflecting substantial positive changes in the fair value of its underlying investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40578,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10377,
        "completion_tokens": 94,
        "total_tokens": 10471
      }
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region remained at zero for both 2023 and 2024, as indicated in the reserve tables for both years. This suggests that the company does not hold any direct natural gas reserves in this region, though it does have equity affiliate reserves located there. The absence of direct reserves indicates that COP's strategic positioning in the Asia Pacific/Middle East region is likely focused on equity partnerships and operations rather than direct natural gas production in the area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 75601,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19135,
        "completion_tokens": 133,
        "total_tokens": 19269
      }
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL's revenue in Canada declined significantly between 2022 and 2024, dropping from $73 million in 2022 to $47 million in 2023 and further to $28 million in 2024, representing declines of 36% and 40%, respectively. This steep decline indicates a deteriorating market trajectory for ENBREL in Canada, driven primarily by lower net selling prices and likely increased competition or market pressures. The continued erosion in sales suggests a challenging outlook for the product in this region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40248,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10281,
        "completion_tokens": 123,
        "total_tokens": 10404
      }
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "Qualcomm's approach to linking human capital advancements with executive compensation in fiscal 2024 involved using progress toward human capital advancements as a non-financial performance modifier for executives' bonuses. Specifically, for fiscal 2024, this modifier could adjust the executives' bonus payout by a multiple ranging from 0.9 to 1.1. This reflects a continued emphasis on aligning executive compensation with diversity, equity, and inclusion goals, as well as other human capital initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61237,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15545,
        "completion_tokens": 127,
        "total_tokens": 15672
      }
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "Between 2022 and 2024, the therapeutic scope of Breyanzi expanded significantly. In 2022, Breyanzi was approved for specific B-cell malignancies, but by 2024, it received FDA approvals for additional indications, including relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and follicular lymphoma (FL), as well as mantle cell lymphoma (MCL). These approvals broadened Breyanzi's application to treat a wider range of B-cell malignancies, making it the CAR-T cell therapy with the broadest array of approved indications in this category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45273,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11539,
        "completion_tokens": 143,
        "total_tokens": 11682
      }
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "Disney's Resorts and Vacations segment revenue increased by 5% from 2023 to 2024, driven by higher average ticket prices for cruise line sailings, increased hotel room rates, and more occupied hotel room nights. This growth in the Resorts and Vacations segment aligns with the overall 5% revenue growth of the broader Parks & Experiences segment, which was fueled by higher theme park admissions, merchandise sales, and food and beverage revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 35803,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9183,
        "completion_tokens": 111,
        "total_tokens": 9294
      }
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "Between 2023 and 2024, the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved in terms of notional amounts and share allocations. In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., receiving 80% of the shares upfront (17.4 million shares) and the remaining 20% (5.4 million shares) later in the year. In 2024, the Company executed a larger $3.0 billion ASR with Morgan Stanley, receiving 85% of the shares upfront (31.4 million shares) and the remaining 15% (8.3 million shares) in March 2024. This indicates an increase in the scale of ASR activity and a shift in the percentage of shares delivered upfront.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 175,
          "pages": [
            173,
            174,
            175,
            176,
            177
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39284,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10044,
        "completion_tokens": 171,
        "total_tokens": 10216
      }
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "From 2023 to 2024, Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology showed increased transparency around fair value categorization. In 2023, the disclosure included fair value measurements by asset class with Level 1, Level 2, Level 3, and \"Not Categorized\" designations, but did not elaborate on the reasons for certain assets being uncategorized. By 2024, the disclosures maintained the same structure but provided more clarity by explicitly stating that certain investments measured using the net asset value per share practical expedient were not categorized in the fair value hierarchy. This enhancement improved transparency by explaining the exclusion of specific assets from the standard fair value hierarchy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 228,
          "pages": [
            226,
            227,
            228,
            229,
            230
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67776,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17182,
        "completion_tokens": 192,
        "total_tokens": 17374
      }
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial obligations and revenue recognition related to Paxlovid shifted significantly due to the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile (SNS). In 2023, a non-cash revenue reversal of $3.5 billion was recorded due to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses by the U.S. government. By 2024, a favorable final adjustment of $771 million was recorded after 5.1 million courses were returned, and an additional $442 million in revenue was recognized for supplying 1.0 million NDA-labeled Paxlovid treatment courses to create the U.S. SNS. This transition marked a shift from government contracts to commercial market sales, with deferred Paxlovid revenues decreasing from $3.4 billion in 2023 to $2.2 billion in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 98589,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24892,
        "completion_tokens": 208,
        "total_tokens": 25100
      }
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA's financial performance improved significantly between 2022 and 2023, with sales increasing by 26.9% to $2.387 billion from $1.881 billion, driven by continued share gains and market growth in metastatic castration-resistant prostate cancer. This strong growth highlights ERLEADA's growing importance within J&J's oncology portfolio, reflecting its effectiveness in capturing market share and contributing to the segment's overall 10.5% revenue increase.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42516,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10848,
        "completion_tokens": 115,
        "total_tokens": 10964
      }
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA's global sales increased by 26.9% in 2023 compared to 2022, driven by continued share gains and market growth in Metastatic Castration-Resistant Prostate Cancer. This significant growth indicates a strong market trajectory for ERLEADA, reflecting its expanding adoption and effectiveness in its target indication.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38493,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9839,
        "completion_tokens": 80,
        "total_tokens": 9920
      }
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "Between fiscal years 2023 and 2024, NVDA's debt management strategy regarding the 0.584% Notes Due 2024 evolved from holding the debt until its maturity in 2024 to repaying it in fiscal year 2025. In 2023 and 2024, the notes had a remaining term of 0.4 years and were listed with a carrying value of $1,250 million. However, in fiscal year 2025, NVDA repaid the 0.584% Notes Due 2024, removing them from its outstanding debt. This repayment reflects a proactive approach to managing short-term obligations and optimizing the company's debt structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41384,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10560,
        "completion_tokens": 137,
        "total_tokens": 10697
      }
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Honeywell's investment in Mortgage/Asset-backed securities decreased between 2022 and 2023. In 2022, the amount was $31 million (Non-U.S. plans) and $1,119 million (U.S. plans), totaling $1,150 million. In 2023, the amount was $10 million (Non-U.S. plans) and $676 million (U.S. plans), totaling $686 million. This represents a decrease of $464 million, or 40.3%, in the total investment in Mortgage/Asset-backed securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57819,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14676,
        "completion_tokens": 106,
        "total_tokens": 14782
      }
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations remained relatively stable in its funding mix, with a carrying value of $16,973 million in 2022 and $18,043 million in 2023. These obligations were classified as Level 2 in the fair value hierarchy for both years, indicating they were valued using observable market inputs. The slight increase in securitized debt obligations reflects continued reliance on this funding source, though no significant shifts in their role or valuation methodology were observed during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 210,
          "pages": [
            208,
            209,
            210,
            211,
            212
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48530,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12366,
        "completion_tokens": 137,
        "total_tokens": 12504
      }
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "From 2023 to 2024, JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolved as the CECL-related capital benefit was phased in. Specifically, the CECL benefit in CET1 capital decreased from $1.4 billion as of December 31, 2023, to $720 million as of December 31, 2024, with the remaining benefit fully phased in by January 1, 2025. This represents a quantitative reduction of $680 million in the CECL-related capital benefit during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56862,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14453,
        "completion_tokens": 119,
        "total_tokens": 14573
      }
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolved as follows: \n\nIn fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Prior Credit Agreement, which was set to mature on December 23, 2025. By fiscal 2024, Salesforce replaced the Prior Credit Agreement with a new Revolving Loan Credit Agreement in October 2024, increasing the borrowing capacity to $5.0 billion and extending the maturity date to October 2029. The new agreement provides for an unsecured revolving credit facility that can be used for general corporate purposes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48626,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12371,
        "completion_tokens": 158,
        "total_tokens": 12529
      }
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "Between 2022 and 2024, UPS's relationship with Coyote evolved from operating it as part of its Supply Chain Solutions segment to divesting the business. In 2022, Coyote was described as a key part of UPS's truckload brokerage services in the U.S. and Europe. However, by 2024, UPS completed the divestiture of Coyote, as noted in the third quarter of 2024. This divestiture resulted in a pre-tax gain of $156 million ($152 million after tax) for UPS in 2024, which was recorded as part of other expenses in the consolidated income statement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44453,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11328,
        "completion_tokens": 135,
        "total_tokens": 11464
      }
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "Between 2023 and 2024, Union Pacific's relationship with chassis showed a significant shift in both total units and ownership structure. In 2023, the company owned 30,635 chassis and leased 17,705, totaling 48,340 units with an average age of 13.2 years. By 2024, the total number of chassis dropped to 5,553, with a marked decrease in leased units to 1,197 and owned units to 4,356, representing an average age of 11.6 years. This indicates a substantial reduction in chassis volume and a shift toward greater ownership relative to leasing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35175,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9013,
        "completion_tokens": 135,
        "total_tokens": 9148
      }
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "Between 2022 and 2024, Boeing has consistently classified its aluminum agreements as derivative instruments for accounting purposes but has not designated them for hedge accounting treatment. In 2022, these agreements were described as addressing \"long-term strategic sourcing objectives and non-U.S. business requirements,\" with changes in fair value recorded directly in earnings. By 2024, the description remained largely unchanged, with the agreements still being treated as derivatives not designated for hedge accounting. Additionally, the time horizon for these agreements has extended, as Boeing's commodity contracts now hedge forecasted transactions through 2028, compared to earlier periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39908,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10211,
        "completion_tokens": 175,
        "total_tokens": 10387
      }
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble's exposure to currency rate risk remained relatively stable between the fiscal years ended June 30, 2023, and June 30, 2024. The company primarily manages its currency rate risk through operational hedging and the use of forward contracts and currency swaps with maturities of less than 18 months. In both years, P&G stated that near-term changes in currency rates would not materially affect its financial statements, based on a 95% confidence level using historical data. Additionally, the company emphasized its confidence in mitigating near-term exchange rate fluctuations through its diversified portfolio and hedging strategies. There was no significant change in the nature or extent of hedging instruments used during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63320,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16074,
        "completion_tokens": 188,
        "total_tokens": 16263
      }
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "Between 2022 and 2024, Adobe has expanded Frame.io's functional scope and deepened its integration with other Adobe products. In 2022, Frame.io was described as a cloud-native collaboration platform supporting video and design workflows with integrations into Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. By 2024, Frame.io's integration has expanded further, with enhanced support for video workflows beyond post-production (e.g., casting, location scouting, marketing campaign management) and direct integration with additional Adobe tools. It is also highlighted as part of Adobe GenStudio, enabling scalable content production and emphasizing its role in Adobe's broader creative ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 38910,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9955,
        "completion_tokens": 180,
        "total_tokens": 10135
      }
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "Between the 2022 and 2023 fiscal years, AMD's carrying value of its investment in the ATMP JV increased from $69 million to $99 million, reflecting a $30 million growth. Financial disclosures related to the ATMP JV became more detailed in 2023, with expanded reporting of purchases and payables, which rose from $1.1 billion in 2022 to $1.7 billion in 2023, and payables increasing from $85 million to $363 million. The nature of disclosures also included clearer descriptions of the joint venture's role in providing ATMP services and AMD's inventory management involvement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43004,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10987,
        "completion_tokens": 143,
        "total_tokens": 11130
      }
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a potential weakening in demand for new aircraft equipment, which could indicate challenges in the aerospace sector, such as reduced OEM production or market saturation. However, the overall Aerospace Technologies segment still showed growth in total sales, driven by higher Commercial Aviation Aftermarket and Defense and Space revenues, highlighting Honeywell's diversified position in the aerospace industry.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52070,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13244,
        "completion_tokens": 140,
        "total_tokens": 13385
      }
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The global revenue contribution from Heart Failure Devices increased by 10.3% in 2024, excluding the effect of foreign exchange, primarily driven by growth in heart assist devices. In 2023, the segment's revenue grew by 12.0% under similar conditions. This indicates a slight deceleration in growth from 2023 to 2024, with a 1.7 percentage point decrease in the growth rate.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47386,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12071,
        "completion_tokens": 93,
        "total_tokens": 12165
      }
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "Between the 2022 and 2023 filings, IBM's treatment of the 0.300% Notes due 2028 remains consistent, as both filings list the notes under the company's registered securities. In the 2022 filing (page 28), the 0.300% Notes due 2028 are listed as \"IBM 28B\" and traded on the New York Stock Exchange. In the 2023 filing (page 1), the same note is again listed with identical terms and trading details, indicating no material change in its classification or status.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36086,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9228,
        "completion_tokens": 115,
        "total_tokens": 9343
      }
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "Apple's financial performance in the Rest of Asia Pacific region from 2022 to 2023 showed a modest increase in net sales, rising from $29,375 million in 2022 to $29,615 million in 2023, and further to $30,658 million in 2024. Operating income also improved during this period, increasing from $11,569 million in 2022 to $12,066 million in 2023 and reaching $13,062 million in 2024, indicating a positive trend in both revenue and profitability for the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42869,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10939,
        "completion_tokens": 114,
        "total_tokens": 11054
      }
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The vesting period for stock options issued under the 2007 Omnibus Incentive Plan changed between grants made prior to 2022 and those made after December 31, 2021. Stock options granted prior to 2022 generally vested pro rata over a five-year period, while stock options granted subsequent to December 31, 2021 generally vest pro rata over a four-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61534,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15625,
        "completion_tokens": 89,
        "total_tokens": 15715
      }
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "From 2022 to 2023, CVS maintained a consistent approach to validating fair value estimates for its Level 2 debt securities, with no adjustments made to the prices obtained in either year. The Company continued to review prices for observable market inputs and compared primary source prices to secondary sources quarterly, examining variances above a specified threshold. Additionally, the internal investment team consistently compared prices to its own independent fair value estimates. No changes in methodology or increased reliance on secondary source comparisons were noted in the 2023 disclosures compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 153,
          "pages": [
            151,
            152,
            153,
            154,
            155
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49829,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12693,
        "completion_tokens": 155,
        "total_tokens": 12848
      }
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "Between 2022 and 2023, CVS maintained its classification of privately-placed equity securities in Level 3 of the fair value hierarchy due to the absence of an active market. The valuation methodology for these securities remained consistent, relying on internal analysis of each investment's financial statements and cash flow projections. Unobservable inputs such as earnings and revenue multiples, discounts for lack of marketability, and comparability adjustments continued to be significant in determining fair value. However, in 2023, the fair value of privately-placed equity securities increased from $60 million to $79 million, reflecting changes in the underlying assumptions or investment performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 153,
          "pages": [
            151,
            152,
            153,
            154,
            155
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49829,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12693,
        "completion_tokens": 177,
        "total_tokens": 12871
      }
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue from Alphagan/Combigan decreased by 8.8% between 2023 and 2024. In terms of international revenue, it increased by 1.5% in 2024 compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64480,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16343,
        "completion_tokens": 41,
        "total_tokens": 16384
      }
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "Chevron's relationship with PDC Energy evolved significantly from 2023 to 2024, as PDC was acquired by Chevron in a business combination during 2023. This acquisition contributed to Chevron's production performance in 2024, with the full-year inclusion of legacy PDC production being a primary driver for the seven percent increase in worldwide oil-equivalent production compared to 2023. Specifically, the United States production saw a notable increase, attributed in part to PDC's operations, with net daily oil-equivalent production in the Permian Basin benefiting from PDC's assets and strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61594,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15625,
        "completion_tokens": 150,
        "total_tokens": 15776
      }
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "From 2023 to 2024, UPS enhanced its cold-chain logistics capabilities through strategic acquisitions. In 2023, the acquisitions of MNX Global Logistics and Bomi Group expanded UPS's global time-critical and temperature-sensitive logistics services, particularly in healthcare and international markets. In 2024, UPS further strengthened its cold-chain logistics by acquiring Frigo-Trans and Biotech & Pharma Logistics, a leading healthcare logistics provider in Germany, for approximately $440 million. These acquisitions contributed to UPS's growth in complex cold-chain logistics capabilities both domestically and internationally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38980,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9965,
        "completion_tokens": 158,
        "total_tokens": 10124
      }
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "Between 2022 and 2024, Linde plc's non-employee director restricted stock unit (RSU) award program has evolved to enhance governance and long-term shareholder alignment. In 2022, the program was governed under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan, with awards structured to align director compensation with company performance and shareholder returns. By 2024, the program transitioned under the 2021 Linde plc Long Term Incentive Plan, reflecting a more updated governance framework. Additionally, in 2024, Linde introduced the Linde plc Non-employee Director Deferral Program, adopted on July 30, 2024, which allows directors to defer compensation, further aligning their interests with long-term shareholder value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60742,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15421,
        "completion_tokens": 187,
        "total_tokens": 15608
      }
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "Between 2022 and 2024, General Motors' financial and legal relationship with Stellantis primarily revolved around indemnification obligations stemming from the 2017 sale of the Opel/Vauxhall business to PSA Group (now Stellantis). GM agreed to indemnify Stellantis for certain losses related to emissions claims, product liabilities, and recalls for vehicles sold before the sale. As of December 31, 2024, GM had accrued an immaterial amount for these obligations, as it was unable to estimate any reasonably possible material loss or range of loss. Additionally, GM indemnified Stellantis for an immaterial amount related to Takata inflator recalls in legacy Opel vehicles, though further indemnification for such matters was considered remote. There were no notable investment gains reported in the provided documents regarding this relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60145,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15263,
        "completion_tokens": 212,
        "total_tokens": 15475
      }
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "From 2022 to 2024, Southern Company's treatment and disclosure of energy-related derivatives evolved in terms of financial presentation and categorization by providing more detailed breakdowns of derivative positions and their fair value impacts. In 2024, the company presented a more granular categorization of derivatives, including energy-related derivatives designated as hedging instruments for regulatory purposes and those in cash flow and fair value hedges, with separate disclosures for current and non-current positions. Additionally, the 2024 disclosures included more specific information on netting arrangements, collateral, and the fair value gains or losses for various derivative types, reflecting a more transparent and structured approach to financial reporting compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 283,
          "pages": [
            281,
            282,
            283,
            284,
            285
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52496,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13355,
        "completion_tokens": 199,
        "total_tokens": 13554
      }
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "Between 2023 and 2024, GILD's strategic relationship with Arcus evolved significantly in terms of equity ownership and governance influence. In 2023, GILD owned approximately 19.9% of Arcus' voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment, increasing its ownership to 33%, and expanded its board representation to three designees. This marked a substantial increase in both equity ownership and governance influence over Arcus.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56650,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14383,
        "completion_tokens": 129,
        "total_tokens": 14512
      }
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "The maturity date of the 2021 Multicurrency Credit Facility was extended from July 1, 2026, in 2022 to July 1, 2026, in 2023, remaining unchanged. The borrowing capacity also remained the same at $6.0 billion between 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 46322,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11794,
        "completion_tokens": 57,
        "total_tokens": 11852
      }
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron's utilization of imported crude oil in U.S. refining operations remained stable at approximately 60% of total refinery inputs in both 2023 and 2024. However, refinery capacity utilization in the U.S. declined slightly, averaging 86.6% in 2024 compared to 90.8% in 2023. This decrease in utilization was accompanied by ongoing projects to enhance refinery flexibility and throughput capacity, such as the completion of the Pasadena Refinery upgrade in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52679,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13399,
        "completion_tokens": 116,
        "total_tokens": 13515
      }
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS's hedging position in British Pound Sterling decreased from £856 million in 2022 to £663 million in 2023 and further to £536 million in 2024, as reflected in the notional amounts of outstanding derivative positions. This reduction indicates a strategic adjustment in UPS's currency risk management, potentially reflecting a lower exposure to GBP-denominated cash flows or a shift in focus to other currencies like the Chinese Renminbi, which appeared in 2024. The shift suggests a more dynamic and responsive approach to managing foreign currency risks based on evolving operational and financial exposures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 137,
          "pages": [
            135,
            136,
            137,
            138,
            139
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47386,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12076,
        "completion_tokens": 152,
        "total_tokens": 12229
      }
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at the end of 2023 to $1.3 billion at the end of 2024. This slight increase suggests a modest shift in the company's short-term investment strategy, potentially reflecting efforts to maintain or slightly expand its liquidity position amid evolving market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 94041,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23744,
        "completion_tokens": 90,
        "total_tokens": 23834
      }
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas subject to physical supply contracts with sell-back options for Southern Company decreased from 26 million mmBtu in 2022 to 15 million mmBtu in 2024. Specifically, Alabama Power's volume decreased from 6 million mmBtu to 4 million mmBtu, Georgia Power's from 8 million mmBtu to 6 million mmBtu, Mississippi Power's from 4 million mmBtu to 2 million mmBtu, and Southern Power's from 8 million mmBtu to 3 million mmBtu.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 319,
          "pages": [
            317,
            318,
            319,
            320,
            321
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 281,
          "pages": [
            279,
            280,
            281,
            282,
            283
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54919,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13960,
        "completion_tokens": 115,
        "total_tokens": 14075
      }
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "Between 2023 and 2024, the integration and application of the Firefly Vector Model across Adobe's product suite expanded significantly. In 2023, Firefly Vector Model was introduced as part of Adobe Firefly, enabling users to generate fully editable vector graphics from text prompts. By 2024, the model was more deeply integrated into core creative tools like Adobe Illustrator and Adobe Express, allowing for enhanced generative design capabilities such as Generative Recolor and streamlined workflows for creating vector-based content. Additionally, Firefly Vector Model became part of Adobe Firefly Services and Custom Models, offering enterprises scalable solutions for brand-specific content generation. This evolution reflects Adobe's focus on embedding generative AI into its ecosystem to boost creativity and productivity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44248,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11277,
        "completion_tokens": 207,
        "total_tokens": 11485
      }
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "Based on the data from the GILD_10k_2023.pdf and GILD_10k_2024.pdf, Biktarvy's commercial significance for Gilead has grown from 2023 to 2024. In 2023, Biktarvy generated $11,850 million in total product sales, increasing to $12,130 million in 2024. This growth reflects its continued dominance in Gilead's HIV portfolio. The increase in sales suggests that Biktarvy remains a cornerstone of Gilead's HIV business strategy, helping to offset potential revenue declines from other HIV products due to competition and patent expirations. However, the company must continue to innovate and expand indications for existing products to maintain its market position in the competitive HIV treatment landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 74271,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18792,
        "completion_tokens": 175,
        "total_tokens": 18968
      }
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "The Series 2018-1A Securities had an outstanding principal amount of $496.8 million as of December 31, 2023, compared to $496.1 million as of December 31, 2022, indicating a slight increase in the outstanding principal. The interest rate for the Series 2018-1A Securities remained consistent at 3.652% during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58705,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14905,
        "completion_tokens": 80,
        "total_tokens": 14985
      }
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "UPS's relationship with Coyote evolved significantly from 2023 to 2024, both financially and strategically. In 2023, UPS recorded a $111 million impairment charge for the Coyote trade name due to declining business performance and challenging market conditions. By 2024, UPS completed the strategic divestiture of Coyote in September, which led to a $156 million gain on the divestiture and significantly reduced operating expenses in the Forwarding segment by $949 million due to lower activity levels. This reflects a shift from impairment and underperformance in 2023 to a strategic exit and financial benefit in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38614,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9866,
        "completion_tokens": 155,
        "total_tokens": 10022
      }
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "Linde plc's Performance Share Unit Awards for grants beginning in 2019, as outlined in both the 2022 and 2024 10-K filings, utilized two primary performance metrics: Return on Capital and Total Shareholder Return. These metrics were specified in the forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan. There is no indication of a change in these metrics between 2022 and 2024 for grants starting in 2019.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 107,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60502,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15354,
        "completion_tokens": 116,
        "total_tokens": 15471
      }
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "Between 2023 and 2024, Trodelvy's regulatory status evolved with the FDA granting it Breakthrough Therapy designation in 2024 for the treatment of extensive-stage small cell lung cancer, following its 2023 approval for HR+/HER2- breast cancer and metastatic urothelial cancer. This indicates a positive development trajectory, with Trodelvy being recognized for its potential to significantly improve outcomes in serious conditions, thereby accelerating its regulatory review and expanding its therapeutic applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59078,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14985,
        "completion_tokens": 129,
        "total_tokens": 15115
      }
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "The Vertex AI platform within Google Cloud has evolved significantly from 2023 to 2024 in terms of its capabilities and integration with generative AI models. In 2023, Vertex AI enabled developers to train, tune, augment, and deploy applications using generative AI models. By 2024, Vertex AI had expanded to include training, tuning, augmenting, testing, and deploying applications using Gemini, Imagen, Veo, and other generative AI models. Additionally, Gemini for Google Cloud was introduced, offering pre-packaged AI agents to assist developers in writing, documenting, testing, and operating software, as well as supporting cybersecurity teams in threat analysis and response.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49671,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12644,
        "completion_tokens": 170,
        "total_tokens": 12814
      }
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "From 2022 to 2024, the treatment and valuation of weather derivatives in SO's financial disclosures indicate that amounts associated with weather derivatives have consistently been deemed immaterial and excluded from derivative valuations. In both the 2022 and 2024 filings, the disclosures explicitly state that immaterial premium and intrinsic value associated with weather derivatives are excluded from the net amounts recognized in the balance sheets. However, in 2024, there is a slight increase in specificity, as the exclusion of weather derivative values is mentioned in the context of both current and deferred regulatory assets and liabilities, suggesting a more detailed breakdown of immaterial items. Overall, the materiality threshold for weather derivatives has remained low and consistent across the two periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 122,
          "pages": [
            120,
            121,
            122,
            123,
            124
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 285,
          "pages": [
            283,
            284,
            285,
            286,
            287
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55373,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14083,
        "completion_tokens": 206,
        "total_tokens": 14289
      }
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "Between 2023 and 2024, Biktarvy's regulatory and market positioning evolved through an expanded FDA-approved indication to treat people with HIV who have suppressed viral loads and known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the label was updated with new safety and efficacy data supporting its use in pregnant individuals with HIV-1. These updates reinforced Biktarvy's role as a versatile and reliable treatment option in managing HIV, particularly in complex patient scenarios.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59106,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14988,
        "completion_tokens": 132,
        "total_tokens": 15120
      }
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "AMT's utilization of the 2021 Multicurrency Credit Facility changed significantly between 2022 and 2023. In 2023, AMT borrowed an aggregate of $3.0 billion and repaid $6.1 billion, including 842.6 million EUR ($919.1 million), under the facility, primarily to repay existing indebtedness and for general corporate purposes. Additionally, the facility was amended in June 2023, extending its maturity date to July 1, 2026, and replacing the LIBOR pricing benchmark with an Adjusted Term SOFR benchmark.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52247,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13287,
        "completion_tokens": 125,
        "total_tokens": 13412
      }
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "Between 2023 and 2024, Google Ad Manager remained a key platform for advertising inventory purchases, but there is no specific mention of a strategic evolution in its role within Alphabet's revenue recognition model. The integration with revenue reporting models continued to reflect gross reporting for ads placed on Google Network properties, where Alphabet acts as the principal, recognizing revenues billed to customers and recording payments to partners as cost of revenues. No material changes in this approach were disclosed in the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51786,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13180,
        "completion_tokens": 138,
        "total_tokens": 13318
      }
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "Between 2023 and 2024, UPS's financial exposure and strategic positioning regarding Roadie evolved as follows: In 2023, UPS recorded a $56 million goodwill impairment charge for Roadie, indicating a decline in its fair value relative to carrying value. By 2024, Roadie was among three reporting units (alongside Global Freight Forwarding and Global Logistics and Distribution) identified as having limited excess fair value over carrying value, exposing it to a higher risk of future impairment. Although no impairment was recorded in 2024, the company noted that a 100 basis point increase in cost of capital or a 10% reduction in projected cash flows could reasonably lead to impairment for these units. This reflects a continued strategic focus on monitoring Roadie's performance and financial risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35964,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9219,
        "completion_tokens": 200,
        "total_tokens": 9420
      }
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "Linde's global helium operations, which are part of the \"Other\" segment, experienced a decline in volumes in 2024 compared to 2023, contributing to a $32 million decrease in sales for the segment. Despite this, operating profit in the Other segment increased by $19 million, or 44%, largely due to insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher helium-related costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38083,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9745,
        "completion_tokens": 103,
        "total_tokens": 9848
      }
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The total value of loans covered under long-term credit protection agreements with FNMA and FHLMC decreased from $8.7 billion in 2023 to $8.0 billion in 2024. This reduction indicates that the Corporation's credit risk exposure on residential mortgage loans has slightly decreased, as fewer loans are now protected under these agreements. However, since all these loans are individually insured, the Corporation does not record an allowance for credit losses related to them, suggesting continued low credit risk for these specific loans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 112686,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 28416,
        "completion_tokens": 134,
        "total_tokens": 28551
      }
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "Between 2023 and 2024, Adobe Firefly evolved as a core component of Adobe's generative AI strategy, enhancing competitive differentiation by offering natively integrated, commercially safe AI capabilities across Creative Cloud, Adobe Express, and other tools. In 2023, Firefly was positioned as a standalone web app with AI-assisted creative expression, while in 2024, it expanded into enterprise offerings with intellectual property indemnification and deeper integration into workflows. Regulatory risks increased due to evolving AI regulations, such as the EU AI Act, which could impose compliance costs, alter monetization strategies, and require costly changes to Firefly's deployment and governance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50590,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12874,
        "completion_tokens": 176,
        "total_tokens": 13050
      }
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "Between 2023 and 2024, Trodelvy's financial performance and regulatory trajectory showed notable progress. In 2023, Trodelvy's product sales increased by 56% to $1.1 billion compared to 2022, driven by higher demand in new and existing geographies. By 2024, the drug received Breakthrough Therapy designation from the FDA for the treatment of adult patients with extensive-stage small cell lung cancer whose disease has progressed on or after platinum-based chemotherapy, marking a significant regulatory milestone. This designation aims to expedite development and regulatory review, reflecting the potential of Trodelvy to improve clinical outcomes for this serious condition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61855,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15672,
        "completion_tokens": 169,
        "total_tokens": 15842
      }
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "Chevron's financial involvement in Angola LNG, as disclosed in its equity investments, decreased from 2022 to 2024. In 2022, Chevron reported equity in earnings from Angola LNG of $1,857 million, which dropped significantly to $405 million in 2024. Additionally, the carrying value of Chevron's investment in Angola LNG was $1,665 million in 2024, down from $1,762 million in 2023, indicating a reduction in its financial commitment. These figures suggest a strategic shift or potential challenges in the performance of the Angola LNG project during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58256,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14797,
        "completion_tokens": 140,
        "total_tokens": 14937
      }
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "From 2023 to 2024, the value of META's Fixed-Rate Senior Unsecured Notes increased significantly from $18.50 billion to $29.0 billion. This increase was primarily driven by the issuance of $10.50 billion in new Notes in August 2024. The Notes have varying maturity dates from 2027 to 2064, with stated interest rates ranging from 4.30% to 5.55% and effective interest rates from 4.42% to 5.60%. The total fair value of the Notes also rose from $18.48 billion in 2023 to $27.83 billion in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45691,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11635,
        "completion_tokens": 123,
        "total_tokens": 11759
      }
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "LIN's financial exposure to helium as a raw material increased from 2023 to 2024, as reflected in the shift from categorizing helium as a \"supply\" to a \"dependency.\" In 2023, raw materials and supplies were valued at $614 million, while in 2024, this figure decreased to $529 million. This decline in raw material inventory, combined with the increased classification of helium as a critical dependency, suggests a higher reliance on helium sourcing, potentially leading to greater exposure to price volatility and supply chain disruptions. The change indicates a strategic or operational shift in helium sourcing or cost management practices, emphasizing its critical role in LIN's operations in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 29515,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7613,
        "completion_tokens": 175,
        "total_tokens": 7788
      }
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "Between 2022 and 2023, PayPal reduced the amount of European customer balances approved for credit activities from $3.8 billion to $3.0 billion. This represents a decrease of $0.8 billion, or a 21.1% reduction.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44345,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11318,
        "completion_tokens": 52,
        "total_tokens": 11370
      }
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Starbucks' exposure to foreign currency - other instruments decreased significantly between 2023 and 2024 in terms of fair value. As of September 29, 2024, the fair value of foreign currency - other derivative assets was $1.9 million, down from $32.0 million as of October 1, 2023. Additionally, the fair value of related derivative liabilities for foreign currency - other was $4.7 million in 2024, compared to $2.0 million in 2023. The expected reclassification impact on earnings for foreign currency - other was $9.5 million in 2024, compared to $39.6 million in 2023, indicating a notable reduction in the anticipated impact on earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 54970,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13975,
        "completion_tokens": 160,
        "total_tokens": 14135
      }
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives for Alabama Power increased from $15 million to $15 million (no change), while for Georgia Power, it increased from $13 million to $13 million (also no change). However, the directional change in their asset versus liability positions shows that Alabama Power's energy-related derivative liabilities increased from $11 million in 2022 to $110 million in 2023, and Georgia Power's liabilities increased from $8 million in 2022 to $124 million in 2023. This indicates a significant shift from asset positions to liability positions for both companies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 281,
          "pages": [
            279,
            280,
            281,
            282,
            283
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83261,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21050,
        "completion_tokens": 153,
        "total_tokens": 21203
      }
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "The asset allocation strategy for the U.S. Retiree Health Care Plan shifted from 2022 to 2023, with the percentage of fixed income securities increasing from 65% to 80%, while the percentage of equity securities decreased from 35% to 20%. This change aligns with the plan's target allocation ranges, which emphasize a higher proportion of fixed income to better match the interest rate sensitivity of liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55092,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14009,
        "completion_tokens": 103,
        "total_tokens": 14112
      }
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "Between 2022 and 2023, Trodelvy received new regulatory approvals for additional indications. In 2023, the FDA approved Trodelvy for the treatment of adult patients with unresectable locally advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. Additionally, the European Commission approved Trodelvy as monotherapy for the treatment of adult patients with unresectable or metastatic HR+/HER2- breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the advanced setting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58566,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14856,
        "completion_tokens": 177,
        "total_tokens": 15034
      }
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "Between 2023 and 2024, Meta's disclosure regarding user perception as a risk factor evolved to emphasize the impact of regulatory and policy changes on user behavior and engagement. In 2023, the focus was on factors like geopolitical events, user sentiment, and platform integrity affecting user growth and engagement. By 2024, Meta highlighted more specific regulatory-driven risks, such as limitations on data use for advertising due to laws like the GDPR and DMA, and the introduction of user alternatives like \"subscription for no ads\" in Europe. Additionally, 2024 emphasized the potential for user disengagement due to changes in platform policies and enforcement decisions, including those from the Oversight Board, reflecting a broader concern about compliance and its indirect impact on user perception and business operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47394,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12084,
        "completion_tokens": 209,
        "total_tokens": 12293
      }
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "The notional amount of Lockheed Martin's variable interest rate swaps increased from $500 million in 2021 to $1.3 billion in 2024. This increase indicates that the company has expanded its use of interest rate derivatives to hedge against interest rate fluctuations, reflecting a proactive approach to managing its interest rate risk exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41759,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10671,
        "completion_tokens": 85,
        "total_tokens": 10757
      }
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "PayPal's allowance for transaction losses slightly decreased between 2022 and 2023, from $66 million to $64 million. The allowance for negative customer balances remained relatively stable, at $218 million in 2023 compared to $212 million in 2022. The provision for transaction losses increased slightly from $1,170 million in 2022 to $1,192 million in 2023, while realized losses decreased from $1,417 million to $1,313 million. This suggests a more cautious approach in 2023, with higher provisions set aside for potential transaction losses, potentially reflecting increased risk management efforts or changes in fraud patterns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50181,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12770,
        "completion_tokens": 157,
        "total_tokens": 12928
      }
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "Starbucks' derivative positions for foreign currency - other changed from fiscal year 2023 to 2024 as follows: derivative assets decreased from $32.0 million to $1.9 million (current assets) and from $22.9 million to $1.7 million (long-term assets), while derivative liabilities increased from $2.0 million to $4.7 million (current liabilities) and from $- to $4.1 million (long-term liabilities). The overall magnitude of the change on the balance sheet was a reduction in net derivative positions for foreign currency - other by approximately $50.3 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 63210,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16037,
        "completion_tokens": 139,
        "total_tokens": 16177
      }
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "From 2022 to 2023, the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions shifted from a gain of $37 million in 2022 to a loss of $44 million in 2023 for Southern Company and Southern Company Gas. This indicates a negative change in the effectiveness or market conditions of these hedging positions during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 295,
          "pages": [
            293,
            294,
            295,
            296,
            297
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64328,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16301,
        "completion_tokens": 90,
        "total_tokens": 16392
      }
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "Between the 2023 and 2024 10-K filings, Walmart's Deferred Compensation Matching Plan was amended and restated, with the effective date of the amendment changing from February 1, 2023, in 2023 to November 8, 2023, in 2024. Additionally, in 2024, the plan was documented and incorporated by reference to the 2024 10-K filing, indicating updated documentation status.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 71125,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18012,
        "completion_tokens": 91,
        "total_tokens": 18103
      }
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "Between 2023 and 2024, the disclosure and treatment of LTIP Units remained consistent in terms of their dilutive effect, as no securities had a material dilutive impact in either year. Both years stated that potentially dilutive securities included LTIP Units, but no adjustments were made to net income or weighted average shares/outstanding units due to the absence of material dilution. Regarding accrual policy, the company continued to accrue dividends or distributions when they were declared in both periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49211,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12526,
        "completion_tokens": 128,
        "total_tokens": 12655
      }
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved significantly between 2023 and 2024 in response to regulatory actions and decisions. In 2023, the EU-U.S. DPF was established as a replacement for the invalidated Privacy Shield, with the European Commission issuing an adequacy decision in July 2023. Meta implemented steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a fine and orders to suspend data transfers. By 2024, Meta continued to engage with regulators to ensure compliance with the EU-U.S. DPF and the GDPR, including addressing concerns around its \"subscription for no ads\" model under the Digital Markets Act (DMA). The company also faced formal proceedings from the European Commission regarding this model, indicating an ongoing effort to adapt its compliance practices to evolving regulatory expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56145,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14264,
        "completion_tokens": 226,
        "total_tokens": 14491
      }
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "Between 2023 and 2024, Linde has increased its emphasis on green hydrogen production by expanding its technologies for renewable hydrogen generation. In 2023, Linde described green hydrogen as being produced by electrolysis using renewable energy or from the steam methane reformation of biomethane. By 2024, the company highlighted its state-of-the-art sustainable technologies in its Engineering business, which support the transition to clean energy and cover the entire hydrogen value chain, including production, liquefaction, storage, and distribution. This evolution reflects a stronger focus on renewable energy sources and the broader adoption of green hydrogen as part of Linde's clean energy strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45130,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11506,
        "completion_tokens": 178,
        "total_tokens": 11684
      }
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company completed the sale of Sequent to Williams Field Services Group on July 1, 2021, resulting in a pre-tax gain of approximately $121 million ($92 million after tax). The sale removed Sequent as a reportable segment under Southern Company Gas, as noted in the 2023 10-K. Financially, the transaction also led to $85 million in additional tax expense due to changes in state apportionment rates. Thus, between 2022 and 2023, Southern Company no longer maintained a relationship with Sequent, and the financial impact was fully realized in 2021.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 302,
          "pages": [
            300,
            301,
            302,
            303,
            304
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40059,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10234,
        "completion_tokens": 139,
        "total_tokens": 10373
      }
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Between 2023 and 2024, Walmart's relationship with the Allswell brand remained consistent within its private brand portfolio, as Allswell was listed among the private brands marketed by Walmart U.S. in both years. In 2023, Allswell was included in the list of private brands such as \"Equate,\" \"George,\" and \"Great Value,\" and in 2024, it was similarly mentioned without any indication of removal or reduced emphasis. This consistency suggests that Allswell continues to be a strategic component of Walmart's private label strategy, aimed at offering high-quality, low-priced products to customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48445,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12340,
        "completion_tokens": 149,
        "total_tokens": 12489
      }
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "The strategic importance of Embedded Processing products evolved from 2022 to 2023 as they maintained growth amid declining Analog revenue. In 2023, Embedded Processing revenue increased by 3% to $3,368 million compared to $3,261 million in 2022, driven by a favorable product mix. However, operating profit declined by 20% to $1,008 million due to higher manufacturing costs. Despite the profit margin contraction, the segment's resilience and growth contrasted with the 15% revenue decline in the Analog segment, highlighting its growing strategic relevance in stabilizing TI's overall performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42119,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10751,
        "completion_tokens": 150,
        "total_tokens": 10901
      }
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "Chevron's involvement in Angola LNG has seen a notable shift in equity earnings, decreasing from $1,857 million in 2022 to $405 million in 2024. This decline suggests a strategic recalibration or operational challenges in the Angola LNG project during this period. Despite this, Chevron maintains a 36.4% stake in Angola LNG, which processes and liquefies natural gas for international markets, indicating its continued commitment to the LNG sector. The reduction in earnings may reflect broader market dynamics, project-specific issues, or adjustments in Chevron's portfolio to align with evolving energy strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63907,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16197,
        "completion_tokens": 154,
        "total_tokens": 16351
      }
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "The CH-53K program has seen a notable production ramp-up within Lockheed Martin's RMS division, contributing to higher product sales in 2024 compared to 2023. This increase indicates that the CH-53K is becoming a more significant contributor to RMS's revenue and is likely playing a more prominent role in the division's portfolio, particularly as it offsets declines in other programs like the VH-92A. The program's growth reflects its importance in supporting military heavy-lift helicopter needs and aligning with international and domestic demand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46467,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11848,
        "completion_tokens": 137,
        "total_tokens": 11986
      }
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "Between 2022 and 2023, PayPal updated its expected credit loss models for revolving consumer receivables in the second quarter of 2023. The most notable evolution was the exclusion of unemployment rates as a macroeconomic factor for revolving credit products after the first quarter of 2023, while continuing to incorporate factors like household disposable income and retail e-commerce sales. Additionally, the reasonable and supportable forecast period for revolving consumer products remained consistent at approximately 5 years in 2023, compared to 2 years in 2022. These changes reflect a more refined approach to modeling macroeconomic impacts on credit losses for revolving consumer credit.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 49526,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12599,
        "completion_tokens": 174,
        "total_tokens": 12773
      }
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks' foreign currency debt-related gains or losses included in AOCI decreased from a net gain of $140.2 million in 2023 to $135.2 million in 2024, indicating a slight reduction in the positive impact of foreign currency fluctuations on its debt. This suggests that while the company still benefits from foreign currency movements, the magnitude of these benefits has slightly diminished, reflecting potential stabilization or reduced exposure in its foreign currency-denominated debt positions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50833,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12942,
        "completion_tokens": 125,
        "total_tokens": 13067
      }
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "Between 2022 and 2023, the fair value of energy-related derivatives for Alabama Power increased from $15 million to $15 million (no change), while for Georgia Power, it increased from $13 million to $13 million (also no change). Despite no change in individual values, the combined liabilities related to energy-related derivatives for both companies increased from $210 million in 2022 to $234 million in 2023, indicating an overall upward trend in their combined liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 327,
          "pages": [
            325,
            326,
            327,
            328,
            329
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 281,
          "pages": [
            279,
            280,
            281,
            282,
            283
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67770,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17180,
        "completion_tokens": 119,
        "total_tokens": 17300
      }
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "Walmart acquired Alert Innovation in fiscal 2023 for $0.4 billion, increasing its ownership to approximately 100%. However, the entity was subsequently sold and deconsolidated in fiscal 2025, indicating that Walmart disposed of its ownership in Alert Innovation by the end of fiscal 2024 or early fiscal 2025.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60204,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15280,
        "completion_tokens": 77,
        "total_tokens": 15357
      }
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "Between 2022 and 2023, the regulatory approval status of Trodelvy expanded, with the FDA approving it for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting in 2022. In 2023, Trodelvy's sales increased by 56% to $1.1 billion, indicating strong demand in new and existing geographies. This growth and expansion of approvals reflect Gilead's oncology strategy of expanding its commercial portfolio and clinical pipeline to drive future growth, emphasizing innovation and the development of transformative therapies to address unmet medical needs in oncology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53076,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13489,
        "completion_tokens": 181,
        "total_tokens": 13670
      }
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's financial relationship with ABG evolved significantly through capital transactions. In 2023, Simon recognized multiple non-cash gains due to dilutions in its ownership stake in ABG, including a $157.1 million pre-tax gain from selling a portion of its interest and a $10.3 million gain from a deemed disposal due to ABG's capital transaction. By 2024, Simon fully exited its remaining interest in ABG, selling it for $1.2 billion and recognizing a substantial pre-tax gain of $414.8 million. These transactions reflect a strategic shift by Simon to divest its stake in ABG, optimizing its portfolio and capital allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50180,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12770,
        "completion_tokens": 167,
        "total_tokens": 12937
      }
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "Chevron's relationship with Chevron Phillips Chemical Company LLC (CPChem) evolved in terms of financial reporting and investment value between 2022 and 2024, as reflected in the provided data. In 2022, Chevron's investment in CPChem was reported at $7,765 million, with equity in earnings of $608 million. By 2024, the investment value increased to $8,571 million, and equity in earnings rose to $903 million, indicating a stronger financial performance and higher returns from the joint venture. Additionally, Chevron provided a loan of $669 million to CPChem to support the Golden Triangle Polymers Project, highlighting Chevron's ongoing commitment to and investment in CPChem's growth initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48099,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12251,
        "completion_tokens": 175,
        "total_tokens": 12426
      }
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "Between the end of 2023 and the end of 2024, Meta completed its 2022 Facilities Consolidation Strategy, which involved subleasing, early termination, or abandonment of office buildings. In 2023, the company had incurred $2,506 million in pre-tax charges related to facilities consolidation, and by 2024, the total restructuring charges under this strategy were $389 million, all related to facilities consolidation. This indicates that the financial impact of the strategy significantly decreased in 2024 as the initiatives were largely completed.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40316,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10299,
        "completion_tokens": 136,
        "total_tokens": 10436
      }
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs from 2022 to 2024 has shown a continued strategic focus on developing and delivering advanced hypersonic strike weapons for the U.S. military. In 2022, the company was already engaged in multiple hypersonics programs with the U.S. Air Force and Army. By 2024, this focus remained strong, with hypersonics programs explicitly listed under both the Missiles and Fire Control (MFC) and Space segments, indicating expanded collaboration with the U.S. Army and Navy. This evolution reflects the company's alignment with national defense priorities and its commitment to advancing next-generation capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 49609,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12622,
        "completion_tokens": 164,
        "total_tokens": 12786
      }
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "From 2022 to 2023, Southern Company's treatment and disclosure of energy-related derivatives showed a shift in both designation and financial impact. In 2023, the company reported a pre-tax loss of $59 million from energy-related derivatives not designated as hedging instruments, primarily impacting natural gas revenues and costs, compared to a $76 million loss in 2022. Additionally, the cumulative fair value hedging adjustments for long-term debt increased slightly for Southern Company, from $282 million in 2022 to $235 million in 2023, indicating a reduction in the hedging impact on debt valuation. These changes reflect adjustments in market conditions and hedging strategies over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 324,
          "pages": [
            322,
            323,
            324,
            325,
            326
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 295,
          "pages": [
            293,
            294,
            295,
            296,
            297
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65744,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16665,
        "completion_tokens": 175,
        "total_tokens": 16840
      }
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "Between 2022 and 2023, Gilead's intellectual property strategy regarding Truvada evolved as the company continued to navigate the loss of exclusivity for Truvada in the United States, which occurred in October 2020. In 2022, the focus shifted to managing the impact of generic competition and mitigating its effects on revenue. By 2023, Gilead's patent disclosures emphasized ongoing efforts to strengthen and diversify its portfolio, including expanding into new therapeutic areas and leveraging strategic collaborations. While Truvada's patent protections had expired, Gilead shifted its emphasis to other key products and innovations, such as lenacapavir and expanded indications for existing therapies, to drive future growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53511,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13596,
        "completion_tokens": 182,
        "total_tokens": 13779
      }
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "Between 2022 and 2024, SPG's use of the Supplemental Facility showed a pattern of borrowing and repayment activities. In 2022, SPG repaid $750 million under the Supplemental Facility. In 2023, SPG borrowed €750 million under the Supplemental Facility and later repaid it in November 2023. In 2024, SPG issued $1.0 billion in senior unsecured notes and used the proceeds to repay $900 million in maturing notes. These activities indicate that SPG used the Supplemental Facility for both short-term liquidity needs and long-term refinancing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51168,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13010,
        "completion_tokens": 134,
        "total_tokens": 13145
      }
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "From 2022 to 2024, MetLife has maintained a strong focus on liquidity and capital management, with cash buffer needs playing a central role in its strategy. In 2022, MetLife reported substantial short-term liquidity of $12.4 billion and liquid assets of $223.0 billion, emphasizing its ability to meet obligations and manage risks through diversified funding sources and stress testing. By 2024, the company continued to prioritize liquidity, maintaining robust short-term liquidity and liquid assets, while also highlighting the importance of cash buffers in supporting capital allocation decisions, regulatory compliance, and risk mitigation. The evolution reflects a strategic emphasis on preserving financial flexibility amid market uncertainties and regulatory demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 122,
          "pages": [
            120,
            121,
            122,
            123,
            124
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52299,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13309,
        "completion_tokens": 193,
        "total_tokens": 13502
      }
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Between 2022 and 2023, Starbucks' exposure to 'Foreign currency - other' derivatives showed notable changes in asset and liability classifications. In 2022, derivative assets related to 'Foreign currency - other' were split between $39.9 million in prepaid expenses and other current assets and $33.5 million in other long-term assets. By 2023, the asset classification shifted to $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets, indicating a significant reduction in overall exposure. On the liability side, in 2022, $0.3 million was classified in accrued liabilities and $- in other long-term liabilities, while in 2023, $4.7 million was in accrued liabilities and $4.1 million in other long-term liabilities, showing an increase in liabilities associated with these derivatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 71340,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18059,
        "completion_tokens": 208,
        "total_tokens": 18268
      }
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "The Coca-Cola Company's financial stake in Coca-Cola FEMSA decreased from 2023 to 2024, with the carrying value of the investment dropping from $1,786 million to $1,786 million in 2023 to $1,786 million to $1,786 million in 2024, as indicated by the difference between fair value and carrying value in Note 6. The strategic engagement remains strong, as Coca-Cola FEMSA is one of the Company's key bottling partners, operating across Latin America and contributing significantly to the Coca-Cola system's unit case volume.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55069,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13990,
        "completion_tokens": 130,
        "total_tokens": 14120
      }
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "Between 2022 and 2024, Intel has positioned FPGAs as a key component within its broader strategy for programmable and adaptable computing solutions. In 2022, FPGAs were highlighted as part of \"adjacent products,\" which included offerings such as modems, Ethernet, and silicon photonics, aimed at complementing platform products to deliver comprehensive solutions. By 2024, FPGAs were integrated into the broader xPU category, which encompasses CPUs, GPUs, AI accelerators, and FPGAs, reflecting their role in addressing diverse computing architectures. Intel's focus on FPGAs has evolved to emphasize their programmability and adaptability in applications such as data centers, AI, and network infrastructure, aligning with the company's strategic shift toward a more diversified and performance-driven product portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 70984,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17976,
        "completion_tokens": 205,
        "total_tokens": 18181
      }
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "From 2022 to 2023, ConocoPhillips' financial activity in the Lower 48 region showed significant changes in asset acquisition and depreciation, depletion, and amortization (DD&A) expenses. Capital expenditures for the Lower 48 increased from $5,630 million in 2022 to $6,487 million in 2023, reflecting higher investment in asset acquisition and development. Additionally, DD&A expenses for the Lower 48 rose from $4,854 million in 2022 to $5,729 million in 2023, indicating increased asset utilization and depletion of reserves in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 164,
          "pages": [
            162,
            163,
            164,
            165,
            166
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 84031,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21243,
        "completion_tokens": 135,
        "total_tokens": 21379
      }
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Between 2022 and 2024, Emerson's ownership in AspenTech increased significantly. In 2022, Emerson owned 55% of AspenTech on a fully diluted basis after acquiring Heritage AspenTech. By 2024, Emerson's ownership had increased to approximately 57%, and on November 5, 2024, Emerson announced a proposal to acquire the remaining shares of AspenTech for $240 per share, which would make AspenTech a wholly owned subsidiary. \n\nFinancially, the inclusion of AspenTech positively impacted gross margins. In 2023, the Heritage AspenTech acquisition contributed 0.6 percentage points to the gross margin increase. By 2024, while acquisition-related inventory step-up amortization negatively impacted margins by 1.3 percentage points, the Test & Measurement acquisition and higher pricing partially offset this, leading to an overall gross margin of 50.8%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41001,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10480,
        "completion_tokens": 211,
        "total_tokens": 10691
      }
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "Between 2022 and 2024, the treatment and availability of shares under the 2015 Director Stock Plan evolved in terms of share recovery and issuance mechanics as follows: The number of shares remaining available for future issuance under the 2015 Director Stock Plan decreased from 34,073,114 in 2022 to 30,660,961 in 2024. This reduction reflects the cumulative effect of shares covered by new awards and imputed reinvested dividends, which outpaced share recoveries. Shares recovered in 2024 continued to follow the same mechanics as prior years, becoming available for reissuance upon events such as award forfeitures, cash settlements, or tax withholding through share tenders. The issuance mechanics remained consistent, with each share issued under the 2015 Director Stock Plan reducing the available share pool by one.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 335,
          "pages": [
            333,
            334,
            335,
            336,
            337
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41299,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10555,
        "completion_tokens": 205,
        "total_tokens": 10761
      }
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "Starbucks' relationship with the Global Coffee Alliance (GCA) showed increased strategic emphasis and revenue contribution from fiscal year 2022 to 2023. In fiscal 2022, the GCA contributed to a $216 million increase in \"Other revenues,\" driven by higher product sales and royalty revenue. By fiscal 2023, the GCA was highlighted as a key component of Starbucks' growth strategy, with continued expansion in global ready-to-drink products and licensed store support, indicating a stronger strategic focus. While specific 2023 revenue figures for the GCA are not provided, the emphasis on innovation and partnership suggests a growing role in Starbucks' financial performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 36951,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9463,
        "completion_tokens": 168,
        "total_tokens": 9632
      }
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "Between 2022 and 2023, NEE's financial stake in the Mountain Valley Pipeline (MVP) significantly declined, as it completely wrote off its investment in 2022. In 2023, NEE's equity method investments totaled $6,156 million, and the difference between the investment carrying amount and underlying equity in net assets was $(1,205) million, with a large portion attributed to the MVP. This indicates a strategic shift away from high-risk, non-core infrastructure projects, focusing instead on more stable and regulated energy assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62514,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15854,
        "completion_tokens": 132,
        "total_tokens": 15987
      }
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Medtronic's InterStim Therapy product line has evolved by expanding its neurostimulator offerings and therapeutic applications. In 2022, the recently launched InterStim Micro and InterStim X neurostimulators were highlighted, with the InterStim II being recharge-free. By 2024, the product line included the InterStim X and InterStim II recharge-free neurostimulators, as well as the InterStim Micro rechargeable neurostimulator, targeting overactive bladder, urinary retention, and chronic fecal incontinence. Additionally, the therapeutic indications remained focused on pelvic health, with continued growth and acceptance of these neurostimulation therapies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41100,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10495,
        "completion_tokens": 171,
        "total_tokens": 10666
      }
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolved significantly from 2022 to 2024. In 2022, SPG increased its ownership in ABG by contributing interests in the licensing ventures of Forever 21 and Brooks Brothers, and by acquiring additional interests in ABG through capital transactions. By 2023, SPG continued to adjust its stake, with ownership diluting slightly to approximately 11.7% due to ABG capital transactions, and recognized non-cash gains on deemed disposals. In 2024, SPG fully exited its investment by selling all remaining interests in ABG for $1.2 billion, resulting in a pretax gain of $414.8 million. This marked the end of SPG's strategic equity relationship with ABG.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50280,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12787,
        "completion_tokens": 186,
        "total_tokens": 12973
      }
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses for the Lower 48 region increased significantly from 2021 to 2023. In 2021, the DD&A expense was $4,067 million, rising to $4,854 million in 2022, and further to $5,729 million in 2023. This upward trend reflects increased investment activity and higher production volumes in the region during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 158,
          "pages": [
            156,
            157,
            158,
            159,
            160
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 73297,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18553,
        "completion_tokens": 95,
        "total_tokens": 18648
      }
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "Verizon's treatment and valuation approach for international bonds in their pension plans remained consistent from 2023 to 2024, with both years categorizing international bonds as Level 2 assets based on matrix pricing and inputs from third-party valuation sources. In 2023, international bonds were valued at $341 million, and in 2024, they were valued at $113 million, indicating a reduction in holdings but no change in valuation methodology.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51724,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13149,
        "completion_tokens": 111,
        "total_tokens": 13260
      }
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "Between 2022 and 2024, Emerson's relationship with AspenTech evolved significantly. In May 2022, Emerson acquired Heritage AspenTech, increasing its stake and integrating AspenTech's industrial software businesses. By 2024, Emerson owned approximately 57% of AspenTech's outstanding shares and proposed to acquire the remaining shares for $240 per share, signaling full operational and financial integration. This progression reflects a shift from a partial ownership and collaborative structure to a near-complete acquisition, aligning AspenTech more closely with Emerson's strategic goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39019,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9975,
        "completion_tokens": 147,
        "total_tokens": 10122
      }
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "Between 2022 and 2023, Starbucks' position in interest rate swaps shifted from being classified as derivative assets and liabilities to primarily liabilities. In 2022, interest rate swaps were listed as $34.0 million in other long-term liabilities and $- in other long-term assets. By 2023, the interest rate swaps were reported as $19.2 million in other long-term liabilities and $- in other long-term assets, indicating a decrease in the asset position and a continued liability classification. This suggests a reduction in the fair value of the swaps and a shift in their net position towards liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 71340,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18058,
        "completion_tokens": 152,
        "total_tokens": 18210
      }
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolved significantly from 2022 to 2023. In 2022, legal and regulatory challenges led to an impairment charge of approximately $0.8 billion, fully writing off the equity method investment of $0.6 billion and recording a $0.2 billion liability for future ARO costs. By 2023, NEER's involvement included equity contributions for the pipeline's construction, with $1,060 million allocated in 2024 for the Mountain Valley Pipeline under capital expenditures. This indicates a shift from impairment and write-offs in 2022 to renewed financial commitments in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69731,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17650,
        "completion_tokens": 163,
        "total_tokens": 17813
      }
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company, which reinsures group annuity insurance contracts covering obligations of European and Canadian pension plans, decreased from $1,643 million as of December 31, 2023, to $1,883 million as of December 31, 2024. This indicates an increase of $240 million in the value of these investments over the one-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56208,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14282,
        "completion_tokens": 104,
        "total_tokens": 14387
      }
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "Intel's approach to the Intel 4 process node evolved significantly from 2022 to 2024. In 2022, Intel 4 was in development as its first EUV lithography node, with a focus on achieving significant density scaling and performance-per-watt improvements. By 2024, Intel 4 had transitioned to high-volume manufacturing, with the Intel Core Ultra processor as its first high-volume client product, beginning shipments in 2023 and ramping production in Ireland. Intel 4 became a key part of Intel's product roadmap, expected to represent an increasing share of processor production in 2025 as the company shifted focus to more advanced nodes like Intel 18A.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43664,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11145,
        "completion_tokens": 162,
        "total_tokens": 11307
      }
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "Between 2022 and 2024, Emerson's strategic relationship with AspenTech evolved significantly in terms of ownership and financial integration. In May 2022, Emerson contributed two of its industrial software businesses to AspenTech and received approximately $6.0 billion in cash, resulting in Emerson owning 55% of AspenTech's outstanding shares. By November 2024, Emerson proposed to acquire the remaining 43% of AspenTech not already owned by Emerson for $240 per share, increasing its ownership to 100% and fully integrating AspenTech into its portfolio. Financially, AspenTech's performance and transactions, such as the Micromine acquisition and foreign currency hedges, were reflected in Emerson's financial statements, and Emerson's 2024 financial results included the impact of its proposed full acquisition of AspenTech.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43284,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11043,
        "completion_tokens": 207,
        "total_tokens": 11250
      }
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "From 2022 to 2024, Intel's approach to the Intel 4 process node has evolved significantly in terms of manufacturing readiness and performance improvements. In 2022, Intel introduced the Intel 4 process node as part of its updated naming structure, marking it as its first EUV lithography node. By 2024, Intel 4 had moved to high-volume manufacturing in Ireland and was used for the Intel Core Ultra processor, which began shipping in 2023. The node offers approximately 20% performance-per-watt improvement over Intel 7 and is expected to represent an increasing portion of Intel's processor production in 2025. This evolution reflects Intel's progress in scaling and adopting advanced manufacturing technologies to enhance product performance and efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58559,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14865,
        "completion_tokens": 189,
        "total_tokens": 15055
      }
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "The role and positioning of InterStim Micro within MDT's Pelvic Health therapies remained consistent between 2022 and 2024, as it continued to be highlighted as a key product for treating overactive bladder, non-obstructive urinary retention, and chronic fecal incontinence. In both years, it was mentioned as part of the Pelvic Health portfolio under the Specialty Therapies division, with a focus on neurostimulation therapies. In 2024, it was specifically noted as a rechargeable neurostimulator contributing to the growth of Pelvic Health therapies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39367,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10055,
        "completion_tokens": 138,
        "total_tokens": 10193
      }
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The disclosure around the dilutive effect of LTIP Units in Simon Property Group's 10-K filings shows consistent reporting across the periods reviewed. For 2022, 2023, and 2024 (as per the 2024 filing), the company explicitly states that no securities, including LTIP units, had a material dilutive effect. This indicates that the potential dilutive impact of LTIP units remained immaterial across these reporting periods, with no significant changes in the materiality of their effect on earnings per share or unit calculations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51175,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13019,
        "completion_tokens": 132,
        "total_tokens": 13151
      }
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "From 2022 to 2024, MetLife's approach to managing cash buffer needs in relation to stock repurchases has emphasized maintaining sufficient liquidity to meet regulatory and operational requirements while balancing shareholder returns. In 2022, the company had a $3.0 billion repurchase authorization with $1.5 billion remaining as of December 31, 2021. By 2024, MetLife continued to highlight the importance of liquidity buffers, noting that cash buffer needs could limit the capital available for repurchases. The company also emphasized that regulatory restrictions, capital requirements, and market conditions could impact its ability to repurchase shares, reflecting a more cautious approach to ensure financial flexibility and compliance with evolving regulatory expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 39487,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10107,
        "completion_tokens": 195,
        "total_tokens": 10302
      }
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "From fiscal year 2022 to 2023, Starbucks' foreign currency - other derivative positions shifted significantly in balance sheet classifications. In 2022, foreign currency - other derivative assets were $39.9 million in \"prepaid expenses and other current assets\" and $33.5 million in \"other long-term assets,\" while derivative liabilities were $0.3 million in \"accrued liabilities\" and $- in \"other long-term liabilities.\" By 2023, derivative assets were $1.9 million in \"prepaid expenses and other current assets\" and $1.7 million in \"other long-term assets,\" with derivative liabilities increasing to $4.7 million in \"accrued liabilities\" and $4.1 million in \"other long-term liabilities.\" This indicates a reduction in asset positions and an increase in liability positions, reflecting a net shift in exposure and potential hedging adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66863,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16949,
        "completion_tokens": 211,
        "total_tokens": 17161
      }
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "Procter & Gamble's global cash management strategy has evolved to prioritize liquidity and operational efficiency in response to its restructuring activities and financial performance from fiscal 2022 to 2024. In fiscal 2022, the company focused on managing cash flow amid rising commodity and transportation costs, with operating cash flow at $16.7 billion and adjusted free cash flow at $13.8 billion, despite a 13% decrease compared to the prior year. The company also implemented extended payment terms with suppliers and a Supply Chain Finance program to optimize working capital. \n\nBy fiscal 2024, the company's cash flow improved significantly, with operating cash flow increasing to $19.8 billion and adjusted free cash flow rising to $16.9 billion, a 21% increase from 2023. This improvement was driven by higher net sales, productivity savings, and cost efficiencies from restructuring efforts, including the liquidation of operations in certain Enterprise Markets. The company also incurred $659 million in restructuring costs in 2024, primarily due to foreign currency translation losses and operational optimization. These strategic actions reflect a more agile and cost-focused approach to global cash management, aligning with the company's broader goal of enhancing profitability and shareholder returns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59603,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15131,
        "completion_tokens": 330,
        "total_tokens": 15461
      }
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's positioning and application of Omniverse evolved significantly in terms of integration with enterprise solutions and simulation technologies. In 2022, Omniverse was highlighted as a real-time 3D design collaboration and virtual world simulation platform, primarily used by artists, designers, and creators for industrial applications such as digital twins and autonomous vehicle testing. By 2023, Omniverse had expanded its role as a core component of NVIDIA's enterprise solutions, serving as a development platform and operating system for building virtual world simulation applications. It was increasingly adopted for industrial digitalization, including real-time 3D product configurators and AI-driven autonomous systems, supported by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 40893,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10451,
        "completion_tokens": 213,
        "total_tokens": 10665
      }
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "AMT's financial commitments related to communications sites from 2023 to 2024 show a significant increase in anticipated spending and future obligations. In 2023, the company expected capital expenditures of $1.545 billion to $1.655 billion, including site construction and data center investments. By 2024, this range increased to $1.545 billion to $1.655 billion, with a specific mention of $450 million allocated for data-center assets. Additionally, operating lease obligations as of December 31, 2024, totaled $11.531 billion, with $7.088 billion of these obligations extending beyond 2029. These figures indicate a growing financial commitment to maintaining and expanding communications infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55460,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14089,
        "completion_tokens": 177,
        "total_tokens": 14267
      }
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "Between 2023 and 2024, ExxonMobil's characterization of asset divestitures in relation to strategic objectives remained consistent in stating that assets are divested when they no longer meet strategic objectives or are worth more to others. However, in 2024, there was a slight shift in the language used to describe the proceeds from these transactions. In 2023, the proceeds were described as being combined with operating cash flow to evaluate cash available for investment and shareholder distributions. In 2024, the language emphasized that proceeds from asset sales are part of the Corporation's disciplined review process to ensure alignment with strategic objectives, reinforcing their role in supporting capital allocation decisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43866,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11205,
        "completion_tokens": 185,
        "total_tokens": 11391
      }
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort increased from 2022 to 2023, as the consolidated assets rose from $9.7 billion to $7.8 billion, while consolidated liabilities increased from $8.1 billion to $7.2 billion during the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 54094,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13749,
        "completion_tokens": 62,
        "total_tokens": 13811
      }
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's risk factor related to Customer Demand Volatility has shown a heightened sensitivity to macroeconomic conditions and supply chain disruptions. In 2024, the company emphasized increased volatility due to economic uncertainties, including inflationary pressures, fluctuating commodity prices, and the lingering effects of global pandemics, which have amplified demand unpredictability. Additionally, Caterpillar highlighted that supply chain disruptions—such as material shortages, logistics constraints, and labor inefficiencies—have become more pronounced, further impacting its ability to meet customer demand and affecting financial performance. This evolution reflects a more complex and interconnected risk environment compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49489,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12607,
        "completion_tokens": 194,
        "total_tokens": 12801
      }
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "The fair value of Net derivative assets (liabilities) increased from $19 million in 2021 to $58 million in 2023 and further to $69 million in 2024. The valuation methodology consistently used discounted cash flows with swap rates as the primary unobservable input, with the weighted average swap rate increasing from 2% in 2021 to 4% in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 220,
          "pages": [
            218,
            219,
            220,
            221,
            222
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 217,
          "pages": [
            215,
            216,
            217,
            218,
            219
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 107446,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 27076,
        "completion_tokens": 85,
        "total_tokens": 27161
      }
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "From 2022 to 2023, NVIDIA's GeForce NOW cloud gaming offering evolved to become more integrated within the company's broader GPU and cloud platform ecosystem. In 2022, GeForce NOW was positioned as a cloud gaming service enabling access to PC games on underpowered devices. By 2023, it was highlighted as part of NVIDIA's unified accelerated computing platform, emphasizing its role in delivering interactive graphics applications across devices and reinforcing NVIDIA's leadership in AI-enhanced computer graphics. Additionally, GeForce NOW was linked to NVIDIA's broader cloud infrastructure, including vGPU and Omniverse, showcasing its alignment with enterprise and creative workflows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 40893,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10448,
        "completion_tokens": 172,
        "total_tokens": 10620
      }
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Between 2022 and 2023, Inlyta's revenue increased by 3% globally, with a 4% increase in the U.S. and a 3% increase internationally. The growth in the U.S. was driven by the adoption of combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced renal cell carcinoma (RCC). However, this growth was partially offset by lower volumes and lower net price in certain European markets. Internationally, the growth was primarily due to continued expansion in emerging markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 72873,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18430,
        "completion_tokens": 132,
        "total_tokens": 18562
      }
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "From 2023 to 2024, the amortization assumptions for network location intangibles evolved as the Company extended the estimated useful life of its tower assets from 20 to 30 years, effective January 1, 2024. This change resulted in a corresponding extension of the amortization period for related intangible assets, which are amortized similarly to towers. Additionally, the impairment review process remained consistent, with evaluations conducted on an individual site basis, primarily triggered by factors such as lack of tenant leases or expenses exceeding revenues. No new impairment charges for network location intangibles were reported in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51189,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13026,
        "completion_tokens": 162,
        "total_tokens": 13189
      }
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana has significantly intensified between 2023 and 2024, with the region becoming a core component of its upstream growth portfolio. In 2023, Guyana's production from the Stabroek Block exceeded 390 thousand barrels of oil per day (kbd), with the third FPSO vessel, Prosperity, achieving nameplate capacity ahead of schedule. By 2024, the company anticipates the addition of two more FPSO vessels, Yellowtail and Uaru, each with initial production capacity of approximately 250 kbd, and aims to operate six FPSO vessels on the Block by year-end 2027. This reflects a strategic focus on scaling production in Guyana as a key growth driver, contributing to increased oil-equivalent production and enhancing the Corporation's global supply portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45988,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11721,
        "completion_tokens": 196,
        "total_tokens": 11917
      }
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "Between 2022 and 2023, the X1 platform's integration with third-party streaming services expanded significantly, with the introduction of the Xumo Stream Box (formerly Flex) and enhanced access to services like Peacock, Disney+, and Netflix. This evolution reflects Comcast's strategy to reduce cord-cutting by offering a hybrid viewing experience that combines traditional cable with popular streaming content in a unified interface. Additionally, by integrating these services and earning commission revenue from their sales, Comcast aims to increase average revenue per user (ARPU) by encouraging customers to consume more premium content through bundled offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44533,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11375,
        "completion_tokens": 167,
        "total_tokens": 11542
      }
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "Between 2023 and 2024, Caterpillar's relationship with FG Wilson, in terms of distribution network coverage for electric power generation systems, expanded. In 2023, FG Wilson's network covered 109 countries through 110 distributors, and by 2024, this network had grown to cover 158 countries through 108 distributors. This indicates an increase in the geographic reach of FG Wilson's distribution network despite a slight reduction in the number of distributors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58627,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14881,
        "completion_tokens": 115,
        "total_tokens": 14997
      }
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "Capital One's exposure to securitized debt obligations decreased between 2022 and 2024. As of December 31, 2024, the carrying value of securitized debt obligations was $14.26 billion, compared to $18.04 billion as of December 31, 2023. The fair value of these obligations also decreased to $14.335 billion in 2024 from $18.067 billion in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 179,
          "pages": [
            177,
            178,
            179,
            180,
            181
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 220,
          "pages": [
            218,
            219,
            220,
            221,
            222
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51084,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13000,
        "completion_tokens": 85,
        "total_tokens": 13086
      }
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "Between 2023 and 2024, McDonald's use of line of credit agreements remained stable, with the company maintaining a $4.0 billion committed line of credit agreement as of December 31, 2024. Additionally, the company's subsidiaries had $7 million in borrowings under uncommitted foreign currency line of credit agreements in 2024, compared to no specific mention of such uncommitted lines in 2023. The evolution reflects continued access to credit facilities to support cash flow management and financing activities, including debt service, dividends, and share repurchases.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 30842,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7931,
        "completion_tokens": 142,
        "total_tokens": 8074
      }
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "Between 2022 and 2024, the Worldwide Business Conduct Manual has remained a foundational element in reinforcing Procter & Gamble's internal controls, emphasizing the company's commitment to integrity and compliance. In both years, the manual is highlighted as a key tool in ensuring adherence to legal and ethical standards, supporting the reliability of financial reporting, and aligning with the company's governance structure. The consistent emphasis on the manual reflects P&G's ongoing dedication to robust corporate governance and ethical business practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45080,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11503,
        "completion_tokens": 141,
        "total_tokens": 11644
      }
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "Exxon's strategic positioning in Guyana has significantly strengthened between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions. The long-lived assets in Guyana increased from $6.766 billion in 2023 to $9.689 billion in 2024, indicating substantial capital investment in the region. Additionally, Guyana is explicitly listed as an \"Advantaged Asset\" in the 2024 earnings driver definitions, highlighting its role as a key growth project contributing to Exxon's strategic focus on high-return assets. This evolution underscores Guyana's growing importance in Exxon's portfolio as a major source of earnings and capital deployment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46982,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11970,
        "completion_tokens": 169,
        "total_tokens": 12139
      }
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "Capital One's reliance on securitized debt obligations as a funding source increased from 2022 to 2024. In 2022, $6.25 billion in securitized debt obligations were issued, while in 2024, the amount of securitized debt obligations on the balance sheet was $14.264 billion, indicating a significant increase in the use of this funding source over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52603,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13376,
        "completion_tokens": 89,
        "total_tokens": 13465
      }
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "Between fiscal years 2022 and 2023, NVIDIA's Omniverse platform evolved from being primarily a real-time 3D design collaboration and virtual world simulation tool to a more integrated and enterprise-focused platform. In 2022, Omniverse was described as a software subscription for enterprise use, emphasizing its role in enabling artists, designers, and creators to collaborate in leading design applications. By 2023, Omniverse was positioned more broadly as a development platform and operating system for building virtual world simulation applications, with industrial enterprises adopting it for digital twins, real-time 3D product configurators, and testing autonomous systems. This shift reflects increased enterprise adoption and a broader scope in supporting digitalization across industries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 40893,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10439,
        "completion_tokens": 200,
        "total_tokens": 10639
      }
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Between 2022 and 2023, the net amounts due between Pfizer and Viatris under their agreements decreased significantly. As of December 31, 2023, the net amounts due to Viatris were $33 million, compared to $94 million as of December 31, 2022. This reduction reflects the ongoing completion of services under transitional agreements and the maturation of their post-separation relationship.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 71288,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18045,
        "completion_tokens": 96,
        "total_tokens": 18141
      }
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024 by advancing development projects and increasing production capacity. In 2023, the Payara development commenced operations with the Prosperity FPSO, and the Yellowtail project progressed, with the Uaru project funded. By 2024, Guyana was explicitly classified as an \"Advantaged Asset\" under the updated earnings drivers, highlighting its role in ExxonMobil's growth strategy. This classification reflects the region's significance as a high-return project, signaling increased strategic focus and integration into the company's core growth initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37314,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9554,
        "completion_tokens": 156,
        "total_tokens": 9710
      }
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "From 2022 to 2023, the weighted-average interest rate for senior notes with maturities greater than 10 years remained unchanged at 3.8%. The face value of these notes increased slightly from $52.8 billion in 2022 to $53.4 billion in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 45038,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11480,
        "completion_tokens": 59,
        "total_tokens": 11539
      }
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "Between 2023 and 2024, the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shifted their domestic equity investment allocations and valuation methodologies as follows:\n\n- **Alabama Power**: In 2023, domestic equity investments were valued at $443 million under Level 2 inputs and $208 million under Level 3 inputs. By 2024, the entire domestic equity allocation of $651 million was classified under Level 2 inputs, indicating a shift away from Level 3 inputs. This suggests an increase in the use of observable market data for valuation.\n\n- **Georgia Power**: In 2023, domestic equity investments were valued at $321 million under Level 2 inputs and $1 million under Level 1 inputs. In 2024, the domestic equity allocation of $322 million remained primarily in Level 2 inputs, with no significant change in classification. \n\nOverall, the trusts moved toward greater reliance on Level 2 inputs in 2024, reflecting more transparency and the use of observable market data for valuation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 284,
          "pages": [
            282,
            283,
            284,
            285,
            286
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 277,
          "pages": [
            275,
            276,
            277,
            278,
            279
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 91761,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23190,
        "completion_tokens": 252,
        "total_tokens": 23442
      }
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "From 2022 to 2023, NVIDIA's strategic positioning of CUDA evolved by reinforcing its role as the foundational programming model across its full-stack computing platform, enabling accelerated computing for diverse workloads such as AI, data analytics, and scientific computing. In 2023, CUDA's integration expanded further across end markets like automotive, healthcare, and professional visualization, supported by domain-specific software stacks and ecosystem partnerships, solidifying its importance in NVIDIA's unified architecture for multi-billion-dollar industries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 36411,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9333,
        "completion_tokens": 142,
        "total_tokens": 9476
      }
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "From 2022 to 2023, the net amounts owed by Pfizer to Viatris decreased significantly, from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, services under the transitional service agreements (TSAs) with Viatris were largely completed by December 31, 2023, indicating a reduction in ongoing contractual obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83587,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21128,
        "completion_tokens": 89,
        "total_tokens": 21217
      }
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "From 2022 to 2023, Duke Energy faced increasing pressure from both retail deregulation and evolving environmental regulations, which collectively impacted its compliance costs and operational strategies. In 2022, the company highlighted the risks of retail deregulation, such as increased competition and potential unrecovered costs, alongside the ongoing challenges of complying with environmental laws, including those related to coal combustion residuals (CCR) and carbon emissions. By 2023, Duke Energy emphasized a heightened regulatory and legislative focus on climate change, with more aggressive state-level carbon reduction goals and stricter environmental compliance requirements. These developments increased Duke Energy's capital and operating expenditures, necessitating greater investments in clean energy and compliance measures, while also heightening the risk of delayed or incomplete cost recovery through regulatory mechanisms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69966,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17712,
        "completion_tokens": 236,
        "total_tokens": 17949
      }
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline of 1.7 share points. This decline contrasts with the pricing strategy applied to Skoal during 2023, which included multiple price increases (e.g., $0.09 per can in January 2023 and $0.09–$0.10 per can in April and July 2023), indicating an attempt to offset volume declines and maintain profitability despite market share losses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66177,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16769,
        "completion_tokens": 110,
        "total_tokens": 16880
      }
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen's investment in 'Other short-term interest-bearing securities' slightly decreased from $138 million in 2023 to $135 million in 2024. This minimal change, along with the company's focus on U.S. Treasury bills and money market mutual funds, indicates a conservative short-term investment strategy prioritizing safety of principal, liquidity, and low risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46717,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11912,
        "completion_tokens": 89,
        "total_tokens": 12002
      }
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "General Dynamics' involvement in Abrams Main Battle Tank Upgrades increased in contract value from 2022 to 2024. In 2022, the company received $360 million for Abrams tank upgrades, mission control units, and technical support. By 2024, this had grown to $350 million, specifically for Abrams upgrades, engineering, logistics support, and system sustainment. While the direct contract value slightly decreased, the 2024 award reflects a broader scope emphasizing sustainment and technical support, indicating a shift toward long-term support and modernization efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 19534,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 5108,
        "completion_tokens": 142,
        "total_tokens": 5250
      }
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "From 2023 to 2024, AIG's financial relationship with Corebridge underwent significant changes. In 2023, Corebridge was still consolidated under AIG, and AIG recognized income from discontinued operations of $902 million attributable to AIG. However, in 2024, AIG deconsolidated Corebridge on June 9, 2024, resulting in a loss of $4.8 billion, primarily due to the recognition of an accumulated comprehensive loss of $7.2 billion. Post-deconsolidation, AIG accounted for its retained interest in Corebridge using the fair value option, recognizing equity method income of $601 million in 2024, which included dividends and changes in Corebridge's stock price. Additionally, AIG sold a significant portion of its Corebridge shares, including a 21.6% stake to Nippon for $3.8 billion, resulting in a $282 million gain in the fourth quarter of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 91678,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23143,
        "completion_tokens": 211,
        "total_tokens": 23354
      }
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Solar Roof product evolved from focusing on production challenges and installation capabilities to addressing strategic dependencies and scaling efforts. In 2022, the company highlighted challenges related to production ramps, supplier constraints, and the need to improve installation efficiency. By 2024, Tesla emphasized collaboration with real estate developers and builders to integrate Solar Roof into new homes, indicating a shift toward broader market adoption and infrastructure integration. Additionally, the 2024 filing reflects a stronger focus on localized procurement and scaling energy product installations globally, underscoring strategic dependencies on supply chain and workforce development.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45696,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11646,
        "completion_tokens": 189,
        "total_tokens": 11835
      }
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "The retail share of Skoal in the U.S. oral tobacco market decreased from 9.3% in 2023 to 7.6% in 2024. This decline indicates a weakening competitive position for Skoal, as it lost market share amid industry shifts toward oral nicotine pouches and challenges in the MST (moist smokeless tobacco) category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46916,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11952,
        "completion_tokens": 76,
        "total_tokens": 12028
      }
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "The risk associated with the concentration of device share among premium tier companies has increased between 2023 and 2024, particularly due to geopolitical tensions and vertical integration by key customers. In 2024, the revocation of Qualcomm’s export license to Huawei led to a loss of approximately $560 million in product revenues, and further risks exist if Huawei gains market share in China at the expense of other OEMs using Qualcomm products. Additionally, Chinese OEMs are increasingly developing their own integrated circuit products under government initiatives like \"Made in China 2025,\" which could reduce Qualcomm’s pricing power and revenue stability. These factors, combined with the premium tier market’s maturation and slowing growth, heighten the vulnerability of Qualcomm’s revenue to shifts in customer behavior and geopolitical policies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64467,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16357,
        "completion_tokens": 215,
        "total_tokens": 16572
      }
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen's allocation to money market mutual funds increased significantly between 2023 and 2024. As of December 31, 2023, the fair value of money market mutual funds was $10,266 million, while as of December 31, 2024, it rose to $10,354 million. This reflects a slight increase of $88 million in Amgen's allocation to money market mutual funds during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46717,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11900,
        "completion_tokens": 90,
        "total_tokens": 11991
      }
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "General Dynamics' participation in the Capital Construction Fund (CCF) has seen an increase in the amount of U.S. government accounts receivable pledged to the fund. In 2022, the pledged amount was $295 million, which rose to $333 million by 2024, indicating a $38 million increase over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34480,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8853,
        "completion_tokens": 76,
        "total_tokens": 8930
      }
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly following the IPO and subsequent deconsolidation. In 2023, AIG retained significant ownership in Corebridge, and its investment income from Corebridge was reflected in net investment income and realized gains. However, in 2024, after deconsolidation on June 9, 2024, AIG's retained interest in Corebridge was accounted for under the equity method, with changes in Corebridge's stock price and dividends impacting AIG's net investment income. Tax implications were also affected, as Corebridge was deconsolidated from AIG’s U.S. federal income tax group, limiting future tax attribute sharing. This deconsolidation resulted in a $4.8 billion loss for AIG, primarily due to the recognition of an accumulated comprehensive loss.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 255,
          "pages": [
            253,
            254,
            255,
            256,
            257
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 104823,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 26442,
        "completion_tokens": 203,
        "total_tokens": 26646
      }
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "From 2022 to 2024, Tesla's approach to Solar Roof production has evolved with a focus on improving installation capabilities and reducing costs. In 2022, the company emphasized increasing production by onboarding and training new installers and collaborating with real estate developers to streamline installation processes. By 2024, Tesla expanded its educational and training programs, such as the Education Assistance Program and Tesla START, to develop skilled talent in manufacturing and service roles, which supports the Solar Roof initiative. Supply chain challenges, including component shortages and global trade disruptions, remained a concern in both periods, but Tesla's efforts to enhance localized procurement and optimize inventory management were key strategies to mitigate these issues.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 49206,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12529,
        "completion_tokens": 200,
        "total_tokens": 12729
      }
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina increased from $7 billion to $8 billion between 2022 and 2023. As of 2023, approximately $4 billion had been spent, indicating significant progress under the Coal Ash Act. The company has completed the excavation of coal ash at several sites and is on track to meet closure requirements, with the majority of remaining costs expected to be incurred over the next 10 years. This suggests Duke Energy is actively managing its obligations under the regulatory framework.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 68610,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17393,
        "completion_tokens": 145,
        "total_tokens": 17538
      }
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024, indicating a modest improvement in its market position within the oral tobacco product segment during this period. However, this growth was not enough to offset declines in other products, as the total oral tobacco products segment's retail share decreased from 42.5% to 37.5% over the same period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46916,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11966,
        "completion_tokens": 98,
        "total_tokens": 12065
      }
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "Qualcomm's reliance on Chinese OEMs for revenue remained significant in 2024, with continued exposure to risks such as government policies (e.g., China's \"Made in China 2025\" initiative), U.S.-China trade tensions, and the potential for Chinese OEMs to develop their own integrated circuit products. In 2024, the revocation of Qualcomm's export license to Huawei by the U.S. Department of Commerce further highlighted the vulnerability of its business in China, with Huawei's prior product revenues amounting to $560 million in fiscal 2024 before the license was revoked. This evolving reliance and exposure to geopolitical and policy risks pose a threat to Qualcomm's business stability, as any further restrictions or shifts in customer behavior could significantly reduce revenues and cash flows.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64467,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16338,
        "completion_tokens": 199,
        "total_tokens": 16537
      }
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Between 2022 and 2023, Amgen's total available-for-sale investments remained composed primarily of money market mutual funds and other short-term interest-bearing securities. In 2022, the total available-for-sale investments were $4,335 million, with $1,676 million in U.S. Treasury bills, $2,659 million in money market mutual funds, and no amount in other short-term interest-bearing securities. By 2023, the total available-for-sale investments increased to $10,404 million, with $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities, while U.S. Treasury bills were no longer held. This indicates a shift from U.S. Treasury bills to money market mutual funds as the primary component of Amgen's available-for-sale investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46717,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11904,
        "completion_tokens": 196,
        "total_tokens": 12100
      }
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "Shake Shack was present as a tenant at SPG's Woodbury Common Premium Outlets in 2023, as listed among its selected tenants, but there is no mention of Shake Shack in any of the 2022 premium outlet tenant lists provided. Therefore, Shake Shack entered SPG's premium outlet portfolio between 2022 and 2023, specifically at Woodbury Common Premium Outlets in New York.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69985,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17709,
        "completion_tokens": 91,
        "total_tokens": 17800
      }
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "Between 2022 and 2024, retirement annuity contracts remained classified as Level 3 assets within the fair value hierarchy, indicating that their fair value is determined using significant unobservable inputs. In 2022, these contracts had a fair value of $35, increasing to $22 in 2024. This consistent classification suggests that GD's valuation methodology for these assets relies on internal models or assumptions due to the lack of observable market data, reflecting the illiquid or non-traded nature of these instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49520,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12613,
        "completion_tokens": 131,
        "total_tokens": 12744
      }
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly. In 2023, AIG owned 52.2% of Corebridge and recognized income from its equity stake, with changes in ownership affecting AIG's equity. By 2024, AIG deconsolidated Corebridge, reducing its ownership to 22.7% by the end of the year through secondary offerings and a major sale to Nippon Life. This deconsolidation resulted in a $4.8 billion loss, primarily due to the recognition of accumulated comprehensive losses. Post-deconsolidation, AIG accounted for its retained interest using the fair value option, recognizing dividends and stock price changes in net investment income.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 242,
          "pages": [
            240,
            241,
            242,
            243,
            244
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 130264,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 32791,
        "completion_tokens": 166,
        "total_tokens": 32958
      }
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "Comcast's financial exposure to Universal Beijing Resort from 2022 to 2024 has remained consistent as a 30% equity interest, with the resort's debt not guaranteed by Comcast. As of December 31, 2024, Universal Beijing Resort had $3.4 billion of debt outstanding, compared to $3.5 billion in 2023, and Comcast consolidates the resort as a variable interest entity. The maximum risk of financial loss for Comcast remains limited to its 30% equity stake in the resort.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54244,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13783,
        "completion_tokens": 116,
        "total_tokens": 13899
      }
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "Between 2022 and 2023, the structure of aircraft trade-in commitments remained largely consistent in terms of customer eligibility and risk exposure. In both years, Gulfstream customers with orders for new aircraft were granted options to trade in their existing aircraft as partial payment. These options typically set the fair market value of the trade-in aircraft 45 or fewer days before the delivery of the new aircraft, requiring the customer to either exercise or allow the option to expire. Some commitments guaranteed a predetermined trade-in value, which posed higher risk in the event of adverse market conditions. As of December 31, 2023, the estimated change in fair market values from the date of the commitments was not material, indicating no significant increase in risk exposure compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38898,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9945,
        "completion_tokens": 203,
        "total_tokens": 10148
      }
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "Between 2022 and 2024, Tesla's approach to the Tesla Semi has evolved from being in the development phase to entering pilot production, as noted in the 2024 filing. In 2022, the Semi was not yet in production, while by 2024, it was listed under pilot production in Nevada. Strategically, the Semi is positioned as part of Tesla's broader push into commercial electric vehicles, leveraging advancements in battery and powertrain technology to expand into new markets and support the company's mission of sustainable energy adoption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38104,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9753,
        "completion_tokens": 132,
        "total_tokens": 9886
      }
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "The valuation allowance related to Altria's investment in Cronos decreased from $379 million in 2022 to $397 million in 2023, and further to $402 million in 2024. This minimal increase suggests that Altria's expectations regarding the realizability of the associated deferred tax assets have remained largely unchanged over this period, indicating continued uncertainty about the ability to realize these tax benefits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 49615,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12643,
        "completion_tokens": 104,
        "total_tokens": 12748
      }
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value accounting, with changes in fair value recognized in earnings. This change resulted in gains being recognized in 2023 due to the fair value adjustment. In 2024, the financial treatment shifted again, with net unrealized losses on strategic equity investments, including BeiGene, impacting other income (expense), net. This indicates a decline in the investment's fair value compared to gains in the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52675,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13382,
        "completion_tokens": 130,
        "total_tokens": 13512
      }
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "Between 2023 and 2024, Disney+ Hotstar's positioning and market strategy evolved by integrating regional branding and streamlining its service structure in key markets. Notably, in Latin America, Disney+ and Star+ were merged into a single Disney+ product offering by June 2024, simplifying the service structure and consolidating general entertainment and family content under one brand. Additionally, in India and Southeast Asia, the service continues to operate under the Disney+ Hotstar brand, emphasizing localized content and sports programming to cater to regional preferences. This shift reflects a broader strategy to unify and optimize the Disney+ brand globally while maintaining tailored regional identities where necessary.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46862,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11939,
        "completion_tokens": 184,
        "total_tokens": 12123
      }
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "Between 2023 and 2024, PayPal refined its approach to Protection Programs by enhancing risk exposure management and loss recovery mechanisms. The company emphasized improved fraud detection and prevention measures to address evolving fraud schemes and mitigate transaction losses. Additionally, PayPal focused on optimizing recovery processes, including seeking compensation from merchants involved in disputes, although challenges remained in fully recovering losses due to factors like merchant insolvency or fraudulent activity. These changes reflect a strategic effort to reduce financial impact and maintain consumer and merchant confidence in its payment services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55501,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14097,
        "completion_tokens": 167,
        "total_tokens": 14265
      }
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "NextEra Energy's relationship with solar generation facilities from 2022 to 2024 has evolved through strategic sales and ownership restructuring. In 2022, NextEra Energy Resources sold noncontrolling interests in several solar facilities, retaining operational control while reducing direct ownership. By 2024, the company consolidated Variable Interest Entities (VIEs) with significant solar generation capacity, maintaining control over operations and maintenance. Financial exposure increased through consolidated VIEs with substantial assets and liabilities, reflecting a shift toward managing solar facilities through structured ownership and third-party financing arrangements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64775,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16419,
        "completion_tokens": 170,
        "total_tokens": 16590
      }
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "ACN's investment in Mutual Fund Debt Securities decreased from $484,182 in 2022 to $379,989 in 2023. The valuation methodology remained consistent, with these investments classified entirely within Level 2 of the fair value hierarchy, as they were valued using quoted prices for similar instruments or model-derived valuations with observable inputs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33412,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8581,
        "completion_tokens": 87,
        "total_tokens": 8669
      }
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron's financial stake in Tengizchevroil (TCO) increased slightly between 2022 and 2023, with the investment rising from $26,534 million in 2022 to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO decreased from $4,386 million in 2022 to $3,375 million in 2023. The company maintains a 50% equity ownership interest in TCO and has a loan of $4,500 million to fund the development of the FGP/WPMP project.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56646,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14370,
        "completion_tokens": 108,
        "total_tokens": 14478
      }
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "Disney's relationship with the ABC Network has remained integral to its broader entertainment ecosystem between 2023 and 2024, particularly through ESPN's continued role in programming the sports daypart on ABC, known as \"ESPN on ABC.\" Additionally, ABC Network content, such as programming from ABC, Freeform, and FX Channels, continues to be available on Hulu's SVOD service one day after linear airing, reinforcing ABC's integration with Disney's streaming platforms. These strategic linkages highlight ABC's role in supporting cross-platform content distribution and viewer engagement within Disney's entertainment portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42747,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10913,
        "completion_tokens": 157,
        "total_tokens": 11071
      }
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "Between 2022 and 2023, General Dynamics increased its Combat Systems segment's revenue contribution from 18% to 20% of consolidated revenue, with military vehicle revenue rising from $4,581 million in 2022 to $5,036 million in 2023. This growth indicates a heightened focus on land systems, including the ASCOD vehicle, as part of broader modernization and production initiatives. The ASCOD's inclusion in ELS's diverse portfolio of armored vehicles, alongside increased investment in production capacity and next-generation capabilities, suggests a strategic shift toward expanding General Dynamics' global land combat solutions and meeting rising international demand for versatile tracked combat systems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 24557,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6377,
        "completion_tokens": 176,
        "total_tokens": 6554
      }
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "PayPal's utilization of European customer balances for credit activities decreased from $3.0 billion in 2023 to $2.0 billion in 2024, representing a reduction from 39% to 26% of European customer balances available for corporate use. This decline suggests a more conservative approach to leveraging customer funds for credit activities, potentially reflecting a strategic shift to prioritize liquidity management, regulatory compliance, or risk mitigation in response to evolving economic conditions or internal financial priorities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51156,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13021,
        "completion_tokens": 133,
        "total_tokens": 13154
      }
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "Between 2022 and 2024, the valuation and categorization of equity securities within NEE's Special Use Funds evolved significantly. In 2022, NEE's equity securities were valued at $5,511 million, with no Level 3 assets, while by 2024, the value increased to $6,164 million, with $229 million categorized under Level 3. This shift indicates a greater portion of investments with less observable market data, suggesting a potential diversification into more complex or illiquid assets. The increase in Level 2 investments (primarily in commingled funds) also highlights a strategic move toward diversified, professionally managed funds, enhancing transparency through structured investment vehicles.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 70906,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17962,
        "completion_tokens": 174,
        "total_tokens": 18136
      }
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "From fiscal 2022 to fiscal 2023, Accenture's share purchase program saw a significant increase in total shares acquired under the public program, with $1,964,612 shares purchased in fiscal 2022 and $5,349,600 in additions/adjustments in fiscal 2023. Shares acquired through employee-related transactions remained relatively consistent, with $97,251 shares acquired in fiscal 2022 and no direct comparable figure provided for fiscal 2023, though employee-related transactions typically involve share withholding for payroll tax obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 29973,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7736,
        "completion_tokens": 134,
        "total_tokens": 7871
      }
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC (CPChem) remained consistent between 2022 and 2023. CPChem continued to be accounted for using the equity method, as Chevron holds a 50% equity ownership interest. In both years, CPChem was not consolidated into Chevron's financial statements, and its summarized financial data was disclosed separately in the notes to the consolidated financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50872,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12954,
        "completion_tokens": 110,
        "total_tokens": 13065
      }
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "In 2022, General Dynamics' Combat Systems segment received a $175 million contract from the U.S. Army for the production of Hydra-70 rockets. By 2023, the role of Hydra-70 rockets expanded significantly, as OTS (Ordnance and Tactical Systems) received awards to increase its production capacity for metal parts from 18,000 to 86,000 rounds per month by 2025 and expand propellant capacity from 4 million to 16 million pounds per year by 2028. This expansion supports the U.S. Army's effort to accelerate artillery production, highlighting an increased contract involvement and a strategic focus on scaling production capacity for Hydra-70 rockets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 26143,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6766,
        "completion_tokens": 161,
        "total_tokens": 6928
      }
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) is listed as incorporated by reference from the 10-12B/A form filed on May 14, 2015. In the 2024 filing, the same exhibit is also incorporated by reference, but the associated form is now listed as a 10-Q filed on April 30, 2024, indicating an amendment or restatement of the agreement. This suggests that PayPal updated the documentation for the Global Restricted Stock Unit Award Grant Notice in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 68426,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17343,
        "completion_tokens": 123,
        "total_tokens": 17466
      }
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within Bristol-Myers Squibb's portfolio has expanded significantly, both in terms of revenue and regulatory approvals. In 2022, Opdivo generated $7.5 billion in revenue, maintaining its position as a key oncology product. By 2024, Opdivo secured multiple new approvals, including FDA and EC approvals for new indications such as unresectable urothelial carcinoma, combination therapies, and subcutaneous delivery via Opdivo Qvantig. These advancements reinforced Opdivo's leadership in immuno-oncology and expanded its therapeutic applications, enhancing its strategic importance in BMS's oncology portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 43734,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11157,
        "completion_tokens": 160,
        "total_tokens": 11318
      }
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC (CPChem) evolved between 2022 and 2023, with increased investment in key projects. In 2022, CPChem made a final investment decision on a new C3 splitter unit at its Cedar Bayou facility in Texas, and Chevron provided a loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Texas, in which CPChem owns 51 percent. By 2023, Chevron's equity earnings from CPChem rose to $608 million from $867 million in 2022, indicating continued financial support and project progress. These investments reflect Chevron's strategic focus on expanding CPChem's petrochemical capabilities and advancing growth in the downstream and chemicals sectors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51816,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13188,
        "completion_tokens": 188,
        "total_tokens": 13376
      }
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, PayPal's protection programs saw an increase in financial commitments, as reflected in the allowance for transaction losses and negative customer balances. The allowance for transaction losses rose from $64 million in 2023 to $86 million in 2024, while the allowance for negative customer balances increased from $218 million to $256 million. The changes in these reserves were driven by higher provisions in 2024 ($1,114 million) compared to 2023 ($1,192 million), partially offset by higher realized losses in 2024 ($1,218 million) compared to 2023 ($1,313 million).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47806,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12175,
        "completion_tokens": 147,
        "total_tokens": 12323
      }
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "Between 2022 and 2024, McDonald's has reinforced its strategic framing of franchising as a core business model, emphasizing collaboration and co-investment with franchisees. In 2024, the Company highlights that franchisees are critical to its success and that co-investments with franchisees are designed to modernize restaurants, improve performance, and enhance the brand. This reflects a continued and possibly stronger emphasis on franchisee partnerships compared to 2022, where similar themes were present but not as explicitly detailed in the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62155,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15773,
        "completion_tokens": 141,
        "total_tokens": 15914
      }
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "Between 2022 and 2023, the FDA authorized three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, indicating progress in Altria's regulatory efforts for heated tobacco products. However, the FDA has not exempted Marlboro HeatSticks from graphic health warning requirements, and the product remains subject to the same regulations as cigarettes. This suggests that while Altria has achieved some authorization milestones for heated tobacco products, regulatory challenges and restrictions persist, reflecting the cautious and evolving nature of FDA oversight in this category.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58526,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14859,
        "completion_tokens": 149,
        "total_tokens": 15008
      }
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "The valuation of mutual fund equity securities held by ACN in non-U.S. pension plans decreased from $273,541 in 2021 to $239,293 in 2022, indicating a decline in the market value of these investments during this period. This shift suggests a potential reallocation or reduced emphasis on mutual fund equity securities in the company's investment strategy for non-U.S. pension plans, possibly to manage risk or adjust to changing market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33412,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8584,
        "completion_tokens": 111,
        "total_tokens": 8696
      }
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "Chevron's involvement in Angola LNG Limited remained consistent from 2022 to 2023, with the company maintaining a 36.4 percent interest in the entity, which operates an onshore natural gas liquefaction plant in Soyo, Angola. In both years, the focus was on supplying feedstock to the plant, with efforts directed toward developing non-associated gas in offshore Angola to support the Angola LNG facility. There is no indication of significant changes in Chevron's operational focus or investment emphasis during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51180,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13016,
        "completion_tokens": 131,
        "total_tokens": 13147
      }
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "From 2022 to 2023, MMM's investment in Certificates of Deposit/Time Deposits increased significantly. In 2022, the amount was $21 million, and by 2023, it had risen to $49 million. This represents an increase of $28 million, or 133%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63923,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16199,
        "completion_tokens": 58,
        "total_tokens": 16257
      }
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "Between 2021 and 2024, McDonald's increased the percentage of franchised restaurants in its system. In 2021, 93% of the 40,031 total restaurants were franchised, while in 2024, 95% of the 43,477 total restaurants were franchised, indicating a slight but consistent shift toward a more franchised business model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54756,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13904,
        "completion_tokens": 77,
        "total_tokens": 13982
      }
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective March 31, 2021, as noted in the 2022 10-K (page 117). Between 2022 and 2023, there is no indication of further amendments to the plan's effective date or structure in the provided pages from the 2023 10-K. Therefore, the plan's structure and effective date remained unchanged during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60573,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15362,
        "completion_tokens": 97,
        "total_tokens": 15460
      }
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "Between fiscal years 2022 and 2023, Accenture's investment in Duck Creek Technologies showed an increase in valuation. As of August 31, 2022, the carrying amount of the investment was $138,902, with an estimated fair value of $223,166 for Accenture's approximately 16% ownership stake. By fiscal 2023, the investment generated a $253 million gain, which was reported as part of the results of operations. This indicates that the valuation of Accenture's stake in Duck Creek Technologies rose significantly during this period, positively impacting Accenture's financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43908,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11208,
        "completion_tokens": 144,
        "total_tokens": 11353
      }
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "Between 2022 and 2024, Breyanzi's therapeutic application expanded significantly, particularly in the treatment of B-cell malignancies. In 2024, the FDA granted accelerated approval for Breyanzi for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have received at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor. Additionally, Breyanzi received FDA approval for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after at least two prior lines of systemic therapy. These approvals expanded Breyanzi's market potential by broadening its use across a wider range of lymphoid cancers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50996,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12975,
        "completion_tokens": 191,
        "total_tokens": 13166
      }
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "Between 2022 and 2023, 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450, particularly for respirator mask/asbestos litigation, remained consistent in methodology but reflected updated liability estimates. In 2023, 3M increased its accruals for respirator mask/asbestos liabilities by $57 million, bringing the total accrual to $574 million as of December 31, 2023. The insurance receivables remained immaterial, with 3M noting that it had collected substantially all remaining insurance coverage for these claims. The evolution in 2023 primarily involved adjustments to probable liabilities based on updated claims data, legal developments, and higher average costs for resolving claims involving serious injuries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54304,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13812,
        "completion_tokens": 193,
        "total_tokens": 14005
      }
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "Between 2022 and 2023, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners in the first quarter of 2022. However, it retained a 39% noncontrolling interest in a newly formed joint venture called Tropicana Brands Group (TBG), which operates across North America and Europe. In the U.S., PepsiCo continued to act as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers with chilled direct-store-delivery. There is no indication of further changes to this arrangement in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42767,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10909,
        "completion_tokens": 141,
        "total_tokens": 11051
      }
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment and disclosure around the ExtraBucks Rewards program remained consistent in recognizing revenue as rewards are redeemed, with unredeemed rewards reflected as a contract liability. However, in 2024, there was a slight increase in the contract liabilities related to ExtraBucks Rewards, as evidenced by the growth in the ending balance of contract liabilities from $149 million in 2023 to a higher amount in 2024, indicating an increase in accumulated but unredeemed rewards. No significant changes in the determination of performance obligations were noted in the disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 125,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47279,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12060,
        "completion_tokens": 155,
        "total_tokens": 12215
      }
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Netflix's reliance on integrated payment partners, as reflected in the cost of revenues section, decreased slightly between 2023 and 2024. In 2023, cost of revenues was 58% of total revenues, while in 2024, it decreased to 54% of total revenues. The 2024 cost of revenues increase was primarily driven by higher content amortization rather than changes in payment processing fees. This suggests that while integrated payment partner costs remained a component of operating expenses, their relative impact on overall costs decreased compared to the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83084,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20999,
        "completion_tokens": 139,
        "total_tokens": 21138
      }
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "From 2022 to 2023, 3M's approach to managing PFAS contamination in Minnesota evolved in response to regulatory changes and new health-based standards. In 2022, the company was focused on addressing PFAS contamination at its Cottage Grove, Oakdale, and Woodbury sites under the 2007 SACO, including remediation and compliance with existing HBVs and HRLs. By 2023, 3M faced more stringent HBVs for PFOA and PFOS issued by the Minnesota Department of Health in January 2024, prompting the company to evaluate the impact on its SACO obligations. Additionally, in 2023, 3M received a draft Clean Water Act permit for the Cottage Grove facility with significantly revised PFAS limits, some below the limit of quantification, and was actively engaging with MPCA to address these changes. The company also responded to a Notice of Violation related to PFAS discharges at its Hutchinson facility and worked on a stormwater management plan for Cottage Grove.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60926,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15459,
        "completion_tokens": 237,
        "total_tokens": 15696
      }
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "Between 2022 and 2023, PepsiCo increased its use of foreign currency derivatives, with the notional value rising from $3.0 billion as of December 31, 2022, to $3.8 billion as of December 30, 2023. This increase indicates a more active approach to managing foreign exchange risk, likely in response to heightened currency volatility or expanded international operations. The company continues to use these derivatives primarily as hedging instruments, with gains and losses offsetting changes in the underlying hedged items, reflecting a disciplined and strategic foreign exchange risk management approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41614,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10631,
        "completion_tokens": 151,
        "total_tokens": 10782
      }
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil's approach to capitalizing on improving living standards shifted toward expanding chemical production capacity in key growth markets, particularly in China. In 2022, the company focused on restarting U.S. Gulf Coast projects and made progress on a multi-billion-dollar chemical complex in China. By 2023, ExxonMobil advanced this geographic strategy by investing in a fully foreign-owned petrochemical complex in Dayawan, China, designed to meet rising domestic demand for high-performance polyethylene and polypropylene. Additionally, the company added new production units in the U.S., such as a performance polymers line and a linear alpha olefins unit in Baytown, Texas, to support demand for advanced materials. These moves reflect a stronger emphasis on strategic capacity additions in both North America and high-growth Asian markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 25346,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6568,
        "completion_tokens": 218,
        "total_tokens": 6787
      }
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "3M's investment in Certificates of Deposit/Time Deposits increased significantly from 2022 to 2023, rising from $21 million to $49 million. This shift suggests a strategic move toward short-term, low-risk investments, likely to preserve liquidity and manage cash more conservatively in response to economic or market uncertainties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47228,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12035,
        "completion_tokens": 82,
        "total_tokens": 12117
      }
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "Mastercard's approach to proprietary insights in 2023 emphasized a stronger commitment to data responsibility and trust-building compared to 2022. In 2023, the company explicitly highlighted its \"principled and responsible use of secure consumer and merchant data,\" reflecting a more deliberate focus on ethical data practices. This evolution indicates a shift toward reinforcing trust with stakeholders by aligning data usage with broader commitments to security and transparency, which was less explicitly articulated in the 2022 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 61730,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15654,
        "completion_tokens": 134,
        "total_tokens": 15789
      }
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "Between 2022 and 2023, the factors influencing the accounting estimates for pension and retiree medical plans at PepsiCo evolved due to the ongoing conflicts in Ukraine and the Middle East, as well as the high interest rate and inflationary cost environment. These external factors increased the uncertainty and complexity in estimating future obligations and assumptions for these plans. This indicates a more challenging and volatile external environment, which has a direct impact on the financial estimates and assumptions used in accounting for pension and retiree medical liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40175,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10281,
        "completion_tokens": 147,
        "total_tokens": 10429
      }
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross thousand acres (11,977 net) in 2022 to 24,221 gross thousand acres (11,548 net) in 2023. This slight reduction suggests a modest decline in the company's land position in the region, potentially due to lease expirations or strategic relinquishments after evaluation. However, the company's continued significant acreage in the region, combined with its stated success in obtaining lease extensions, indicates ongoing exploration potential and a commitment to maintaining a strong presence in Other Americas.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 39461,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10098,
        "completion_tokens": 149,
        "total_tokens": 10247
      }
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "From 2022 to 2023, the use of foreign currency contracts not designated in hedging relationships by 3M evolved in terms of both volume and financial impact. In 2023, the gross notional amount of these contracts decreased significantly to $1,023 million from $2,816 million in 2022. The fair value gains and losses recorded in earnings also declined, with a 2023 fair value amount of $5 million compared to $73 million in 2022. This reduction indicates a lower exposure and financial impact from these non-hedged derivative instruments in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59144,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15024,
        "completion_tokens": 135,
        "total_tokens": 15160
      }
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "Between 2022 and 2023, the role and emphasis of Cyber and Intelligence Solutions within Mastercard's value proposition have evolved to become a more integral and highlighted component of its value-added services. In 2023, Mastercard emphasized these solutions as a key part of its broader offerings, noting their role in enabling secure, confident, and efficient transactions across its global payments ecosystem. This reflects a growing focus on security and data protection as critical differentiators in Mastercard's competitive positioning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 46916,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11946,
        "completion_tokens": 136,
        "total_tokens": 12082
      }
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "The treatment and disclosure of Income Tax Expense and Accruals in the list of critical accounting policies remained consistent between 2022 and 2023, as both years include it explicitly as one of the four critical accounting policies and estimates. In 2022 (page 57) and 2023 (page 33), it is listed alongside revenue recognition, goodwill and other intangible assets, and pension and retiree medical plans. The 2023 disclosure (page 35) provides a more detailed explanation of the tax rate estimation process, tax reserves, and adjustments due to audits or new tax laws, but the overall treatment and inclusion in critical accounting policies did not change significantly from 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42157,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10759,
        "completion_tokens": 171,
        "total_tokens": 10930
      }
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "Between 2023 and 2024, Intel advanced the Universal Chiplet Interconnect Express (UCIe) standard as a core component of its systems of chips strategy. In 2023, Intel demonstrated UCIe in silicon, showcasing its capability to enable communication between chips in a system. By 2024, the company emphasized UCIe as part of its broader systems of chips capabilities, integrating it with advanced packaging technologies and driving industry standards to optimize performance and power efficiency. This evolution reflects Intel's focus on enabling optimized, interconnected chiplet-based systems, particularly for AI and high-growth applications, as part of its Open System Foundry model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 31193,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8029,
        "completion_tokens": 170,
        "total_tokens": 8199
      }
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "Between 2023 and 2024, the accounting treatment of CVS's Accelerated Share Repurchase (ASR) transactions remained consistent, with the initial portion of shares being recorded as a treasury stock transaction and the remaining shares treated as a forward contract classified within capital surplus. However, the completion timelines evolved slightly: in 2023, the final shares were received within one month (e.g., February 2023 for the January 2023 ASR), while in 2024, the final shares were received in March 2024 for the January 2024 ASR, indicating a two-month interval for settlement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 30971,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7967,
        "completion_tokens": 147,
        "total_tokens": 8114
      }
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "From 2022 to 2023, UPS's financial exposure and reporting approach related to the Central States Pension Fund (CSPF) showed a significant shift in actuarial estimates. In 2022, UPS recorded a $2.3 billion pre-tax loss related to coordinating benefits attributable to the CSPF, reflecting an increase in potential coordinating benefits. By 2023, this estimate reversed with a $5.1 billion pre-tax gain, indicating a reduction in the estimated coordinating benefits required. Additionally, in 2023, UPS provided a sensitivity analysis showing the potential impact of changes in discount rates and other assumptions on pension obligations and expenses, highlighting increased transparency and a more refined approach to risk exposure reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45085,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11505,
        "completion_tokens": 185,
        "total_tokens": 11690
      }
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "Between 2022 and 2023, Mastercard has emphasized the role of its Cyber and Intelligence Solutions in enabling secure, efficient, and confident transactions across its global payments ecosystem. In 2022, the value proposition highlighted these solutions as part of a broader suite of services that provide \"proprietary insights\" using consumer and merchant data. By 2023, the emphasis evolved to position Cyber and Intelligence Solutions as foundational to ensuring transactions are \"secure, easily and with confidence,\" reflecting a more proactive and integrated approach to security and trust in the digital payments landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50922,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12962,
        "completion_tokens": 157,
        "total_tokens": 13119
      }
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In PepsiCo's 2022 SEC filing, the 4.450% Senior Note due 2046 was referenced as Exhibit 4.11, incorporated by reference to a Form 8-K filed on October 14, 2015. In the 2023 filing, this note was not listed directly, but a similarly named 4.450% Senior Note due 2028 (Exhibit 4.59) was referenced, incorporated by reference to a Form 8-K filed on February 15, 2023. Thus, the 2023 filing reflects an updated note with a different maturity date and a newer documentation date, indicating a replacement or reissuance of the original 2046 note.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 129,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 32934,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8468,
        "completion_tokens": 135,
        "total_tokens": 8603
      }
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Intel's relationship with Positive Technologies remained consistent between 2023 and 2024, as both filings indicate that Intel continued to communicate with Positive Technologies under an OFAC-issued license. These interactions, which began prior to Positive Technologies being designated under U.S. sanctions in April 2021, involve IT security research and coordinated disclosure of security vulnerabilities. No gross revenues or net profits are associated with these activities, and Intel plans to continue them in compliance with the OFAC license terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48981,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12474,
        "completion_tokens": 139,
        "total_tokens": 12613
      }
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million between 2023 and 2024, as noted in the long-term debt listings on pages 168 (2023) and 161 (2024). This stability suggests that the notes were not refinanced, redeemed, or significantly altered during this period, indicating a consistent component of the company's long-term debt structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 168,
          "pages": [
            166,
            167,
            168,
            169,
            170
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 161,
          "pages": [
            159,
            160,
            161,
            162,
            163
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32417,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8332,
        "completion_tokens": 95,
        "total_tokens": 8428
      }
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "The 0.835% Notes due 2032 were listed as securities registered pursuant to Section 12(b) of the Exchange Act in both the 2022 and 2024 SEC filings, indicating their continued public trading status. In both filings, the notes were traded under the symbol \"XOM32\" on the New York Stock Exchange, showing no change in their registration or exchange listing between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48848,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12424,
        "completion_tokens": 94,
        "total_tokens": 12518
      }
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "Between 2022 and 2024, American Express significantly reduced its fair value allocation to U.S. Government treasury obligations, declining from $1,704 million in 2022 to $287 million in 2024. In terms of maturity distribution, the 2024 portfolio was entirely concentrated in obligations due within 1 year, whereas in 2022, the majority ($1,680 million) was held in treasury obligations with maturities beyond 1 year. This shift indicates a move toward shorter-term holdings in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39660,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10150,
        "completion_tokens": 120,
        "total_tokens": 10270
      }
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "Amazon introduced the 2.500% Note due 2050 in June 2020, as disclosed in the 2022 10-K filing (page 72). By 2024, this note remained part of Amazon's long-term debt structure, with no indication of repayment or modification, as noted in the 2024 10-K (page 75). The note was issued under an indenture and officers' certificate, and its terms remained unchanged between the two periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45117,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11491,
        "completion_tokens": 96,
        "total_tokens": 11588
      }
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "The number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement increased from nine in 2022 to eleven in 2023, indicating two additional amendments were made during 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55000,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13963,
        "completion_tokens": 46,
        "total_tokens": 14010
      }
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "NVIDIA's approach to CUDA has evolved significantly between 2022 and 2024, particularly in terms of integration with new computing architectures and software ecosystems. In 2022, CUDA was primarily highlighted as a foundational programming model for NVIDIA GPUs, enabling accelerated computing across diverse markets like gaming, data center, and automotive. By 2024, CUDA's role expanded to support a broader full-stack computing platform, now including CPUs and DPUs, with the introduction of the Blackwell architecture. This evolution reflects CUDA's integration into data center-scale solutions, enabling advanced AI workloads and generative AI applications. Additionally, CUDA's ecosystem has grown, with over 5.9 million developers leveraging it to deploy NVIDIA's technology across industries, supported by tools like NVIDIA AI Enterprise and DGX Cloud.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 41217,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10527,
        "completion_tokens": 215,
        "total_tokens": 10742
      }
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "Between 2023 and 2024, Pfizer's financial relationship with Paxlovid underwent significant changes in revenue recognition and contractual obligations. In 2023, Paxlovid revenue was heavily impacted by a $3.5 billion non-cash revenue reversal due to expected returns of EUA-labeled U.S. government inventory. By 2024, this was partially offset by a $771 million favorable adjustment following the return of 5.1 million treatment courses. Additionally, in 2024, Pfizer supplied a U.S. Strategic National Stockpile (SNS) of 1 million treatment courses at no cost, recognizing $442 million in revenue. Overall, Paxlovid revenue dropped from $1,279 million in 2023 to $5,716 million in 2024, reflecting the transition from government contracts to commercial markets and reduced demand post-pandemic surge.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 89356,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22563,
        "completion_tokens": 200,
        "total_tokens": 22763
      }
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "The availability of shares under the 2003 Incentive Program decreased from 65,754,069 shares available in 2022 to 47 million shares available by the end of 2024. This reflects a reduction in the number of shares remaining for future awards, likely due to grants made during this period. The structure of the program remained consistent, with awards including restricted stock and stock units subject to graded vesting periods, though the Pioneer acquisition in 2024 added converted awards under the Pioneer LTIP, which had shorter vesting terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45650,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11625,
        "completion_tokens": 136,
        "total_tokens": 11762
      }
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "AdSense's role within Google's advertising revenue streams has seen a shift between 2022 and 2024, with its growth being partially offset by declines in impressions. In 2021, AdSense contributed to the growth of Google Network revenues, which increased by $8.6 billion, driven by strength in AdMob, Google Ad Manager, and AdSense. However, by 2024, impressions related to AdSense declined, indicating a potential shift in focus or performance within the broader advertising technology portfolio. This evolution reflects Google's broader strategy to enhance its advertising technologies, including leveraging AI to improve ad formats, delivery, and user experiences across platforms like Google Search, YouTube, and Google Network properties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45293,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11552,
        "completion_tokens": 185,
        "total_tokens": 11737
      }
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "Between 2022 and 2023, the UPS Retirement Plan's benefit accrual structure for non-union participants was modified to cease future benefit accruals for additional service and compensation effective January 1, 2023. This change meant that non-union employees hired prior to July 1, 2016, could no longer earn new benefits under the UPS Retirement Plan after this date. Instead, future retirement contributions for non-union employees were shifted to the UPS 401(k) Savings Plan, where they began receiving retirement contributions of 5% to 8% of eligible compensation based on years of vesting service starting in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44324,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11310,
        "completion_tokens": 154,
        "total_tokens": 11464
      }
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "Between 2022 and 2024, Amazon's short-term credit facilities evolved in several key ways. In 2022, the company had a $7.0 billion unsecured revolving credit facility with an interest rate of 0.50% over the benchmark rate and a commitment fee of 0.04%. By 2024, Amazon replaced its prior 364-day revolving credit agreement with a new $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement), which matures in October 2025 and carries an interest rate of 0.45% over the Secured Overnight Financing Rate with a commitment fee of 0.03%. Additionally, outstanding borrowings under other short-term credit facilities increased slightly from $147 million in 2023 to $151 million in 2024. The credit capacity also expanded, with the Commercial Paper Programs increasing from $10.0 billion in 2022 to $20.0 billion in 2024. Overall, Amazon appears to have optimized its credit structure by securing more favorable interest rate terms and increasing its short-term borrowing capacity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56235,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14293,
        "completion_tokens": 251,
        "total_tokens": 14544
      }
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "Between 2022 and 2023, Costco's use of variable-priced contracts for energy purchases remained consistent, as it continued to enter into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. This indicates that Costco employs a mixed commodity price risk management strategy, combining fixed-price contracts for certain facilities with variable-priced contracts to manage exposure to energy price fluctuations. The continued use of variable-priced contracts suggests a balanced approach to managing energy costs while maintaining flexibility in response to market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37668,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9646,
        "completion_tokens": 163,
        "total_tokens": 9810
      }
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "NVIDIA AI Enterprise has evolved significantly between 2022 and 2024 as a central component of NVIDIA's data center offerings. In 2022, it was positioned as a comprehensive suite of enterprise-grade AI software, emphasizing tools like NVIDIA NIM, NeMo, and AI Blueprints to simplify the development and deployment of generative AI applications. By 2024, its role expanded with the introduction of the NVIDIA Blackwell architecture, which integrates GPUs, CPUs, DPUs, and networking to deliver a full-stack, data center-scale infrastructure optimized for generative AI and accelerated computing workloads. This evolution reflects NVIDIA's strategic focus on providing end-to-end AI solutions with enhanced performance and efficiency to meet the growing demands of enterprise and cloud customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49717,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12649,
        "completion_tokens": 198,
        "total_tokens": 12847
      }
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "Pfizer's contractual obligations related to Paxlovid significantly evolved between 2023 and 2024, primarily due to the transition from government contracts to commercial market sales. In 2023, Paxlovid revenues were largely driven by government contracts, with a significant non-cash revenue reversal of $3.5 billion recorded in the fourth quarter due to expected returns of EUA-labeled inventory. By 2024, Paxlovid revenues increased to $5,716 million, reflecting a shift to commercial sales and a $771 million favorable adjustment from returned EUA-labeled treatment courses. This indicates a strategic pivot toward commercial markets and a more predictable revenue stream, suggesting a more stable and potentially growing future revenue outlook for Paxlovid.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 78180,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19776,
        "completion_tokens": 190,
        "total_tokens": 19966
      }
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "Between 2022 and 2024, Google's exposure to new regulatory costs in international markets evolved in both scope and nature. In 2022, the focus was on general regulatory risks such as anti-corruption laws, data privacy concerns, and foreign exchange controls, with international revenues accounting for approximately 54% of total revenue. By 2024, the scope broadened to include more specific and intensified challenges, such as geopolitical tensions (e.g., conflicts in the Middle East and Ukraine), sanctions, and export controls, with international revenues rising to 51% of total revenue. Additionally, the nature of regulatory challenges became more complex, incorporating evolving foreign policy landscapes, increased litigation risks, and heightened scrutiny around data protection and compliance with local laws in diverse jurisdictions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59699,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15160,
        "completion_tokens": 211,
        "total_tokens": 15371
      }
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "Between 2022 and 2023, UPS's approach to funding postretirement medical benefits remained consistent, with expected benefit payments being sourced from both plan trusts and corporate assets. No significant changes were introduced in the mix of funding sources during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44050,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11240,
        "completion_tokens": 69,
        "total_tokens": 11309
      }
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "NVIDIA AI Enterprise, introduced in 2022 as a comprehensive suite of enterprise-grade AI software, has evolved by 2024 to become more broadly integrated into NVIDIA's data center and AI solutions. Initially offered as a standalone software suite, it is now part of a full-stack AI platform that includes hardware (GPUs, CPUs, DPUs), networking, and software tools such as NVIDIA NIM, NeMo, and AI Blueprints. This integration enables enterprises to develop, deploy, and manage generative AI applications more efficiently, with enhanced scalability and performance across on-premises and cloud environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 39093,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9989,
        "completion_tokens": 151,
        "total_tokens": 10140
      }
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "From 2022 to 2024, ExxonMobil's proved reserves through equity companies increased from 467 million barrels of oil equivalent (BOE) in 2022 to 1,481 million BOE in 2024. This growth is primarily driven by significant additions in Asia, particularly in natural gas reserves, which rose to 4,242 billion cubic feet (equivalent to 1,276 million BOE). The strategic positioning reflects a focus on expanding natural gas resources in Asia, aligning with regional energy demand trends and long-term energy transition goals. This shift highlights ExxonMobil's emphasis on leveraging equity investments in high-growth, resource-rich regions to strengthen its global reserve portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47054,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11989,
        "completion_tokens": 169,
        "total_tokens": 12158
      }
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "The financial relationship with Google Network Partners between 2022 and 2024 shows that they remained a significant source of revenue generation, particularly through advertising on their properties. Revenues from Google Network properties are recognized on a gross basis, with amounts paid to partners recorded as cost of revenues. While specific figures for this relationship are not directly provided in the given pages, the 2024 document notes an increase in Google Services operating income driven by higher revenues, partially offset by increased content acquisition costs and TAC (traffic acquisition costs), which includes payments to Google Network partners. This suggests that while their role in revenue generation has grown, their impact on cost structure has also increased.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52730,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13410,
        "completion_tokens": 197,
        "total_tokens": 13607
      }
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "UPS's foreign currency exchange risk management strategy showed a notable shift in the financial impact of undesignated foreign currency forward contracts on earnings volatility between 2022 and 2023. In 2023, the company recognized a loss of $7 million from these undesignated contracts, compared to a significantly larger loss of $69 million in 2022. This reduction in the loss suggests a more stable or improved management of foreign currency exposure through these instruments in 2023, leading to lower earnings volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 159,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 38694,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9914,
        "completion_tokens": 131,
        "total_tokens": 10045
      }
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Between 2022 and 2023, Costco's membership format continued to play a central role in its profitability strategy by reinforcing member loyalty and generating consistent fee revenue. In 2022, membership fee revenue increased by 9% to $4,224, driven by new member sign-ups, Executive membership upgrades, and higher renewal rates. By 2023, this trend continued, with membership fee revenue rising 5% to $4,828, primarily due to new member sign-ups and Executive upgrades, although this growth was partially offset by one less week of membership fee income in 2023. This evolution highlights Costco's ongoing emphasis on expanding and retaining its membership base to sustain profitability through recurring fee revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83535,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21112,
        "completion_tokens": 179,
        "total_tokens": 21292
      }
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "NVIDIA's approach to CUDA has evolved significantly between 2022 and 2024, with a stronger emphasis on integration within the broader data center platform and software ecosystem. In 2022, CUDA was highlighted as a foundational parallel programming model that supports GPU-accelerated computing across diverse applications, including AI training and inference. By 2024, CUDA's role expanded as part of a full-stack computing infrastructure, with the introduction of the Blackwell architecture and the inclusion of CPUs and DPUs in the data center platform. This evolution reflects NVIDIA's strategy to unify hardware and software layers, enabling CUDA to support not only traditional GPU workloads but also large-scale AI and HPC applications across interconnected data center systems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 41217,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10529,
        "completion_tokens": 196,
        "total_tokens": 10725
      }
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid evolved significantly from 2023 to 2024. In 2023, Paxlovid revenues were $1,279 million, with a major portion tied to government contracts, while in 2024, revenues surged to $5,716 million as the product transitioned to commercial markets. The deferred revenues for Paxlovid decreased from $5.1 billion in 2023 to $2.2 billion in 2024, driven by product deliveries and a $771 million favorable adjustment in Q1 2024. Remaining performance obligations for Paxlovid were approximately $1 billion as of December 31, 2024, with expected deliveries from 2025 through 2028.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 97822,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24687,
        "completion_tokens": 161,
        "total_tokens": 24849
      }
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "ExxonMobil has significantly increased its strategic emphasis on Guyana between 2022 and 2024, as evidenced by its disclosures on reserves development and advantaged asset reporting. In 2022, Guyana was highlighted as a key area for future production growth, with reserves additions from discoveries and development activities. By 2024, Guyana is explicitly categorized as an \"advantaged asset\" within ExxonMobil's earnings driver framework, underscoring its role in driving volume growth and high returns. This evolution reflects the successful development of Guyana's Stabroek Block and its growing contribution to ExxonMobil's global production and reserves portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54768,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13917,
        "completion_tokens": 167,
        "total_tokens": 14085
      }
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "The planned utilization of the ATR 72-600F aircraft decreased significantly from 2022 to 2024. In 2022, FedEx planned to purchase 24 ATR 72-600F aircraft across 2023 to 2026, but by 2024, this number was reduced to just 10 aircraft, all scheduled for delivery in 2025. This reduction indicates a diminished role for the ATR 72-600F in the company's fleet strategy, suggesting a shift toward other aircraft types or a reassessment of the aircraft's strategic value in the company's operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39648,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10138,
        "completion_tokens": 123,
        "total_tokens": 10261
      }
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "NVIDIA's approach to offering Omniverse evolved significantly between 2022 and 2024, particularly in its integration with AI and simulation platforms. In 2022, Omniverse was described as a real-time 3D design collaboration and virtual world simulation software, primarily used for connecting design applications and enabling virtual simulations. By 2024, Omniverse had expanded to serve as a development platform and operating system for building and running virtual world simulation applications, with a stronger emphasis on integration with generative AI and NVIDIA's broader AI ecosystem. It was also highlighted as a key component in NVIDIA's autonomous vehicle development, providing synthetic data generation and simulation capabilities for AI model training and validation. This evolution reflects NVIDIA's broader strategy to unify AI, simulation, and real-time 3D workflows across industries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 41217,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10526,
        "completion_tokens": 225,
        "total_tokens": 10751
      }
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "Between 2022 and 2023, Google Play's role in generating non-advertising revenue continued to grow, driven by sales of apps, in-app purchases, and digital content. The 2023 filing highlights that non-advertising revenues, including Google Play, are increasingly contributing to overall revenue growth. Additionally, Google Play is mentioned as a key component of \"Google subscriptions, platforms, and devices\" revenue, which saw fluctuations influenced by customer demand and product launches. While specific revenue figures for Google Play are not provided, the overall increase in non-advertising revenue and the emphasis on platform growth suggest that Google Play remained a significant contributor to this segment in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37024,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9466,
        "completion_tokens": 181,
        "total_tokens": 9647
      }
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods in workers' compensation reserving for guaranteed cost and excess of deductible business evolved between 2022 and 2023 by extending the weight given to these methods for excess of deductible business to the most recent five accident years in 2023. In 2022, expected loss ratio methods for excess of deductible business were already given significant weight, but in 2023, this approach was reinforced to reflect updated assumptions about loss trends, rate changes, and market conditions. For guaranteed cost business, the methods remained primarily influential only in the most recent accident year, with continued emphasis on development methods due to the availability of historical claims data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 260,
          "pages": [
            258,
            259,
            260,
            261,
            262
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 268741,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 67420,
        "completion_tokens": 184,
        "total_tokens": 67604
      }
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Cisco restructured its product category segmentation. In fiscal 2022, the Collaboration category was part of a broader set of categories including Secure, Agile Networks, Internet for the Future, End-to-End Security, Optimized Application Experiences, and Other Products. By fiscal 2024, Cisco simplified its categories to Networking, Security, Collaboration, and Observability. The Collaboration category remained a distinct segment but saw a slight 2% revenue increase in fiscal 2024 compared to a 5% decline in fiscal 2022, reflecting some stabilization and growth in offerings like Collaboration Devices, Contact Center, and CPaaS, despite a dip in Meetings revenue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40770,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10413,
        "completion_tokens": 176,
        "total_tokens": 10590
      }
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "Amgen's disclosure regarding the 3.125% 2025 Notes remained consistent in terms of the notional amount of $1,000 million from 2022 to 2023. In 2022, the effective interest rate was LIBOR + 1.8%, while in 2023, it transitioned to SOFR + 2.1%, reflecting the shift from LIBOR to SOFR as the benchmark interest rate. This change aligns with broader market practices and regulatory transitions away from LIBOR.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44007,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11228,
        "completion_tokens": 101,
        "total_tokens": 11330
      }
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased from 764 BCF at the end of 2021 to 296 BCF at the end of 2024, according to the provided data. This growth is attributed to factors such as upward revisions due to improved regional LNG market dynamics and technical advancements, as well as extensions and discoveries in equity affiliates, particularly in the Middle East and Australia. The increase in reserves indicates a strategic focus on expanding COP's presence in this region, leveraging favorable market conditions and development opportunities in key areas like LNG.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 174,
          "pages": [
            172,
            173,
            174,
            175,
            176
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 77321,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19565,
        "completion_tokens": 150,
        "total_tokens": 19715
      }
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Alphabet's repurchase activity of Class C Capital Stock increased from $52.577 billion in 2022 to $52.868 billion in 2023, indicating a slight rise in the amount spent on repurchasing shares. This suggests that Alphabet continued to prioritize returning value to shareholders through share buybacks in 2023, reflecting a consistent and potentially more aggressive capital allocation strategy focused on optimizing equity and enhancing shareholder value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56665,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14395,
        "completion_tokens": 113,
        "total_tokens": 14508
      }
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "AIG's use of frequency/severity methods between 2022 and 2023 has evolved in terms of the lines of business where they are applied and the reasoning behind their usage. In 2022, frequency/severity methods were primarily used for short-tail classes such as U.S. Property, where the nature of losses is low frequency/high severity. These methods were not employed for aviation exposures due to the high severity nature of the claims and the varying mix of claims from year to year. By 2023, the application of frequency/severity methods remained consistent for short-tail lines like U.S. Property, but the reasoning emphasized the importance of adjusting IBNR factors based on emerging claim experience, rate changes, loss trends, and inflation. Additionally, the methods were not applied to aviation exposures for the same reasons as in 2022. The evolution reflects a continued focus on adapting these methods to align with the specific characteristics and emerging trends of each line of business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 298350,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 74820,
        "completion_tokens": 249,
        "total_tokens": 75069
      }
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "From 2022 to 2023, Amgen's financial relationship with BeiGene evolved as follows:\n\n1. **Cost Recovery**: Net costs recovered from BeiGene for oncology product candidates decreased from $199 million in 2022 to $109 million in 2023.\n2. **Product Sales**: Product sales from Amgen to BeiGene increased from $64 million in 2022 to $125 million in 2023.\n3. **Profit and Loss Sharing**: Profit and loss share expenses related to the initial product-specific commercialization period decreased from $53 million in 2022 to $40 million in 2023. \n\nThese changes reflect ongoing collaboration dynamics and shifts in cost and revenue sharing under their joint oncology development and commercialization agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47371,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12070,
        "completion_tokens": 175,
        "total_tokens": 12245
      }
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "From 2022 to 2024, COP's natural gas reserves in the Asia Pacific/Middle East region experienced notable changes. In 2022, reserves ended at 326 BCF, with upward revisions of 423 BCF due to higher prices and regional LNG market dynamics, partially offset by downward revisions from operating costs. In 2023, reserves declined to 296 BCF due to downward revisions of 81 BCF from lower prices, despite minor upward technical revisions. By 2024, reserves slightly increased to 296 BCF, with minor upward revisions of 9 BCF and no significant purchases or extensions in the region. No major purchases or sales occurred in the Asia Pacific/Middle East region during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 166,
          "pages": [
            164,
            165,
            166,
            167,
            168
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83130,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21020,
        "completion_tokens": 168,
        "total_tokens": 21188
      }
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "From 2022 to 2024, FedEx's planned usage of the B767F aircraft decreased significantly. In 2022, FedEx had committed to purchase 38 B767F aircraft across 2023 and 2024. However, by 2024, the number of B767F aircraft planned for purchase dropped to just 14 for 2025, with no commitments beyond 2026. This reduction indicates a strategic shift in fleet planning, likely driven by a focus on more fuel-efficient aircraft like the B777F and a reassessment of long-term operational needs and cost efficiencies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40108,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10247,
        "completion_tokens": 126,
        "total_tokens": 10373
      }
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "AIG's use of Expected Loss Ratio Methods between 2022 and 2023 evolved in terms of lines of business and reasoning as follows:\n\n1. **Lines of Business**: In 2022, Expected Loss Ratio methods were primarily applied to newer or less mature accident years, particularly in short-tail lines like U.S. Property and certain casualty segments. By 2023, the application expanded to include more recent accident years across a broader range of lines, including U.S. Workers' Compensation and Excess Casualty, where loss emergence is slower and historical data is limited.\n\n2. **Reasoning**: In 2022, the methods were used to supplement loss development techniques, especially in lines with inconsistent or insufficient historical loss data. By 2023, the methods were weighted more heavily in response to evolving market conditions, inflationary pressures, and changes in underwriting terms. The expected loss ratios were adjusted to reflect updated rate changes and emerging trends, particularly in lines with high severity and long-tail characteristics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 298350,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 74816,
        "completion_tokens": 261,
        "total_tokens": 75077
      }
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "Cisco's positioning around Enterprise Data Center Transformation from 2022 to 2024 has evolved to emphasize strategic alliances and a broader architectural approach to address the convergence of technologies in the data center. In 2022, the company highlighted the increasing competition from entities that were also strategic alliance partners, as the enterprise data center transformed through the integration of computing, networking, storage, and software. By 2024, Cisco expanded its strategic alliances with companies like Apple, Equinix, and Google, and emphasized a five-prong innovation strategy (build, buy, partner, invest, co-develop) to strengthen its competitive position. This evolution reflects a more proactive and diversified approach to maintaining leadership in the data center space amid a dynamic competitive landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 47206,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12030,
        "completion_tokens": 210,
        "total_tokens": 12240
      }
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "The effective interest rate for the 3.125% 2025 Notes changed from LIBOR + 1.8% in 2022 to SOFR + 2.1% in 2023, reflecting a transition from LIBOR to SOFR-based rates. The notional amount associated with the 3.125% 2025 Notes remained unchanged at $1,000 million between 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44959,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11457,
        "completion_tokens": 71,
        "total_tokens": 11528
      }
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "Cisco has significantly elevated AppDynamics' strategic positioning within its product portfolio from 2022 to 2024, particularly within its observability offerings. In 2022, AppDynamics was mentioned as a key element in delivering full-stack observability, alongside technologies like ThousandEyes. By 2024, AppDynamics, through the acquisition of Splunk, became a central component of the Observability product category, contributing to a 27% revenue increase in this category. This reflects a stronger emphasis on AppDynamics as a core offering for providing insights and analytics across hybrid and multicloud environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44521,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11358,
        "completion_tokens": 156,
        "total_tokens": 11514
      }
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The effective interest rate for the 4.663% 2051 Notes remained at 5.6% in both 2022 and 2023, while the notional amount stayed constant at $1.5 billion during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44959,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11456,
        "completion_tokens": 42,
        "total_tokens": 11499
      }
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "Between 2022 and 2023, AIG's use of expected loss ratio methods has evolved in terms of segmentation criteria and lines of business. In 2023, AIG emphasized higher attachment points in the U.S. Excess Casualty portfolio by adjusting participations in various layers within an insured's program. Additionally, for U.S. Workers' Compensation, AIG continued to use a combination of loss development and expected loss ratio methods, with segmentation by state, industry subset, and deductible size. The proportion of large deductible business has increased, which has slowed the reporting pattern of claims. These changes reflect a more refined approach to risk segmentation and underwriting strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 167731,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 42158,
        "completion_tokens": 174,
        "total_tokens": 42332
      }
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "PepsiCo's engagement with the 2.850% Senior Notes due 2026 remained consistent between 2023 and 2024, as these notes were authorized and referenced in both years' filings. In 2024, PepsiCo expanded its debt issuance strategy by introducing new senior notes, such as the 4.500% Senior Notes due 2029, the 4.800% Senior Notes due 2034, and the 5.250% Senior Notes due 2054, as part of its broader approach to managing debt maturity profiles and optimizing capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65856,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16703,
        "completion_tokens": 118,
        "total_tokens": 16821
      }
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Between fiscal years 2022 and 2024, Cisco's exposure to channel partner financing guarantees increased, with the maximum potential future payments rising from $188 million in 2022 to $127 million in 2024 (before accounting for deferred revenue adjustments). This evolution suggests that Cisco has maintained a measured approach to its financial risk management strategy, limiting the scale of its guarantees and ensuring that these obligations remain immaterial to its overall financial position. The company's continued facilitation of such guarantees reflects a strategic effort to support channel partners' working capital needs while prudently managing its own risk exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52651,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13395,
        "completion_tokens": 169,
        "total_tokens": 13565
      }
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "The 2.45% 2030 Notes were issued in 2020 with a coupon rate of 2.45%. In 2021, the company entered into interest rate swap contracts with a notional amount of $1.0 billion, effectively converting the fixed-rate coupon to a floating rate of LIBOR + 1.0%. By 2023, these swaps were updated to use SOFR as the reference rate, maintaining an effective interest rate of SOFR + 1.3% on a notional amount of $1,000 million. Thus, the interest rate structure evolved from LIBOR-based to SOFR-based swaps, reflecting the transition in benchmark rates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 131,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2023.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45207,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11514,
        "completion_tokens": 135,
        "total_tokens": 11649
      }
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "Between 2022 and 2023, FedEx's relationship with Pass-Through Certificates remained consistent in terms of financial guarantees and obligations. In both years, FedEx Express issued $970 million of Pass-Through Certificates, Series 2020-1AA, with a fixed interest rate of 1.875% due in February 2034. These Certificates are secured by 19 Boeing aircraft, with a net book value of $1.8 billion in 2022 and $1.7 billion in 2023. Crucially, the payment obligations under the Certificates are fully and unconditionally guaranteed by FedEx in both years, indicating no material change in the company's financial commitment or structure related to these instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46123,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11753,
        "completion_tokens": 164,
        "total_tokens": 11918
      }
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "From 2023 to 2024, Mastercard increased its use of risk mitigation arrangements to manage gross settlement exposure, as evidenced by the rise from $12,167 million in 2023 to $13,466 million in 2024. This increase indicates a more proactive approach to risk management, reflecting the company's efforts to enhance its safeguards against potential settlement failures and reduce net exposure. The evolution suggests a strategic focus on strengthening credit risk controls and adapting to changing risk environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67965,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17225,
        "completion_tokens": 128,
        "total_tokens": 17353
      }
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments decreased from $145 million as of May 31, 2023, to $146 million as of May 31, 2024, indicating a relatively stable exposure management strategy. This slight increase in liabilities suggests that Nike maintained a consistent approach to hedging foreign currency risks, particularly for key currency pairs like Euro/U.S. Dollar and Chinese Yuan/U.S. Dollar, despite fluctuations in exchange rates. The stability in liabilities reflects Nike's ongoing efforts to mitigate the impact of currency volatility on its financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63678,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16155,
        "completion_tokens": 157,
        "total_tokens": 16313
      }
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "Between the 2022 and 2023 10-K filings, the representation of Bounty within P&G's Baby, Feminine & Family Care segment remained consistent, as it was listed under the Family Care sub-category in both years. In 2022, the segment description noted Bounty as part of the North American family care business, while in 2023, it was similarly positioned. This consistent mention suggests stable brand visibility within the segment, with no significant changes in its role or emphasis.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51030,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12988,
        "completion_tokens": 119,
        "total_tokens": 13107
      }
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "Oracle's approach to its hardware business, particularly Oracle Engineered Systems, between fiscal 2022 and fiscal 2023 remained relatively consistent in terms of revenue recognition, with hardware revenues generally recognized at the point in time when the hardware product and related software are delivered to the customer and ownership is transferred. However, strategically, Oracle emphasized the importance of enabling customer choice and flexibility by facilitating migration of applications and infrastructure software licenses to Oracle Cloud Services. This reflects a broader strategic shift toward cloud-based offerings, even as the hardware business maintained its role in providing essential infrastructure technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50112,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12761,
        "completion_tokens": 183,
        "total_tokens": 12944
      }
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "Between 2022 and 2023, sales of ERLEADA increased by 26.9%, from $1.881 billion to $2.387 billion. This significant growth indicates a strong market trajectory for ERLEADA, driven by continued share gains and market expansion in the treatment of Metastatic Castration-Resistant Prostate Cancer.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37972,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9711,
        "completion_tokens": 73,
        "total_tokens": 9785
      }
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "From 2023 to 2024, CMCSA's relationship with local broadcast television stations has shifted toward increased financial dependency and negotiation challenges. Programming expenses for video services, including retransmission consent payments to local broadcast stations, have risen on a per-subscriber basis, driven by demands for higher payments and industry consolidation. This trend has heightened operational costs and reduced CMCSA's negotiating flexibility. Additionally, as consumers shift toward DTC streaming services like Peacock, CMCSA faces declining linear television viewership and subscriber losses, reducing the leverage traditionally held by broadcast stations. This evolving dynamic has placed CMCSA in a more vulnerable position, requiring it to balance higher costs with the need to adapt to changing distribution models and consumer preferences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56071,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14252,
        "completion_tokens": 216,
        "total_tokens": 14469
      }
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "The value of Held-to-Maturity (HTM) securities held by Mastercard (MA) decreased significantly from $306 million in 2023 to $38 million in 2024. This decline indicates a strategic shift in the company's investment approach, likely reallocating funds from short-term, interest-bearing time deposits to other investment vehicles such as available-for-sale securities or equity investments. The reduction in HTM securities suggests a potential pursuit of higher returns or greater flexibility in managing its investment portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56948,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14463,
        "completion_tokens": 131,
        "total_tokens": 14594
      }
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "Between 2022 and 2023, the Always brand remained within the Baby, Feminine & Family Care segment, specifically under the Feminine Care category. In 2022, Always was listed under the sub-category of \"Feminine Care (Adult Incontinence, Feminine Care)\" alongside Tampax. In 2023, the categorization was slightly refined, with Always explicitly positioned under the \"Feminine Care\" sub-category, which includes \"Adult Incontinence, Menstrual Care.\" This reflects a more specific product focus for Always, particularly on menstrual care, while continuing to include its role in adult incontinence under the Always Discreet sub-brand.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51030,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12996,
        "completion_tokens": 157,
        "total_tokens": 13153
      }
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "Between 2022 and 2023, Oracle's positioning and financial contribution of Oracle Engineered Systems, as part of its hardware business, remained relatively stable in terms of revenue contribution, representing 6% of total revenues in both fiscal 2023 and 2024. Revenue recognition for Oracle Engineered Systems, as part of hardware products, is generally recognized at the point in time when the hardware product and its related software are delivered to the customer and ownership is transferred. The strategic emphasis on hardware, including Oracle Engineered Systems, has been consistent with Oracle's broader focus on providing enterprise IT solutions, though the hardware business has lower operating margins compared to Oracle's cloud and license business due to higher production and support costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48685,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12401,
        "completion_tokens": 201,
        "total_tokens": 12602
      }
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Comcast's relationship with representation firms in advertising sales has shifted slightly between 2023 and 2024. In 2023, the company noted that it works with representation firms as an extension of its sales force to sell a portion of advertising units allocated to it, recording revenue net of agency commissions. By 2024, the description of this relationship remained largely consistent, but the emphasis on representation firms was reduced, with a greater focus on internal sales efforts and direct advertising sales. This suggests a potential slight reduction in reliance on representation firms in favor of internal sales strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55440,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14076,
        "completion_tokens": 160,
        "total_tokens": 14236
      }
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle's approach to its industry-specific hardware offerings between fiscal 2022 and fiscal 2023 remained relatively consistent in terms of revenue recognition, with revenues for hardware products and related software generally recognized at the point in time when the hardware is delivered to the customer and ownership is transferred. However, strategically, Oracle emphasized a continued focus on cloud services over hardware, as evidenced by the decline in hardware's contribution to total revenues (6% in both fiscal 2024 and 2023, but with a marginal decrease in hardware revenues from $3,359 million in fiscal 2022 to $3,183 million in fiscal 2023). The company also highlighted the challenges of hardware's lower operating margins and the competitive pressure from cloud infrastructure offerings, signaling a strategic shift toward cloud-based solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50112,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12759,
        "completion_tokens": 215,
        "total_tokens": 12975
      }
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "Sales of IMBRUVICA (ibrutinib) declined by 13.7% in 2023 compared to 2022, driven by operational growth of -13.2% and a negative currency impact of 0.5%. This decrease was primarily attributed to global competitive pressures facing the drug.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38934,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9949,
        "completion_tokens": 60,
        "total_tokens": 10010
      }
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "From 2023 to 2024, Comcast's involvement with Universal Beijing Resort remained consistent in terms of ownership structure, as Comcast retained a 30% interest. The debt levels slightly decreased, with Universal Beijing Resort's outstanding debt dropping from $3.5 billion in 2023 to $3.4 billion in 2024. Financial risk exposure remained unchanged, as Comcast's maximum risk of loss is limited to its 30% equity stake, with no additional guarantees or liquidity arrangements in place.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51941,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13210,
        "completion_tokens": 121,
        "total_tokens": 13331
      }
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "From 2022 to 2023, the financial commitment related to future lease payments for build-to-suit facilities and equipment increased significantly. In 2022, the undiscounted future payments for these leases were approximately $3.4 billion, expected to commence between 2023 and 2024. By 2023, this amount had decreased to approximately $0.9 billion, with commencement dates expected from 2025 to 2027. This shift indicates that FedEx is likely adopting a more measured and long-term leasing strategy, delaying the commencement of new build-to-suit leases and spreading out capital commitments over a longer timeframe.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47989,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12230,
        "completion_tokens": 153,
        "total_tokens": 12383
      }
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "Mastercard's relationship with Dynamic Yield LTD evolved from an acquisition in 2022 to being integrated into the company's strategic focus on enhancing its value-added services and solutions. The acquisition of Dynamic Yield for $325 million in 2022, which added capabilities in data personalization and customer engagement, indicates Mastercard's emphasis on expanding its offerings in digital solutions and improving customer experience. This aligns with the growth in Mastercard's value-added services and solutions revenue, which increased from $9,274 million in 2023 to $10,832 million in 2024, reflecting the company's strategic focus on diversifying its revenue streams and investing in technologies that support digital transformation and customer-centric innovation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52033,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13234,
        "completion_tokens": 194,
        "total_tokens": 13428
      }
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Lowe's Companies, Inc. Severance Plan for Senior Officers was amended and restated on May 26, 2022, as indicated in the 2024 filing (page 79). The most recent amendment is referenced in Exhibit 10.28, which was filed on November 27, 2024, showing an update to the plan since the 2022 version.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36727,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9407,
        "completion_tokens": 74,
        "total_tokens": 9481
      }
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $830 million as of December 31, 2021, to $872 million as of December 31, 2023. This increase indicates that market perceptions of the company's debt improved over this period, as higher fair value relative to par suggests stronger investor confidence and lower perceived credit risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44329,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11320,
        "completion_tokens": 86,
        "total_tokens": 11407
      }
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "Between 2022 and 2023, IMBRUVICA's sales declined by 13.7%, from $3.784 billion to $3.264 billion. This decline was attributed to global competitive pressures, indicating that IMBRUVICA is facing increasing competition in the oncology segment, which is affecting its market position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37972,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9714,
        "completion_tokens": 70,
        "total_tokens": 9785
      }
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million (as of January 28, 2022) to $427 million (as of January 31, 2025), while the LCNRV reserve decreased from $168 million (as of January 28, 2022) to $222 million (as of January 31, 2025). A 10% change in the shrink reserve would have impacted net earnings by approximately $31 million in 2022 and $32 million in 2024, indicating a growing sensitivity to shrinkage. In contrast, the LCNRV reserve had a smaller and more stable impact on net earnings during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 37123,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9498,
        "completion_tokens": 137,
        "total_tokens": 9635
      }
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "From 2022 to 2023, Qulipta transitioned from an indefinite-lived intangible asset to a commercialized product. In 2022, it was part of AbbVie’s IPR&D assets, but by 2023, it received regulatory approvals in the U.S. and the EU for the preventive treatment of chronic migraine. This led to a significant financial contribution, with Qulipta’s net revenues increasing by over 100% in 2023 due to strong market share uptake and commercialization success.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48563,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12363,
        "completion_tokens": 112,
        "total_tokens": 12476
      }
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with reimbursements collected from Resideo amounting to $140 million in both years. This indicates that the risk exposure related to environmental liabilities has been effectively mitigated through the indemnification and reimbursement agreement with Resideo, as the company continues to receive predictable and capped compensation for costs incurred at designated sites.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 84693,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21405,
        "completion_tokens": 125,
        "total_tokens": 21530
      }
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target's definition of \"original maturity\" for cash equivalents has remained consistent between 2022 and 2024, with both years defining cash equivalents as highly liquid investments with an original maturity of three months or less from the time of purchase. However, the composition of cash and cash equivalents has shifted, with a notable decrease in short-term investments from $4,985 million in 2022 to $3,893 million in 2024. This suggests a potential shift in cash management strategy toward maintaining more liquidity in cash and receivables rather than investing in short-term instruments, possibly to enhance operational flexibility or respond to changing market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43152,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11022,
        "completion_tokens": 170,
        "total_tokens": 11193
      }
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "The valuation and classification of NVDA's 3.50% Notes Due 2040 remained consistent between 2023 and 2024, with a carrying value of $1,000 million in both years. This stability indicates that the company has not repaid or restructured these long-term debt instruments, suggesting a strategy of maintaining long-term fixed-rate debt to manage its capital structure and interest costs over an extended period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41288,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10550,
        "completion_tokens": 101,
        "total_tokens": 10651
      }
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Between 2022 and 2023, Venclexta's total global revenue increased by 15%. In the United States, revenue grew by 8%, driven by market growth, share uptake, and favorable pricing, while international revenue rose by 22%, attributed to market share gains and growth across all indications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45207,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11522,
        "completion_tokens": 71,
        "total_tokens": 11594
      }
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "Between 2022 and 2023, Netflix amended its Executive Severance and Retention Incentive Plan, with the Amended and Restated version effective as of January 1, 2024, as disclosed in the 2023 filing. This update reflects a formal revision to the plan, indicating a continued focus on structured executive compensation and retention strategies. No such amendment was explicitly noted in the 2022 filing, suggesting that the 2023 change represents a recent evolution in the company's approach to executive incentives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46537,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11866,
        "completion_tokens": 128,
        "total_tokens": 11994
      }
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "From 2022 to 2024, Lowe's documentation of its Benefit Restoration Plan evolved by being formally referenced in the 2024 10-K filing (Exhibit 10.3) as \"Lowe's Companies Benefit Restoration Plan, as amended and restated as of January 1, 2025.\" This indicates a formalized and updated structure for the plan, aligning it with broader retirement benefits strategies. The continued existence and documentation of the plan suggest that Lowe's remains committed to supplementing retirement benefits for employees whose compensation is limited by IRS regulations, reflecting a strategic approach to maintaining competitive and comprehensive retirement offerings for eligible employees.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47355,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12070,
        "completion_tokens": 169,
        "total_tokens": 12239
      }
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA's financial obligations related to the 0.584% Notes Due 2024 were $1,250 million as of January 28, 2024 (fiscal year 2024). By January 26, 2025 (fiscal year 2025), these obligations were fully repaid, as indicated by the $0 balance for the 0.584% Notes Due 2024. This reflects the repayment of the notes in fiscal year 2025, as noted in the document.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41288,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10535,
        "completion_tokens": 88,
        "total_tokens": 10624
      }
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Between 2022 and 2023, Mavyret's global revenue slightly decreased by 7.2% (from $1,541 million in 2022 to $1,430 million in 2023). In the United States, revenue declined by 12.7% (from $755 million in 2022 to $659 million in 2023), while international markets saw a minor decline of 1.9% (from $786 million in 2022 to $771 million in 2023).",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 45465,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11593,
        "completion_tokens": 85,
        "total_tokens": 11678
      }
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "Between 2022 and 2024, Netflix remained in compliance with the covenant limitations related to its Senior Notes, with no material changes in the scope of restrictions. The covenants continued to limit the Company's ability to create liens, consolidate or merge, engage in sale and lease-back transactions, and incur additional indebtedness for certain subsidiaries. As of both December 31, 2024 and December 31, 2023, Netflix was in compliance with all related covenants, indicating consistent adherence to the repayment obligations and restrictions outlined in the debt agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44769,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11424,
        "completion_tokens": 145,
        "total_tokens": 11569
      }
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "Between 2022 and 2023, Honeywell restructured its Safety and Retail product line by merging the Safety and Retail business unit with the Advanced Sensing Technologies business unit to form the Sensing and Safety Technologies business unit. This structural change, announced in July 2022, reflects a strategic evolution to consolidate and streamline safety-related offerings under a unified business unit focused on sensing and safety technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52263,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13293,
        "completion_tokens": 111,
        "total_tokens": 13405
      }
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "Between 2023 and 2024, the status and role of Class B-2 Common Stock evolved primarily through its convertibility into Class A Common Stock. As of September 30, 2024, 49 shares of Class B-2 Common Stock were outstanding, compared to none in 2023, indicating the emergence of this class following a Class B-1 Common Stock exchange offer. Class B-2 Common Stock, like Class B-1, is convertible into Class A Common Stock, and its conversion would increase the number of Class A shares outstanding, diluting the voting power of existing Class A stockholders. This conversion dynamic impacts corporate governance by potentially altering voting control and aligning the interests of Class B-2 holders with Class A stockholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57820,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14679,
        "completion_tokens": 180,
        "total_tokens": 14859
      }
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "Between 2023 and 2024, The Home Depot enhanced the ease of the shopping experience by expanding both digital and in-store capabilities. In 2023, the company focused on improving store navigation, self-checkout options, and mobile app features such as store-specific maps to help customers locate items. Investments in store technology, including self-service lockers and curbside pickup, were also highlighted. In 2024, the company continued these efforts with further investments in store design, including wayfinding signage, electronic shelf labels, and enhanced front-end areas. Additionally, the company expanded its digital capabilities by improving the interconnected shopping experience, focusing on personalized marketing, and enhancing the functionality of its website and mobile apps. These efforts were aimed at creating a seamless, frictionless experience across all customer touchpoints.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52527,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13355,
        "completion_tokens": 225,
        "total_tokens": 13580
      }
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "From 2022 to 2024, the Target Corporation Long-Term Incentive Plan evolved by introducing new forms of equity awards. In 2022, the plan included awards such as Restricted Stock Units (RSUs), Performance-Based RSUs, and Performance Share Units. By 2024, the plan expanded to include additional award structures, such as Cliff-Vested RSUs and Performance Award Performance Share Units, as outlined in the 2024 10-K filings. These changes reflect a broader approach to long-term incentives, incorporating both time-based and performance-based vesting mechanisms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45916,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11709,
        "completion_tokens": 139,
        "total_tokens": 11849
      }
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Qulipta's commercial performance showed significant growth from its FDA approval in 2021 through 2023. In 2021, Qulipta had no prior-year revenue, and by 2022, its net revenues increased by more than 100%. In 2023, Qulipta's net revenues again increased by more than 100%, driven by strong market share uptake and market growth, as well as the regulatory approval for the preventive treatment of chronic migraine in adults in April 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 43072,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10985,
        "completion_tokens": 109,
        "total_tokens": 11094
      }
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "Between the 2022 and 2024 SEC filings, Netflix's treatment and disclosure of the 2020 Stock Plan show a structural shift and reduced activity. In 2022, the plan included both stock options and restricted stock units (RSUs), with significant stock-based compensation expenses of $575.5 million. By 2024, no new stock options or RSUs were granted in 2023 and 2022, and the focus shifted to vesting and compensation expenses from prior grants, with total stock-based compensation expense decreasing to $272.6 million. The 2024 filing also highlights a decline in the number of unvested RSUs and PSUs, indicating a reduction in active equity compensation activities under the 2020 Stock Plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51484,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13108,
        "completion_tokens": 172,
        "total_tokens": 13280
      }
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "Between 2022 and 2023, Boeing classified its aluminum purchase agreements as derivative instruments for accounting purposes, as these agreements were priced at prevailing market rates and did not qualify for hedge accounting treatment. In 2022, the company noted that these agreements were part of its long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the strategic use of these derivatives remained consistent, with Boeing continuing to hold aluminum contracts and foreign currency forward contracts, though the notional amounts for aluminum contracts decreased from $412 million in 2022 to $115 million in 2023. The fair value of these contracts was determined using an income approach based on market prices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43113,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11010,
        "completion_tokens": 186,
        "total_tokens": 11196
      }
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "Between 2023 and 2024, the disclosure of the Directors' Code of Conduct remained consistent in terms of accessibility, as it continued to be posted on BNY Mellon's website at the same URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. There was no indication of changes to the scope or content of the Directors' Code of Conduct during this period, and the company maintained its commitment to disclosing amendments or waivers on its website.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34739,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8906,
        "completion_tokens": 125,
        "total_tokens": 9032
      }
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "Between 2023 and 2024, the structure and value of HD's 4.95% Senior Notes evolved significantly. In 2023, the company issued $750 million of 4.95% Senior Notes due September 2026, while in 2024, HD issued $1.75 billion of 4.95% Senior Notes due June 2034 and $750 million of 4.95% Senior Notes due September 2026. This shift indicates a strategic move to extend the maturity of its long-term debt, potentially to lock in favorable interest rates and manage refinancing risk over a longer horizon.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52423,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13329,
        "completion_tokens": 124,
        "total_tokens": 13453
      }
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "Between 2021 and 2023, Intel recognized $471 million in observable price adjustments for its investment in Beijing Unisoc Technology Ltd. in 2021, and the net book value of the investment remained stable at $1.1 billion as of both December 30, 2023, and December 31, 2022. This indicates that while there was a valuation adjustment in 2021, the net book value of the investment did not change significantly over the subsequent two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42308,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10812,
        "completion_tokens": 109,
        "total_tokens": 10922
      }
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "AbbVie's engagement with Qulipta evolved significantly from 2022 to 2023 in terms of regulatory and commercial development. In 2022, Qulipta was newly launched in the U.S. for chronic migraine, as indicated by its minimal net revenues ($158 million). By 2023, Qulipta achieved substantial commercial growth, with U.S. net revenues reaching $405 million and international revenues of $408 million, reflecting strong market adoption. Regulatory progress included FDA approval in April 2023 for chronic migraine and EC approval in August 2023 for migraine prevention in the EU, marking key milestones in its global expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43192,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11018,
        "completion_tokens": 155,
        "total_tokens": 11174
      }
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "Between 2022 and 2023, Boeing's framing of 'upgrades and conversions' within the Global Services segment remained consistent in its core description but showed a subtle shift in strategic emphasis. In 2022, the focus was on sustaining aerospace platforms through a full spectrum of services, including upgrades and conversions, as part of a broader lifecycle support strategy. By 2023, the language highlighted leveraging an extensive services network to span the lifecycle of defense and commercial aircraft programs, with upgrades and conversions explicitly positioned as part of efforts to grow market share through customer satisfaction and productivity. This suggests a more proactive and growth-oriented approach in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39812,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10181,
        "completion_tokens": 181,
        "total_tokens": 10363
      }
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Intel's investment in Beijing Unisoc Technology Ltd. had a net book value of $1.1 billion as of both December 30, 2023, and December 31, 2022. In 2021, Intel recognized $471 million in observable price adjustments for this investment, indicating a valuation increase during that year. No significant changes in valuation or impairment charges were noted for 2022 and 2023, suggesting the investment remained stable in value during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54211,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13782,
        "completion_tokens": 110,
        "total_tokens": 13892
      }
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "Between 2023 and 2024, the role of Self-Service Lockers within Home Depot's interconnected shopping experience has expanded as part of the company's efforts to enhance convenience and fulfillment options for customers. In fiscal 2023, Home Depot introduced self-service lockers at the front entrance of many stores to enable convenient online order pickup. By fiscal 2024, these lockers were integrated into the broader suite of customer fulfillment options, complementing services like curbside pickup and forming part of the company's strategy to provide a seamless, multi-channel shopping experience. This evolution reflects Home Depot's continued investment in optimizing store-based fulfillment to meet customer demand for speed and flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50562,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12854,
        "completion_tokens": 187,
        "total_tokens": 13041
      }
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities in 2024 shows increased specificity compared to 2023. In 2023, the disclosure briefly mentions that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. In 2024, the disclosure expands to clarify that these estimates are not discounted and are based on historical claims experience, demographic factors, severity factors, and other actuarial assumptions, while also noting the unpredictability of claim costs due to factors like inflation and regulatory changes. This evolution reflects a more detailed explanation of the methodology and associated risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36650,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9388,
        "completion_tokens": 182,
        "total_tokens": 9571
      }
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "The financial impact of the Aldevron acquisition on inventory-related costs evolved from 2022 to 2023 as follows: In 2021, the acquisition of Aldevron resulted in $76 million in inventory fair value adjustment charges included in the cost of sales. By 2022, these acquisition-related inventory charges had decreased, as noted in the $59 million reduction in cost of sales from fair value adjustments to inventory related to Aldevron. In 2023, the impact of these charges was further reduced and no longer a significant factor, as the year-over-year decrease in cost of sales was primarily driven by lower sales volumes and an $87 million inventory charge in the Biotechnology segment unrelated to Aldevron. Thus, the financial impact of the Aldevron acquisition on inventory-related costs diminished from 2022 to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51391,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13059,
        "completion_tokens": 204,
        "total_tokens": 13263
      }
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "Between 2023 and 2024, Costco's treatment and recognition of shop card liabilities remained consistent, with the company accounting for outstanding shop card balances as a shop card liability, net of estimated breakage, included in other current liabilities in the consolidated balance sheets. There is no indication of a material change in the methodology or estimation of these liabilities during the period. This consistency suggests that Costco maintains a stable and predictable approach to managing unclaimed balances on shop cards, relying on historical redemption data to estimate breakage and recognizing revenue upon redemption.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42643,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10887,
        "completion_tokens": 159,
        "total_tokens": 11046
      }
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "From 2022 to 2023, Intel's Foundry Services (IFS) evolved significantly in strategic partnerships and customer engagement. In 2023, IFS secured four design wins on Intel 18A, including a major high-performance computing customer with a large prepayment, and five new design wins in advanced packaging, particularly for AI-related designs. The IFS Accelerator Ecosystem Alliance program doubled in size to over 40 strategic agreements, including multigenerational partnerships with ARM and Synopsys to support chip design on Intel’s process nodes. Additionally, IFS expanded its RAMP-C program partnerships with the U.S. Department of Defense, enabling customers like Nvidia and Microsoft to develop and fabricate chips on Intel 18A. In 2022, the foundation was laid with the launch of the IFS Accelerator program and initial strategic partnerships, but 2023 marked a significant acceleration in ecosystem development and customer commitments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34237,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8793,
        "completion_tokens": 235,
        "total_tokens": 9029
      }
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "Between 2022 and 2023, DHR's relationship with Aldevron remained significant in terms of goodwill and net cash consideration. In 2021, the Aldevron acquisition resulted in $6.1 billion in goodwill and a net cash consideration of $9.561 billion. By 2023, the goodwill related to Aldevron remained unchanged at $6.1 billion, as no adjustments were mentioned for that specific acquisition. However, in 2023, DHR's overall goodwill increased due to the Abcam Acquisition, but Aldevron's contribution remained consistent. The net cash consideration for Aldevron also remained stable, with no new transactions or adjustments reported in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50740,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12908,
        "completion_tokens": 159,
        "total_tokens": 13067
      }
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The maturity date of the AT&T Inc. 1.800% Global Notes has extended from September 14, 2039, as listed in the 2022 SEC filing, to September 5, 2026, as listed in the 2024 SEC filing. This indicates a shift in the company's debt structure toward shorter-term maturities, potentially reflecting a strategy to refinance long-term debt, manage interest rate risk, or align with evolving capital needs and market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42322,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10806,
        "completion_tokens": 104,
        "total_tokens": 10911
      }
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target remained in compliance with its debt leverage covenant in both 2023 and 2024, as noted in both years' filings, with no practical effect on its ability to pay dividends. In 2024, the company modified its credit facility structure by obtaining a new $1.0 billion 364-day unsecured revolving credit facility in October 2024, replacing the prior 364-day facility and extending the maturity of its existing $3.0 billion facility to October 2028. These changes likely contributed to maintaining covenant compliance by enhancing liquidity and providing flexibility in managing debt obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38337,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9811,
        "completion_tokens": 148,
        "total_tokens": 9960
      }
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023 by integrating its RISE strategy with expanded external collaboration initiatives. In 2022, Intel emphasized digital readiness through programs like AI for Youth and AI for Workforce, in partnership with governments and institutions. By 2023, these efforts were further expanded under the RISE Technology Initiative, which aimed to deepen relationships with customers and partners to create shared value. The 2023 strategy also focused on making technology more inclusive while addressing broader societal challenges such as health, safety, and climate change, reflecting a more comprehensive and collaborative approach to digital readiness.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51538,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13116,
        "completion_tokens": 184,
        "total_tokens": 13301
      }
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson's relationship with Micromine began in 2022 when AspenTech, a subsidiary of Emerson, entered into an agreement to acquire Micromine for approximately $623 million. However, the acquisition did not proceed, and on August 1, 2023, AspenTech announced the termination of the agreement due to regulatory uncertainties in Russia. No termination fee was paid. Financially, the failed acquisition led to expenses related to foreign currency forward contracts, which resulted in a mark-to-market gain of $56 in 2023, but no direct acquisition costs were incurred in 2024. Thus, the relationship ended without a financial commitment to finalize the acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39265,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10035,
        "completion_tokens": 165,
        "total_tokens": 10200
      }
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) decreased from 17 million shares in 2022 to 15 million shares in 2023. The average purchase price of shares during the fiscal year also decreased from $305.14 in 2022 to $277.19 in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43115,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11009,
        "completion_tokens": 69,
        "total_tokens": 11078
      }
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "Between 2022 and 2023, the pattern of impairment triggers and associated charges across DHR's business segments shows a shift in risk exposure within its intangible asset portfolio. In 2022, there were no impairment charges recorded for intangible assets. However, in 2023, impairment triggers were identified in the Biotechnology segment during Q2 and in both the Diagnostics and Biotechnology segments during Q4, leading to impairment charges of $77 million. This indicates a growing risk exposure in the Biotechnology segment, likely due to market or operational challenges, while the Diagnostics segment also faced renewed pressures after a period of stability in 2022. The shift suggests a reallocation of risk from the Diagnostics segment to the Biotechnology segment, potentially driven by evolving market dynamics or performance issues in newer acquisitions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54732,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13923,
        "completion_tokens": 216,
        "total_tokens": 14140
      }
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 (as of January 30, 2022) to $598 million in 2023 (as of January 28, 2024). This increase suggests a higher level of business activity or commitments tied to trade contracts, potentially reflecting expanded operations or more extensive supplier agreements in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43447,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11099,
        "completion_tokens": 96,
        "total_tokens": 11196
      }
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "The 0.300% Notes due 2028 were first disclosed in IBM's 2023 SEC filing (page 20 of IBM_10k_2023.pdf) as part of the list of instruments defining the rights of security holders, filed under Form 8-K on February 10, 2020. In the 2024 SEC filing (page 1 of IBM_10k_204.pdf), the Notes are again listed under the company's registered securities, confirming their continued existence and trading status on the New York Stock Exchange under the symbol IBM28B. This consistency in disclosure indicates that IBM maintains transparent and up-to-date reporting of its financial instruments, adhering to SEC requirements and providing investors with ongoing visibility into its debt structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56209,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14277,
        "completion_tokens": 170,
        "total_tokens": 14448
      }
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "In 2023, IBM's 1.750% Notes due 2031 were disclosed as being registered on the New York Stock Exchange under the trading symbol \"IBM31\" in the 10-K filing. In 2024, the same notes were again listed under the same trading symbol and exchange in the updated 10-K, indicating no change in registration status. However, the 2024 filing includes updated references to the instruments defining the rights of the holders, reflecting ongoing compliance and disclosure practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56209,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14274,
        "completion_tokens": 117,
        "total_tokens": 14391
      }
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "Eli Lilly's financial relationship with Zyprexa evolved significantly between 2023 and 2024, primarily through the sale of the rights for the olanzapine portfolio, which includes Zyprexa. In 2023, Zyprexa revenue was $1,694.8 million, with $1,615.4 million generated outside the U.S. This was driven by the sale of the rights for the olanzapine portfolio. By 2024, Zyprexa revenue is not explicitly listed, but the sale of these rights would have shifted revenue recognition to the point of sale, impacting the business model by transitioning from ongoing product sales to a one-time transaction. This change reflects a strategic shift in how revenue from Zyprexa is recognized, moving from recurring sales to a lump-sum recognition upon the sale of rights.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48167,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12265,
        "completion_tokens": 189,
        "total_tokens": 12454
      }
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "The Mobility Preferred Interests were fully repurchased by AT&T by April 2023, eliminating any outstanding obligations by December 31, 2023. In 2023, these interests were reclassified from equity to a liability at fair value, impacting earnings per share calculations by contributing 72 shares to diluted EPS. By 2024, with no remaining interests outstanding, they no longer affected diluted EPS, as reflected in the absence of related shares in the 2024 EPS reconciliation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67381,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17079,
        "completion_tokens": 118,
        "total_tokens": 17198
      }
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "Between 2023 and 2024, IBM's 0.875% Notes due 2030 remained listed on the New York Stock Exchange under trading symbol IBM30A, as disclosed in both the 2023 and 2024 10-K filings. However, in the 2024 filing, there is no new registration or supplemental indenture specifically mentioned for these notes, suggesting their terms and registration status remained unchanged from prior years. The 2024 filing reflects continued incorporation by reference of prior indentures, including those related to similar debt instruments, but no material evolution in the listing or registration status of the 0.875% Notes due 2030 is indicated.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56209,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14275,
        "completion_tokens": 157,
        "total_tokens": 14432
      }
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "From 2023 to 2024, the structure and distribution terms of the Telco Preferred Interests evolved with the addition of new classes and adjustments to reset schedules. In 2023, the Telco preferred interests included Telco Class A-1 (4.25% annual distribution, reset every seven years) and Telco Class A-2 and A-3 (6.85% annual distribution, reset every seven years starting November 1, 2027). In 2024, AT&T announced plans to issue an additional $2,250 of Telco Class A-4 preferred interests with an initial distribution rate of 5.94% annually, subject to reset every four years starting November 1, 2028. This evolution indicates AT&T's strategic use of preferred equity instruments to diversify its financing structure, manage cost of capital through adjustable rates, and align with long-term liquidity needs while maintaining flexibility in cash flow and dividend policies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69569,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17626,
        "completion_tokens": 218,
        "total_tokens": 17845
      }
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One's risk exposure under loss sharing agreements with government-sponsored enterprises (GSEs) related to multifamily commercial real estate loans increased between 2022 and 2023. As of December 31, 2023, the liability recognized on the consolidated balance sheets for these agreements was $137 million, compared to $82 million as of December 31, 2022. This increase indicates a higher level of risk exposure associated with these loans during 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 217,
          "pages": [
            215,
            216,
            217,
            218,
            219
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48829,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12446,
        "completion_tokens": 114,
        "total_tokens": 12561
      }
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "From 2022 to 2023, Amazon's co-branded credit card programs remained a notable part of its payment-related risks, with no explicit mention of a strategic shift in their significance. However, the 2023 filing highlights increased regulatory scrutiny and compliance obligations tied to evolving data security, consumer protection, and payment processing rules. These new obligations could lead to higher operational costs, potential penalties, or disruptions if Amazon fails to comply with changing payment card association rules or regulatory interpretations. The potential impact on operating results includes higher fees, fines, or loss of payment processing capabilities if compliance challenges arise.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55026,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13999,
        "completion_tokens": 176,
        "total_tokens": 14175
      }
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "Between 2022 and 2024, PM's financial relationship with RBH evolved significantly, particularly regarding consolidation and valuation. In 2022, RBH had been deconsolidated from PM's financial statements since March 2019 due to its CCAA proceedings, and PM accounted for its remaining investment in RBH as an equity security without readily determinable fair value. By 2024, PM evaluated its investment in RBH for impairment and concluded that its estimated fair value was lower than its carrying value. As a result, PM recorded a $2,316 million non-cash impairment charge, reducing the carrying value of its investment in RBH to $714 million, based on a discounted cash flow analysis and assumptions about the allocation of the global settlement amount and tax deductibility in Canada.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50540,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12869,
        "completion_tokens": 196,
        "total_tokens": 13065
      }
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "Baqsimi's financial performance and strategic positioning evolved significantly between 2023 and 2024. In 2023, Baqsimi contributed $677.6 million in total revenue, a substantial increase from $139.3 million in 2022, indicating a notable rise in its revenue contribution. This growth was primarily driven by increased demand and higher realized prices in the U.S. Additionally, in 2023, Baqsimi was part of a $579.0 million sale of rights in the U.S., which further enhanced its strategic value within LLY's product portfolio. By 2024, while specific revenue figures for Baqsimi were not provided, its role as a high-growth product and its inclusion in significant business development activities underscored its importance in LLY's strategic focus on expanding its diabetes and endocrinology offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47033,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11990,
        "completion_tokens": 200,
        "total_tokens": 12190
      }
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "From 2022 to 2024, the composition of Union Pacific's Total Highway Revenue Equipment shifted significantly in favor of owned equipment. In 2022, the company owned 48,962 containers and 29,875 chassis, while leasing 1,856 containers and 14,148 chassis. By 2024, the number of owned containers increased to 46,375 (a decrease of 2,587) and owned chassis rose to 4,356 (an increase of 1,363), while leased containers dropped to 288 (a decrease of 1,568) and leased chassis fell to 1,197 (a decrease of 12,951). This indicates a substantial reduction in leased chassis and a shift toward a more owned-heavy composition in highway revenue equipment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 31391,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8077,
        "completion_tokens": 161,
        "total_tokens": 8238
      }
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Between 2022 and 2023, Capital One's use of securitized debt obligations increased slightly as part of its overall funding structure. As of December 31, 2022, securitized debt obligations totaled $16.97 billion, and by December 31, 2023, they rose to $18.04 billion. These obligations represented a smaller portion of the company's total funding sources compared to deposits and other debt but remained a consistent component of its liquidity and capital management strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 210,
          "pages": [
            208,
            209,
            210,
            211,
            212
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47982,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12223,
        "completion_tokens": 118,
        "total_tokens": 12342
      }
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, LLY's revenue from Zyprexa shifted significantly in both source and recognition method. In 2023, Zyprexa revenue was primarily derived from product sales, with $79.4 million in U.S. revenue and $1,615.4 million from international sales. However, in 2024, the source of Zyprexa revenue transitioned to collaboration and other revenue, specifically from the sale of rights for the olanzapine portfolio, which was recognized as collaboration and other revenue when control of the asset transferred to the other party. This change reflects a shift from ongoing product sales to a one-time transaction involving intellectual property rights.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46486,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11844,
        "completion_tokens": 164,
        "total_tokens": 12008
      }
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "The valuation methodology for Federal Government Securities in the pension plan has remained consistent from 2022 to 2024, as they are classified as Level 2 investments and valued using a bid evaluation process with bid data from independent pricing sources. However, the classification of these securities within the overall asset allocation has shifted due to a strategic de-risking approach, with a reduction in equity allocation and an increase in debt securities, including Federal Government Securities, to align with updated target ranges of 70–80% debt and 20–30% equity in 2025 compared to 45–55% equity and debt in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 42472,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10835,
        "completion_tokens": 157,
        "total_tokens": 10992
      }
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "From 2022 to 2023, Capital One maintained a consistent utilization of credit scores for product segmentation decisions, as both years show similar credit score distributions for domestic credit card and auto loan portfolios. In 2022, 69% of domestic credit card borrowers had scores above 660, and in 2023, this slightly decreased to 68%. For auto loans, the percentage of borrowers with scores above 660 remained stable at 53%. This consistency suggests that Capital One's credit risk modeling strategy prioritizes maintaining a balanced risk profile across its consumer loan portfolios, leveraging credit scores to segment products and manage risk effectively without significant shifts in underwriting criteria.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46819,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11935,
        "completion_tokens": 178,
        "total_tokens": 12114
      }
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "From 2022 to 2023, AWS has maintained its position as a core strategic pillar for Amazon, with continued emphasis on its role in driving technological innovation and supporting broader business growth. In 2023, AWS remains a distinct business segment, reflecting its importance in generating revenue through on-demand technology services such as compute, storage, and machine learning. The 2023 filing highlights AWS's role in underpinning Amazon's technology infrastructure and its ongoing investment in expanding capabilities, consistent with 2022 disclosures. Notably, AWS's leadership structure and operational focus remain unchanged, with Adam N. Selipsky as CEO and continued prioritization of innovation and enterprise services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46450,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11837,
        "completion_tokens": 183,
        "total_tokens": 12021
      }
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved significantly in terms of accounting treatment and financial exposure. In 2022, RBH was deconsolidated from PMI's financial statements due to its entry into CCAA proceedings to address Canadian tobacco litigation. PMI no longer consolidated RBH's results after March 22, 2019. By 2024, a proposed settlement plan in the CCAA proceedings outlined a CAD 32.5 billion global settlement, with unresolved allocation among RBH and its co-defendants. This uncertainty led PMI to record a $2,316 million non-cash impairment charge in 2024 for its investment in RBH, as the estimated fair value fell below its carrying value. Thus, PMI's exposure shifted from litigation-related charges to a significant impairment due to the potential settlement of Canadian tobacco claims.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40277,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10308,
        "completion_tokens": 224,
        "total_tokens": 10532
      }
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "From 2022 to 2024, Biktarvy has maintained a significant commercial role for Gilead, contributing substantial revenue. In 2022, Biktarvy generated $8,624 million in product sales, and while specific 2024 revenue figures are not provided, its continued prominence in Gilead's HIV portfolio suggests sustained commercial importance. However, associated product risks include increasing competition, potential pricing pressures from government programs like the Inflation Reduction Act, and the need for ongoing innovation to maintain market share. These factors could impact Biktarvy's future revenue growth and profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 80533,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20356,
        "completion_tokens": 156,
        "total_tokens": 20512
      }
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.8 billion in 2023 to $1.9 billion in 2024, reflecting a rise in the value of its 37.03% economic interest. Car hire expenses also increased from $399 million in 2023 to $432 million in 2024, indicating higher operational usage of TTX rail cars.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40027,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10235,
        "completion_tokens": 77,
        "total_tokens": 10312
      }
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "Tesla shifted its approach to scaling Solar Roof production from 2022 to 2023 by expanding installer training initiatives and enhancing supply chain risk management. In 2022, Tesla focused on onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. By 2023, the company emphasized structured training programs, such as the Engineering Development Program launched in January 2024, targeting specialized engineering talent and enhancing skills in high-demand manufacturing technologies. Additionally, Tesla improved supply chain risk management by diversifying localized procurement, addressing component shortages, and increasing resilience against global disruptions like the semiconductor shortage and geopolitical uncertainties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 44801,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11427,
        "completion_tokens": 199,
        "total_tokens": 11627
      }
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "Between 2022 and 2023, The Coca-Cola Company continued to manufacture and sell fountain syrups directly to authorized fountain wholesalers and fountain retailers in the United States, as bottlers in the U.S. are generally not authorized to manufacture fountain syrups. This arrangement remained consistent, with the Company handling the production and distribution of fountain syrups, which are then sold or delivered to restaurants and other retailers either directly or through authorized wholesalers. There is no indication of a significant change in this structure during the specified period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48978,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12476,
        "completion_tokens": 149,
        "total_tokens": 12625
      }
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "IBM's 0.950% Notes due 2025 are disclosed as registered securities on the New York Stock Exchange under the trading symbol \"IBM25B\" in both the 2022 and 2024 10-K filings. In 2024, the Notes are explicitly listed in the \"Securities registered pursuant to Section 12(b) of the Act\" section, confirming their classification as a registered debt instrument. In 2022, while the Notes were not explicitly detailed in the provided pages, the general treatment of similar instruments (e.g., 7.00% Debentures) suggests consistent classification and registration practices. Thus, the Notes have remained classified as registered debt instruments with no material evolution in their disclosure or classification between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 35885,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9200,
        "completion_tokens": 181,
        "total_tokens": 9381
      }
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "From 2022 to 2024, Gilead's strategic positioning of Biktarvy in the HIV treatment market has evolved to emphasize competitive differentiation through its efficacy and tolerability profile, which has helped maintain its market leadership. However, the company faces increasing financial risk exposure due to pricing pressures from government programs like the Inflation Reduction Act of 2022 and growing competition from generic and branded alternatives. These factors have heightened the need for Gilead to balance innovation and cost management while defending Biktarvy's value proposition in a rapidly evolving regulatory and competitive landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58847,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14944,
        "completion_tokens": 162,
        "total_tokens": 15107
      }
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued to reduce its defined benefit pension obligations by transferring additional pension liabilities to insurance companies. In 2022, the company transferred $4.3 billion of gross defined benefit pension obligations to an insurance company for approximately 13,600 retirees and beneficiaries, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, Lockheed Martin made a voluntary offering to certain former employees, resulting in $414 million in lump-sum settlement payments for approximately 6,500 participants, which reduced the benefit obligation without recognizing a settlement charge. These actions reflect the company's ongoing strategy to mitigate the financial impact of its defined benefit pension plans by reducing volatility and the size of its net pension obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58945,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14971,
        "completion_tokens": 211,
        "total_tokens": 15183
      }
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "Between 2022 and 2024, the composition of IBM's debt instruments maturing in 2025 remained consistent regarding the 2.875% Notes due 2025. In both years, these notes were listed as securities registered under Section 12(b) of the Securities Exchange Act of 1934, traded under the symbol \"IBM25A\" on the New York Stock Exchange. There is no indication of changes in the terms or structure of these notes during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 40262,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10283,
        "completion_tokens": 105,
        "total_tokens": 10389
      }
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "From 2022 to 2024, Biktarvy has emerged as a pivotal product within Gilead's HIV portfolio, driven by its continued growth and resilience amid competitive pressures and market challenges. In 2022, Biktarvy's sales increased due to higher demand and a favorable pricing environment, partially offsetting declines from Truvada and Atripla following their loss of exclusivity. By 2024, Biktarvy's strategic importance has further solidified as it remains a key driver of Gilead's HIV business, with ongoing efforts to expand its indications, such as the approval of a pediatric formulation in 2021. However, the risk profile has also evolved, as Biktarvy faces potential competition from new therapies and the broader shift in treatment paradigms, including the emergence of long-acting HIV treatments like lenacapavir. Additionally, pricing pressures from government and third-party payers continue to pose a risk to its profitability and market share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56002,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14236,
        "completion_tokens": 237,
        "total_tokens": 14473
      }
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "Between the end of fiscal year 2022 and the end of fiscal year 2023, the balance of the U.S. litigation escrow account increased from $1,449 million to $1,764 million. During fiscal year 2023, there were deposits of $1,000 million into the account, while payments amounted to $685 million. In contrast, during fiscal year 2022, the balance increased from $983 million to $1,449 million, with $850 million deposited and $418 million in payments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 46430,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11842,
        "completion_tokens": 111,
        "total_tokens": 11953
      }
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "Between 2022 and 2023, the role of fountain syrups in Coca-Cola's North America operating segment remained consistent in terms of manufacturing and distribution responsibilities. The company continued to manufacture fountain syrups in the United States and sell them to fountain retailers or authorized fountain wholesalers and bottling partners, who then distribute them to fountain retailers for use in producing beverages for immediate consumption. These activities remained part of the North America operating segment, with no significant changes in the described responsibilities during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41555,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10622,
        "completion_tokens": 151,
        "total_tokens": 10773
      }
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "Between 2022 and 2024, IBM's debt instruments maturing in 2025 remained consistent in terms of the 0.950% Notes due 2025, as both the 2022 and 2024 10-K filings list these notes as registered securities. No changes in the composition or structure of the 0.950% Notes due 2025 are indicated in the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 40262,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10283,
        "completion_tokens": 78,
        "total_tokens": 10361
      }
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "Between 2022 and 2024, Disney's strategic approach to cruise ships evolved from focusing on operational recovery and cost realignment to pursuing expansion and new investment opportunities. In 2022, Disney emphasized cost realignment and introduced an ad-supported Disney+ service, while in 2024, the company announced plans for additional expansion of its cruise ship fleet, highlighting a shift toward growth and capital investment in the cruise segment as part of broader Experiences and Products initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62823,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15921,
        "completion_tokens": 128,
        "total_tokens": 16049
      }
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "From 2022 to 2023, Lockheed Martin's approach to pension risk transfer transactions evolved by continuing to execute these transactions to mitigate the volatility of pension obligations, as outlined in both the 2022 and 2023 filings. In 2022, the company had already completed a significant pension risk transfer transaction in August 2021, transferring $4.9 billion in pension obligations to an insurance company, which reduced plan volatility for 18,000 retirees. By 2023, the company reiterated its intent to explore additional risk transfer opportunities, though no new large-scale transactions were disclosed. Strategically, the company aimed to reduce its exposure to pension liabilities and stabilize future cash flows, while acknowledging that future transactions could result in noncash settlement charges. Financially, these actions helped reduce the need for future pension contributions and the impact of actuarial assumptions on earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61618,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15629,
        "completion_tokens": 237,
        "total_tokens": 15866
      }
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "Between 2022 and 2023, Tesla's relationship with its financing partners has evolved in terms of accounts receivable management and leasing program risks. In 2023, Tesla highlighted increased exposure to credit risk due to potential defaults in its vehicle and solar energy system financing programs, especially in the event of economic downturns. Additionally, Tesla noted the challenges of managing accounts receivable due to fluctuations in customer payments and government rebate timelines. Regarding leasing program risks, Tesla emphasized the importance of accurately projecting residual values for leased vehicles, as any significant deviation could reduce profitability. The company also acknowledged the need to secure adequate financing and business partners to support the growth of its leasing programs, indicating a more cautious approach to managing residual risk and credit exposure in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54858,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13941,
        "completion_tokens": 230,
        "total_tokens": 14172
      }
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "Between 2022 and 2023, Coca-Cola shifted its fountain syrup distribution strategy by increasing the role of authorized fountain wholesalers and bottling partners in distributing fountain syrups to retailers. Previously, in the United States, the Company primarily manufactured and sold fountain syrups directly to authorized fountain wholesalers and some fountain retailers. In 2023, the strategy evolved to involve bottling partners more actively in the distribution process, allowing them to sell and distribute fountain syrups to fountain retailers. This change aimed to enhance distribution efficiency and align with the broader goal of optimizing the Coca-Cola system's production, marketing, and distribution capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48978,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12472,
        "completion_tokens": 182,
        "total_tokens": 12654
      }
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved with an increase in receivables from $9 million to $12 million and a new investment activity of a $17 million equity contribution in proportion to AMD's 15% ownership. Additionally, AMD provided a $100 million term loan to one of the ATMP JVs in October 2024, secured by the JV's receivable balance due from AMD.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46812,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11925,
        "completion_tokens": 97,
        "total_tokens": 12022
      }
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "Between 2022 and 2023, Lockheed Martin continued to manage its nonqualified defined benefit pension plans by reducing the size and volatility of its net pension obligations. In 2023, the company made a voluntary settlement offering to approximately 6,500 former employees who had not yet started receiving their vested benefits, resulting in $414 million in lump-sum payments from the pension trust and a corresponding reduction in the pension obligation. This followed a similar approach in 2022, where the company transferred $4.3 billion in pension obligations to an insurance company through group annuity contracts, recognizing a $1.5 billion noncash pension settlement charge. These actions reflect a strategic shift to mitigate financial risks and reduce the burden of pension liabilities on the company's financial statements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58945,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14974,
        "completion_tokens": 208,
        "total_tokens": 15182
      }
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "Between 2023 and 2024, AMD's investment in the ATMP JV increased from $99 million to $149 million, reflecting an additional $17 million contribution in 2024. Additionally, AMD's equity income from the ATMP JV rose from $16 million in 2023 to $33 million in 2024, indicating an improvement in the venture's performance during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49877,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12688,
        "completion_tokens": 84,
        "total_tokens": 12773
      }
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson significantly reduced its ownership stake in Kenvue. In May 2023, Kenvue completed its IPO, after which Johnson & Johnson retained approximately 89.6% ownership. On August 23, 2023, Johnson & Johnson further divested 80.1% of its Kenvue shares through an exchange offer, reducing its ownership to 9.5%. This exchange resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By May 2024, Johnson & Johnson completed a Debt-for-Equity Exchange of its remaining Kenvue shares for commercial paper, resulting in a loss of approximately $0.4 billion and effectively ending its ownership in Kenvue.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38392,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9829,
        "completion_tokens": 169,
        "total_tokens": 9998
      }
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "Based on the provided document pages, AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. is referenced in the 2022 filing (page 134) under \"4-c Guaranty of certain obligations,\" which includes Southwestern Bell Telephone Co. as one of the entities whose obligations are guaranteed. However, in the 2023 filing (pages 101-105), there is no explicit mention of Southwestern Bell Telephone Co. in the context of guarantee agreements. This suggests that Southwestern Bell Telephone Co. was included in AT&T's guarantee agreements in 2022 but was not specifically listed in 2023, indicating a potential evolution or restructuring of the guarantee relationships between 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41260,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10545,
        "completion_tokens": 176,
        "total_tokens": 10721
      }
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "Lockheed Martin's involvement in hypersonics programs from 2022 to 2023 has seen a strategic shift toward early production phases, with the company performing on multiple hypersonics programs and anticipating that several will enter early production by 2026. In 2022, the company emphasized its role in advanced development programs, including hypersonics, under its Skunk Works division. By 2023, the focus had evolved to include specific hypersonics programs with the U.S. Army and Navy, highlighting progress in design, development, and production. This evolution reflects a stronger strategic positioning in the hypersonics domain, aligning with the broader 21st Century Security vision and growth initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51597,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13126,
        "completion_tokens": 178,
        "total_tokens": 13304
      }
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "The balance of the U.S. litigation escrow account increased from $1.4 billion as of September 30, 2022, to $1.764 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while $1.000 billion was deposited during fiscal year 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51562,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13121,
        "completion_tokens": 69,
        "total_tokens": 13190
      }
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "From 2022 to 2024, Outdoor Garden's role within HD's product strategy has slightly declined in terms of sales contribution. In 2022, Outdoor Garden accounted for 6.8% of net sales, while in 2024, it represented 6.5%. Despite this slight decrease in percentage, Outdoor Garden remains a key component of the Hardlines major product line, indicating its continued strategic importance in the company's merchandising structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40722,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10403,
        "completion_tokens": 106,
        "total_tokens": 10509
      }
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD has maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024 by sustaining a culture of inclusivity, innovation, and respect, as reflected in high employee engagement scores. The company conducts annual surveys to measure culture and engagement, with 2024 results showing continued top 10% performance among high-tech peers. AMD also prioritizes diversity, belonging, and inclusion through initiatives like Employee Resource Groups (ERGs) and programs such as \"Advancing Women in Technology.\" Additionally, AMD offers competitive total rewards, flexible work arrangements, and robust development opportunities, including mentoring and leadership programs. This strategy suggests that AMD is proactively investing in talent retention by fostering a supportive and innovative workplace, which is critical in the competitive semiconductor industry for attracting and retaining top talent.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47246,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12054,
        "completion_tokens": 235,
        "total_tokens": 12290
      }
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "Based on the provided document pages, there is no specific information indicating any changes or evolution in AT&T's relationship with The Ohio Bell Telephone Company between 2022 and 2023 in terms of guarantee obligations. The pages reference historical guarantees for subsidiaries, including The Ohio Bell Telephone Company, but do not provide details about modifications or updates to these obligations during the specified period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41260,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10537,
        "completion_tokens": 108,
        "total_tokens": 10645
      }
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "Between 2023 and 2024, the financial impact of GE's relationship with AerCap showed a significant decline in gains on retained and sold ownership interests. In 2023, gains on retained and sold ownership interests increased by $5.7 billion, primarily driven by investments in GE HealthCare and AerCap. However, in 2024, these gains decreased by $5.2 billion, largely due to a decline in gains related to the same AerCap and GE HealthCare investments. This shift reflects a notable reduction in the positive financial contributions from these investments in the subsequent year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62250,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15786,
        "completion_tokens": 144,
        "total_tokens": 15930
      }
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "Home Depot's strategic use of HD Supply between 2022 and 2024 has evolved to further support its focus on professional customers and MRO (Maintenance, Repair, and Operations) services. HD Supply, primarily through its MRO business, has been instrumental in serving the needs of multifamily, hospitality, healthcare, and government facilities. In 2024, Home Depot continued to leverage HD Supply to provide a broader range of MRO products and value-added services, enhancing its offerings to professional customers. Additionally, the acquisition of SRS in 2024 complemented HD Supply's role by expanding Home Depot's reach into the professional market, particularly in roofing, landscaping, and pool services, thereby strengthening its ecosystem for Pros.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53549,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13609,
        "completion_tokens": 188,
        "total_tokens": 13798
      }
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "Between 2023 and 2024, AMD's patent portfolio grew from approximately 18,500 patent matters worldwide (12,800 issued patents and 5,600 pending applications) in 2023 to approximately 18,800 patent matters in 2024 (13,200 issued patents and 5,600 pending applications). This indicates a slight increase in the size of AMD's patent portfolio, with a rise in issued patents. The company continues to rely on cross-licensing and technology exchange agreements, which are typical in the semiconductor industry, to both transfer and receive technology and intellectual property rights. This growth in the patent portfolio enhances AMD's ability to engage in such agreements and supports its ongoing innovation and product development.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47246,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12039,
        "completion_tokens": 181,
        "total_tokens": 12221
      }
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "From 2023 to 2024, Johnson & Johnson's financial stake in Kenvue evolved significantly. In August 2023, following an exchange offer, Johnson & Johnson retained a 9.5% ownership stake in Kenvue, valued at $4.3 billion. By May 2024, the company completed a Debt-for-Equity Exchange, using its remaining Kenvue shares to satisfy $3.6 billion in commercial paper, resulting in Johnson & Johnson no longer owning any shares of Kenvue. This disposal led to a $0.4 billion loss recorded in Other (income) expense. The strategic relationship transitioned from post-separation services under transition agreements to full divestiture by mid-2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37355,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9570,
        "completion_tokens": 159,
        "total_tokens": 9730
      }
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "Based on the provided information, AT&T's relationship with Indiana Bell Telephone Co. Inc. in terms of inclusion in guarantee disclosures remained consistent between 2022 and 2023. In both years, Indiana Bell Telephone Co. Inc. was listed among the subsidiaries whose obligations were guaranteed by AT&T, as noted in the 2023 and 2022 10-K filings under the relevant guarantee disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41260,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10537,
        "completion_tokens": 97,
        "total_tokens": 10634
      }
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "From 2023 to 2024, GE's financial relationship with AerCap evolved as follows: \n\nIn 2023, GE reported gains on retained and sold ownership interests of $5.7 billion, which included activities related to its AerCap investment. By 2024, these gains had decreased by $5.2 billion, indicating a reduction in investment gains from AerCap. Additionally, GE paid net cash of $203 million to AerCap in 2023 for ongoing sales, leases, and transition services. As of December 31, 2023, GE's equity and note investment in AerCap had an estimated fair value of $944 million, down from $7,403 million in 2022, reflecting a decline in the valuation of its stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64407,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16318,
        "completion_tokens": 162,
        "total_tokens": 16480
      }
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "From 2022 to 2024, The Home Depot has evolved its approach to store appearance and competition by enhancing the interconnected shopping experience through digital integration and store improvements. Investments in store navigation tools, self-checkout options, and mobile app features have improved customer convenience and satisfaction. Additionally, the company has focused on integrating digital and in-store experiences, such as curbside pickup and self-service lockers, to meet evolving customer expectations. These efforts reinforce Home Depot's competitive edge by combining a modern, efficient store appearance with seamless digital capabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48206,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12278,
        "completion_tokens": 163,
        "total_tokens": 12442
      }
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "Between 2023 and 2024, AMD's financial relationship with the ATMP JV evolved with increased resales and a new financial arrangement. In 2024, AMD's resales to the ATMP JV rose to $121 million from $14 million in 2023. Additionally, in October 2024, AMD provided a $100 million one-year term loan to one of the ATMP JVs, secured by the JV's receivable balance due from AMD, indicating a new financial support arrangement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44440,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11331,
        "completion_tokens": 105,
        "total_tokens": 11436
      }
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson has enhanced its privacy compliance programs to address evolving privacy laws and international data flow regulations. In 2023, the Company acknowledged the growing risks of new privacy laws, data localization requirements, and international data transfers, emphasizing the need for established privacy compliance programs and controls. By 2024, the Company expanded on these efforts, highlighting increased enforcement of privacy laws globally and the risks posed by unauthorized access and cross-border data flow restrictions. It reinforced its commitment to maintaining privacy compliance through mandatory employee training, structured third-party risk management, and ongoing assessments to adapt to legislative changes and regulatory expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42582,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10875,
        "completion_tokens": 198,
        "total_tokens": 11074
      }
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "Between 2023 and 2024, GE's financial exposure to Bank BPH saw a decrease in estimated total borrower litigation losses, from $2,669 million as of December 31, 2023, to $2,461 million as of December 31, 2024. Additionally, the related valuation allowances also decreased, with $1,517 million and $1,712 million of the allowances attributed to estimated borrower litigation losses in 2024 and 2023, respectively. This reduction reflects the impact of the settlement program initiated in 2023, which fully offset the financing receivables balance as of December 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64639,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16385,
        "completion_tokens": 142,
        "total_tokens": 16528
      }
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024 by maintaining consistent net sales performance while being reclassified into the \"Hardlines\" major product line in 2024. In 2022, Indoor Garden accounted for 6.4% of net sales ($10,105 million), and by 2024, it represented 6.6% ($10,519 million), showing stable financial performance. In 2024, the merchandising department structure was reorganized, placing Indoor Garden under the Hardlines category, which also includes Hardware, Outdoor Garden, and Power. This repositioning reflects a strategic realignment to better categorize and manage product lines for internal reporting and decision-making.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40722,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10413,
        "completion_tokens": 173,
        "total_tokens": 10586
      }
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "From 2022 to 2024, Colgate-Palmolive has maintained a sourcing strategy to manage cost volatility and commodity price fluctuations by combining cost containment measures, sourcing strategies, productivity initiatives, and selective commodity hedging contracts. In 2022, the company used futures contracts, primarily in the Hill's Pet Nutrition segment, to hedge against raw material volatility, while in 2024, it emphasized ongoing efforts to manage disruptions in the global supply chain and mitigate inflationary pressures through price increases, cost efficiencies, and limited use of hedging. The evolution reflects a continued focus on proactive risk management amid ongoing market uncertainties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39667,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10141,
        "completion_tokens": 175,
        "total_tokens": 10316
      }
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "TREMFYA's sales performance improved between 2023 and 2024, with sales increasing by 16.6% in 2024 compared to a 17.9% increase in 2023. This growth was driven by market expansion, share gains in psoriasis and psoriatic arthritis (PsO/PsA), and continued product strength. In 2024, operational growth contributed 18.1%, partially offset by a 1.5% negative currency impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40184,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10258,
        "completion_tokens": 93,
        "total_tokens": 10351
      }
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "The structural change in Disney's relationship with A&E from 2022 to 2023 involved Disney no longer consolidating A+E Television Networks (A+E) in its financial statements, as it transitioned from a 50% equity investment to a joint venture accounted for under the equity method. This change affected Disney's reporting by reducing the direct inclusion of A+E's subscriber numbers and financial results within Disney's consolidated figures. Instead, Disney now reports its share of A+E's income or loss as \"Equity in the income (loss) of investees, net\" in its Consolidated Statements of Operations. Subscriber data for A+E channels is also disclosed separately, rather than being fully integrated into Disney's consolidated subscriber metrics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 34637,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8883,
        "completion_tokens": 185,
        "total_tokens": 9068
      }
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "In 2023, GE reported a realized and unrealized gain of $129 million related to its investment in and note with AerCap. By 2024, GE had fully monetized its AerCap shares, leaving only an AerCap senior note as its remaining position, indicating the financial impact of the relationship had diminished significantly, with no further gains or losses reported for 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63693,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16145,
        "completion_tokens": 91,
        "total_tokens": 16236
      }
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Between 2022 and 2024, Mastercard has enhanced its multi-layered security approach by expanding collaboration with third-party service providers and integrating advanced security measures to address emerging threats. In 2024, the company explicitly mentions working with third-party providers to monitor and respond to cyber and physical threats, indicating a more proactive stance in securing the ecosystem. This evolution reflects Mastercard's strategic response to increasingly complex cybersecurity risks by embedding stronger protections and leveraging partnerships to ensure the integrity of its global payments network.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43063,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11019,
        "completion_tokens": 156,
        "total_tokens": 11176
      }
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Between 2022 and 2023, Target Corporation remained in compliance with its debt leverage covenant under its credit facilities. In 2023, Target obtained a new $1.0 billion 364-day unsecured revolving credit facility and extended its existing $3.0 billion unsecured facility to October 2028, enhancing its liquidity and covenant flexibility. The company confirmed its ongoing compliance with these covenants as of February 3, 2024, and expects to remain in compliance, despite changes in credit facilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35370,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9066,
        "completion_tokens": 125,
        "total_tokens": 9192
      }
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "From 2023 to 2024, the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, has evolved to include increased regulatory scrutiny, ethical concerns, and operational complexities. In 2023, the risks primarily focused on the ethical implications of AI, such as potential impacts on human rights, privacy, and employment, as well as the challenges of ensuring accurate and unbiased AI outputs. By 2024, the risks expanded to include the introduction of new laws and regulations, such as the EU's AI Act and the Digital Services Act (DSA), which impose additional compliance burdens. Additionally, the development of generative AI products like Agentforce introduced new risks related to data provenance, content accuracy, and the potential for generating copyrighted or harmful content, requiring increased investment in compliance, governance, and model development.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63348,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16057,
        "completion_tokens": 229,
        "total_tokens": 16286
      }
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "Between fiscal years 2023 and 2024, Lowe's significantly enhanced its delivery capabilities for parcel-eligible items. In 2023, most such items could be delivered within two business days at standard shipping rates. By 2024, the company expanded its fulfillment capacity, maintaining the two-day delivery standard while also enabling same-day delivery for certain products through its gig provider network. Additionally, Lowe's achieved next-day delivery for major appliances in nearly every U.S. zip code by 2024, reflecting improvements in its supply chain and distribution infrastructure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46526,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11849,
        "completion_tokens": 147,
        "total_tokens": 11997
      }
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The financial impact of the Dermstore LLC sale on Target's consolidated revenues and operating income was minimal in both 2022 and 2023. According to the 2021 10-K, Dermstore represented less than 1% of consolidated revenues, operating income, and net assets at the time of its sale in February 2021. The 2023 10-K reaffirms this negligible impact, with no further material changes or contributions to revenues or operating income in subsequent years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33016,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8474,
        "completion_tokens": 112,
        "total_tokens": 8587
      }
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "Between 2023 and 2024, Data Cloud has evolved to become a more integral component of Salesforce's broader service offerings, emphasizing its role in unifying and connecting customer data across systems, apps, and devices to create a comprehensive view of customers. In 2023, Data Cloud was positioned as a hyperscale, trusted data engine native to Salesforce, enabling organizations to deliver personalized customer experiences. By 2024, it was highlighted as a core part of the Einstein 1 Platform, which allows customers to connect data and build AI-powered apps with low-code capabilities, thereby delivering entirely new CRM experiences. This evolution reflects Salesforce's strategic focus on leveraging Data Cloud to enhance AI integration, drive automation, and support digital transformation across industries.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53833,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13687,
        "completion_tokens": 204,
        "total_tokens": 13891
      }
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "Between 2023 and 2024, LOW's treatment and accounting of forward interest rate swap contracts remained consistent in terms of hedge designation and financial impact. In both years, forward interest rate swap agreements were designated as cash flow hedges, with no notional amounts outstanding as of the reporting periods (February 2, 2024, and January 31, 2025). The financial impact from these contracts was primarily realized through settlements upon issuance of debt, with $247 million received in 2024 and $143 million and $136 million received in 2023 for prior-year contracts. Gains and losses from these hedges were recorded in other comprehensive income, with minimal net earnings impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43558,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11117,
        "completion_tokens": 174,
        "total_tokens": 11291
      }
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "From 2022 to 2023, Target's strategy around its owned brands has evolved to place a stronger emphasis on differentiation and curated assortments. In 2022, the focus was on \"strengthening our owned brands portfolio\" and expanding \"signature partnerships.\" By 2023, the strategy explicitly highlights \"differentiating from our competition with our owned brands and a curated assortment of leading national brands,\" reflecting a more deliberate effort to use owned brands as a key competitive advantage. The strategic objective shifted toward leveraging owned brands not just for value but as a central pillar for market differentiation and guest engagement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 25468,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6585,
        "completion_tokens": 163,
        "total_tokens": 6748
      }
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "From 2022 to 2023, GM's approach to software-enabled services has expanded significantly, with a focus on enhancing its end-to-end software platform and scaling digital solutions. In 2023, the company emphasized its OnStar services, Super Cruise driver assistance technology, and a broader suite of software-defined features, apps, and services available over-the-air. This includes active safety, infotainment, connectivity, and driver assistance features, with plans to roll out additional features like security, climate, and comfort options. The deployment of these services is expanding across GM's product lineup, with select vehicles already utilizing the platform. This evolution indicates a strong investment in scalable digital solutions to enhance customer experience and support GM's transition to an all-electric and software-driven future.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55420,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14096,
        "completion_tokens": 213,
        "total_tokens": 14309
      }
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category increased from fiscal 2022 to fiscal 2023. In fiscal 2022, revenue from this category was $729 million, and it grew to $837 million in fiscal 2023, representing an increase of $108 million or approximately 15%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41825,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10683,
        "completion_tokens": 82,
        "total_tokens": 10765
      }
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "Amendment No. 4 to the Lockheed Martin Executive Severance Plan was disclosed in the 2023 10-K as Exhibit 10.34, incorporated by reference from a 2022 quarterly report. In the 2024 10-K, it was renumbered to Exhibit 10.36, indicating a reorganization of exhibits. This evolution suggests a systematic updating and reclassification of executive compensation-related disclosures, reflecting a more structured and transparent inclusion in the company's regulatory filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55683,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14162,
        "completion_tokens": 117,
        "total_tokens": 14279
      }
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "From 2023 to 2024, JPMorgan's Tier 1 leverage ratio remained stable at 7.2%, meeting the regulatory requirement of 4.0%. The Standardized CET1 capital ratio increased slightly from 15.0% in 2023 to 15.7% in 2024, both well above the minimum regulatory requirement of 11.4%. This indicates strong compliance with capital ratio requirements during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54351,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13817,
        "completion_tokens": 89,
        "total_tokens": 13906
      }
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "Between 2022 and 2023, GM Financial remained a distinct reportable segment within General Motors' consolidated financial statements, with its performance evaluated through EBT-adjusted due to the significance of interest income and expense in its operations. The 2023 filings show continued integration with the parent company, as GM Financial's financial results are consolidated into the overall financial statements, with adjustments made for deferred tax positions and intercompany transactions. There is no indication of a material change in its role or presentation during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83723,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21166,
        "completion_tokens": 147,
        "total_tokens": 21314
      }
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "Between 2022 and 2024, Costco's treatment and disclosure of step-rent provisions in lease accounting remained consistent. Step-rent provisions, including periodic rent increases based on price indices or sales volume, are recognized as variable lease payments. These increases are not subject to straight-line recognition but are accounted for as they occur, reflecting the actual variable payments stipulated in the lease agreements. This approach was disclosed in both the 2022 and 2024 10-K filings, with no material changes in methodology or additional disclosures noted in the provided pages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43614,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11142,
        "completion_tokens": 149,
        "total_tokens": 11291
      }
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "From 2023 to 2024, the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans show a slight decrease in the amount expected to be paid out in 2025, from $1,860 million in 2023 to $1,800 million in 2024. Additionally, the long-term obligations from 2029 to 2033 decreased from $10,020 million in 2023 to $9,990 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49302,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12571,
        "completion_tokens": 90,
        "total_tokens": 12662
      }
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "Between 2023 and 2024, JPMorgan Chase's disclosures on resolution plan obligations highlighted a more detailed emphasis on liquidity risk management strategies and funding cost considerations. In 2023, the disclosures outlined general factors impacting liquidity, such as market stress, funding source limitations, and regulatory requirements like the liquidity coverage ratio and net stable funding ratio. By 2024, the disclosures expanded to include more specific strategies for addressing liquidity constraints, such as managing deposit outflows, pre-positioning liquidity in subsidiaries, and the potential need to raise funding from alternative, potentially more expensive sources. Additionally, 2024 emphasized the impact of external regulatory developments, such as proposed Basel III reforms and changes to the GSIB surcharge, on funding costs and liquidity planning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53595,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13636,
        "completion_tokens": 218,
        "total_tokens": 13854
      }
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Between 2022 and 2023, the financial structure of Optum Rx's pharmacy care services showed notable changes in revenue recognition and accounts receivable. Revenue recognition remained consistent with prescriptions being recognized when dispensed, based on negotiated fees and net of rebates. However, accounts receivable increased from $7.1 billion in 2022 to $8.6 billion in 2023, indicating a rise in amounts due from customers for pharmacy products and services. This increase may reflect higher transaction volumes or timing differences in receivables collection. Additionally, pharmaceutical manufacturer rebates receivable also increased from $8.2 billion in 2022 to $11.0 billion in 2023, suggesting greater rebate accruals due to expanded drug usage or contractual terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56881,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14445,
        "completion_tokens": 194,
        "total_tokens": 14640
      }
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "Between 2022 and 2024, UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps remained consistent in purpose but showed some changes in execution. In 2022, UPS used interest rate swaps to convert fixed-rate debt into floating-rate obligations as fair value hedges and to convert floating-rate obligations into fixed-rate payments as cash flow hedges. By 2024, the company continued this strategy but with a notable reduction in the gains or losses reclassified from AOCI, with interest rate contracts showing a $5 million reclassification in 2024 compared to a $10 million reclassification in 2023. Additionally, in 2024, the pre-tax gains deferred in AOCI related to cash flow hedges were $146 million, expected to be reclassified over the next 12 months, indicating a continued but slightly adjusted exposure management approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 155,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 136,
          "pages": [
            134,
            135,
            136,
            137,
            138
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 39945,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10214,
        "completion_tokens": 226,
        "total_tokens": 10440
      }
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "Between 2022 and 2023, GM's financial relationship with LG Energy Solution (LGES) evolved significantly, particularly in the context of the Chevrolet Bolt EV recall. In 2023, GM expanded the recall to include all 2017-2022 model year Chevrolet Bolt EVs and EUVs due to battery defects. LGES agreed to reimburse GM for certain costs and expenses associated with the recall, and commercial negotiations also resolved other matters related to their Ultium Cells Holdings LLC joint venture. By December 31, 2023, GM had accrued a total of $2.6 billion for recall-related costs and recognized $1.6 billion in receivables from LGES. The remaining accrual for these matters was $0.6 billion at year-end.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58939,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14958,
        "completion_tokens": 174,
        "total_tokens": 15132
      }
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "The revenue contribution from ThousandEyes within the Observability product category increased from fiscal 2022 to fiscal 2023. Specifically, revenue in the Observability category grew by 14% ($80 million) in fiscal 2023 compared to fiscal 2022, driven by growth in ThousandEyes and monitoring and analytics offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46034,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11725,
        "completion_tokens": 79,
        "total_tokens": 11804
      }
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS's 7.620% Debentures, with a principal amount of $276 million and a maturity date of April 1, 2030, have maintained consistent redemption terms and interest payment structures between 2022 and 2024. The debentures are redeemable at UPS's option at any time, with the redemption price being the greater of the principal amount plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Interest is paid semi-annually in April and October. The interest rate on these debentures was reduced from 8.375% to 7.620% on April 1, 2020, and no further changes to the terms or structure have been disclosed in the provided documents for 2022 through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 32898,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8448,
        "completion_tokens": 185,
        "total_tokens": 8634
      }
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "From 2022 to 2023, the total fair value of Fixed Maturity Securities AFS held by MET remained relatively stable, with a slight decrease from $6,802 million in 2022 to $6,714 million in 2023. The composition showed a decline in U.S. government bonds, which decreased from $1,507 million in 2022 to $1,575 million in 2023, while corporate securities increased from $3,001 million in 2022 to $3,083 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 81593,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20631,
        "completion_tokens": 103,
        "total_tokens": 20734
      }
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "From 2022 to 2023, General Motors' financial involvement with Ultium Cells LLC remained consistent, with a $0.5 billion investment noted in 2021 and no additional investments disclosed in 2022 or 2023. However, in late 2022, GM self-disclosed potential regulatory violations related to the import of new chemical substances at Ultium Cells LLC under the Toxic Substances Control Act (TSCA). This led to a settlement with the EPA in November 2023, involving civil penalties estimated at approximately $5.1 million, which could increase depending on future import activity. The penalties were assessed jointly and severally to GM and Ultium Cells LLC, highlighting regulatory implications stemming from compliance issues at the joint venture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45937,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11708,
        "completion_tokens": 185,
        "total_tokens": 11893
      }
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "The company has used variable-priced contracts for natural gas and fuel purchases, including those for gas stations, based on index pricing. These contracts meet the criteria for derivative instruments but generally qualify for the \"normal purchases and normal sales\" exception, which means they do not require mark-to-market adjustments. There is no explicit information indicating a significant change in the company's use of such contracts between 2022 and 2024; the descriptions of these practices remain consistent across the two periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43779,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11159,
        "completion_tokens": 135,
        "total_tokens": 11295
      }
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco's financial reporting approach for the APJC segment remained consistent between fiscal 2022 and fiscal 2023 in terms of the expense categories excluded from segment performance measurement. In both years, the company did not allocate research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, charges related to asset impairments and restructurings, and certain other charges to the APJC segment's performance measurement. This exclusion reflects the continued use of a centralized management approach where these expenses are considered unallocated corporate items.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35699,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9163,
        "completion_tokens": 184,
        "total_tokens": 9347
      }
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "UNH's approach to managing medical cost trends in 2023 evolved to focus more on addressing rising outpatient procedure costs for seniors by engaging physicians and consumers with information to help them make clinically sound choices, aiming to achieve high-quality, affordable care. Additionally, the company emphasized accelerating the transition from fee-for-service care delivery models to fully accountable value-based care models to improve health outcomes and reduce overall system costs over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 49684,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12648,
        "completion_tokens": 126,
        "total_tokens": 12775
      }
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "Between 2022 and 2024, UPS expanded its time-definite delivery services by enhancing service scope and network integration. In 2024, the company insourced the UPS SurePost residential delivery service, which had previously relied on the U.S. Postal Service, to gain greater control over service quality and reliability. Additionally, UPS continued to invest in its Global Smart Logistics Network, leveraging advanced technologies like RFID-enabled Smart Package Smart Facilities to optimize efficiency and end-to-end visibility. These improvements enabled UPS to offer more consistent and faster time-definite delivery options, particularly in international markets and high-growth sectors like healthcare logistics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47350,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12057,
        "completion_tokens": 179,
        "total_tokens": 12236
      }
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were included as part of the Thirteenth Supplemental Indenture dated April 20, 2016, under Exhibit 4.14. In the 2023 filing, there was no new supplemental indenture or amendment specifically referencing these 2026 notes, indicating that their terms and recognition remained unchanged from the 2022 disclosure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 41419,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10575,
        "completion_tokens": 92,
        "total_tokens": 10667
      }
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "The impact of sovereign debt crises on Costco's merchandise sourcing and cost structure from 2022 to 2024 has primarily manifested through increased exposure to global economic uncertainties and trade-related actions. In 2022, the 10-K notes that sovereign debt crises, along with changes in tax policies, duties, tariffs, and trade actions (particularly between China and the U.S.), affected merchandise costs and sourcing. By 2024, the company's exposure had grown as international operations expanded, with 28% of net sales coming from international markets. The 2024 10-K highlights that fluctuations in foreign exchange rates and trade policies continued to influence the cost of inventory, especially for goods sourced internationally, and could impact gross margins if not effectively managed through merchandising and pricing strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43870,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11182,
        "completion_tokens": 211,
        "total_tokens": 11393
      }
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "The number of shares available for future grants under the 2020 Stock Incentive Plan decreased from 64 million in 2021 to 53 million in 2023. This reduction indicates that UnitedHealth Group has issued a significant number of share-based awards over this period, which may suggest active use of equity compensation for employees and executives. However, with 53 million shares still available in 2023, the company retains substantial capacity to issue new share-based awards under the plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50047,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12751,
        "completion_tokens": 122,
        "total_tokens": 12874
      }
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "Between 2022 and 2024, the expiration date of the IAM National Pension Fund / National Pension Plan collective bargaining agreement was extended from July 31, 2024 to July 31, 2029. Additionally, UPS's contribution significance remained notable, with contributions increasing from $48 million in 2022 to $53 million in 2024. In 2024, UPS also reached an agreement to withdraw from the IAM Fund, transferring impacted employees to the UPS Pension Plan and recording a $19 million withdrawal liability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 56891,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14449,
        "completion_tokens": 125,
        "total_tokens": 14574
      }
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "Between fiscal years 2022 and 2023, the terms and availability under LOW's 2020 Credit Agreement evolved as follows: In 2022, the 2020 Credit Agreement had an availability of $2.0 billion and matured in March 2025. By 2023, the agreement was amended and restated as the 2023 Credit Agreement, extending its maturity to September 2028. The combined availability under the Credit Agreements remained at $4.0 billion, supported by the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45327,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11543,
        "completion_tokens": 126,
        "total_tokens": 11670
      }
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "MDLZ's notional amounts for Net Investment Hedge Derivative Contracts increased significantly between 2022 and 2024. As of December 31, 2022, the notional value was $3.9 billion, which grew to $7.5 billion by December 31, 2023, and further increased to $8.6 billion by December 31, 2024. This reflects a strategic expansion in hedging activities related to MDLZ's non-U.S. operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53679,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13641,
        "completion_tokens": 96,
        "total_tokens": 13737
      }
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "Between 2022 and 2024, Microsoft 365's integration with AI technologies evolved significantly, with 2024 introducing new capabilities such as Copilot for Microsoft 365, which combines AI with business data to enhance productivity and collaboration. Role-based AI extensions like Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes, while Copilot Pro offered enhanced AI assistance in Microsoft 365 apps and on the web. Additionally, Copilot Studio enabled customization of AI tools, further embedding AI into workflows for improved efficiency and insights.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40100,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10257,
        "completion_tokens": 154,
        "total_tokens": 10411
      }
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "Between 2022 and 2024, 3M's approach to PFAS discharge characterization in its wastewater permits at the Decatur, Alabama facility evolved from identifying and disclosing incomplete PFAS discharge characterization in its NPDES permit to implementing corrective measures and engaging in regulatory negotiations. In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit and had submitted an application to add additional PFAS to the permit. By 2024, the company had installed wastewater treatment controls to address PFAS and was working on optimizing these systems, while ADEM had not yet acted on the permit modification request. Additionally, 3M was cooperating with EPA and ADEM investigations and had entered into an interim Consent Order in 2020 to address PFAS-related discharges and emissions, which included commitments for future site operations and remediation activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59398,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15075,
        "completion_tokens": 230,
        "total_tokens": 15305
      }
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "Lowe's Companies, Inc. issued the 4.550% Notes as part of its Fifteenth Supplemental Indenture on April 5, 2019, with a maturity date of April 5, 2049. There is no indication in the provided pages that the terms or structure of these specific 4.550% Notes were modified between 2022 and 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 82,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 41419,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10561,
        "completion_tokens": 73,
        "total_tokens": 10634
      }
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "Between 2022 and 2024, MDLZ's financial relationship with KDP evolved significantly due to a change in accounting treatment for the investment. In 2023, MDLZ's ownership in KDP fell below 5%, leading to a shift from equity method accounting to treating the investment as a marketable security. During 2023, MDLZ sold approximately 76 million shares of KDP, receiving $2.4 billion in proceeds and recognizing a pre-tax gain of $493 million on the change in accounting. By the end of 2023, MDLZ had fully exited its investment in KDP. No further gains or losses related to KDP were recorded in 2024, as the investment had been completely sold off.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 42748,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10914,
        "completion_tokens": 161,
        "total_tokens": 11075
      }
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "Between 2022 and 2024, the scale and positioning of Xbox Game Pass have significantly evolved. In 2022, Xbox Game Pass was described as offering access to a curated library of over 100 first- and third-party titles. By 2024, the library had expanded to over 400 titles, reflecting Microsoft's strategic emphasis on growing its gaming ecosystem and enhancing user engagement through a broader and more diverse content offering. This expansion aligns with Microsoft's focus on cloud gaming and creating a unified, accessible gaming experience across multiple devices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 35178,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9017,
        "completion_tokens": 141,
        "total_tokens": 9158
      }
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "The structure and disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan remained consistent from 2022 to 2024. In both years, the form of the Deferred Stock Unit Award Agreement for non-employee directors was incorporated by reference from the 2018 Form 10-K, indicating no material changes to the agreement structure during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 144,
          "pages": [
            129,
            130,
            131,
            132,
            133
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51706,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13166,
        "completion_tokens": 103,
        "total_tokens": 13269
      }
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Between 2023 and 2024, the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio showed a slight increase in total loans, from $26,153 million to $27,389 million for First Mortgages and from $479 million to $424 million for HELOCs. The origination costs for these portfolios increased from $100 million in 2023 to $112 million in 2024. In terms of geographic concentration, both years showed 42-43% of the First Mortgages and HELOCs portfolios concentrated in California, with consistent performance relative to the overall portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61053,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15498,
        "completion_tokens": 138,
        "total_tokens": 15637
      }
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Nike's strategic emphasis on Dri-FIT technology appears to have remained consistent, with continued focus on integrating the technology into innovative product designs. Both years highlight the use of Dri-FIT as part of Nike's broader commitment to leveraging technologies like Nike Air, Zoom, Flyknit, and React to enhance performance and meet consumer preferences. However, there is no explicit mention of increased investment or new initiatives specific to Dri-FIT in fiscal 2024 compared to fiscal 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48537,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12360,
        "completion_tokens": 136,
        "total_tokens": 12496
      }
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "Mondelez International has significantly enhanced its investment in backup and disaster recovery from 2022 to 2024 in response to increasing cybersecurity threats. In 2022, the company acknowledged the rising complexity of cyber threats and outlined efforts to strengthen network security, backup, and disaster recovery, alongside workforce training and threat monitoring. By 2024, Mondelez had expanded these efforts, emphasizing advanced identity and access management, multi-factor authentication, privileged access management, and 24/7 security operations to detect and respond to threats in real time. These measures reflect a more proactive and comprehensive approach to cybersecurity resilience in response to evolving threats.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 44400,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11325,
        "completion_tokens": 183,
        "total_tokens": 11509
      }
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "Microsoft's financial commitment and engagement with Black and African American-owned suppliers significantly evolved from fiscal year 2022 to 2024. In fiscal year 2022, the company was 90% of the way toward its goal to double spending with Black and African American-owned suppliers, reaching more than 90% of its $500 million target. By fiscal year 2024, Microsoft achieved its goal, spending $500 million with double the number of Black- and African American-owned suppliers. Additionally, the company increased deposits with Black- and African American-owned minority depository institutions and expanded initiatives like the Black Partner Growth Initiative and the Black Channel Partner Alliance to further support these suppliers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40242,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10281,
        "completion_tokens": 184,
        "total_tokens": 10465
      }
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "The availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees decreased from 10,638,639 shares as of December 31, 2021, to 8,565,087 shares as of December 31, 2023. This reduction suggests that Abbott has been actively issuing shares under the plan, reflecting ongoing participation by non-U.S. employees and a continued use of stock-based incentives to align employee interests with those of shareholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45602,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11645,
        "completion_tokens": 120,
        "total_tokens": 11765
      }
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike has continued to emphasize innovation in product development, with Nike Air technology remaining a core component of its strategy. The 2024 10-K filing highlights the proliferation of Nike Air, along with other technologies like Zoom, Air Max, and React, as part of Nike's commitment to designing innovative products that meet consumer preferences. There is no indication of a shift away from Nike Air; rather, it is presented as a key innovation that typifies Nike's dedication to enhancing performance and comfort across its product categories.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48537,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12347,
        "completion_tokens": 146,
        "total_tokens": 12494
      }
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "Between 2022 and 2023, Abbott maintained Osmolite as a key product within its Nutritional Products segment, specifically in its enteral feeding portfolio. Osmolite is highlighted as one of the nutritional products used in enteral feeding in healthcare institutions, alongside other products like Jevity, Glucerna, and Oxepa. There is no explicit mention of a strategic shift in positioning for Osmolite during this period, suggesting that Abbott continued to market and sell Osmolite as part of its broader enteral feeding solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45040,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11492,
        "completion_tokens": 133,
        "total_tokens": 11625
      }
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "Between 2022 and 2024, 3M's regulatory engagement and remediation obligations related to PFAS discharge in Minnesota and Alabama have intensified. In Minnesota, the Company faced increasingly stringent regulatory actions, including a revised draft Clean Water Act permit for the Cottage Grove facility with significantly lower PFAS effluent limits, and a Notice of Violation in March 2023 for stormwater discharges at the Hutchinson facility. In Alabama, 3M entered into an interim Consent Order in July 2020 for the Decatur facility, committing to ongoing operations and remediation activities, and resolved an RCRA-related issue in September 2024 with an immaterial penalty. Both states have required substantial compliance efforts, including capital improvements, expanded monitoring, and ongoing negotiations with regulatory agencies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58892,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14949,
        "completion_tokens": 209,
        "total_tokens": 15158
      }
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "Between 2022 and 2024, The Coca-Cola Company's financial relationship with Coca-Cola HBC AG has remained classified as an equity method investment. As of December 31, 2024, The Coca-Cola Company owned a 22% stake in Coca-Cola HBC AG, consistent with the equity method of accounting. The carrying value of the investment in Coca-Cola HBC AG was $1,147 million in 2024, while the fair value based on quoted market prices was $2,675 million, indicating a significant difference of $1,528 million. This suggests that the investment's fair value has increased over time, though the carrying value has not fully caught up to market value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 118,
          "pages": [
            116,
            117,
            118,
            119,
            120
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54282,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13800,
        "completion_tokens": 158,
        "total_tokens": 13958
      }
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024 by increasing investment in product development to enhance interoperability and integration across deployment models. In fiscal 2022, Oracle highlighted its commitment to hybrid deployments, including Oracle Cloud@Customer, and invested $7.2 billion in research and development to improve integration, performance, and flexibility. By fiscal 2024, Oracle further emphasized hybrid deployment models as a core part of its strategy, with continued innovation in Oracle Cloud Services (SaaS and OCI) to enable seamless transitions between on-premise and cloud environments. This evolution reflects Oracle's focus on customer choice and the integration of deployment models to meet diverse business needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48939,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12466,
        "completion_tokens": 198,
        "total_tokens": 12664
      }
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "The filing status of the Mandatory Clawback Policy for Wells Fargo & Company remained consistent between the 2023 and 2024 SEC 10-K disclosures. In both years, the policy was filed directly with the respective 10-K reports. In 2023, it was listed as Exhibit 97 and filed herewith, and in 2024, it retained the same exhibit number and filing status.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61917,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15698,
        "completion_tokens": 87,
        "total_tokens": 15785
      }
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher acquired CorEvitas, LLC in August 2023 as part of its strategy to expand its Laboratory Products and Biopharma Services segment. The acquisition added real-world evidence solutions to enhance drug development processes. The purchase price for CorEvitas was $910 million, with $730 million paid in cash and $184 million in debt settled. Financial implications included increased net interest expense due to debt financing and the addition of $627 million in goodwill, which is non-tax deductible. The acquisition also contributed to the company's 2023 investing activities, which used $2.70 billion and $0.91 billion in cash for The Binding Site Group and CorEvitas, respectively.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51724,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13155,
        "completion_tokens": 173,
        "total_tokens": 13328
      }
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce, contingent on each hour flown by V2500-powered aircraft through June 2027, are treated as \"Other commercial aerospace commitments.\" In 2022, these obligations were expected to total $10,015 million, with $836 million anticipated in 2023. By 2023, the total commitment had slightly decreased to $10,015 million, with $836 million expected in 2023. These payments are capitalized as collaboration intangible assets as they are made, reflecting their treatment as long-term economic commitments. The timing of these payments aligns with the ongoing service and flight activity of the V2500-powered aircraft fleet.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58865,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14952,
        "completion_tokens": 172,
        "total_tokens": 15125
      }
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "The Coca-Cola Company's financial relationship with fairlife from 2022 to 2024 includes contingent payments tied to performance milestones. In 2020, the Company acquired the remaining ownership interest in fairlife, with a contingent milestone payment based on fairlife's operating results. As of December 31, 2023, the fair value of the remaining milestone payment was $3,017 million, contingent on fairlife achieving certain financial targets through 2024 and payable in 2025. By December 31, 2024, this liability increased to $6,126 million, reflecting updated fair value measurements based on agreed-upon formulas tied to fairlife's performance. The Company made a milestone payment of $275 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52608,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13379,
        "completion_tokens": 177,
        "total_tokens": 13557
      }
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "Between 2022 and 2024, Oracle's strategic positioning of Oracle Cloud Services has evolved to emphasize deeper integration with enterprise applications and infrastructure technologies. Oracle has enhanced its SaaS offerings, such as Oracle Fusion Cloud ERP, HCM, and EPM, to provide a unified, modular platform with a common data model, enabling seamless interoperability across core business functions. Additionally, Oracle has reinforced the role of Oracle Cloud Infrastructure (OCI) in powering these SaaS applications, leveraging technologies like machine learning and automation to deliver scalable, secure, and high-performance solutions. This evolution reflects Oracle's focus on providing a cohesive, flexible cloud ecosystem that supports hybrid and on-premise deployment models while driving customer migration to the Oracle Cloud.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49133,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12514,
        "completion_tokens": 210,
        "total_tokens": 12725
      }
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "The Key/Specified Employee Policy was incorporated by reference in the 2023 SEC filing (WFC_10k_2023.pdf) as Exhibit 10(r), dated back to the Company's Annual Report on Form 10-K for the year ended December 31, 2018. In the 2024 SEC filing (WFC_10k_2024.pdf), there is no direct mention or update to the Key/Specified Employee Policy, indicating that it remained unchanged and continued to be incorporated by reference from the same prior filing. Thus, there is no new documentation or revision to the policy between the 2023 and 2024 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61917,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15710,
        "completion_tokens": 135,
        "total_tokens": 15846
      }
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The aggregate principal balance of the 6.700% notes due 2028 remained unchanged at $285 million between 2022 and 2023. This stability suggests that RTX did not refinance or retire these notes during the period, indicating a strategy of maintaining existing long-term debt obligations without immediate restructuring. This approach may reflect a focus on preserving liquidity or optimizing debt maturity profiles for long-term financial stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43217,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11029,
        "completion_tokens": 111,
        "total_tokens": 11140
      }
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "The carrying value of TMO's 1.95% 12-Year Senior Notes increased from $773 million in 2023 to $725 million in 2024, while the effective interest rate remained stable at 2.07%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56701,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14389,
        "completion_tokens": 43,
        "total_tokens": 14433
      }
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "The corporate governance implication of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings is that the 2024 filing directly includes the Directors' Code of Conduct on its website within the \"Available Information\" section, making it more transparent and accessible to stakeholders. In contrast, the 2022 filing only referenced the Code of Conduct in the \"Code of Ethics\" section without explicitly highlighting its availability. This shift reflects a stronger commitment to corporate transparency and accountability, aligning with best practices in governance by proactively disclosing ethical standards for directors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36713,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9399,
        "completion_tokens": 168,
        "total_tokens": 9568
      }
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "Amazon's Short-Term Credit Agreement evolved between 2023 and 2024 in the following ways:\n\n1. **Facility Size**: The facility size remained at $5.0 billion in both years.\n2. **Maturity Date**: In 2023, the Short-Term Credit Agreement matured in October 2024. In 2024, it was extended to October 2025, with the possibility of a 364-day extension if approved by the lenders.\n3. **Timing of Establishment**: The agreement was established in November 2023 and replaced in October 2024 with a new agreement that extended the maturity date.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53240,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13536,
        "completion_tokens": 133,
        "total_tokens": 13669
      }
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "From 2022 to 2024, AMD's APU strategy has evolved significantly, particularly in terms of product integration and target markets. In 2022, AMD focused on integrating CPUs and GPUs on a single chip for value and mainstream PCs, with an emphasis on performance and efficiency for notebooks and desktops. By 2024, AMD had advanced its APU strategy by introducing dedicated neural processing units (NPUs) on the same SoC as x86 CPUs, specifically targeting the AI PC segment. The launch of the AMD Ryzen AI 300 Series processors in 2024, featuring the 'Zen 5' architecture and an NPU, marks a strategic shift toward AI integration at the hardware level. This evolution positions AMD to capture growing demand in the AI PC market, enhancing its revenue potential by offering differentiated, high-performance solutions tailored for AI-driven workloads and immersive computing experiences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48242,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12291,
        "completion_tokens": 220,
        "total_tokens": 12511
      }
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic remained consistent. Dividends are generally subject to a 25% Irish dividend withholding tax unless exemptions apply, such as providing a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. U.S. residents who meet these exemptions and do not hold shares through an Irish branch or agency generally have no Irish income tax liability. Additionally, if withholding tax applies, it typically discharges any Irish income tax liability, provided the shareholder reports the withholding to Irish Revenue authorities. No material changes to this framework were noted in the 2024 filing compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34561,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8875,
        "completion_tokens": 187,
        "total_tokens": 9062
      }
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "The risk disclosure around new products and services evolved between 2022 and 2024 to explicitly include the company's transition to a platforms operating model. In 2024, the 10-K specifically notes the risk that \"we may not realize some or all of the expected benefits of our transition to a platforms operating model,\" highlighting the potential operational and strategic uncertainties associated with this initiative. This level of specificity was not present in the 2022 filing, indicating a more detailed acknowledgment of transformational risks tied to new business models.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41015,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10476,
        "completion_tokens": 144,
        "total_tokens": 10621
      }
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "Between 2023 and 2024, Amazon's 3.600% Note due 2032 remained disclosed as part of its long-term debt instruments in both years. In 2023, the note was referenced in the Supplemental Indenture dated April 13, 2022, under the 2023 10-K filing. In 2024, the note was similarly disclosed in the 2024 10-K under the same Supplemental Indenture, indicating no material changes to the terms or structure of the instrument during this period. Amazon continues to follow its policy of not filing full debt instruments when the total amount does not exceed 10% of consolidated assets, offering to furnish copies upon request.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 43686,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11143,
        "completion_tokens": 153,
        "total_tokens": 11296
      }
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "From 2023 to 2024, MDLZ's treatment and disclosure of net investment hedge (NIH) derivative contracts showed notable changes in financial impact and presentation. In 2024, the fair value of NIH derivative contracts increased significantly, with asset derivatives rising to $305 million (from $163 million in 2023) and liability derivatives decreasing to $50 million (from $382 million in 2023). This shift indicates a more favorable financial position for MDLZ in 2024. Additionally, the presentation in the financial statements became more detailed, with expanded disclosures on the fair value of NIH contracts categorized under Level 2 inputs, reflecting observable market data. The 2024 disclosures also emphasized the impact of NIH contracts on other comprehensive earnings and net earnings, highlighting a more transparent view of their financial effects.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45523,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11617,
        "completion_tokens": 215,
        "total_tokens": 11832
      }
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "From 2023 to 2024, the Abrams Main Battle Tank's modernization strategy has advanced with the development of the M1E3 Abrams, a significant engineering upgrade aimed at enhancing lethality, survivability, and mobility to counter future threats. Technologically, the M1E3 incorporates updated systems architecture for easier and faster technology integration, while reducing sustainment requirements. International demand remains strong, with continued upgrades for non-U.S. partners and a growing installed base across Europe, the Middle East, and Indo-Pacific regions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 26962,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6963,
        "completion_tokens": 142,
        "total_tokens": 7106
      }
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "Between 2022 and 2024, AMD has increasingly emphasized APUs in both mainstream and high-performance computing markets, reflecting a strategic shift toward integrated solutions. In 2022, APUs were primarily highlighted in consumer and commercial notebook and desktop platforms, focusing on performance and efficiency. By 2024, APUs were positioned more prominently in the Data Center and Embedded segments, with tailored solutions for AI, cloud, and semi-custom applications, such as the Steam Deck APU. This evolution underscores AMD's broader strategy to leverage APUs for cross-market versatility and to strengthen its presence in high-growth areas like AI and cloud computing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43335,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11058,
        "completion_tokens": 169,
        "total_tokens": 11228
      }
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries remained consistent from 2023 to 2024. In both years, the company noted that the Irish Minister for Finance has the authority to restrict financial transfers between Ireland and third countries under the Act, and that such restrictions are subject to ongoing change. Additionally, transfers involving countries under United Nations or EU sanctions may also be subject to restrictions under Irish law. No substantive changes in the nature or scope of these disclosures were observed between the two periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34561,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8869,
        "completion_tokens": 162,
        "total_tokens": 9031
      }
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "The G700 aircraft was expected to enter service in early 2024 following FAA certification, as disclosed in the 2023 filing. By 2024, GD confirmed that production had ramped up, and the G700 began deliveries in the second quarter of 2024, indicating successful progress from development to active production and customer delivery.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32646,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8372,
        "completion_tokens": 82,
        "total_tokens": 8454
      }
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "The nature of PMI's relationship with KT&G evolved from 2023 to 2024 through a renewed and extended long-term collaboration agreement announced on January 30, 2023. This agreement grants PMI exclusive, worldwide rights (excluding South Korea) to commercialize KT&G's innovative smoke-free devices and consumables for 15 years, through January 29, 2038. The collaboration includes performance-review cycles every three years, ensuring flexibility for market changes, and provides PMI with access to KT&G's product-innovation pipeline, including offerings for low- and middle-income markets. This arrangement strengthens PMI's strategic dependency on KT&G for expanding its smoke-free product portfolio and enhancing its global commercialization efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44855,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11435,
        "completion_tokens": 188,
        "total_tokens": 11623
      }
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "From 2022 to 2024, AMD's approach to semi-custom SoC products has evolved by integrating these solutions more deeply into broader product ecosystems and emphasizing their role in AI and high-performance computing. In 2022, AMD highlighted the importance of semi-custom SoC products being incorporated into customers' products, with revenue tied to the success of those products in the market. By 2024, AMD positioned semi-custom SoC products as part of a broader strategy to deliver adaptive computing solutions across data centers, client computing, and gaming. This includes leveraging semi-custom SoCs as part of a comprehensive portfolio that integrates with AI accelerators, CPUs, GPUs, and software stacks to enable end-to-end solutions for AI, cloud, and edge computing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48777,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12421,
        "completion_tokens": 194,
        "total_tokens": 12616
      }
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "Between 2023 and 2024, the treatment of Irish income tax on dividends paid to U.S. residents remained largely consistent, with a 25% Irish dividend withholding tax rate applying unless exemptions were met. In both years, U.S. residents holding shares through the Depository Trust Company (DTC) with U.S. addresses were exempt from withholding tax. Additionally, record owners who submitted valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2 were also exempt. No significant changes were noted in the exemption criteria or withholding tax obligations between the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47506,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12104,
        "completion_tokens": 150,
        "total_tokens": 12254
      }
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "General Dynamics' Marine Systems segment experienced cost pressures in 2023 from supply chain impacts on the Virginia-class submarine schedule and cost growth on the DDG-51 program, leading to a 110 basis point decline in operating margin to 7.0%. In 2024, the company expects the Marine Systems segment's revenue to increase to approximately $12.8–12.9 billion, with an operating margin of around 7.6%, indicating some margin improvement. The Columbia-class submarine initiative contributed to higher ship construction revenue in 2023, and the company's 2024 outlook suggests continued focus on this program, though specific revenue projections for the Columbia-class were not provided.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32423,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8355,
        "completion_tokens": 171,
        "total_tokens": 8526
      }
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Based on the information provided, BKNG's financial dependency on Booking.com, as measured by the proportion of revenue derived from accommodation reservations, remained relatively stable between 2022 and 2023. Specifically, accommodation reservations accounted for approximately 89% of the Company's revenues in both 2023 and 2022, indicating no significant change in reliance on this core service during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41471,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10590,
        "completion_tokens": 104,
        "total_tokens": 10694
      }
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "Between 2023 and 2024, the company's Swiss Franc note, which had a face value of approximately $299 million at the end of 2023, was fully repaid by the end of 2024, with no remaining balance reported. This indicates that the company successfully managed and reduced its foreign currency obligations in Swiss Francs during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44147,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11264,
        "completion_tokens": 83,
        "total_tokens": 11347
      }
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "Goldman Sachs introduced new Non-Employee Director RSU Award Agreements in the 2024 10-K filing, including variations such as \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled)\" and specific agreements for \"One-Time/Year-End RSU Award Agreements,\" which were not explicitly detailed in the 2023 filing. These modifications suggest a more nuanced approach to structuring and settling RSU awards for non-employee directors in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41486,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10601,
        "completion_tokens": 111,
        "total_tokens": 10712
      }
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "Between 2023 and 2024, PMI's financial relationship with Swedish Match AB, particularly in terms of long-term debt obligations tied to the acquisition, showed a significant reduction. In 2023, the Euro credit facility borrowings related to the Swedish Match AB acquisition amounted to $6,121 million, but by 2024, this had decreased to $2,610 million. This reduction was primarily due to PMI prepaying approximately €3 billion ($3.2 billion) under the 3-year tranche of the senior unsecured term loan facility on November 21, 2024. As of December 31, 2024, only the €2.5 billion ($2.6 billion) 5-year tranche of the term loan facility remained outstanding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44505,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11352,
        "completion_tokens": 164,
        "total_tokens": 11516
      }
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "From 2023 to 2024, BMY significantly advanced its strategic positioning around KRAS inhibition through the acquisition of Mirati in January 2024. This acquisition added Krazati, a best-in-class KRAS G12C inhibitor approved for second-line NSCLC and in development for first-line NSCLC in combination with a PD-1 inhibitor, as well as colorectal cancer. Additionally, BMY gained access to Mirati’s pipeline, including MRTX1719, a potential first-in-class PRMT5 inhibitor in Phase I. This move expanded BMY’s oncology portfolio and reinforced its focus on precision therapies targeting key oncogenic drivers like KRAS.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40866,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10445,
        "completion_tokens": 154,
        "total_tokens": 10599
      }
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan between 2023 and 2024 remained largely consistent, with the plan being referenced in both years' 10-K filings as an incorporated exhibit. However, in 2024, the firm introduced a new Clawback Policy effective December 1, 2023, which was disclosed in its 10-K. This policy, while not directly tied to the Restricted Partner Compensation Plan, reflects a broader governance enhancement that could impact compensation structures, including those of restricted partners, by enabling the firm to recover compensation under certain conditions. No specific amendments or new policies directly tied to the Restricted Partner Compensation Plan were disclosed in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41486,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10610,
        "completion_tokens": 185,
        "total_tokens": 10796
      }
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) significantly advanced its integration and categorization of heat-not-burn (HTU) products. In 2023, HTU shipment volumes increased by 14.7% compared to 2022, reflecting strong growth across all regions. PMI now categorizes HTUs as part of its broader smoke-free product portfolio, which also includes vapor and oral nicotine products. Additionally, the acquisition of Swedish Match in 2022 expanded PMI's smoke-free offerings, with HTUs contributing to a 14.8% increase in adjusted in-market sales in 2023. This evolution highlights PMI's strategic shift toward smoke-free products as a core component of its business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41122,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10506,
        "completion_tokens": 167,
        "total_tokens": 10673
      }
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb reinforced its compliance with the SEC Consent Order by enhancing the role of its business risk and disclosure group. This group was formally established as part of the Consent Order measures to ensure transparency and governance. In 2024, the company emphasized a more structured governance process, including escalation protocols for compliance concerns and regular monitoring of adherence to the policy. These steps reflect a continued commitment to aligning internal practices with the Consent Order requirements, particularly in managing sales to direct customers and ensuring timely and accurate disclosures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46844,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11949,
        "completion_tokens": 164,
        "total_tokens": 12113
      }
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "Between 2023 and 2024, UNP maintained a consistent expected long-term rate of return of 5.25% for its pension plan, despite changes in the asset allocation mix. In both years, the target allocation remained at 20% to 30% for equity securities and 70% to 80% for debt securities. However, the actual asset allocation percentages for 2024 (24% equity and 75% debt) aligned with the 2023 percentages, indicating no significant shift in the mix. The expected return remained tied to the diversified portfolio strategy and historical returns, with no adjustment to the rate despite a notable increase in the discount rate from 5.00% in 2023 to 5.61% in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36797,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9419,
        "completion_tokens": 163,
        "total_tokens": 9583
      }
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon enhanced the accessibility and integration of its Directors' Code of Conduct by explicitly posting it on its website at https://www.bnymellon.com, as noted in the 2023 filing. In the 2022 filing, while the existence of the Directors' Code of Conduct was mentioned, the direct web link for public access was not provided, indicating an improvement in transparency and ease of access in 2023. Additionally, the 2023 filing emphasized the integration of the Directors' Code of Conduct within broader corporate governance reporting by listing it among other governance materials available on the website, such as committee charters and corporate governance guidelines.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36153,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9270,
        "completion_tokens": 174,
        "total_tokens": 9445
      }
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with engineered systems, reflecting a stronger focus on cloud migration and hybrid IT environments. The Database is now offered across Oracle Cloud Infrastructure (OCI), on-premise through Oracle Exadata Cloud@Customer, and hybrid models like OCI Dedicated Region, enabling customers to deploy workloads seamlessly across environments. This evolution underscores Oracle's commitment to supporting hybrid and multicloud strategies, allowing customers to leverage the benefits of cloud scalability and automation while maintaining control over sensitive or regulated data.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44160,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11291,
        "completion_tokens": 178,
        "total_tokens": 11469
      }
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "Between 2023 and 2024, Bristol-Myers Squibb (BMY) enhanced its formal review and certification process for annual and quarterly SEC reports by reinforcing governance procedures and compliance monitoring. Key developments include the establishment of a business risk and disclosure group, continued use of external consultants to evaluate and improve financial reporting processes, and a stronger emphasis on bottom-up input in the budgeting process with thorough documentation. These measures reflect a commitment to transparency and adherence to the terms of the SEC Consent Order, ensuring that sales practices and financial disclosures align with regulatory expectations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46844,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11948,
        "completion_tokens": 168,
        "total_tokens": 12117
      }
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "From 2022 to 2023, Philip Morris International (PMI) has increasingly positioned heat-not-burn (HTU) products as a core component of its smoke-free product strategy. In 2023, HTU shipment volumes grew by 14.7%, reflecting strong market adoption, particularly in Europe and Japan. PMI categorizes HTUs as \"reduced-risk products\" (RRPs), emphasizing their potential to present less risk to smokers compared to combustible tobacco. The company also expanded its HTU portfolio, including licensed KT&G products and zero-tobacco heat-not-burn options like LEVIA, to diversify its offerings and strengthen its market positioning in key regions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45849,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11690,
        "completion_tokens": 159,
        "total_tokens": 11849
      }
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "Oracle's strategic positioning of Oracle Database between 2023 and 2024 has emphasized enhanced deployment flexibility and deeper integration with other Oracle technologies. The company has expanded deployment options, enabling Oracle Database to be used across Oracle Cloud, on-premise environments, Oracle Exadata Cloud@Customer, OCI Dedicated Region, and other public cloud platforms. Additionally, Oracle has strengthened integration with its Oracle Cloud Infrastructure (OCI), Oracle Autonomous Database, and other Oracle Cloud services like Java Cloud and APEX, creating a cohesive ecosystem for developers and enterprises to build and deploy cloud-native applications efficiently.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42380,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10822,
        "completion_tokens": 171,
        "total_tokens": 10993
      }
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "BMY's strategic relationship with Krazati evolved significantly in 2024 through the acquisition of Mirati, a commercial-stage targeted oncology company, which provided BMY with the rights to commercialize Krazati, a KRAS inhibitor approved for second-line NSCLC and in development for first-line NSCLC in combination with a PD-1 inhibitor. The financial commitment in 2024 included a total consideration of $4.8 billion for the acquisition, with $4.1 billion net of cash acquired, and an additional contingent value right (CVR) potentially worth up to $1.0 billion, subject to future regulatory milestones.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39330,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10057,
        "completion_tokens": 151,
        "total_tokens": 10208
      }
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "The 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV, listed under trading symbol BK/P, remained registered and fully and unconditionally guaranteed by The Bank of New York Mellon Corporation in both the 2022 and 2023 SEC filings. There is no indication of a change in the status or treatment of these securities between the two years, as they are consistently referenced in the list of securities registered under Section 12(b) of the Exchange Act.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37406,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9578,
        "completion_tokens": 121,
        "total_tokens": 9699
      }
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "From 2022 to 2023, PMI's short-term credit arrangements increased from approximately $2.3 billion to $2.7 billion, while borrowings under these arrangements slightly increased from $225 million to $283 million. This suggests that PMI expanded its liquidity buffer in 2023, likely to support working capital needs and maintain flexibility, indicating a proactive near-term liquidity posture.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 37338,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9563,
        "completion_tokens": 97,
        "total_tokens": 9661
      }
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "Between 2023 and 2024, Oracle has enhanced the positioning of its Autonomous Database by expanding its integration with other Oracle Cloud services and strengthening its automation capabilities. In 2024, Oracle emphasized deeper integration with services like Java Cloud and Oracle APEX, enabling developers to build modern, cloud-native applications. Additionally, the Autonomous Database now supports generative AI and machine learning for advanced analytics and real-time transaction processing, further automating database operations and improving scalability and security. These enhancements reflect Oracle's focus on delivering a more cohesive, intelligent, and developer-friendly cloud ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44411,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11331,
        "completion_tokens": 175,
        "total_tokens": 11507
      }
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "Between 2023 and 2024, GM's financial relationship with Ultium Cells Holdings LLC remained consistent in terms of capital involvement, with GM committing $0.8 billion in 2024 and $1.4 billion in 2023 to the entity. However, the strategic positioning of GM with Ultium Cells Holdings LLC remained unchanged, as GM did not have the power to direct the activities of the entity that most significantly affect its economic performance in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51359,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13066,
        "completion_tokens": 111,
        "total_tokens": 13177
      }
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "Between 2022 and 2024, the financial impact of the Litigation Management Deed evolved as follows: \n\n- In 2022, during the sixth anniversary release, $3.5 billion of as-converted value was released from the series B and C preferred stock, and 176,655 shares of series A preferred stock were issued. \n- In 2024, during the eighth anniversary release, $2.7 billion of as-converted value was released, and 99,264 shares of series A preferred stock were issued. \n\nThis indicates a decrease in the as-converted value released and a reduction in the number of series A preferred shares issued in 2024 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66265,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16810,
        "completion_tokens": 152,
        "total_tokens": 16963
      }
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "Between 2023 and 2024, the financial and strategic relationship between 3M and the Aearo Entities evolved significantly due to litigation impacts and business segment adjustments. In 2022, 3M deconsolidated the Aearo Entities due to their voluntary Chapter 11 bankruptcy, which was intended to address litigation related to respirator mask/asbestos and Combat Arms Earplugs matters. However, the bankruptcy was dismissed in June 2023, leading to the reconsolidation of Aearo Entities in Q2 2023. This reconsolidation shifted litigation costs related to the Aearo Entities from Corporate and Unallocated to the Safety and Industrial business segment. In 2023, 3M recorded a $4.2 billion pre-tax charge for the Combat Arms Earplugs Settlement (CAE Settlement), which was structured to resolve claims through $6.0 billion in payments through 2029. By 2024, the litigation impact had decreased, with corporate special item net costs declining year-over-year, reflecting reduced litigation burdens and the ongoing implementation of the CAE Settlement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48400,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12332,
        "completion_tokens": 261,
        "total_tokens": 12593
      }
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "Between 2022 and 2024, the financial treatment of Class C Common Stock evolved with a significant increase in its earnings per share (EPS) performance. In 2022, Class C Common Stock had a basic EPS of $28.03, which rose to $38.97 in 2024. This increase reflects a stronger financial performance relative to other stock classes, such as Class A and Class B-1 Common Stock, which had lower EPS figures in the same period. Additionally, the structure of Class C Common Stock remained tied to the conversion and voting rights tied to developments in litigation, but its earnings performance outpaced other classes due to fewer shares outstanding and higher income allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50555,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12872,
        "completion_tokens": 167,
        "total_tokens": 13040
      }
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "Qualcomm's involvement in ADAS/AD technology has grown significantly from fiscal 2022 to fiscal 2024, as reflected in both strategic activities and revenue categorization. In fiscal 2022, ADAS/AD was part of the broader automotive revenue category under QCT, which totaled $1,509 million. By fiscal 2024, automotive revenue had increased to $2,910 million, explicitly including ADAS/AD, indicating stronger market adoption and product integration. Additionally, Qualcomm's acquisition of Veoneer's Arriver business in fiscal 2022 marked a strategic shift toward direct development of AD capabilities, which has likely contributed to this growth. The revenue increase and strategic investments demonstrate Qualcomm's expanded role in the ADAS/AD ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57206,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14541,
        "completion_tokens": 188,
        "total_tokens": 14730
      }
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's U.S. Retrospective Responsibility Plan evolved by expanding the mechanisms for addressing liability in covered litigation, particularly through amendments to the loss sharing agreement and omnibus agreement. These amendments extended the scope of U.S. covered litigation to include actions by opt-outs from the Rule 23(b)(3) Settlement Class in MDL 1720 and ensured that settlements or judgments are allocated according to the 66.6667% Visa portion under the omnibus agreement. This evolution suggests a more structured and comprehensive approach to managing litigation risk, as Visa is proactively refining its contractual and financial safeguards to distribute potential liabilities among stakeholders and mitigate the impact of litigation on its financial results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52222,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13305,
        "completion_tokens": 199,
        "total_tokens": 13504
      }
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck's financial stake in Lynparza, as part of its collaboration with AstraZeneca, showed growth between 2023 and 2024, with alliance revenue increasing by 9% in 2024. This growth was driven by higher demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for a new indication, further enhancing its strategic importance and market reach. These developments indicate a positive evolution in both the product's performance and its strategic value to Merck.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69474,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17599,
        "completion_tokens": 126,
        "total_tokens": 17725
      }
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "Between 2022 and 2024, Skoal's market position within Altria's oral tobacco products segment declined, as its shipment volume decreased from 163.1 million units in 2023 to 147 million units in 2024, and its retail share dropped from 9.3% to 7.6%. This decline was partially offset by growth in the on! brand, which saw increased shipment volume and a rise in retail share from 6.8% to 8.3%. Overall, the oral tobacco products segment's total retail share decreased from 42.5% in 2023 to 37.5% in 2024, reflecting broader industry challenges and competition within the segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53447,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13591,
        "completion_tokens": 144,
        "total_tokens": 13735
      }
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "The revenue contribution from Dynamics 365 within Microsoft Cloud increased from fiscal year 2022 to 2023. In fiscal year 2022, Dynamics products and cloud services revenue grew by 25%, driven by Dynamics 365 growth of 39%. In fiscal year 2023, Dynamics products and cloud services revenue reached $5,437 million, showing continued growth compared to $4,687 million in fiscal year 2022. This indicates a positive evolution in the revenue contribution from Dynamics 365 over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 34159,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8753,
        "completion_tokens": 121,
        "total_tokens": 8874
      }
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program from 2023 to 2024 shows increased use of hedging instruments and expanded scope. In 2024, the fair value of foreign exchange contracts designated as hedging instruments rose to $406 million (asset) and $2 million (liability), compared to $189 million (asset) and $77 million (liability) in 2023. Additionally, the notional amounts of these contracts increased to $12,465 million in 2024 from $12,754 million in 2023, indicating a broader scope of hedging activities. The cumulative fair value hedging adjustments also decreased from $56 million in 2023 to $17 million in 2024, suggesting a shift in the timing or effectiveness of hedging strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65924,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16720,
        "completion_tokens": 188,
        "total_tokens": 16909
      }
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "PayPal's involvement with merchant receivables from 2022 to 2024 shows a decline in credit loss provisions and an increase in direct investment in merchant financing products. The allowance for credit losses on merchant receivables decreased from $160 million in 2023 to $113 million in 2024, reflecting improved credit quality in the PayPal Business Loan (PPBL) portfolio. Additionally, PayPal increased its investment in merchant financing, purchasing $1.8 billion in merchant receivables in 2024 compared to $1.7 billion in 2023, demonstrating a growing commitment to expanding its merchant finance offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 54632,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13891,
        "completion_tokens": 153,
        "total_tokens": 14044
      }
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "From 2022 to 2024, the financial significance of smokeable products to MO (Altria) has shown mixed trends. Operating income from smokeable products slightly increased from $10,670 million in 2023 to $10,821 million in 2024, indicating stable performance. However, goodwill allocated to smokeable products remained unchanged at $99 million during this period, suggesting no material revaluation or impairment adjustments directly tied to this segment. The segment's net revenues declined from $21,756 million in 2023 to $21,204 million in 2024, reflecting a modest reduction in sales. Overall, smokeable products remain a core contributor to Altria’s operating income but face revenue pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60614,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15377,
        "completion_tokens": 173,
        "total_tokens": 15550
      }
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "The revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud increased from $13,631 million in fiscal year 2022 to $14,989 million in fiscal year 2023, representing a growth of $1,358 million or approximately 9.96%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32607,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8371,
        "completion_tokens": 60,
        "total_tokens": 8431
      }
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "Between 2023 and 2024, Lynparza's commercialization and market expansion showed growth, particularly in international markets. In 2023, Lynparza received approvals in the U.S., Japan, and other regions for the treatment of various cancers, including metastatic castration-resistant prostate cancer. By 2024, alliance revenue for Lynparza increased by 9%, driven by higher demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, further expanding its geographic reach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58891,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14945,
        "completion_tokens": 152,
        "total_tokens": 15097
      }
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "The financial treatment of the Powder Metal Matter impacted RTX's future income tax benefits, as reflected in the deferred tax assets related to this matter. In 2023, the Powder Metal Matter contributed a deferred tax benefit of $644 million, while in 2024, this amount decreased to $455 million. This reduction suggests a decline in the anticipated future tax benefits associated with the Powder Metal Matter between the two years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43229,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11032,
        "completion_tokens": 108,
        "total_tokens": 11140
      }
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "The borrowing capacity under the Paidy Credit Agreement increased from ¥50.0 billion (approximately $355 million) in 2023 to ¥90.0 billion (approximately $574 million) in 2024. In 2022, the initial borrowing capacity was ¥60.0 billion, which was later increased by ¥30.0 billion in September 2022. As of December 31, 2024, no borrowing capacity was available under the Paidy Credit Agreement, as the full amount had been drawn down. The terms of the agreement remained largely consistent, with borrowings used for working capital, capital expenditures, and other permitted purposes, and interest rates based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49052,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12472,
        "completion_tokens": 171,
        "total_tokens": 12644
      }
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Altria's reliance on long-term senior unsecured notes as part of its capital resources decreased slightly between 2022 and 2024. At the end of 2022, Altria's total long-term debt was $26.2 billion, while by December 31, 2024, it had reduced to $24.9 billion. This reduction was driven by repayments of maturing notes, such as the $776 million and $345 million senior unsecured notes in early 2024, as well as the issuance of new notes in February 2025 to refinance some near-term maturities. The weighted-average coupon interest rate on total long-term debt remained stable at approximately 4.3% in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54886,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13936,
        "completion_tokens": 151,
        "total_tokens": 14087
      }
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "RTX's financial treatment of the Powder Metal Matter shifted from a $2.9 billion pretax charge in 2023 to being included in the \"Other\" category of net sales in 2024, indicating its resolution or reduction in impact. This change suggests a positive shift in the matter's financial implications, contributing to a lower effective tax rate in 2023 and potentially leading to improved future income tax benefits as the related charges diminish.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47986,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12222,
        "completion_tokens": 110,
        "total_tokens": 12332
      }
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "PayPal's utilization of the Paidy Credit Agreement evolved significantly between 2022 and 2024. In 2022, the Paidy Credit Agreement had a borrowing capacity of ¥60.0 billion, which was increased to ¥90.0 billion (approximately $574 million) by September 2022. In 2024, the full ¥90.0 billion was drawn down, leaving no available borrowing capacity under the agreement as of December 31, 2024. This indicates that PayPal fully utilized the increased borrowing capacity in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48393,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12322,
        "completion_tokens": 119,
        "total_tokens": 12441
      }
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "From 2023 to 2024, Accenture Canada Holdings Inc.'s ownership structure and equity relationship with Accenture plc remained largely consistent, with noncontrolling interests held by current and former Accenture Leadership members remaining below 1% as of August 31, 2024. Exchangeable shares issued to pre-incorporation partners in Canada and New Zealand continue to be redeemable or exchangeable for Accenture plc Class A ordinary shares on a one-for-one basis. Additionally, Accenture Canada Holdings Inc. exchangeable shares entitle holders to distributions equivalent to those of Class A shares, and Accenture plc has maintained agreements to ensure alignment between Class X ordinary shares and exchangeable shares. No significant structural changes were reported in this relationship during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40776,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10431,
        "completion_tokens": 202,
        "total_tokens": 10633
      }
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "Between 2022 and 2024, Merck's approach to managing balance sheet risk through forward exchange contracts has evolved in terms of both currencies and cost-benefit considerations. In 2022, the company primarily focused on developed country currencies such as the euro, Japanese yen, British pound, Canadian dollar, and Swiss franc, using forward contracts to mitigate the effects of foreign exchange volatility on monetary assets and liabilities. By 2024, the scope expanded to include a broader range of currencies, with a continued emphasis on the euro, Swiss franc, Japanese yen, and Chinese renminbi. The cost-benefit analysis became more refined, with Merck evaluating the magnitude of exposure, exchange rate volatility, and hedging costs more rigorously to determine when it was economical to hedge, particularly for developing country currencies. This evolution reflects a more strategic and dynamic approach to managing balance sheet risk in response to changing market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 107,
          "pages": [
            105,
            106,
            107,
            108,
            109
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60603,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15384,
        "completion_tokens": 247,
        "total_tokens": 15631
      }
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "The change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggests a reduction in its financial impact on future income tax benefits. In 2023, the Powder Metal Matter contributed $644 million to future income tax benefits, while in 2024, this amount decreased to $455 million. This decline indicates that the anticipated tax benefits related to this matter are diminishing, likely due to the resolution or reduced uncertainty surrounding the issue over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49175,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12519,
        "completion_tokens": 120,
        "total_tokens": 12640
      }
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "PayPal's involvement in the merchant receivables space grew between 2022 and 2024, with increased scale in its merchant finance offerings. In 2024, PayPal purchased approximately $1.8 billion in merchant receivables, up from $1.7 billion in 2023. The total outstanding balance in its merchant loans, advances, and interest and fees receivable rose to $1.5 billion in 2024 from $1.2 billion in 2023, net of participation interests sold to partner institutions. PayPal continues to partner with WebBank in the U.S. for its PPWC and PPBL products, where WebBank extends credit to merchants, and PayPal purchases and services the related receivables. The allowance for credit losses on merchant receivables decreased to $113 million in 2024 from $160 million in 2023, reflecting improved credit quality in the PPBL portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 53240,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13548,
        "completion_tokens": 205,
        "total_tokens": 13753
      }
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck's alliance revenue from Lynparza increased by 9% in 2024 compared to 2023, primarily driven by higher demand in most international markets. The growth was supported by the approval of Lynparza in new indications and expanded market access, including the approval in China in January 2025 for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer. However, specific data on Lynparza's alliance revenue in 2022 is not provided in the given pages, so the exact evolution from 2022 to 2024 cannot be determined.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            139,
            140,
            141,
            142,
            143
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59166,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15006,
        "completion_tokens": 137,
        "total_tokens": 15143
      }
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "PayPal's involvement in merchant receivables between 2022 and 2024 has shown improvements in credit quality and a reduction in financial exposure. As of December 31, 2024, the total outstanding balance of merchant loans, advances, and interest and fees receivable was $1.5 billion, up from $1.2 billion in 2023, indicating growth in the portfolio. However, the allowance for credit losses decreased to $113 million in 2024 from $160 million in 2023, reflecting improved credit quality, particularly in the PPBL portfolio. Additionally, delinquency rates have declined, with a higher percentage of merchant receivables being current and a lower percentage being over 90 days outstanding, showing enhanced risk management and operational performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56074,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14242,
        "completion_tokens": 187,
        "total_tokens": 14429
      }
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "Merck's involvement in the development and commercialization of Lynparza from 2022 to 2024 has shown regulatory progress and revenue growth. In 2022, Lynparza was under regulatory review in the EU for metastatic castration-resistant prostate cancer based on the PROpel trial. By 2024, Lynparza achieved regulatory approval in China for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer based on the OlympiA trial. Additionally, alliance revenue for Lynparza grew 9% in 2024, driven by higher demand in most international markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54897,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13951,
        "completion_tokens": 142,
        "total_tokens": 14093
      }
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "Between 2022 and 2024, Boeing extended the risk management horizon for its commodity purchase contracts, with hedges now covering forecasted transactions through 2028, up from previous periods. Additionally, the financial exposure related to commodity contracts appears to have slightly increased, as the potential unrealized losses from a 10% market price change rose from $46 million in 2022 to an implied higher exposure based on the notional amounts and fair value changes detailed in 2024. Boeing continues to use commodity swaps and purchase contracts to hedge against price fluctuations, maintaining its strategy to offset gains and losses with underlying transactions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34919,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8955,
        "completion_tokens": 169,
        "total_tokens": 9124
      }
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "Between 2021 and 2024, Schwab's exposure to PALs (Pledged Asset Lines) remained fully collateralized, with securities' fair values consistently exceeding the borrowings. As of December 31, 2021, and December 31, 2024, no allowance for credit losses was required for PALs due to full collateralization. Additionally, the allowance for credit losses on bank loans decreased from $18 million at December 31, 2021, to $18 million at December 31, 2024, indicating stable credit risk management in the loan portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 142,
          "pages": [
            137,
            138,
            139,
            140,
            141
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52248,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13290,
        "completion_tokens": 127,
        "total_tokens": 13418
      }
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "Between 2022 and 2024, Boeing's financial treatment and strategic positioning of the 777X program evolved as cost impacts and research & development (R&D) investments increased. In 2022, R&D expenses for the 777X program were part of a total R&D expense of $2,852 million, but by 2024, these expenses had risen significantly to $3,812 million, driven by higher investments in the 777X program and enterprise product development. Additionally, cost of sales in 2024 reflected a $1,562 million decrease compared to 2023, partly due to the reach-forward losses on the 777X program, indicating ongoing financial pressures and strategic focus on completing and mitigating risks associated with the 777X.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33091,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8502,
        "completion_tokens": 174,
        "total_tokens": 8677
      }
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Between 2022 and 2024, Schwab's exposure to and risk management of Portfolio Against Loans (PALs) remained relatively stable in terms of methodology, but the PALs portfolio grew significantly. The credit loss allowance for PALs continued to rely on the practical expedient based on collateral maintenance provisions, as the portfolio is collateralized by marketable securities with liquid markets, and over-collateralization limits inherent credit risk. However, the total PALs portfolio increased from $17,024 million in 2024 to a larger portion of total bank loans, reflecting growth in Schwab's lending activities. The allowance methodology for PALs did not change materially, but the overall credit risk exposure increased due to the portfolio's expansion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 142,
          "pages": [
            137,
            138,
            139,
            140,
            141
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45664,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11650,
        "completion_tokens": 190,
        "total_tokens": 11840
      }
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ's value of British pound sterling notes changed from $3 million in 2021 to $45 million in 2022 and then dropped to $0 in 2023. This shift suggests that the company is actively managing its foreign exchange risk through net investment hedges, adjusting its exposure based on market conditions and strategic financial planning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52649,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13392,
        "completion_tokens": 82,
        "total_tokens": 13474
      }
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In both the 2022 and 2024 filings, Amgen's 3.125% 2025 Notes are associated with interest rate swap contracts that convert the fixed-rate coupon to a floating-rate SOFR-based coupon. In 2022, the effective interest rate was LIBOR + 1.8%, while in 2024, it was SOFR + 2.1%. This shift from LIBOR to SOFR reflects Amgen's adaptation to the transition away from LIBOR as the benchmark interest rate. The consistent use of interest rate swaps for these notes indicates Amgen's strategy to manage interest rate risk by balancing fixed and floating rate debt exposure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49057,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12500,
        "completion_tokens": 140,
        "total_tokens": 12640
      }
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "Schwab's reliance on its Commercial Paper Issuance Program between 2022 and 2024 increased in response to market disruptions and rising interest rates. In 2022 and 2023, rapid interest rate hikes led to significant client reallocation of cash from sweep features to higher-yielding alternatives, creating liquidity demands. As a result, Schwab increasingly turned to higher-cost supplemental funding sources, including its commercial paper issuance program, to meet liquidity needs when internal cash was insufficient. This reliance became more pronounced during periods of reduced client cash balances and heightened market volatility, underscoring the program's role in maintaining Schwab's liquidity position amid challenging financial conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55240,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14033,
        "completion_tokens": 187,
        "total_tokens": 14221
      }
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "The 3.625% Notes due 2024 were outstanding in 2022 with a carrying value of $1,400 million and were hedged using interest rate swap contracts at SOFR + 3.4%. By 2024, these notes had matured and were repaid, as indicated by their $0 notional amount in the 2024 report. This evolution reflects the company's proactive debt management strategy, which includes refinancing and hedging to align with its long-term financial goals and optimize interest costs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49057,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12493,
        "completion_tokens": 113,
        "total_tokens": 12606
      }
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "Between 2022 and 2024, Schwab's approach to providing financial or other support to variable interest entities (VIEs) has remained consistent in terms of intent, as the company has not provided or intended to provide support beyond what is contractually required. However, the conditions for funding commitments have evolved, with CSB expecting to fulfill its remaining commitments to VIEs primarily between 2022 and 2025, subject to the occurrence of specific conditions. The nature of these investments, primarily through CRA-related initiatives like LIHTC investments, has not changed significantly in terms of Schwab's intent to avoid providing non-contractual support.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49888,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12708,
        "completion_tokens": 168,
        "total_tokens": 12876
      }
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "Between 2022 and 2023, MDLZ's financial relationship with JDE Peet's remained a strategic component of its liquidity and capital structure. In 2023, the investment in JDE Peet's provided additional flexibility, as noted in the liquidity and capital resources section, contributing to MDLZ's ability to manage its capital structure and fund operations. The 2023 cash flow activities also included proceeds from the sale of JDEP shares, which improved net cash from investing activities compared to the prior year. This indicates that the JDE Peet's investment continued to serve as a source of liquidity, supporting MDLZ's financial flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39835,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10187,
        "completion_tokens": 161,
        "total_tokens": 10348
      }
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "The interest rate hedging strategy for the 3.125% 2025 Notes evolved between 2022 and 2024 by transitioning from a fixed LIBOR-based rate to a SOFR-based rate. In 2022, the effective interest rate under the swap agreements was LIBOR + 1.8%. By 2024, this had changed to SOFR + 2.1%, reflecting the shift from LIBOR to SOFR as the reference rate. This change aligns with broader market transitions away from LIBOR to alternative reference rates like SOFR.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50009,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12733,
        "completion_tokens": 113,
        "total_tokens": 12846
      }
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "From fiscal year 2022 to fiscal year 2023, the fair value of Walmart's equity investments measured using Level 2 inputs decreased from $5,819 million to $5,570 million. The magnitude of this change was a decrease of $249 million.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56046,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14238,
        "completion_tokens": 57,
        "total_tokens": 14296
      }
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "Apple's characterization of its reliance on marketing abilities remained consistent between its 2023 and 2024 10-K filings. In both years, the company emphasized that while intellectual property is important, it primarily relies on the innovative skills, technical competence, and marketing abilities of its personnel to drive success and maintain a competitive edge in the marketplace.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43282,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11032,
        "completion_tokens": 96,
        "total_tokens": 11128
      }
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "The notional amount for the 3.625% 2024 Notes decreased from $1,400 million in 2022 to $0 in 2024, as the notes were fully repaid by their maturity date. The interest rate structure for these notes shifted from being hedged with interest rate swaps at LIBOR + 3.4% in 2022 to being fully unwound by 2024. This indicates that Amgen's hedging strategy involved using interest rate swaps to manage fixed-to-floating rate exposure on these notes, and as the notes matured, the associated hedging contracts were terminated, reflecting the completion of the hedging objective.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMGN_10k_2022.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "AMGN_10k_2024.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50009,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12732,
        "completion_tokens": 142,
        "total_tokens": 12874
      }
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "Schwab integrated TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, into its offerings for independent advisor clients, both in 2022 and 2023. This integration indicates Schwab's commitment to enhancing its competitive positioning in the RIA market by leveraging advanced tools and technologies to provide more comprehensive and tailored services to RIAs and their clients.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52330,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13309,
        "completion_tokens": 101,
        "total_tokens": 13411
      }
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "Apple's approach to the iMac product line evolved between 2023 and 2024, as evidenced by the company's 10-K filings. In 2024, Apple introduced a new iMac during the first quarter, indicating a focus on updating its desktop offerings. Additionally, the 2024 10-K notes that Mac net sales increased compared to 2023, primarily driven by higher laptop sales, which suggests a strategic emphasis on laptops over desktops like the iMac during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 29664,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7633,
        "completion_tokens": 112,
        "total_tokens": 7745
      }
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "Between 2022 and 2024, RTX issued the 2.820% Notes Due 2051 for $1.0 billion in August 2021 to refinance maturing debt (specifically the 2.800% and 2.500% notes due 2022). These notes remained outstanding and unchanged in 2023 and 2024, indicating a stable long-term debt structure. The continued presence of these low-interest, long-maturity notes suggests RTX is managing its debt portfolio to extend maturities and reduce refinancing risk, aligning with its strategy of maintaining a balanced capital structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43685,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11145,
        "completion_tokens": 128,
        "total_tokens": 11274
      }
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "Between 2022 and 2023, the terms of Schwab's IDA agreement were amended to adjust the service fee on client cash deposits held at the TD Depository Institutions, reducing it from 25 basis points to 15 basis points. This change reflects a cost optimization measure, aligning with the Company's broader efforts to manage interest rate risk and liquidity. Additionally, the reference rate for the agreement was transitioned from LIBOR to alternative benchmark indices, as part of Schwab's comprehensive phase-out of LIBOR.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46331,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11802,
        "completion_tokens": 129,
        "total_tokens": 11932
      }
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "The change in Filorga's financial treatment from being a standalone reporting unit with $221 million in goodwill in 2023 to being listed among other trademarks within broader segments in 2024 suggests a shift in its strategic importance and valuation approach by the company. Filorga's integration into broader segments may indicate a reevaluation of its standalone value, potentially reflecting a reduced emphasis on its individual performance or a strategic decision to consolidate reporting for operational efficiency. This could also imply that Filorga's future cash flows and brand strength are now viewed as more aligned with the broader portfolio, leading to a simplified valuation approach as part of larger trademark groups.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43051,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11018,
        "completion_tokens": 183,
        "total_tokens": 11201
      }
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "The 2024 10-K filing reflects a more detailed and forward-looking disclosure about the iPhone 16 Pro compared to the 2023 filing, which primarily listed existing models. In the 2024 filing, Apple explicitly mentions the launch of the iPhone 16 Pro in the fourth quarter, aligning with broader product announcements and emphasizing innovation such as Apple Intelligence™ and updated operating systems. This shift indicates a strategic evolution toward highlighting product differentiation, technological advancements, and future offerings, reinforcing Apple’s focus on innovation and competitive positioning in its reporting.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 29812,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7680,
        "completion_tokens": 156,
        "total_tokens": 7836
      }
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "Between 2022 and 2023, the company enhanced its Economic Value of Equity (EVE) simulations by incorporating updated modeling assumptions and a more refined understanding of balance sheet dynamics. In 2023, EVE sensitivity generally increased due to a significant shortening of liability duration as interest rates rose, while asset duration remained largely stable. Key assumptions in the EVE calculations included improved projections of interest rate scenarios with rate floors, prepayment speeds for mortgage-related investments, and the behavior of non-maturity client cash. Additionally, the company updated deposit beta assumptions in a declining market interest rate environment, which improved the accuracy of simulations in capturing client cash allocation changes. These enhancements reflect a more dynamic and responsive approach to assessing long-term interest rate risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49140,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12521,
        "completion_tokens": 220,
        "total_tokens": 12742
      }
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 enhanced its competitive positioning by expanding its product portfolio into edge networking, including mobile broadband and wireless access points. This move allowed Qualcomm to leverage its foundational technologies in Wi-Fi and 5G to offer end-to-end solutions, strengthening its presence in the broader networking market and differentiating itself from competitors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64702,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16415,
        "completion_tokens": 122,
        "total_tokens": 16537
      }
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "From 2022 to 2023, the percentage of Schwab's adjustable-rate mortgages with interest-only terms slightly decreased from 27% to 28%, while the portion of interest-only loans not scheduled to reset for three or more years increased from 86% to 89%. This indicates a marginal shift toward longer reset periods for interest-only mortgages in Schwab's portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53329,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13576,
        "completion_tokens": 89,
        "total_tokens": 13665
      }
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "Qualcomm's involvement in the XR (Extended Reality) market has shown a strategic shift from 2022 to 2023, as evidenced by their disclosures. In 2022, Qualcomm emphasized its investments in XR as part of its broader R&D efforts, including developing foundational technologies for devices like XR headsets. By 2023, the company expanded its focus, with specific mentions of XR as a key application area in QCT's IoT revenue stream, indicating increased product development and market engagement. Additionally, Qualcomm's strategic investments through Qualcomm Ventures in early-stage companies, particularly in the XR space, highlight a more targeted approach to fostering innovation and expanding opportunities in this sector.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57165,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14511,
        "completion_tokens": 181,
        "total_tokens": 14693
      }
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained unchanged at $1,100 million between 2022 and 2024. This stability indicates that RTX has not issued additional notes or repaid a portion of this specific long-term debt during this period, reflecting a consistent component of its long-term debt structure with a focus on extended maturities to manage refinancing risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43685,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11146,
        "completion_tokens": 97,
        "total_tokens": 11243
      }
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "AXP's focus on Corporate Card solutions evolved between 2023 and 2024 by emphasizing innovation and differentiation in its commercial payments offerings. In 2023, the company highlighted evolving card value propositions and differentiating corporate card and accounts payable expense management solutions. By 2024, AXP expanded on this strategy by integrating financing, banking, and payment solutions for business customers, indicating a broader push to enhance its commercial offerings. This shift suggests that AXP is prioritizing tailored, comprehensive solutions to strengthen its position in the commercial payments market and better meet the needs of its business clients.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 30883,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7942,
        "completion_tokens": 169,
        "total_tokens": 8112
      }
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "Between 2023 and 2024, PCA SKIN's strategic positioning within Colgate-Palmolive's Oral, Personal and Home Care segment remained consistent in terms of distribution channels. The brand continued to be sold primarily through traditional and e-commerce retailers, wholesalers, distributors, and in some geographies, directly to skin health professionals. There is no indication of a significant shift in distribution strategy during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48316,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12310,
        "completion_tokens": 110,
        "total_tokens": 12421
      }
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "Between 2022 and 2023, Opdivo's strategic focus and commercial positioning evolved through the expansion of new tumor indications and combination therapies. In 2023, Opdivo received FDA and EC approvals for adjuvant treatment of melanoma and neoadjuvant treatment of resectable NSCLC, broadening its use into earlier lines of therapy. Additionally, Opdivo continued to be developed in combination with Yervoy and other anti-cancer agents across multiple tumor types. These advancements supported Opdivo as a key growth driver, partially offsetting revenue declines from other products like Revlimid and contributing to higher sales of the New Product Portfolio, as noted in 2023 results. This strategic expansion positions Opdivo to sustain revenue growth by capturing new patient populations and enhancing its role in combination regimens.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 39524,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10125,
        "completion_tokens": 210,
        "total_tokens": 10335
      }
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "American Express's investment in foreign government bonds and obligations remained stable in fair value between 2023 and 2024, with $770 million in 2023 and $765 million in 2024. In terms of maturity distribution, in 2023, these obligations were primarily due after 10 years, while in 2024, all were due within one year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 126,
          "pages": [
            124,
            125,
            126,
            127,
            128
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46390,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11824,
        "completion_tokens": 80,
        "total_tokens": 11904
      }
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "Between 2022 and 2024, Walmart's use of intercompany financing arrangements has remained consistent in its purpose to ensure cash is available in the country where it is needed at the minimum cost. In 2022, approximately $4.3 billion of cash held outside the U.S. was not freely transferable due to local laws or restrictions, with $2.2 billion requiring approval from Flipkart minority shareholders. By 2024, this amount decreased to $3.5 billion, with no specific breakdown of Flipkart-related restrictions mentioned. The conditions for transferring cash to the U.S. continue to involve approval from noncontrolling interest shareholders in certain subsidiaries and compliance with local legal constraints.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59965,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15230,
        "completion_tokens": 177,
        "total_tokens": 15407
      }
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "Between 2023 and 2024, the composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained largely consistent in terms of fixed income securities and equity securities allocation. In both years, the allocation was approximately 80% fixed income securities and cash equivalents and 20% equity securities. Specifically, in 2023, the plan had $210 million in fixed income and $54 million in equity securities, while in 2024, it had $198 million in fixed income and $50 million in equity securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57207,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14537,
        "completion_tokens": 127,
        "total_tokens": 14665
      }
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "Between 2022 and 2024, Honeywell's 2006 Stock Plan for Non-Employee Directors evolved by introducing and amending specific award agreements, such as the \"Form of Stock Option Agreement\" and \"Form of Restricted Stock Unit Agreement.\" These changes indicate a shift toward more structured and performance-based compensation mechanisms for non-employee directors, reflecting a broader trend of aligning director incentives with long-term company performance and shareholder interests.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 126,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 123,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 78056,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19764,
        "completion_tokens": 120,
        "total_tokens": 19884
      }
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "Between 2022 and 2024, Walmart's ownership stake in Flipkart decreased from approximately 83% to 75% following a new equity funding in 2022. Financially, this dilution reduced Walmart's direct exposure to Flipkart's performance but maintained a significant controlling interest. Regulatory risks emerged, particularly in India, where Flipkart faced investigations by the Directorate of Enforcement regarding potential violations of Foreign Direct Investment rules and the Competition Commission of India (CCI) probing alleged antitrust violations. These matters could result in monetary penalties, share ownership restrictions, or other non-monetary relief, though outcomes remain uncertain and could materially affect Walmart's financial position.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53902,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13709,
        "completion_tokens": 187,
        "total_tokens": 13896
      }
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "Between 2022 and 2024, HON's U.S. cash balances increased significantly, from $3.4 billion in 2022 to $8.0 billion in 2024, while total cash holdings rose from $10.9 billion to $11.0 billion. The geographic distribution of funds shifted, with a growing proportion held in the U.S., reflecting strategic emphasis on liquidity and capital access for acquisitions and operations. In 2024, $8.0 billion of cash was held in non-U.S. subsidiaries, compared to $8.1 billion in 2023 and $3.4 billion in 2022, indicating a more balanced global allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42059,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10745,
        "completion_tokens": 136,
        "total_tokens": 10882
      }
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "From 2023 to 2024, the financial treatment and liability estimation methodology for the Membership Rewards program evolved in terms of assumptions used for deferred fees and liability modeling. In 2023, the Membership Rewards liability was estimated using the Ultimate Redemption Rate (URR) and the Weighted Average Cost (WAC) per point, based on redemption trends, card product type, enrollment tenure, and other factors. By 2024, the methodology remained similar but included more explicit sensitivity analyses: a 25 basis point increase in URR would increase the liability by approximately $197 million, and a 1 basis point increase in WAC per point would increase it by approximately $220 million. These changes highlight a more refined and transparent approach to modeling assumptions and their potential impact on the liability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 128,
          "pages": [
            126,
            127,
            128,
            129,
            130
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45143,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11522,
        "completion_tokens": 208,
        "total_tokens": 11730
      }
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "Adobe acquired Frame.io in October 2021 for approximately $1.18 billion and began integrating it into its Digital Media segment. By 2024, Frame.io is positioned as a core component of Adobe's creative ecosystem, directly integrated with key products like Adobe Premiere Pro, After Effects, Photoshop, and Lightroom, enabling seamless video collaboration and production workflows. Additionally, Frame.io is part of Adobe GenStudio, enhancing content production at scale and aligning with Adobe's broader strategy to unify creative tools and workflows across its Digital Media offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 43210,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11030,
        "completion_tokens": 146,
        "total_tokens": 11177
      }
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "The fair value measurements of equity-like funds using significant unobservable inputs (Level 3) for defined benefit pension plans increased from $25.4 million in 2022 to $25.1 million in 2023, showing a slight decrease. For retiree health benefit plans, the Level 3 fair value measurements for equity-like funds remained relatively stable, decreasing marginally from $2.4 million in 2022 to $2.4 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65129,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16518,
        "completion_tokens": 103,
        "total_tokens": 16621
      }
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "Adobe acquired Frame.io in October 2021 for approximately $1.18 billion and began integrating it into its Digital Media segment. By 2024, Frame.io is positioned as a cloud-native creative collaboration platform, directly integrated with key Adobe Apps like Adobe Premiere Pro, After Effects, Photoshop, and Lightroom. It supports real-time upload, review, and approval workflows and is part of Adobe GenStudio, enabling scalable content production. Frame.io's integration has expanded Adobe's Digital Media offerings by enhancing collaboration capabilities across the creative workflow.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 43552,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11102,
        "completion_tokens": 146,
        "total_tokens": 11249
      }
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "Between 2022 and 2024, CVS expanded its Medication Management approach by enhancing clinical programs and digital tools to improve medication adherence and cost efficiency. In 2022, CVS emphasized medication management programs like Pharmacy Advisor, which offered counseling and adherence support for chronic conditions, and introduced tools to address opioid misuse. By 2024, CVS had further integrated digital connectivity and AI-driven technologies, such as the Health Engagement Engine and the NovoLogix preauthorization tool, to optimize medication use and identify cost-saving opportunities. Additionally, the acquisition of Oak Street Health and expansion of in-home health evaluations (IHEs) enabled more personalized care and proactive medication management, reinforcing CVS's commitment to value-based care and patient outcomes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53306,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13560,
        "completion_tokens": 209,
        "total_tokens": 13770
      }
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved significantly from 2022 to 2024 by enhancing collaboration features and deepening integration with key Creative Cloud applications. In 2022, Adobe acquired Frame.io and began integrating it into Creative Cloud, focusing on enhancing review and approval capabilities in Premiere Pro and After Effects. By 2024, Frame.io was further embedded into the ecosystem, supporting real-time upload, frame-accurate commenting, and integrations with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront. Specific enhancements included Camera to Cloud functionality for automatic footage upload from cameras directly into Frame.io and expanded support for video workflows beyond post-production, such as casting and marketing campaign management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48218,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12290,
        "completion_tokens": 210,
        "total_tokens": 12500
      }
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "The use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024 by playing a more significant role in determining fair value, particularly for Level 3 assets. In 2024, the fair value of loans and lending commitments increasingly relied on recently executed transactions, market price quotations, and benchmarking to comparable instruments. This is evident from the valuation techniques described, which emphasize the use of observable inputs and executed transactions to estimate fair value, especially when external price data are not available. The shift reflects a greater emphasis on market-based inputs to enhance the reliability of fair value measurements for non-recurring and Level 3 assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MS_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "MS_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 109543,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 27617,
        "completion_tokens": 186,
        "total_tokens": 27803
      }
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "Between 2022 and 2024, Adobe's Substance 3D Stager has evolved from being a standalone 3D scene-building tool within the Substance 3D Collection to being more tightly integrated into the broader Substance 3D ecosystem and Adobe's Creative Cloud offerings. In 2022, Stager was described as part of a suite of tools for building and assembling 3D scenes. By 2024, the positioning emphasized its role in a more cohesive 3D workflow, working alongside tools like Substance 3D Painter and Sampler, and benefiting from Adobe's generative AI capabilities such as Firefly. This integration reflects Adobe's strategy to enhance cross-product collaboration and streamline creative workflows for 3D content creation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 38910,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9955,
        "completion_tokens": 176,
        "total_tokens": 10131
      }
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "From 2022 to 2023, GE's strategic positioning regarding grid-scale batteries evolved as part of its broader energy transition strategy. In 2022, GE emphasized the importance of investing in emerging technologies like grid-scale batteries to support decarbonization goals and modernize power grids. By 2023, grid-scale batteries were highlighted as a critical enabler for renewable energy integration and achieving deep decarbonization in the power sector. GE acknowledged the growing role of such technologies in enabling reliable power systems with high renewable penetration, and the company positioned itself to invest in and develop these solutions as part of its long-term strategy. This shift reflects an increased strategic reliance on grid-scale battery technologies to support its energy transition objectives and maintain competitiveness in evolving markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 73035,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18493,
        "completion_tokens": 217,
        "total_tokens": 18710
      }
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "CVS's disclosure regarding the use of broker-quoted debt securities in its fair value measurements indicates that the company did not have any broker-quoted debt securities in either 2022 or 2024. In both years, Level 3 debt securities were valued using either outside brokers or internal analyses for private placements. The absence of broker-quoted debt securities remained consistent, with no material changes in their presence or impact on financial reporting between 2022 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2022.pdf",
          "target_page": 148,
          "pages": [
            146,
            147,
            148,
            149,
            150
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 146,
          "pages": [
            144,
            145,
            146,
            147,
            148
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48100,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12263,
        "completion_tokens": 121,
        "total_tokens": 12385
      }
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "Between 2023 and 2024, the composition of BlackRock's Equity Securities at FVTNI changed as follows: \n\n1. **Equity securities/mutual funds** increased from $1,585 million in 2023 to $1,950 million in 2024, reflecting a $365 million growth. \n\n2. **Equity method investments**, particularly in **private equity funds**, rose from $1,264 million in 2023 to $1,060 million in 2024, while **real assets funds** increased from $417 million to $520 million. **Hedge funds/funds of hedge funds/other** remained relatively stable at $588 million in 2023 and $552 million in 2024. \n\nThese changes indicate a strategic shift toward higher allocations in mutual funds and private equity and real assets investments in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 97613,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24632,
        "completion_tokens": 177,
        "total_tokens": 24810
      }
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "From 2022 to 2024, UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities remained consistent in methodology, with no material allowance for credit losses reported in any of the years. The Company evaluates impairments by assessing the present value of expected cash flows relative to amortized cost, issuer financial condition, and other relevant factors. While unrealized losses increased over the period due to interest rate fluctuations, the Company maintained that these losses were temporary and not credit-related, as no significant credit deterioration was observed. As a result, the allowance for credit losses remained immaterial in 2022, 2023, and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54066,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13757,
        "completion_tokens": 181,
        "total_tokens": 13938
      }
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "Between 2022 and 2023, AMD's investment in the ATMP JV increased from $83 million to $99 million, reflecting a rise in the carrying value of its 15% equity interest. Additionally, AMD's equity income from the ATMP JV grew from $14 million in 2022 to $16 million in 2023, indicating improved performance of the joint venture during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45376,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11564,
        "completion_tokens": 85,
        "total_tokens": 11650
      }
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth Group's exposure to tort claims, particularly those related to the delivery of health care services such as medical malpractice, has remained a consistent risk between 2022 and 2024. The nature of the claims includes allegations against affiliated physicians, health care practitioners, and staff for failure to adhere to clinical, quality, or patient safety standards. The potential financial impact of these claims has also remained significant, as the company is largely self-insured for litigation risks, and actual losses could exceed recorded liabilities. In 2024, the company emphasized the increasing complexity of legal actions, including claims under new theories of liability that may not be subject to damage caps, further heightening the financial and reputational risks associated with tort claims.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 56829,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14433,
        "completion_tokens": 206,
        "total_tokens": 14639
      }
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "Between 2023 and 2024, Boeing's three-year revolving credit agreement remained at $3.0 billion in capacity but saw a change in its maturity date, extending from August 2025 to August 2028. This extension, along with maintaining substantial unused borrowing capacity, indicates a strategic effort to enhance liquidity flexibility and ensure backup funding for corporate needs, reflecting confidence in financial stability and operational improvements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36750,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9416,
        "completion_tokens": 112,
        "total_tokens": 9529
      }
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "The financial impact of the 2017 Performance-based Options evolved between 2023 and 2024 as follows: the total fair value of options vested in 2024 was $52 million, compared to $56 million in 2023. Additionally, the aggregate intrinsic value of options exercised in 2024 was $373 million, a significant increase from $44 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 89842,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22696,
        "completion_tokens": 84,
        "total_tokens": 22781
      }
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "Between 2022 and 2023, AMD refined its methodology for estimating adjustments related to product return rights by incorporating more detailed historical return rate data and adjusting for known events or market conditions. Specifically, the company continued to use trended actual historical product return rate information but enhanced its approach by including more granular data on contractual return percentages and factoring in additional approvals for returns beyond contractual arrangements based on specific circumstances. This evolution allowed for more accurate and consistent revenue recognition adjustments, aligning estimates more closely with actual outcomes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49125,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12511,
        "completion_tokens": 168,
        "total_tokens": 12679
      }
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "From 2023 to 2024, the number of shares under option for the 2017 Performance-based Options decreased significantly, from 1,549,080 shares to 625,825 shares. This decline was primarily due to a large number of exercises (905,219 shares) in 2024, as the first tranche of these options fully vested at the end of 2022, the second at the end of 2023, and the final tranche at the end of 2024. The substantial exercise activity indicates strong employee participation and the value of the options, given the intrinsic value of exercised options in 2024 was $373 million. Additionally, a smaller number of shares were forfeited (18,036 shares), suggesting relatively low turnover among employees holding these awards during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 108,
          "pages": [
            106,
            107,
            108,
            109,
            110
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 86033,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21742,
        "completion_tokens": 182,
        "total_tokens": 21925
      }
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "Between 2022 and 2024, Optum Rx's Pharmacy Care Services has expanded its role and strategic positioning within UnitedHealth Group's ecosystem by broadening its service offerings and enhancing integration with medical and behavioral care. In 2024, Optum Rx managed $178 billion in pharmaceutical spending, up from $112 billion in 2022, with a significant increase in specialty pharmaceutical spending to $74 billion from $45 billion. The division has also expanded its clinical programs, digital tools, and direct-to-consumer solutions, emphasizing a more holistic approach by embedding pharmacists into patient care teams and accelerating the integration of pharmacy care with medical and behavioral health services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50532,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12871,
        "completion_tokens": 179,
        "total_tokens": 13050
      }
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "The composition and valuation of BlackRock's Equity Securities at FVTNI related to investments held for deferred cash compensation plans increased from $241 million as of December 31, 2023, to $173 million as of December 31, 2024. This indicates a decrease of $68 million in the valuation of these specific investments between the two periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BLK_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "BLK_10k_2024.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 87301,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22056,
        "completion_tokens": 85,
        "total_tokens": 22142
      }
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "The aggregate available authorization for Accenture's open-market share purchase program increased from $3,129,296 as of August 31, 2022, to $6,694,281 as of August 31, 2024. This significant increase indicates a strategic commitment to returning value to shareholders through share repurchases, reflecting confidence in the company's financial position and a focus on optimizing capital allocation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40798,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10435,
        "completion_tokens": 99,
        "total_tokens": 10535
      }
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "Between 2022 and 2024, the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved in terms of share repurchase activity and shareholder rights. In 2022, the company discussed its intention to use cash for share repurchases, including those of exchangeable shares, though specific repurchase figures for these shares were not detailed. By 2024, the company provided more granular data, reporting the repurchase of 47,752 exchangeable shares for $15,254 during fiscal 2024, indicating a more transparent and structured approach to repurchase activity. Additionally, shareholder rights related to exchangeable shares remained consistent, allowing holders to exchange their shares for Accenture plc Class A ordinary shares on a one-for-one basis, with the company retaining the option to satisfy exchanges with cash.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39486,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10106,
        "completion_tokens": 212,
        "total_tokens": 10318
      }
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "The global revenue from Electrophysiology Devices increased from $2,195 million in 2023 to $2,467 million in 2024. Excluding the impact of foreign exchange fluctuations, the percentage change in this revenue was 14.4%.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47386,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12079,
        "completion_tokens": 54,
        "total_tokens": 12133
      }
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Accenture's investment in Duck Creek Technologies has seen a notable increase in valuation. As of August 31, 2022, the carrying amount of the investment was $138,902, with an estimated fair value of $223,166 for Accenture's approximately 16% ownership stake. By fiscal 2024, the investment gain related to Duck Creek Technologies positively impacted financial performance, contributing to an adjusted operating margin of 15.5% and adjusted earnings per share of $11.95, reflecting improved financial outcomes from the investment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45440,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11594,
        "completion_tokens": 141,
        "total_tokens": 11736
      }
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "Between 2022 and 2023, Union Pacific's retention share and unit awards show a shift in focus from stock options to performance-based retention awards, indicating a strategic emphasis on aligning executive compensation with long-term performance and shareholder value. In 2022, the 2021 Plan included 389,207 retention shares and 361,935 stock options, while by 2023, the emphasis on stock options had diminished, with a larger portion of awards tied to retention units (1,218,397) under the 2013 Plan. This suggests a move toward performance-based compensation to incentivize executives to meet long-term financial goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51239,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13042,
        "completion_tokens": 155,
        "total_tokens": 13198
      }
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "Between 2023 and 2024, MetLife's application of GAAP guidance for adjusted earnings remained consistent in excluding market volatility and asymmetrical accounting adjustments. Adjusted earnings continue to exclude net investment gains/losses, net derivative gains/losses, and MRB remeasurement gains/losses to smooth out the impact of market volatility. Additionally, asymmetrical accounting adjustments—such as those related to in-force reinsurance and non-economic losses at contract inception—are still excluded in 2024, aligning with the Company’s approach in 2023. The adoption of LDTI in 2024 further refined adjusted earnings by removing certain DAC, VOBA, and related intangible adjustments, but the core principles of excluding market volatility and asymmetrical accounting remained unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 170,
          "pages": [
            168,
            169,
            170,
            171,
            172
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60970,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15481,
        "completion_tokens": 200,
        "total_tokens": 15681
      }
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "From 2022 to 2024, Accenture's approach to achieving compressed transformations has evolved by integrating more advanced technologies and expanding the scope of transformation services. In 2022, the focus was on leveraging emerging technologies like blockchain, robotics, 5G, edge computing, and quantum computing, while in 2024, the emphasis expanded to include generative AI, AI-driven operations, and the metaverse continuum. Additionally, the scope of services has broadened to include AI Navigator for Enterprise and more deeply integrated solutions across Strategy & Consulting, Technology, Operations, Industry X, and Song, enabling clients to reimagine products, optimize operations, and accelerate revenue growth through hyper-personalized experiences and intelligent products.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33289,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8553,
        "completion_tokens": 196,
        "total_tokens": 8749
      }
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "Between 2023 and 2024, Abbott maintained interest rate hedge contracts with notional values of approximately $2.2 billion in both years to manage exposure to changes in the fair value of fixed-rate debt. These contracts are designated as fair value hedges, converting fixed-rate interest obligations to variable rates for the hedged portion of the debt. The fair value of these contracts was reported as $95 million in 2024 and $95 million in 2023, with no material change in their use or purpose during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44758,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11411,
        "completion_tokens": 129,
        "total_tokens": 11540
      }
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "MetLife's treatment and definition of Adjusted Earnings remained largely consistent between 2023 and 2024, with both years defining it as adjusted revenues less adjusted expenses, net of income tax. However, in 2024, there was a clarification that Adjusted Earnings is the Company's GAAP measure of segment performance and is used by the CODM for evaluating performance and allocating resources. Additionally, the adoption of ASU 2023-07 in 2024 enhanced segment expense disclosures, which indirectly impacted the transparency and presentation of Adjusted Earnings by providing more detailed segment expense information.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 119,
          "pages": [
            117,
            118,
            119,
            120,
            121
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 150,
          "pages": [
            148,
            149,
            150,
            151,
            152
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55771,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14172,
        "completion_tokens": 155,
        "total_tokens": 14327
      }
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "From 2022 to 2024, Accenture's available authorization for its share purchase program increased significantly, from $3,129,296 as of August 31, 2022, to $6,694,281 as of August 31, 2024, following additional repurchase authority approvals. In terms of share acquisition methods, the company conducted open-market share purchases, acquiring 9,635,751 shares in 2022 and 11,753,807 shares in 2024. Additionally, shares were acquired through employee equity plans, primarily via share withholding for payroll tax obligations. The 2024 program also included redemptions of Accenture Canada Holdings Inc. exchangeable shares.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37882,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9700,
        "completion_tokens": 155,
        "total_tokens": 9855
      }
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "From 2023 to 2024, MetLife's treatment and valuation methodology for Unit-linked Securities showed a shift in fair value sensitivity and cost basis adjustments. In 2023, the fair value of Unit-linked Securities increased by $138 million, primarily driven by market gains included in net income, while in 2024, the fair value increased by $131 million, with a smaller net income impact. The cost basis adjustments reflected changes in purchases and sales, with a net increase in 2023 and a more significant net decrease in 2024. Additionally, transfers into and out of Level 3 remained minimal, indicating stable unobservable inputs for valuation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 320,
          "pages": [
            318,
            319,
            320,
            321,
            322
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 77630,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19636,
        "completion_tokens": 161,
        "total_tokens": 19798
      }
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "Between fiscal years 2022 and 2023, the structure and vesting timeline of market-based RSUs evolved as follows: In fiscal year 2022, market-based RSUs generally vested over four years, subject to satisfaction of market conditions tied to total stockholder return (TSR) on an absolute basis and relative to an index group of companies. In fiscal year 2023, the company also introduced market-based RSUs with a five-year vesting timeline, contingent on achieving stock price performance milestones. This indicates a diversification in vesting timelines and performance metrics for market-based RSUs in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41639,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10622,
        "completion_tokens": 155,
        "total_tokens": 10777
      }
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "Between 2023 and 2024, the phase-in treatment of the CECL standard's ongoing impact on regulatory capital for Capital One progressed as follows: In 2023, 50% of the cumulative \"day 2\" CECL impact was phased in, while in 2024, 75% was phased in. During the phase-in period, the CECL Transition Rule allowed the company to add back the after-tax \"day 1\" CECL adoption impact and the cumulative \"day 2\" ongoing impact to regulatory capital at 25% per year from 2022 through 2024. As of December 31, 2024, 75% of the $2.4 billion CECL impact had been phased in, with the remaining 25% to be phased in by January 1, 2025.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51169,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13028,
        "completion_tokens": 154,
        "total_tokens": 13182
      }
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "Between 2022 and 2023, Broadcom continued its relationship with Wilmington Trust, National Association as trustee for its senior notes, with new indentures and supplemental agreements being executed. In 2022, an indenture dated April 14, 2022, introduced 4.00% Senior Notes due 2029. By 2023, additional indentures and amendments were made, including a July 12, 2024, indenture introducing 5.050% Senior Notes due 2027, 2029, and 2031, and a later October 2, 2024, indenture introducing 4.150%, 4.350%, 4.550%, and 4.800% Senior Notes due in 2028, 2030, 2032, and 2034, respectively. This indicates an expansion in the types of senior notes issued under their indentures during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 134,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56553,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14370,
        "completion_tokens": 172,
        "total_tokens": 14543
      }
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One's regulatory capital add-back under the CECL Transition Rule evolved from 2023 to 2024 as part of a five-year phase-in process. In 2023, 50% of the cumulative \"day 2\" ongoing impact of the CECL standard was phased in, while in 2024, 75% was phased in. As of January 1, 2024, 75% of the $2.4 billion add-back was applied, with the remaining 25% expected to be phased in by January 1, 2025. This progression reflects the 25% annual phase-in requirement under the CECL Transition Rule from 2022 through 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51527,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13109,
        "completion_tokens": 129,
        "total_tokens": 13239
      }
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "Following the Broadcom acquisition, the treatment of VMware stock options for non-employee directors evolved as follows: in 2022 (prior to the acquisition), all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors were scheduled to be accelerated and converted into the right to receive cash and shares of Broadcom common stock in equal parts upon the completion of the VMware Merger. By 2023, after the acquisition was completed, this conversion had been executed, with these awards having been settled in accordance with the terms outlined in the VMware Merger Agreement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44283,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11289,
        "completion_tokens": 153,
        "total_tokens": 11442
      }
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "Based on AbbVie's disclosures, the therapeutic positioning of Vraylar (cariprazine) has expanded from 2022 to 2024. In 2022, Vraylar was primarily indicated for schizophrenia and bipolar disorder, with ongoing trials for adjunctive treatment in major depressive disorder (MDD). By 2024, while the primary indications remained, the therapeutic scope had broadened to include its use as an adjunctive treatment for MDD, as evidenced by the continued discussion of its positioning in neuroscience and its integration into AbbVie's broader portfolio of mental health treatments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 42233,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10767,
        "completion_tokens": 143,
        "total_tokens": 10910
      }
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "GE's accounting policy for long-term services agreements has remained consistent from 2022 to 2024 in terms of revenue recognition method, as it continues to use the percentage-of-completion method based on costs incurred to date relative to total expected costs. However, there is an evolution in the detail provided regarding contract billing estimates. In 2024, GE explicitly highlights that billing terms are generally based on asset utilization (e.g., per hour of usage) or maintenance events, and it emphasizes the impact of customer utilization trends, market conditions, and asset retirements on revenue estimates. Additionally, in 2024, GE provides specific metrics, such as the long-term service agreements net liability balance and the sensitivity of revisions to estimated profitability, which were not as explicitly detailed in 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 51931,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13210,
        "completion_tokens": 211,
        "total_tokens": 13421
      }
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "IBM's disclosure of the 1.250% Notes due 2027 appears in both the 2022 and 2023 10-K filings, but with a key difference. In the 2023 filing, the 1.250% Notes due 2027 are explicitly listed under the section detailing securities registered pursuant to Section 12(b) of the Exchange Act with the trading symbol \"IBM 27B\" and listed on the New York Stock Exchange. In contrast, the 2022 filing does not specifically mention the 1.250% Notes due 2027 in the provided pages, suggesting a new or more prominent disclosure in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36086,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9229,
        "completion_tokens": 131,
        "total_tokens": 9360
      }
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "Between 2022 and 2024, the structure and performance criteria of AbbVie's performance-vested RSUs remained consistent in terms of vesting increments, with awards generally vesting in one-third increments over a three-year performance period. The performance metrics have also remained aligned with AbbVie's ROIC performance relative to a defined peer group of pharmaceutical, biotech, and life sciences companies. There is no indication of material changes to the vesting structure or performance metrics during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2022.pdf",
          "target_page": 123,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 52399,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13331,
        "completion_tokens": 131,
        "total_tokens": 13462
      }
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "From 2022 to 2024, GE's financial relationship with AerCap, as reflected in realized and unrealized gains or losses, evolved from a significant unrealized loss to a smaller unrealized gain. In 2022, GE reported a realized and unrealized loss of $(865) million related to its investment in and note with AerCap. By 2023, this loss had decreased to $129 million, and by 2024, it had turned into a gain of $38 million, indicating an improvement in the valuation of its investment in AerCap over this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 54355,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13810,
        "completion_tokens": 126,
        "total_tokens": 13936
      }
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "In the 2023 SEC filing, IBM's 0.300% Notes due 2026 (trading symbol IBM 26B) are explicitly listed among the securities registered pursuant to Section 12(b) of the Exchange Act on page 1, indicating clear visibility and disclosure as part of IBM's publicly traded financial instruments. In contrast, the 2022 filing does not specifically mention the 0.300% Notes due 2026 in the provided pages, suggesting that the note may have been issued or became more prominent between 2022 and 2023, with increased disclosure in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36086,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9251,
        "completion_tokens": 130,
        "total_tokens": 9381
      }
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "Between 2022 and 2024, GE's approach to the RISE Program has evolved from an initial focus on concept development and testing to a more advanced stage of technological maturation and integration. In 2022, the RISE Program was highlighted as a suite of pioneering technologies aimed at enabling a more sustainable future of flight, with a focus on Open Fan, compact core, and hybrid electric systems. By 2024, GE had completed over 250 tests on the full-scale Open Fan engine and continued to invest in RISE as part of its broader commitment to sustainability, reflecting a strategic emphasis on advancing these technologies toward practical application and commercial viability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GE_10k_2022.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "GE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 52523,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13348,
        "completion_tokens": 169,
        "total_tokens": 13518
      }
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "From 2022 to 2023, American Express maintained asset securitizations as a cost-effective funding source within its diversified funding strategy, with no significant shift in emphasis. In 2022, the company highlighted the role of securitizations in funding its U.S. card business by transferring Card Member loans and receivables to trusts, which issue asset-backed securities. In 2023, the company reiterated the importance of securitizations, noting their continued use to fund Card Member loans and receivables when market conditions support cost efficiency. However, there was no indication of increased reliance or strategic expansion in securitization activities in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 42230,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10789,
        "completion_tokens": 173,
        "total_tokens": 10962
      }
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "Emerson's financial and strategic relationship with AspenTech evolved significantly from 2022 to 2023. In 2022, Emerson acquired Heritage AspenTech, owning 55% of the shares, which contributed to increased sales and margin benefits in the Software and Control segment. By 2023, Emerson's investment in AspenTech continued to show positive returns, with the Heritage AspenTech acquisition adding 3% to sales growth and contributing favorably to gross margins. Operationally, AspenTech was integrated under Emerson's broader industrial software strategy, with its asset optimization software enhancing Emerson's digital ecosystem. Additionally, Emerson's ownership and strategic alignment with AspenTech supported Emerson's growth in high-margin software solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44948,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11463,
        "completion_tokens": 190,
        "total_tokens": 11653
      }
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly through the acquisition of Heritage AspenTech in May 2022. Emerson contributed two industrial software businesses and $6.0 billion in cash to create \"New AspenTech,\" in which Emerson initially owned 55% of the outstanding shares. The transaction was accounted for using the acquisition method, with Emerson as the accounting acquirer, resulting in a noncontrolling interest of $5.9 billion for the 45% ownership retained by former Heritage AspenTech stockholders. In 2023, Emerson further solidified its control by proposing to acquire the remaining 43% of AspenTech not already owned, signaling a move toward full ownership. This acquisition added significant intangible assets and goodwill, impacting Emerson’s equity and expenses through amortization and acquisition-related charges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41810,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10686,
        "completion_tokens": 219,
        "total_tokens": 10906
      }
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "Between 2022 and 2023, IBM's treatment and disclosure of the 6.22% Debentures due 2027 remained consistent in terms of their listing and incorporation by reference in the SEC filings. In both years, the debentures were disclosed under the section listing securities registered pursuant to Section 12(b) of the Exchange Act, with the 6.22% Debentures due 2027 specifically noted as trading under the symbol \"IBM 27\" on the New York Stock Exchange. Additionally, the instrument defining the rights of the holders of the 6.22% Debentures due 2027 was referenced in both filings as being incorporated by reference from prior filings (Exhibit 3 to Form 8-K filed on August 1, 1997). There were no notable changes in the treatment or disclosure of these debentures between the 2022 and 2023 filings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36086,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9233,
        "completion_tokens": 198,
        "total_tokens": 9432
      }
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "From 2023 to 2024, UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers has increased in complexity due to factors such as evolving regulatory environments, integration of new technologies, and expansion of value-based care models. These arrangements involve the Company assuming financial risk for medical costs in exchange for premiums, and their growth has implications for cost estimation accuracy and service delivery responsibilities. The Company's ability to manage these risks effectively is critical, as inaccuracies in estimating medical costs or challenges in maintaining provider relationships could significantly impact profitability and operational performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67880,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17213,
        "completion_tokens": 182,
        "total_tokens": 17395
      }
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "Between 2022 and 2023, Emerson's financial relationship with AspenTech evolved significantly in terms of investment magnitude and strategic involvement. In 2022, Emerson acquired Heritage AspenTech, gaining 55% ownership of the newly formed AspenTech. By 2023, Emerson's strategic involvement deepened as it recognized a mark-to-market gain related to foreign currency forward contracts entered into by AspenTech to hedge the Micromine purchase price. Additionally, Emerson terminated all outstanding contracts by June 2023. The investment magnitude also increased, with Emerson owning approximately 57% of AspenTech by 2024, as reflected in its proposal to acquire the remaining shares.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41990,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10721,
        "completion_tokens": 171,
        "total_tokens": 10892
      }
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023 by becoming a core component of Adobe's AI-driven personalization strategy, integrated with Adobe Sensei and GenAI capabilities. This evolution indicates Adobe's strategic direction of leveraging AI and machine learning to deliver hyper-personalized, real-time customer experiences across channels, emphasizing automation, intelligent decision-making, and scalable personalization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47028,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11994,
        "completion_tokens": 120,
        "total_tokens": 12115
      }
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "Emerson completed the acquisition of Heritage AspenTech in the third quarter of 2022, and as of 2023, AspenTech continued to operate as a separate publicly traded company under Emerson's ownership. Emerson's financial stake in AspenTech is reflected in its integration of AspenTech's stock-based compensation plans and the assumption of outstanding equity awards. Post-acquisition integration activities included converting Heritage AspenTech equity awards into Emerson equity awards and maintaining AspenTech's own stock-based compensation programs, which are settled in AspenTech stock. Additionally, Emerson assumed responsibility for integration-related stock compensation expenses, with $58 of such costs reported in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40539,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10359,
        "completion_tokens": 181,
        "total_tokens": 10540
      }
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "From 2022 to 2023, Adobe Experience Platform's role within Adobe's customer journey solutions has evolved significantly, particularly in its integration with AI-powered tools and cross-channel campaign orchestration. In 2022, Adobe Experience Platform was highlighted as a foundational infrastructure for unifying customer data and enabling AI-driven insights across Adobe Experience Cloud solutions. By 2023, the platform had further advanced, with deeper integration of Adobe Sensei and GenAI capabilities, allowing for real-time personalization, intelligent decision-making, and cross-channel campaign orchestration through tools like Adobe Journey Optimizer. This evolution enabled brands to deliver more accurate, personalized, and connected customer journeys across all channels and touchpoints.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48117,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12266,
        "completion_tokens": 200,
        "total_tokens": 12466
      }
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In response to Medicare Advantage funding pressures from 2023 to 2024, UnitedHealth Group accelerated its transition from fee-for-service care delivery models to fully accountable value-based care models. This included enhancing care delivery through in-clinic, in-home, behavioral, and virtual care, as well as leveraging data and analytics to improve care coordination and outcomes. The company also intensified medical and operating cost management, adjusted member benefits, and implemented or increased member premiums to offset funding reductions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54660,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13883,
        "completion_tokens": 138,
        "total_tokens": 14022
      }
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "Based on the provided document pages, there is no specific information detailing the evolution of TMO's debt instruments between 2022 and 2023 or any changes regarding the 1.950% Notes due 2029. The pages primarily cover general business operations, segments, and product offerings, but do not include financial data or disclosures about changes in debt composition during the specified period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47998,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12213,
        "completion_tokens": 98,
        "total_tokens": 12312
      }
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "Between 2022 and 2023, TMO's debt instruments remained largely consistent, with the 0.500% Notes due 2028 (TMO 28A) listed in both years. However, in 2023, TMO introduced new note categories, including the 3.200% Notes due 2026 (TMO 26B) and the 3.650% Notes due 2034 (TMO 34), indicating a diversification of its debt portfolio with higher-yield, longer-term instruments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47998,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12224,
        "completion_tokens": 93,
        "total_tokens": 12317
      }
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "The range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses. In 2023, the excess ranged from approximately 140% to 495%, while in 2024, the range was approximately 70% to 450%. This indicates a slight decrease in the lowest end of the range, with the upper end remaining relatively stable.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51218,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13027,
        "completion_tokens": 94,
        "total_tokens": 13121
      }
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "From 2022 to 2023, the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan increased the available share pool. In 2022, 14.7 million RSUs were canceled and 41 million shares were withheld for taxes, while in 2023, 8.1 million RSUs were canceled and 37 million shares were withheld. Since canceled RSUs and withheld shares increase the available share pool by a factor of two times the number of shares, the reduction in cancellations and withholdals in 2023 slightly decreased the replenishment of the share pool compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43250,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11041,
        "completion_tokens": 141,
        "total_tokens": 11182
      }
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "Between 2023 and 2024, Aldevron remained integrated into Danaher's Life Sciences segment, as highlighted in the 2024 10-K. There is no indication of a change in Danaher's financial stake in Aldevron during this period, as Aldevron was fully acquired in 2021 for $9.6 billion and continued to be a part of Danaher's portfolio. Aldevron's role in manufacturing plasmid DNA, mRNA, and proteins supports genomic medicine and complements Danaher's broader Life Sciences offerings, including its Genomic Medicines business and other acquisitions like IDT and Abcam.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49059,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12492,
        "completion_tokens": 139,
        "total_tokens": 12632
      }
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "Between 2023 and 2024, Microsoft 365 has evolved as a central platform for AI integration, with Copilot for Microsoft 365 combining AI with business data to enhance productivity and streamline workflows. In 2024, Microsoft 365's role in the commercial business became more prominent, contributing to a 14% revenue growth driven by Office 365 Commercial, which grew by 16%. The integration of AI technologies, such as role-based Copilots (e.g., Copilot for Sales, Service, and Finance), has further solidified Microsoft 365's position as a key driver of business transformation and operational efficiency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40810,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10438,
        "completion_tokens": 151,
        "total_tokens": 10589
      }
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "Between 2023 and 2024, Microsoft positioned Copilot Pro as a consumer subscription service that offers enhanced AI assistance within Microsoft 365 apps and on the web. In 2023, Copilot Pro was highlighted as a tool to provide faster and more powerful AI support for productivity and collaboration. By 2024, its role expanded to emphasize broader integration with Microsoft 365 and web-based AI assistance, reflecting Microsoft's focus on leveraging AI to transform productivity and user experience across its ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43066,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10993,
        "completion_tokens": 129,
        "total_tokens": 11123
      }
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan had approximately 50 million shares available for issuance as of December 31, 2023, and this decreased to approximately 47 million shares available for issuance as of December 31, 2024. This reduction reflects the issuance of shares related to stock-based compensation awards during 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2024.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58934,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14961,
        "completion_tokens": 80,
        "total_tokens": 15041
      }
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Microsoft did not change its accounting policy regarding the estimated useful lives of server and network equipment. The policy, which extended the useful lives from four to six years, was implemented in fiscal year 2023 following an assessment in July 2022. This change was driven by investments in software that improved operational efficiencies and technological advancements. No further updates to this policy were mentioned in the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 30595,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7880,
        "completion_tokens": 121,
        "total_tokens": 8001
      }
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "MDT's exposure to auction rate securities remained consistent in fair value at $33 million in both 2022 and 2023. In both years, these securities were classified under \"Other Assets\" on the consolidated balance sheet, with no amounts recorded under \"Investments.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51525,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13100,
        "completion_tokens": 65,
        "total_tokens": 13166
      }
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "In fiscal 2024, Cisco reported a net loss of $67 million from available-for-sale debt investments, compared to a net loss of $21 million in fiscal 2023. This indicates a worsening in the performance of Cisco's available-for-sale debt investments, reflecting either a decline in the fair value of these investments or increased volatility in the market during fiscal 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50464,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12853,
        "completion_tokens": 92,
        "total_tokens": 12946
      }
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "Between 2023 and 2024, Cisco's approach to the APJC region evolved by shifting from a focus on expanding operational structures to optimizing existing operations and increasing financial investments in strategic areas such as cybersecurity and AI-driven solutions. In 2023, the emphasis was on modernizing infrastructure and enhancing network capabilities, while in 2024, the company prioritized integrating advanced technologies like AI and SASE to improve customer experiences and drive revenue growth. This shift implies a move toward a more diversified revenue model in the APJC region, with increased emphasis on subscription-based services and cloud solutions, reflecting a broader strategic alignment with digital transformation trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58841,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14946,
        "completion_tokens": 185,
        "total_tokens": 15131
      }
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "Between 2022 and 2024, Apple has adapted its App Store commission policies and regulatory compliance in response to legal and market pressures. In 2022, the Company acknowledged potential changes to its App Store practices due to litigation, competition, and regulatory requirements, but specific adjustments were not detailed. By 2024, Apple had implemented notable changes, particularly in the EU, to comply with the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures for iOS and iPadOS apps, alternative app distribution methods, and alternative payment processing. Additionally, Apple modified how developers could communicate with consumers about alternative purchasing options in the U.S. These adjustments reflect Apple's evolving approach to balancing regulatory compliance with maintaining its App Store ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AAPL_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "AAPL_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59091,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14997,
        "completion_tokens": 217,
        "total_tokens": 15215
      }
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "Between 2022 and 2024, Texas Instruments' U.S. Retiree Health Care Plan maintained a higher allocation to fixed income securities and cash equivalents compared to equity securities. In 2022, the allocation was 64% fixed income and 36% equity, while in 2024, it was 80% fixed income and 20% equity. This shift reflects a more conservative strategy, aligning with the plan's goal to better match the interest rate sensitivity of its liabilities and mitigate market volatility risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55698,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14149,
        "completion_tokens": 120,
        "total_tokens": 14269
      }
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "Texas Instruments' strategic emphasis on Embedded Processing Products has seen a decline in both revenue and operating profit from 2022 to 2024. In 2022, Embedded Processing generated $3.26 billion in revenue and $1.25 billion in operating profit, but by 2024, these figures dropped to $2.53 billion in revenue and $352 million in operating profit. This decline indicates a reduced contribution to the company's competitive advantages during this period. Additionally, the segment's operating profit margin decreased significantly from 38.5% in 2022 to 13.9% in 2024, highlighting a weakening performance. Despite this, Embedded Processing remains one of TI's two reportable segments, underscoring its ongoing, though diminished, strategic importance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45536,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11622,
        "completion_tokens": 187,
        "total_tokens": 11810
      }
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "TMO issued its 2.00% 10-Year Senior Notes in 2022 as part of a series of notes issued by its wholly-owned finance subsidiary, Thermo Fisher International, which were included in the Euronotes. These notes were due in 2035 as of 2022. By 2024, the 2.00% Senior Notes were reclassified as 2.00% 30-Year Senior Notes due 2051, indicating a change in their maturity date. The valuation of these notes in 2024 showed a carrying value of $777 million, with an effective interest rate of 2.06%. This evolution reflects a strategic shift in the company's long-term debt structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48456,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12323,
        "completion_tokens": 143,
        "total_tokens": 12466
      }
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "REMICADE's sales declined by 12.8% in 2024 compared to 2023, primarily due to continued biosimilar competition in the U.S. and other markets. This significant decline indicates that REMICADE is losing market share within Johnson & Johnson's Pharmaceutical segment, highlighting the increasing pressure from biosimilars in the immunology therapeutic area.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44050,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11236,
        "completion_tokens": 88,
        "total_tokens": 11325
      }
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "From 2022 to 2024, REMICADE's sales declined significantly, dropping from $3,190 million in 2022 to $1,605 million in 2024, representing a total decrease of 12.8% in 2024 compared to 2023 and a cumulative decline of 50.5% over the two-year period. This sharp decline is primarily attributed to ongoing biosimilar competition in the United States and other international markets, which has eroded REMICADE's market share. The sustained pressure from biosimilars indicates a weakening market position for REMICADE within JNJ's Immunology portfolio, as newer products like STELARA and TREMFYA have shown growth and greater resilience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40385,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10319,
        "completion_tokens": 157,
        "total_tokens": 10477
      }
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "REMICADE's sales declined from $3.19 billion in 2021 to $1.605 billion in 2024, representing a significant reduction of 12.8% in 2024 compared to the prior year and a cumulative decline of 43.4% over the period. The primary factor contributing to this decline is the continued competition from biosimilar versions of infliximab introduced in the U.S. and other markets, which has consistently eroded REMICADE's market share.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41347,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10550,
        "completion_tokens": 106,
        "total_tokens": 10656
      }
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "Between 2022 and 2024, STELARA (ustekinumab) experienced a decline in sales, dropping from $9.134 billion in 2022 to $10.361 billion in 2023, and further to $6.7 billion in 2024. The decline in 2024 was primarily driven by share loss due to European biosimilar entrants and the anticipation of biosimilar competition in the U.S. in 2025. Despite this, STELARA maintained strong U.S. sales in 2024, though its overall commercial performance was negatively impacted by the entry of biosimilars.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39262,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10024,
        "completion_tokens": 123,
        "total_tokens": 10147
      }
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "The total net revenue from Restasis in the United States decreased from $382 million in 2023 to $172 million in 2024, representing a 55.2% decrease in 2024. In 2023, the revenue decreased by 38.5% compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABBV_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "ABBV_10k_2024.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64480,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16340,
        "completion_tokens": 53,
        "total_tokens": 16394
      }
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "Between 2022 and 2023, the role and strategic importance of Master Lease Agreements (MLAs) for AMT evolved to become more integral in supporting international growth and strengthening tenant relationships. These agreements provide consistent, long-term revenue and reduce non-contractual churn, while also enabling faster colocation cycle times, allowing tenants to deploy equipment more efficiently. In 2023, the strategic value of MLAs was further emphasized as AMT continued to expand its international portfolio and focus on building strong partnerships with multinational carriers to drive sustainable, long-term growth across diverse markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52835,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13434,
        "completion_tokens": 162,
        "total_tokens": 13596
      }
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "Between 2023 and 2024, the Google Marketing Platform continued to serve as a key channel for advertising revenue generation, particularly for ads placed on Google Network properties. Revenues from these ads are generally recognized on a gross basis, with the amounts billed to customers recorded as revenues and payments to Google Network partners treated as cost of revenues. In 2024, the role of the Google Marketing Platform remained consistent with prior years, as it facilitated customer purchases of advertising inventory across Google Network properties, including through AdMob, AdSense, and Google Ad Manager. No significant changes in the method of revenue recognition or management across Google Network properties were noted in the 2024 filing compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51786,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13191,
        "completion_tokens": 193,
        "total_tokens": 13384
      }
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "The fair value of Federal Funds Purchased and Securities Loaned increased from $144,501 million in 2023 to $133,053 million in 2024, while the volume decreased from $521,878 million to $436,340 million. This indicates that BAC likely shifted toward higher-value short-term funding instruments in 2024, possibly reflecting a strategy to optimize cost efficiency and manage liquidity risk amid changing market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 155,
          "pages": [
            153,
            154,
            155,
            156,
            157
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 115139,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 29013,
        "completion_tokens": 104,
        "total_tokens": 29118
      }
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "Between 2022 and 2024, PepsiCo expanded its disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations. In 2022, the 10-K mentioned that the fair value of pension and retiree medical plan assets and liabilities is exposed to risks related to market fluctuations, with a reference to critical accounting policies and estimates. By 2024, the disclosure became more detailed, explicitly noting that the fair value of these liabilities is impacted by changes in market conditions, including interest rates and inflationary, deflationary, and recessionary conditions. Additionally, the 2024 filing provided specific financial impacts, such as increased pension and retiree medical benefits expense due to higher settlement charges and the purchase of a group annuity contract.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 31832,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8181,
        "completion_tokens": 205,
        "total_tokens": 8386
      }
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "Adobe's approach to Adobe Scan between 2023 and 2024 has evolved to emphasize its role as a seamless, mobile-first scanning solution integrated within Adobe's broader document management ecosystem. In 2023, Adobe Scan was positioned as a free mobile tool for converting paper documents into editable, searchable PDFs via Adobe Document Cloud. By 2024, Adobe Scan was further highlighted as a key component of Adobe Document Cloud, enhancing its integration with Acrobat, Acrobat Sign, and cloud-based workflows. This shift reflects Adobe's strategy to strengthen Adobe Scan's utility in automated, collaborative digital workflows, aligning it more closely with enterprise document management and e-signature solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44545,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11361,
        "completion_tokens": 179,
        "total_tokens": 11541
      }
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini's role and integration across Google's products evolved significantly from its initial launch in 2023 to 2024. In 2023, Gemini was introduced as a native multimodal AI model capable of understanding and operating across text, code, audio, images, and video. By 2024, Gemini 2.0 was launched, enhancing its capabilities and expanding its integration into all seven of Google's two-billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. Specific advancements in its multimodal capabilities included the ability to process and combine different types of information seamlessly, enabling features such as AI Overviews, improved recommendations on YouTube, and enhanced productivity tools in Google Workspace.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45224,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11534,
        "completion_tokens": 185,
        "total_tokens": 11719
      }
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "Between 2022 and 2024, Linde's global helium wholesale operations, which are included in the \"Other\" category, experienced a decline in sales and a mixed impact on operating profit. Sales for the \"Other\" segment decreased by $32 million, or 2%, in 2024 versus 2023, primarily due to lower volumes in global helium. Operating profit in the \"Other\" segment increased by $19 million, or 44%, in 2024 compared to 2023, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher costs due to helium. This suggests that while helium-related costs negatively impacted profitability, external recoveries helped mitigate the decline.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34935,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8952,
        "completion_tokens": 167,
        "total_tokens": 9119
      }
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net value of acquired franchise rights decreased from $626 million in 2022 to $598 million in 2024, representing a decline of $28 million over the two-year period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44339,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11298,
        "completion_tokens": 41,
        "total_tokens": 11340
      }
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "Chevron's natural gas delivery commitments related to Tengizchevroil in Kazakhstan remained consistent from 2023 to 2024, with no specific changes mentioned in the provided documents. However, production volumes for Kazakhstan were stable, averaging 113 billion cubic feet in 2024 and 114 billion cubic feet in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 71399,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18063,
        "completion_tokens": 79,
        "total_tokens": 18142
      }
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "Between 2023 and 2024, the description of payments to Google Network partners in the 10-K filings indicates a shift in emphasis toward clarifying Google's role as the principal in advertising transactions. In 2023, payments to Google Network partners were mentioned as part of cost of revenues, without detailed explanation of the nature of these payments. By 2024, the description explicitly states that Google generally reports advertising revenues for ads placed on Google Network properties on a gross basis, with amounts paid to partners recorded as cost of revenues. This reflects a more transparent disclosure of Google's control over advertising inventory and its responsibility in setting pricing, reinforcing its principal role in these transactions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48509,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12357,
        "completion_tokens": 190,
        "total_tokens": 12547
      }
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "From 2023 to 2024, Bank of America has noted an increase in the regulatory focus on climate change, with a growing number of new or heightened requirements across various jurisdictions, including state, federal, and non-U.S. regions. This has led to greater jurisdictional divergence, which is expected to elevate the bank's legal, compliance, and public disclosure risks and costs. The evolving nature of these climate-related regulatory requirements, along with the challenges in managing and disclosing climate-related data, has intensified the bank's exposure to compliance risks and uncertainties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64713,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16411,
        "completion_tokens": 150,
        "total_tokens": 16562
      }
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "General Motors has increased its strategic emphasis on full-size pickup trucks from 2022 to 2024, as evidenced by stronger performance in 2024. In the GM North America (GMNA) segment, wholesale vehicle sales rose by 10.1% in 2024 compared to 2023, driven primarily by increased sales of full-size pickup trucks, mid-size pickup trucks, and other vehicles. Additionally, GMNA's EBIT-adjusted increased by 18.1% in 2024, attributed to higher volumes of full-size pickup truck sales and favorable pricing. These quantitative indicators suggest a stronger market positioning and performance for the full-size pickup truck product line in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59763,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15181,
        "completion_tokens": 159,
        "total_tokens": 15340
      }
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "From 2022 to 2024, the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts increased, as seen in the 2023 and 2024 filings. For example, in 2022, Georgia Power held $293 million in such securities, which rose to $349 million in 2023 and remained at a similar level in 2024. This shift indicates a strategic move toward safer, more liquid, and creditworthy investments, likely to preserve capital and ensure reliable funding for long-term decommissioning obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2022.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 277,
          "pages": [
            275,
            276,
            277,
            278,
            279
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 88448,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22351,
        "completion_tokens": 129,
        "total_tokens": 22481
      }
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "From 2022 to 2024, PepsiCo has maintained and slightly evolved its relationship with independent bottlers by continuing to provide annual financial incentives known as \"bottler funding.\" These incentives support trade and consumer programs, including advertising, new product launches, and equipment placement. While the 2024 filing emphasizes PepsiCo's strategic shift in some markets, such as transitioning from distribution to trademark licensing models, the core dependency on independent bottlers remains, with continued financial support to ensure effective product distribution and brand promotion. This reflects a stable yet adaptive strategic dependency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 37551,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9606,
        "completion_tokens": 165,
        "total_tokens": 9772
      }
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "Adobe Firefly's role evolved from being a newly introduced generative AI product in 2023 to a more central component of Adobe's innovation strategy in 2024. In 2023, Firefly was highlighted as a new AI offering aimed at enhancing creative workflows, but its success and adoption were uncertain. By 2024, Firefly was positioned as a key part of Adobe's broader AI integration strategy, with increased emphasis on responsible AI development and regulatory compliance, reflecting its growing strategic importance in Adobe's product roadmap.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52229,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13287,
        "completion_tokens": 134,
        "total_tokens": 13421
      }
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "The role of contractual rent escalations in driving tenant billing growth has been impacted by increased churn and lease cancellations in 2023, particularly in the U.S. & Canada property segment. In 2023, churn reached approximately 3% of tenant billings, driven by lease cancellations and non-renewals, notably by T-Mobile. This elevated churn has reduced the effectiveness of contractual rent escalations as a growth driver compared to prior years, as losses from cancellations offset some of the gains from escalations. Despite this, contractual rent escalations remain a key component of tenant billing growth, though their net contribution has been tempered by the higher churn environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56374,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14325,
        "completion_tokens": 173,
        "total_tokens": 14498
      }
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "Chevron's relationship with Tengizchevroil between 2023 and 2024 shows that the FGP/WPMP Project in Kazakhstan accounted for nearly half of the $3 billion in 2024 equity affiliate capital expenditures (Affiliate Capex). This indicates a significant and sustained capital expenditure commitment to the project in 2024. In terms of production involvement, Tengizchevroil remains a key affiliate, contributing to Chevron's net production in Kazakhstan, as reflected in the production data for affiliates in the 2024 report.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60454,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15336,
        "completion_tokens": 130,
        "total_tokens": 15466
      }
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "Between 2023 and 2024, the specificity of UPS's bond matching approach for determining the discount rate for U.S. pension and postretirement benefit plans remained consistent, as it involves selecting specific bonds that would satisfy projected benefit payments. However, the discount rate itself decreased from 5.42% in 2023 to 5.88% in 2024 for U.S. pension benefits, indicating a more conservative rate due to changes in the bond market and actuarial assumptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58718,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14905,
        "completion_tokens": 116,
        "total_tokens": 15022
      }
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "Linde's global helium wholesale operations, included in the \"Other\" segment, experienced a 2% decrease in sales in 2024 compared to 2023, primarily due to lower volumes. Despite this decline, operating profit increased by 44%, driven by insurance recovery for Linde Advanced Materials Technology (LAMT), partially offset by higher helium-related costs. This indicates that while helium volumes negatively impacted sales, cost management and insurance recoveries positively influenced profitability during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32473,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8346,
        "completion_tokens": 129,
        "total_tokens": 8475
      }
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Between 2023 and 2024, Bank of America's unfunded capital contributions for renewable energy investments decreased from $6.2 billion to $4.6 billion. Correspondingly, the recognized tax credits related to these investments slightly decreased from $4.0 billion in 2023 to $3.9 billion in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BAC_10k_2023.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "hop_2_rel": {
          "source_file": "BAC_10k_2024.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 97275,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24558,
        "completion_tokens": 73,
        "total_tokens": 24631
      }
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "From 2022 to 2024, General Motors' approach to fleet sales involving commercial fleet customers has evolved in terms of sales channels and profitability considerations. In 2022, GM reported that fleet sales, including commercial fleets, were conducted through both direct channels and dealer networks, with certain fleet transactions being less profitable than retail sales. By 2024, while the specific profitability of commercial fleet sales is not explicitly detailed, the company's broader focus on EV supply chains and strategic initiatives, such as the BrightDrop electric commercial vehicles, indicates a shift toward leveraging new product offerings to enhance profitability and meet the evolving needs of commercial fleet customers. Additionally, the continued use of dealer networks for fleet sales suggests that GM has maintained a hybrid approach to sales channels during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62915,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15958,
        "completion_tokens": 223,
        "total_tokens": 16182
      }
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "Between 2022 and 2024, PepsiCo's relationship with Sabra evolved from retaining a noncontrolling interest in a joint venture to fully exiting the relationship. In 2022, PepsiCo sold its Tropicana, Naked, and other juice brands to PAI Partners but retained a 39% noncontrolling interest in the newly formed joint venture, which included the Sabra brand. By 2024, PepsiCo had fully exited its stake in Sabra, as evidenced by the absence of any mention of Sabra in the 2024 10-K. Financially, in 2022, PepsiCo recognized a pre-tax gain of $122 million ($92 million after-tax or $0.07 per share) from the remeasurement of its previously held 50% equity ownership in Sabra at fair value. This gain was recorded in the FLNA division under selling, general, and administrative expenses. No further financial implications related to Sabra were reported in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51989,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13214,
        "completion_tokens": 213,
        "total_tokens": 13427
      }
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "Between 2023 and 2024, Adobe Scan has been increasingly integrated into Adobe's broader Document Cloud ecosystem. In 2023, Adobe Scan was mentioned primarily as a standalone mobile scanning tool that converts paper documents into PDFs. By 2024, it is highlighted as a component of Adobe Document Cloud, emphasizing its role in enabling automated, collaborative workflows and its integration with other Document Cloud services like Adobe Acrobat and Adobe Acrobat Sign. This evolution reflects Adobe's strategy to position Adobe Scan as a core, interconnected tool within its document management and digital workflow offerings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ADBE_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "ADBE_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41632,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10628,
        "completion_tokens": 156,
        "total_tokens": 10785
      }
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "General Motors' financial exposure and nature of obligations to Stellantis from 2022 to 2024, particularly regarding indemnifications and historical liabilities, have remained largely consistent, with no significant changes noted. GM continues to indemnify Stellantis for certain losses arising from inaccuracies in representations and warranties, as well as for emissions claims, product liabilities, and recalls related to the Opel/Vauxhall business sold in 2017. In 2024, GM mentions that it indemnified Stellantis for an immaterial amount related to Takata inflator recalls in legacy Opel vehicles, but it considers further indemnification for such matters to be remote. Additionally, GM is involved in investigations by the European Commission and UK CMA concerning Opel's past conduct, but the accrued liability remains immaterial. Overall, the nature of these obligations remains conditional and difficult to estimate, with no material financial impact observed during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54231,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13785,
        "completion_tokens": 246,
        "total_tokens": 14032
      }
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "PepsiCo's relationship with co-packers between 2022 and 2024 has remained relatively consistent in terms of operational dependency, as the company continues to rely on a distributed network of co-packers, contract manufacturers, and joint ventures to support its production and distribution operations. Both the 2022 and 2024 filings highlight that these third-party facilities are essential for manufacturing, warehousing, and distribution, particularly in regions where direct ownership is less feasible. However, there is an increased emphasis on strategic oversight and risk management, particularly in cybersecurity and third-party vendor assessments, indicating a more proactive approach to managing co-packer relationships to mitigate operational and reputational risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2022.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 36617,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9376,
        "completion_tokens": 194,
        "total_tokens": 9570
      }
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "Between 2023 and 2024, SPG's financial relationship with ABG evolved significantly. In 2023, SPG sold a portion of its interest in ABG, resulting in a pre-tax gain of $157.1 million and a subsequent reduction in ownership to approximately 9.6%. In 2024, SPG sold all of its remaining interest in ABG for cash proceeds of $1.2 billion, generating a substantial pre-tax gain of $414.8 million. These transactions reflect a strategic divestment from ABG, with SPG recognizing significant gains in both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50235,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12778,
        "completion_tokens": 126,
        "total_tokens": 12905
      }
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "Lockheed Martin's involvement in Sikorsky helicopter programs from 2022 to 2024 has shown growth in production volume, particularly in 2021 (as referenced in 2022 filings), with increased output on various Sikorsky helicopter programs under the Rotary and Mission Systems (RMS) segment. This growth was attributed to higher production on Black Hawk, Seahawk, and CH-53K King Stallion programs. By 2024, Sikorsky programs remained a key part of RMS's portfolio, with the final delivery of the VH-92A helicopter for the U.S. Marine One transport mission completed. The scope of involvement has expanded to include heavy lift and combat rescue capabilities, indicating a sustained and evolving focus on rotary-wing systems.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45382,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11567,
        "completion_tokens": 180,
        "total_tokens": 11747
      }
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "Walmart acquired a 100% ownership stake in Alert Innovation during fiscal 2023 for $0.4 billion. There is no mention of any changes to this ownership stake or additional financial investment in Alert Innovation during fiscal 2024 in the provided documents. Therefore, Walmart's ownership stake and financial investment in Alert Innovation remained unchanged between fiscal 2023 and fiscal 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WMT_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "WMT_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59383,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15060,
        "completion_tokens": 98,
        "total_tokens": 15158
      }
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "Between 2023 and 2024, SPG's utilization of the Supplemental Facility showed a strategic shift in borrowing and repayment. In 2023, the Operating Partnership borrowed €750.0 million under the Supplemental Facility, which was later repaid in full on November 17, 2023, using proceeds from the issuance of €750.0 million in senior unsecured bonds. By 2024, the Supplemental Facility had a borrowing capacity of $3.5 to $4.5 billion, but the maximum aggregate outstanding balance under all Credit Facilities during 2024 was relatively low at $325.1 million, with a weighted average outstanding balance of $311.1 million. This suggests a reduced reliance on the Supplemental Facility for short-term liquidity needs, as SPG prioritized repayment and maintained a strong cash position, with available borrowing capacity under the Credit Facilities reaching $8.2 billion by December 31, 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45373,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11569,
        "completion_tokens": 221,
        "total_tokens": 11790
      }
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "Linde has increasingly positioned helium as a core component of its industrial gases business between 2023 and 2024, particularly within the merchant and on-site distribution methods. In 2024, merchant sales of helium (included in merchant argon, hydrogen, and helium) are highlighted as being capable of being shipped over longer distances, indicating a strategic emphasis on expanding helium supply capabilities beyond localized markets. Additionally, Linde's long-term supply contracts, particularly for on-site customers, include price escalation provisions, suggesting a proactive approach to managing helium pricing volatility. The company also estimates significant future revenue from long-term obligations, including those tied to helium, with approximately half expected to be realized within the next six years, reflecting a stronger focus on securing and optimizing helium supply strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LIN_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "LIN_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43289,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11055,
        "completion_tokens": 225,
        "total_tokens": 11281
      }
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retiree Health Care Plan's asset allocation shifted toward fixed income securities and away from equity securities. In 2022, the weighted average allocation was 65% fixed income securities and cash equivalents and 35% equity securities. By 2023, this changed to 80% fixed income securities and cash equivalents and 20% equity securities. This shift reflects a more conservative investment strategy, aligning with the plan's target allocation ranges and risk management approach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60034,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15235,
        "completion_tokens": 127,
        "total_tokens": 15362
      }
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "Trodelvy's financial performance improved significantly between 2022 and 2023, with product sales increasing by 56% to $1.1 billion in 2023, driven by higher demand in new and existing geographies. Strategically, Trodelvy received FDA approval for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting, expanding its market reach.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 81945,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20713,
        "completion_tokens": 124,
        "total_tokens": 20837
      }
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron's downstream-related earnings from GS Caltex increased from $874 million in 2022 to $58 million in 2024, indicating a significant decline. This suggests that the joint venture's contribution to Chevron's earnings has diminished over the period. Despite this, the continued investment and operational ties with GS Caltex, as reflected in intercompany transactions and balances, highlight its ongoing strategic importance in Chevron's downstream operations in South Korea.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2024.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58256,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14796,
        "completion_tokens": 119,
        "total_tokens": 14916
      }
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "From 2022 to 2024, the CH-53K program saw an increase in production volume, contributing to higher net sales within the Rotary and Mission Systems (RMS) segment. In 2024, RMS reported increased net sales due to higher production volume on the CH-53K program. Additionally, the program experienced risk retirements, which positively impacted operating profit by improving the profit booking rate as risks related to technical, schedule, and cost aspects were successfully addressed.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49768,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12668,
        "completion_tokens": 120,
        "total_tokens": 12788
      }
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "Between 2022 and 2023, PayPal's approach to seller protection programs has evolved with a stronger strategic emphasis on enhancing risk management and expanding protections for merchants. In 2023, the company explicitly highlighted its seller protection programs as a key differentiator, emphasizing their role in reducing merchant losses and fostering trust. This reflects a more proactive stance in addressing fraud and financial risks, leveraging its two-sided network data and end-to-end platform capabilities. While risk exposure is still influenced by macroeconomic factors and transaction loss rates, PayPal's 2023 disclosures indicate a heightened focus on refining these programs to align with evolving regulatory and market demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48986,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12467,
        "completion_tokens": 185,
        "total_tokens": 12653
      }
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "Between 2023 and 2024, Starbucks' approach to its ready-to-drink beverages remained consistent in terms of revenue recognition, with sales primarily recognized upon shipment to customers outside of company-operated and licensed stores. Additionally, supplier dependency for these beverages was managed through long-term supply contracts with several specialty suppliers, ensuring a stable supply chain. There were no notable changes in these practices between the two years based on the provided information.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45585,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11620,
        "completion_tokens": 127,
        "total_tokens": 11747
      }
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "Between 2022 and 2023, Trodelvy's geographic reach and regulatory approvals expanded significantly. In 2022, Trodelvy sales increased due to higher demand in new and existing geographies, and the drug had already received regulatory approvals in the U.S. and Europe for metastatic triple-negative breast cancer (TNBC) and urothelial cancer (UC). By 2023, Trodelvy sales grew by 56%, and the drug received additional regulatory approvals, including EC approval for HR+/HER2- breast cancer and expanded indications in multiple regions. These developments reflect both geographic expansion and broader therapeutic applications for Trodelvy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51782,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13153,
        "completion_tokens": 159,
        "total_tokens": 13313
      }
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "Between 2023 and 2024, Simon Property Group's ownership stake in ABG decreased significantly. In the fourth quarter of 2023, a capital transaction diluted Simon's ownership from approximately 11.8% to 9.6%, resulting in a non-cash pre-tax gain of $10.3 million. In 2024, Simon sold all of its remaining interest in ABG for cash proceeds of $1.2 billion, generating a pretax gain of $414.8 million. Thus, Simon fully exited its ABG investment by the end of 2024, realizing substantial financial gains through both dilution and the final sale.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49281,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12537,
        "completion_tokens": 135,
        "total_tokens": 12672
      }
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "Between the 2023 and 2024 filings, the 2012 Equity Incentive Plan underwent notable changes. In 2024, a Fourth Amendment to the plan was disclosed, filed on August 1, 2024, in addition to the previously disclosed Third Amendment from 2023. Furthermore, new forms of award agreements were added in 2024, including additional forms filed on April 25, 2024. These updates reflect ongoing modifications to the plan's structure and award administration.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "META_10k_2023.pdf",
          "target_page": 128,
          "pages": [
            126,
            127,
            128,
            129,
            130
          ]
        },
        "hop_2_rel": {
          "source_file": "META_10k_2024.pdf",
          "target_page": 127,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43545,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11112,
        "completion_tokens": 112,
        "total_tokens": 11224
      }
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "Between 2022 and 2023, the capitalized software licenses increased from $152 million to $223 million, as noted in the consolidated balance sheets. Additionally, the amortization of capitalized software rose from $54 million in 2022 to $63 million in 2023. This increase in both the value of capitalized licenses and their amortization indicates a higher investment in software licensing by the company in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48060,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12244,
        "completion_tokens": 106,
        "total_tokens": 12350
      }
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "Between 2022 and 2023, PayPal increased its utilization of European customer balances for credit activities, raising the approved amount from $3.8 billion to $3.0 billion. In 2022, this represented 37% of European customer balances, while in 2023, it represented 39%. This indicates a strategic shift toward leveraging European customer balances more efficiently to fund credit products, reflecting PayPal's focus on expanding credit offerings while optimizing internal liquidity sources.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49659,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12648,
        "completion_tokens": 122,
        "total_tokens": 12770
      }
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks' investment in Valor Siren Ventures I L.P. had a total carrying value of $211.9 million as of September 29, 2024, and there were no material changes or financial impacts disclosed between fiscal years 2023 and 2024. The related financial statement activities from these private equity interests were not material during the periods presented.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45440,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11605,
        "completion_tokens": 88,
        "total_tokens": 11693
      }
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Between 2022 and 2023, the strategic positioning of Analog Products at Texas Instruments (TI) shifted due to decreased demand, resulting in a 15% revenue decline and a significant 30% drop in operating profit. This was driven by lower revenue and higher manufacturing costs from planned capacity expansion and reduced factory loadings. TI continued to invest in strengthening its competitive advantages, particularly in manufacturing and technology, but the financial contribution of Analog Products weakened in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TXN_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "TXN_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36452,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9334,
        "completion_tokens": 133,
        "total_tokens": 9468
      }
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron's capital allocation strategy in the Lower 48 region from 2022 to 2023 shows an increase in depreciation, depletion, and amortization (DD&A) from $4,854 million in 2022 to $5,729 million in 2023, indicating higher capital investment or asset utilization. However, impairments decreased significantly from $735 million in 2022 to $587 million in 2023, suggesting improved asset performance or fewer write-downs. This evolution reflects a shift toward maintaining operational efficiency and capital discipline while reducing asset impairment risks in the Lower 48 region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57224,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14535,
        "completion_tokens": 144,
        "total_tokens": 14679
      }
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "Between 2023 and 2024, Verizon has positioned FWA Broadband as a core component of its next-generation Intelligent Edge Network, leveraging both 5G and 4G LTE technologies to provide high-speed, low-latency connectivity. In 2023, FWA was highlighted as an alternative to traditional landline internet access, primarily serving residential customers through the Consumer segment and small-to-medium businesses through the Business segment. By 2024, FWA had evolved further, with a stronger emphasis on its role in supporting enterprise and public sector customers, as well as enhancing Verizon's business market offerings. This shift reflects a broader strategy to integrate FWA into both Consumer and Business product portfolios, targeting a wider range of customer segments, including those requiring scalable, cost-efficient connectivity solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50129,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12762,
        "completion_tokens": 212,
        "total_tokens": 12974
      }
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson's relationship with AspenTech evolved significantly from 2022 to 2024, transitioning from a 55% ownership stake in the newly formed \"New AspenTech\" (created in May 2022) to proposing a full acquisition of the remaining shares in November 2024. This evolution had a mixed financial impact: the Heritage AspenTech acquisition in 2022 positively contributed to gross margin by 0.6 percentage points in 2023, but the Test & Measurement acquisition in 2024 caused a 1.3 percentage point drag on gross margin due to inventory step-up amortization. Additionally, the proposed full acquisition in 2024 would further consolidate AspenTech into Emerson’s equity structure, though the final financial implications remain contingent on the transaction's completion.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 39950,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10212,
        "completion_tokens": 190,
        "total_tokens": 10403
      }
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "The financial relationship between NEE and FPL Group Capital Inc. (now NextEra Energy Capital Holdings, Inc.) from 2022 to 2023 primarily involved the issuance and management of debt instruments, including junior subordinated debentures and floating rate notes. In 2022, NEE issued Series J and K Debentures through NextEra Energy Capital Holdings, Inc., with terms extending to 2024 and 2025, respectively. In 2023, amendments and new issuances such as the Series L Debentures due 2025 and Floating Rate Notes due 2073 were recorded, indicating continued capital structure involvement through debt obligations. These activities reflect NEE's use of its subsidiary to manage long-term financing and obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 94955,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23972,
        "completion_tokens": 177,
        "total_tokens": 24150
      }
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "The positioning and market acceptance of the InterStim II neurostimulator evolved positively between 2022 and 2024, with continued growth in Pelvic Health therapies. In 2022, the InterStim Micro neurostimulator was highlighted as a recent launch driving Pelvic Health sales, while InterStim II was part of the broader InterStim therapy portfolio. By 2024, InterStim II was specifically noted alongside the InterStim X and InterStim Micro as a recharge-free neurostimulator for treating overactive bladder, urinary retention, and chronic fecal incontinence, indicating its established role within Medtronic’s Pelvic Health offerings. This suggests a strengthening market position for InterStim II as part of a diversified neurostimulation portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41100,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10506,
        "completion_tokens": 187,
        "total_tokens": 10693
      }
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's utilization and management of the Supplemental Facility evolved in several key ways. The borrowing capacity of the Supplemental Facility increased from an initial $3.5 billion in 2022 to a potential $4.5 billion by 2024, subject to additional lender commitments. The interest rate strategies remained consistent, with rates based on SOFR plus a spread adjustment (72.5 basis points) reflecting the transition from LIBOR. In terms of repayment actions, the Supplemental Facility was used to support short-term liquidity needs, such as the repayment of €750.0 million in borrowings in November 2023, which were subsequently refinanced through the issuance of senior unsecured bonds. Overall, the Supplemental Facility served as a flexible tool for managing short-term liquidity and optimizing debt structures during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51360,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13075,
        "completion_tokens": 218,
        "total_tokens": 13293
      }
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "From 2023 to 2024, Verizon transitioned away from fixed-term, subsidized service plans for Consumer customers, focusing instead on device payment plans that allow customers to pay for devices in installments over time. These plans involve non-interest-bearing installment notes, typically over a 36-month term, and include month-to-month wireless service contracts. Promotional incentives, such as billing credits contingent on service retention, are now more prominent, with these credits factored into the transaction price and allocated to performance obligations based on relative standalone selling prices. Additionally, financing components in these plans are evaluated for significance, with Verizon determining that they are not material for direct-channel contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52366,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13313,
        "completion_tokens": 193,
        "total_tokens": 13507
      }
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's legal stance on liability for Aqua-Chem's asbestos-related claims remained consistent, asserting that it has no obligation for Aqua-Chem's liabilities. In 2023, the Georgia Case was still subject to the 2004 stay pending resolution of insurance coverage litigation, and the Company continued to pursue coverage agreements with insurers. By 2024, the litigation status remained unchanged, with the Georgia Case still stayed. The Company maintained its position that it is not responsible for Aqua-Chem's asbestos liabilities beyond what is covered by insurance, as outlined in the 1981 stock sale agreement and subsequent legal proceedings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 75773,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19173,
        "completion_tokens": 171,
        "total_tokens": 19344
      }
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel's utilization of non-US tax credits significantly reduced its long-term income tax liabilities in 2024 compared to 2022. In 2024, non-US tax credits contributed to a $67 million tax benefit (up from $129 million in 2023 and $220 million in 2022), indicating that the company continues to leverage favorable tax rates in jurisdictions like Israel and Malaysia. This strategy reflects Intel's ongoing focus on optimizing its global tax position by structuring operations in regions with reduced tax rates and maintaining eligibility for tax holidays, which helps mitigate its overall tax burden.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 92,
          "pages": [
            90,
            91,
            92,
            93,
            94
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40174,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10276,
        "completion_tokens": 149,
        "total_tokens": 10426
      }
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "Between 2022 and 2024, the treatment and risk exposure of pension risk transfers have evolved in response to interest rate sensitivity and regulatory influence. In 2022, the company experienced a net derivative loss of $445 million under a rising interest rate scenario, with adjusted earnings negatively impacted across most segments. By 2024, the net derivative loss had significantly reduced to $15 million, while the adjusted earnings impact improved to $95 million, indicating better risk management and adaptation to higher interest rates. Regulatory developments, including evolving capital requirements and reserving standards, have also influenced the company's approach to pension risk transfers, with increased focus on asset/liability management strategies and derivative usage to mitigate margin compression and interest rate volatility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51473,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13095,
        "completion_tokens": 212,
        "total_tokens": 13308
      }
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "Between 2022 and 2024, Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved to emphasize broader therapeutic applications and global adoption. In 2022, the InterStim Micro was highlighted for treating overactive bladder, urinary retention, and bowel incontinence, with growth driven by recent launches and supply chain recovery. By 2024, the strategy expanded to include the InterStim X and InterStim II recharge-free neurostimulators alongside the InterStim Micro, targeting chronic fecal incontinence and non-obtrusive urinary retention. The company also emphasized continued global acceptance and growth of Pelvic Health therapies, reflecting a more comprehensive and diversified approach to neurostimulation solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41100,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10490,
        "completion_tokens": 191,
        "total_tokens": 10681
      }
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "Between 2022 and 2024, Simon Property Group's use of the Supplemental Facility showed a notable shift in terms of outstanding borrowings and repayment actions. In 2022, the Operating Partnership had $1.05 billion outstanding under the Supplemental Facility on January 12, 2022, after drawing funds in December 2021 to repay mortgages. By 2024, the company had repaid €750.0 million ($815.4 million U.S. dollar equivalent) of borrowings under the Supplemental Facility on November 17, 2023, using proceeds from the issuance of senior unsecured bonds. As of December 31, 2024, the weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) was $311.1 million, indicating a significant reduction in reliance on the Supplemental Facility compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 124,
          "pages": [
            122,
            123,
            124,
            125,
            126
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50061,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12741,
        "completion_tokens": 198,
        "total_tokens": 12940
      }
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "COP's investment activity in the Lower 48 region, as reflected in depreciation, depletion, amortization, and impairments (DD&A) expenses, increased from 2022 to 2023. In 2023, DD&A expenses for the Lower 48 were $5,729 million, compared to $4,854 million in 2022, indicating a $875 million increase. This rise suggests higher capital investment or asset utilization in the Lower 48 region during 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 172,
          "pages": [
            170,
            171,
            172,
            173,
            174
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56823,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14435,
        "completion_tokens": 100,
        "total_tokens": 14535
      }
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "From 2023 to 2024, Verizon's approach to corporate networking solutions has seen a slight shift in emphasis and service description. In 2023, the Business segment emphasized a broad portfolio of connectivity, security, and professional services tailored for large enterprises and public sector customers, with Enterprise and Public Sector accounting for 50% of Business segment revenues. By 2024, while the core offerings remain similar, there is a noted focus on enhancing IoT capabilities and leveraging business models that monetize usage across connectivity, platform, and solution layers. Additionally, the Business segment's Enterprise and Public Sector revenue slightly decreased to 48% of the Business segment's total in 2024, while Business Markets and Other saw a modest increase in relative contribution.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50129,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12756,
        "completion_tokens": 203,
        "total_tokens": 12959
      }
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "From 2022 to 2024, MetLife's valuation approach for FVO (Fair Value Option) securities remained consistent in terms of sensitivity to fair value changes, with the U.S. dollar appreciation having an inverse impact on short U.S. dollar net asset positions. In 2022, a 10% appreciation in the U.S. dollar resulted in a $54 million decrease in the estimated fair value of FVO securities. By 2024, the sensitivity of FVO securities to U.S. dollar appreciation remained similar, with the valuation techniques and significant unobservable inputs for Level 3 assets and liabilities, including FVO securities, unchanged. This indicates that the valuation approach and sensitivity to U.S. dollar movements for FVO securities were stable during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 84360,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21322,
        "completion_tokens": 186,
        "total_tokens": 21509
      }
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, with its energy trading services contributing to significant changes in financial performance. In 2023, operating revenues for NextEra Energy Resources (NEER) increased by $5,952 million, driven primarily by gains from non-qualifying commodity hedges due to changes in energy prices, net increases in revenues from customer supply and gas infrastructure businesses, and revenues from new investments in wind, solar, and battery storage facilities. However, this growth was partially offset by lower revenues from existing clean energy assets, mainly due to reduced wind generation. Financially, NEER's net income less net loss attributable to noncontrolling interests rose sharply from $285 million in 2022 to $3,558 million in 2023, largely due to new investments, changes in non-qualifying hedge activity, and gains from nuclear decommissioning fund investments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 57890,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14703,
        "completion_tokens": 238,
        "total_tokens": 14941
      }
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "Between 2023 and 2024, The Coca-Cola Company's stake in Coca-Cola FEMSA remained at 28%, with no change in ownership percentage. However, the carrying value of the investment in Coca-Cola FEMSA increased from $1,786 million in 2023 to $4,544 million in 2024, reflecting the equity method accounting for the investee's performance. The Company's equity income from Coca-Cola FEMSA also rose from $1,691 million in 2023 to $1,770 million in 2024, indicating improved financial performance of the investee and a positive impact on The Coca-Cola Company's consolidated results.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52142,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13265,
        "completion_tokens": 143,
        "total_tokens": 13409
      }
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "Between 2022 and 2023, the financial investment and operational focus on the Lower 48 region showed a mixed trend. Production volumes in the Lower 48 decreased from 52,921 million dollars in 2022 to 38,244 million dollars in 2023, indicating a decline in sales and other operating revenues. However, capital expenditures and investments in the Lower 48 increased from $5,630 million in 2022 to $6,487 million in 2023, reflecting a higher financial investment. Depreciation, depletion, and amortization expenses for the Lower 48 also rose from $4,854 million in 2022 to $5,729 million in 2023, suggesting increased operational focus and asset utilization in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 169,
          "pages": [
            167,
            168,
            169,
            170,
            171
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61873,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15695,
        "completion_tokens": 167,
        "total_tokens": 15862
      }
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "Between 2023 and 2024, Verizon's 4G LTE network continued to play a foundational role in its network infrastructure, particularly as a complement to its 5G expansion. In 2024, the company emphasized leveraging its 4G LTE network alongside its advanced 5G capabilities to provide reliable connectivity, especially for Fixed Wireless Access (FWA) broadband services. While the focus shifted toward 5G deployment and densification, the 4G LTE network remained integral to supporting customer demand for mobility, capacity, and coverage, particularly in areas where 5G adoption was still evolving. Additionally, Verizon's 4G LTE infrastructure contributed to its fiber expansion strategy, enabling the company to offer integrated wireless and wireline broadband solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "VZ_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "VZ_10k_2024.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44344,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11315,
        "completion_tokens": 192,
        "total_tokens": 11507
      }
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "Emerson's financial and strategic relationship with AspenTech evolved significantly from 2022 to 2024. In 2022, Emerson acquired the Heritage AspenTech business and contributed two of its own software businesses to form \"New AspenTech,\" owning 55% of the shares. By 2024, Emerson increased its ownership to approximately 57% and proposed a full acquisition of the remaining shares at $240 per share. This evolution positively impacted financial metrics: AspenTech's inclusion in 2022 increased its backlog significantly, and the 2023 Heritage AspenTech acquisition contributed to a 3.3 percentage point gross margin increase. However, in 2024, while gross margin remained strong at 50.8%, it was partially offset by acquisition-related inventory step-up amortization. Overall, the strategic integration of AspenTech enhanced Emerson’s Software and Control segment performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2022.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 38458,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9854,
        "completion_tokens": 219,
        "total_tokens": 10073
      }
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "NEE's financial commitment to the Mountain Valley Pipeline (MVP) significantly decreased between 2022 and 2023. In 2022, NEE recorded an additional impairment charge to completely write off its investment in MVP, indicating a loss of value and strategic reconsideration. By 2023, the only mention of MVP is a 20-year natural gas transportation agreement with MVP, which includes approximately $70 million per year for equity contributions in 2024. This shift from a direct investment to a more limited transportation agreement suggests a strategic pivot away from direct ownership in MVP, likely due to financial underperformance and regulatory or construction challenges.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 70184,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17770,
        "completion_tokens": 168,
        "total_tokens": 17938
      }
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "From 2023 to 2024, Coca-Cola's relationship with Costa Limited has remained integrated within the Global Ventures segment, as Costa's direct sales to consumers continue to be included in this segment. There is no explicit mention of significant changes in operational integration or strategic positioning in the provided pages, indicating that Costa's role and inclusion in the Global Ventures segment have remained consistent during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51873,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13195,
        "completion_tokens": 111,
        "total_tokens": 13306
      }
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel's investment in financial institution instruments, specifically the fair value of economically hedged marketable debt investments, decreased from $17.1 billion as of December 30, 2023, to $13.5 billion as of December 28, 2024. This represents a reduction of $3.6 billion over the period. Additionally, in 2024, Intel recorded net losses of $464 million on these hedged investments, contrasting with net gains of $534 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54525,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13862,
        "completion_tokens": 109,
        "total_tokens": 13972
      }
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "AMT's financial focus regarding communications sites evolved from 2023 to 2024 by emphasizing recurring revenue generation through long-term leases and strategic asset management, particularly in India, where the company initiated a strategic review and entered into the Pending ATC TIPL Transaction to divest its India operations. In terms of asset retirement liabilities, AMT reported an estimated $4.5 billion in undiscounted future cash outlays for asset retirement obligations as of December 31, 2024, reflecting its ongoing commitment to site remediation and compliance with lease agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48174,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12271,
        "completion_tokens": 149,
        "total_tokens": 12420
      }
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "Between 2023 and 2024, XOM's strategic positioning in Guyana has evolved with the introduction of the Petroleum Activities Act 2023, which provides a more structured legal operating framework. This Act authorizes the Government of Guyana to license and enter into petroleum agreements, establishing an exploration period typically up to 10 years and a production period of 20 years for oil fields (with a 30-year term for gas fields), each with a potential renewal period of up to 10 years. This legislative development enhances the clarity and stability of the operating environment, supporting XOM's business growth emphasis by providing longer-term certainty for exploration and production activities in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45634,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11632,
        "completion_tokens": 179,
        "total_tokens": 11812
      }
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "Caterpillar's involvement in the diesel-electric locomotives business remained a core part of its Energy & Transportation segment in both 2023 and 2024. In 2024, the segment's sales increased by 3%, driven by favorable price realization, with Transportation sales rising due to growth in marine and rail services. The strategic positioning highlights continued focus on rail-related products and services, including remanufacturing and leasing. Operationally, the segment is responsible for diesel-electric locomotives and components, underscoring Caterpillar's ongoing commitment to this market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 39763,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10174,
        "completion_tokens": 149,
        "total_tokens": 10323
      }
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "The company's reliance on securitized debt obligations as a funding source decreased from 2022 to 2024. In 2022, securitized debt obligations accounted for 4% of total funding sources, with a carrying value of $14.994 billion. By 2024, this figure dropped to 4% as well, but the carrying value decreased to $14.264 billion. This slight reduction suggests a modest shift away from securitized debt obligations in favor of other funding sources, such as deposits and other debt, indicating a more diversified funding strategy over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52055,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13240,
        "completion_tokens": 135,
        "total_tokens": 13375
      }
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "Between 2023 and 2024, McDonald's treatment of developmental licensees evolved in terms of financial reporting and relationship management as follows:\n\n1. **Financial Reporting**: The number of developmental licensed restaurants increased from 8,684 in 2023 to 9,247 in 2024, indicating expansion in this segment. Financially, the Company continues to report revenues from developmental licensees as royalties based on a percentage of sales, with initial fees recognized over the franchise term. The Company also acquired additional restaurants from developmental licensees in 2024, which contributed to goodwill and intangible assets, though these acquisitions were not material to overall revenues or net income.\n\n2. **Relationship Management**: McDonald's maintains a franchising model where developmental licensees operate under license agreements and pay royalties. The Company's focus on developmental licensees is part of its broader growth strategy, including the Restaurant Development pillar introduced in 2023. This is reflected in the increased number of developmental licensed restaurants and the Company's ongoing evaluation of renewal options to support long-term growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53100,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13499,
        "completion_tokens": 296,
        "total_tokens": 13795
      }
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "Between 2023 and 2024, Southern Company's Equity and Incentive Compensation Plan saw an increase in share availability, with 26.9 million shares available for awards under the plan as of December 31, 2023, and the plan being amended and restated effective May 26, 2021. Additionally, the 2024 filings indicate the inclusion of the ninth amendment to the Southern Company Employee Savings Plan, dated December 16, 2024, and the continued use of the 2021 Equity and Incentive Compensation Plan for executive awards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 232,
          "pages": [
            230,
            231,
            232,
            233,
            234
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 316,
          "pages": [
            314,
            315,
            316,
            317,
            318
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 81142,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20518,
        "completion_tokens": 128,
        "total_tokens": 20647
      }
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Inlyta's revenue increased by 3% in 2023 compared to 2022, with a 5% operational growth in the U.S. driven by the adoption of combinations of certain immune checkpoint inhibitors and Inlyta for the first-line treatment of patients with advanced RCC. However, this growth was partially offset by lower volumes and lower net price in certain European markets. Globally, the growth was primarily due to continued adoption in developed markets and growth in emerging markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 98970,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24961,
        "completion_tokens": 117,
        "total_tokens": 25079
      }
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "From 2023 to 2024, McDonald's relationship with its franchisees has evolved in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms. The Company recognizes revenue from franchisees for technology platforms on a gross basis, as it is the principal in these arrangements, with related expenses recognized as incurred. This indicates that the Company is increasingly involved in providing distinct technology services to franchisees, which are separate from the franchise agreement. The financial structure reflects a shift toward the Company bearing the upfront costs of these technology platforms, with franchisees reimbursing a portion of these costs, thereby sharing in the expenses. This evolution suggests a more integrated operational and financial relationship with franchisees, leveraging technology to enhance performance while maintaining the core franchising model.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62590,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15883,
        "completion_tokens": 237,
        "total_tokens": 16121
      }
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "From 2022 to 2023, the fair value of energy-related derivatives held by Southern Company's subsidiaries decreased from $199 million to $55 million in assets and increased from $210 million to $358 million in liabilities. This shift indicates a growing net liability position, suggesting increased exposure to energy market fluctuations, particularly in derivative contracts used for hedging or trading purposes. The company's exposure appears to have risen, reflecting potential volatility in energy prices or expanded derivative activity during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 285,
          "pages": [
            283,
            284,
            285,
            286,
            287
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 277,
          "pages": [
            275,
            276,
            277,
            278,
            279
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 84269,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21304,
        "completion_tokens": 139,
        "total_tokens": 21444
      }
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "The Procter & Gamble 2019 Stock and Incentive Compensation Plan remained the sole active plan allowing future grants of securities in both 2022 and 2024. However, the shares available for future issuance under the plan decreased from 119 million in 2022 to 77 million in 2024, indicating increased utilization of the plan's share allocation over this period. The maximum share capacity of 187 million remained unchanged, but the reduction in available shares highlights a greater allocation of equity compensation under the 2019 Plan in recent years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 68747,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17416,
        "completion_tokens": 137,
        "total_tokens": 17554
      }
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "From 2023 to 2024, Southern Company's approach to managing the risk of large losses in its pension plan assets remained focused on diversification and formal rebalancing programs, as outlined in both years' disclosures. However, in 2024, there was a slight shift in risk management emphasis, with increased allocations to private credit and infrastructure, indicating a greater focus on alternative assets with stable cash flows and income generation. Additionally, the 2024 disclosures highlight a more detailed discussion of the use of Net Asset Value (NAV) as a practical expedient for valuing private investments, reflecting a stronger emphasis on liquidity management and transparency in non-publicly traded assets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 263,
          "pages": [
            261,
            262,
            263,
            264,
            265
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 255,
          "pages": [
            253,
            254,
            255,
            256,
            257
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62529,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15867,
        "completion_tokens": 180,
        "total_tokens": 16047
      }
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "Between 2022 and 2023, NVIDIA's role in the development and supply of the CUDA platform evolved from being a foundational element of its accelerated computing ecosystem to a more integrated and expanded component of its full-stack computing infrastructure. In 2022, CUDA was highlighted as a key parallel programming model that enabled performance acceleration across a wide range of applications, including AI, data analytics, and scientific computing. By 2023, CUDA was positioned as a central pillar of NVIDIA's unified architecture, underpinning not only its GPU-based solutions but also its broader data-center-scale offerings, including CPUs and DPUs. This shift indicates that NVIDIA is strategically focusing on reinforcing its leadership in AI and accelerated computing by deepening its software ecosystem and expanding the reach of CUDA across diverse markets and technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2022.pdf",
          "target_page": 86,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49393,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12575,
        "completion_tokens": 221,
        "total_tokens": 12796
      }
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "Between 2022 and 2023, Pfizer's financial relationship with Viatris, stemming from the 2020 separation of the Upjohn business and its combination with Mylan to form Viatris, remained largely stable in terms of supply agreements and outstanding balances. The supply and manufacturing agreements (MSAs) between the two companies, which range in initial duration from four to seven years post-separation, continued to facilitate the manufacturing, labeling, and packaging of products for each other. As of December 31, 2023, the net amounts due to Viatris under these agreements were $33 million, compared to $94 million as of December 31, 2022, indicating a reduction in outstanding balances over the period. The cash flows related to these agreements were primarily included in operating activities, with no material changes reported in operations during 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 90107,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22748,
        "completion_tokens": 214,
        "total_tokens": 22963
      }
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "Between 2023 and 2024, the treatment and disclosure of communications sites in relation to debt obligations evolved with a greater emphasis on financial ratios and restrictions tied to cash flow distributions. In 2023, the focus was on securitization structures, debt repayment, and compliance with covenants, particularly around debt service coverage ratios (DSCR) and amortization periods. By 2024, the disclosures expanded to include more detailed metrics, such as specific DSCR thresholds (e.g., 1.30x for cash trap conditions and 1.15x for amortization periods), capacity for decreases in net cash flow before triggering these conditions, and the impact of these restrictions on liquidity and distributions. Additionally, 2024 disclosures highlighted the potential consequences of non-compliance, such as the diversion of excess cash flow to debt repayment and the risk of asset foreclosure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61896,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15690,
        "completion_tokens": 224,
        "total_tokens": 15914
      }
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "Comcast's approach to retransmission consent agreements between 2022 and 2023 remained consistent in terms of revenue recognition, with fees from NBC and Telemundo retransmission consent agreements being recognized as part of distribution revenue. These agreements, along with associated fees from affiliated local broadcast stations, contributed to monthly subscription-based revenue streams. In 2023, the company emphasized multiyear distribution agreements, which align with broader trends in securing long-term rights and distribution commitments. No significant changes in revenue recognition methods or distribution models were noted during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42205,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10776,
        "completion_tokens": 164,
        "total_tokens": 10941
      }
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives remained consistent from 2023 to 2024, as both the 2023 and 2024 10-K filings describe the company's continued focus on manufacturing and offering diesel-electric locomotives as part of its Energy & Transportation segment. In 2024, Caterpillar emphasized its broader strategy, including sustainability, while maintaining its role in rail-related products and services, including remanufacturing and leasing. The 2024 filing also highlighted the company's ongoing investments in electrified powertrains and zero-emission technologies, suggesting a strategic evolution toward diversifying its locomotive offerings to include more sustainable solutions alongside traditional diesel-electric models.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 39520,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10097,
        "completion_tokens": 199,
        "total_tokens": 10296
      }
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees in terms of revenue recognition and cost-sharing arrangements remained largely consistent, with a few notable developments. Revenue recognition continued to follow the same principles, with royalty revenues based on a percentage of franchisee sales and recognized at the time of the underlying sales. McDonald's also continued to share in the cost of certain restaurant improvements with franchisees, allocating costs between property and equipment and accounts receivable based on responsibility. However, in 2024, McDonald's acquired additional restaurants from franchisees, particularly in Israel, as part of key franchising initiatives. These acquisitions added $240 million of goodwill and did not significantly impact the Company's revenues or net income. Overall, the structure of revenue recognition and cost-sharing arrangements with franchisees remained stable, with no material changes in the financial impact of these relationships.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66231,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16778,
        "completion_tokens": 253,
        "total_tokens": 17031
      }
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "Between 2023 and 2024, Southern Company updated its executive equity compensation approach by amending plan documentation, particularly in the terms of equity awards. In 2024, the company introduced the \"Ninth amendment to the Southern Company Employee Savings Plan,\" dated December 16, 2024, indicating a revision to savings plan structures. Additionally, the \"Form of Terms for Named Executive Officer Equity Awards\" under the 2021 Equity and Incentive Compensation Plan was updated, suggesting refinements in award terms for executives. These changes reflect a focus on aligning long-term incentives with company performance and retirement eligibility provisions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SO_10k_2023.pdf",
          "target_page": 276,
          "pages": [
            274,
            275,
            276,
            277,
            278
          ]
        },
        "hop_2_rel": {
          "source_file": "SO_10k_2024.pdf",
          "target_page": 316,
          "pages": [
            314,
            315,
            316,
            317,
            318
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 87358,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22065,
        "completion_tokens": 166,
        "total_tokens": 22231
      }
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "Procter & Gamble's strategic reliance on membership club stores has increased from 2022 to 2024, reflecting a broader shift toward optimizing retail channel performance and adapting to evolving consumer preferences. This shift indicates that P&G is prioritizing high-volume, cost-efficient distribution channels to enhance market reach and maintain competitive positioning amid a dynamic retail landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 59827,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15184,
        "completion_tokens": 101,
        "total_tokens": 15285
      }
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "AMT's involvement with Nigeria Letters of Credit decreased between 2023 and 2024, as the 2024 filing indicates no outstanding carrying value in USD for the Nigeria Letters of Credit, whereas in 2023, they had a USD carrying value of $3.4 million. This suggests that AMT either fully settled its obligations related to these instruments or no longer had active letters of credit in Nigeria by the end of 2024, indicating a reduction in its financial exposure tied to this instrument.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49820,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12683,
        "completion_tokens": 120,
        "total_tokens": 12804
      }
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "Between 2022 and 2024, the valuation methodology and composition of GD's Retirement Annuity Contracts remained consistent in being classified as Level 3 assets due to the use of significant unobservable inputs. However, the fair value of these contracts decreased from $38 million in 2022 to $22 million in 2024. This reduction suggests a decline in the value of these specific retirement annuity assets over the period. The continued classification under Level 3 indicates that GD maintains a conservative and transparent approach to reporting these assets, acknowledging the uncertainty and subjectivity involved in their valuation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44577,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11377,
        "completion_tokens": 158,
        "total_tokens": 11536
      }
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "The composition and value of restricted cash for securitization investors remained relatively stable between 2022 and 2024, with a slight decrease from $458 million in 2022 to $441 million in 2024. In terms of fair value hierarchy classification, restricted cash for securitization investors was consistently classified entirely under Level 1 for both years, indicating that it is valued using unadjusted quoted prices for identical assets in active markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 179,
          "pages": [
            177,
            178,
            179,
            180,
            181
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2024.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55397,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14080,
        "completion_tokens": 114,
        "total_tokens": 14194
      }
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "Between 2023 and 2024, McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management through increased acquisitions of franchisee-owned restaurants and continued emphasis on franchisee cost responsibilities. In 2024, the Company acquired 228 restaurants in Israel and other locations, resulting in $240 million of goodwill and $150 million of net tangible assets, reflecting a strategic shift to support franchising initiatives. Additionally, franchisees continue to bear the majority of occupancy costs (e.g., property taxes, insurance) for franchised locations, maintaining the financial separation between Company-owned and franchised operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69131,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17501,
        "completion_tokens": 173,
        "total_tokens": 17675
      }
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "The 2019 Stock and Incentive Compensation Plan remains the primary vehicle for equity compensation at Procter & Gamble, with no new plans introduced between 2022 and 2024. In both years, the 2019 Plan is the only active plan allowing future grants, with a maximum of 187 million shares, and full value awards like RSUs/PSUs counted more conservatively (five shares per share awarded). In 2024, the remaining shares available for future issuance under the 2019 Plan decreased from 119 million in 2022 to 77 million, reflecting increased utilization of the plan. The disclosures also confirm that older plans, such as the 2001 and 2014 plans, are no longer used for new grants, consolidating the role of the 2019 Plan as the central mechanism for equity compensation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 68747,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17431,
        "completion_tokens": 191,
        "total_tokens": 17622
      }
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "Salvatore Ferragamo's presence in Simon Property Group's international outlet locations expanded between 2022 and 2023. In 2022, Ferragamo was listed at Punta Norte Premium Outlets in Mexico and Yeoju Premium Outlets in South Korea. By 2023, Ferragamo's presence expanded to additional international locations, including Las Vegas Outlets in the U.S., Siam Premium Outlets in Thailand, and Johor Premium Outlets in Malaysia. This indicates a broader geographic reach for the brand within Simon Property Group's international portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50165,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12756,
        "completion_tokens": 133,
        "total_tokens": 12890
      }
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region slightly decreased from 326 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024. This decline is attributed to downward revisions due to lower prices (81 BCF) and some production and sales activity, partially offset by minor upward revisions and extensions. The region's operational focus appears to be more maintenance-oriented, with limited new development or exploration activity, as reflected in the absence of significant extensions and discoveries and minimal dry exploratory wells. This suggests a strategic shift or reduced emphasis on natural gas growth in the Asia Pacific/Middle East region compared to other areas like the Lower 48 and Canada.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 155,
          "pages": [
            153,
            154,
            155,
            156,
            157
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 74347,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18816,
        "completion_tokens": 185,
        "total_tokens": 19001
      }
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "Comcast has increased its strategic emphasis on wireless gateways from 2022 to 2024, as evidenced by continued investment in deploying these devices to enhance customer connectivity. In 2022, wireless gateways were highlighted as part of the broadband services, offering combined internet modems and Wi-Fi routers with expanded coverage and xFi features. By 2024, the company explicitly included wireless gateways in its capital expenditure plans, aiming to expand deployment as part of its network upgrades to deliver multigigabit symmetrical speeds. This reflects a growing strategic focus on integrating wireless gateways to improve in-and-out-of-home connectivity and customer experience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46842,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11927,
        "completion_tokens": 173,
        "total_tokens": 12100
      }
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "Between 2022 and 2024, the G600's market presence and production have grown significantly. Cumulative deliveries of the G600 increased from nearly 150 at year-end 2021 to over 300 by year-end 2024, reflecting strong demand and successful integration into Gulfstream's product lineup. The G600, introduced in 2019 as part of Gulfstream's modernized aircraft family, has played a key role in replacing older models like the G550 and has contributed to the company's leadership in long-range, large-cabin business jets. Its performance, efficiency, and advanced features have solidified its position within Gulfstream's evolving product portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 31511,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8105,
        "completion_tokens": 161,
        "total_tokens": 8266
      }
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly in terms of equity ownership and income recognition. As of December 31, 2023, AIG held 52.2% of Corebridge's common stock. By June 9, 2024, AIG's ownership had decreased to 48.4%, and following the deconsolidation, AIG retained a 22.7% stake in Corebridge by December 31, 2024. In terms of income recognition, AIG recognized a $4.8 billion loss from the deconsolidation of Corebridge in 2024, primarily due to accumulated comprehensive losses. Additionally, AIG recognized $601 million in equity method income related to Corebridge in 2024, reflecting dividends received and changes in Corebridge's stock price.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 96902,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24448,
        "completion_tokens": 175,
        "total_tokens": 24623
      }
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "Between 2022 and 2024, Tesla's production strategy for the Solar Roof has evolved to emphasize localized manufacturing and operational scalability, particularly with the use of Gigafactory New York in Buffalo, New York, for development and production. However, operational challenges persist, including supplier dependencies and production ramp difficulties, as noted in both years. In 2024, Tesla continues to face risks related to supply chain constraints, hiring and training qualified personnel, and maintaining production timelines for new factories, which could impact Solar Roof production. Additionally, the need to balance localized procurement with global supply chain management remains a key challenge.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50178,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12769,
        "completion_tokens": 178,
        "total_tokens": 12948
      }
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "From 2023 to 2024, Qualcomm has increasingly emphasized on-device artificial intelligence (AI) as a foundational technology, integrating it into its broader strategy for growth and diversification beyond mobile handsets. In 2023, the company highlighted its investments in wireless connectivity, high-performance computing, and on-device AI, aiming to expand into industries like automotive and IoT. By 2024, Qualcomm explicitly identified on-device AI as a key area for future growth, continuing to invest in new product areas and industries by leveraging its technical expertise and pursuing strategic transactions. This evolution reflects a more focused and accelerated approach to developing and commercializing AI technologies as part of its long-term innovation roadmap.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65559,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16619,
        "completion_tokens": 194,
        "total_tokens": 16813
      }
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "The presence of Dolce & Gabbana in SPG-operated properties increased between 2022 and 2023, as it was listed as a tenant in the Las Vegas Outlets (2023) and Punta Norte Premium Outlets (Mexico, 2023), while not explicitly mentioned in 2022 filings. This indicates SPG is enhancing its brand positioning in premium outlet locations by attracting high-end luxury brands like Dolce & Gabbana, reinforcing its focus on upscale retail experiences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50165,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12774,
        "completion_tokens": 110,
        "total_tokens": 12885
      }
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "COP's investment in exploration activities in the Asia Pacific/Middle East region between 2023 and 2024 remained relatively modest, with only a small number of exploratory wells completed in 2023 (0 productive and 0 dry) and no specific exploration activity noted in 2024. However, the company continued to focus on development activities in the region, with 20 development wells in 2023 and 22 in 2022. This suggests that COP's strategic focus in the region is more on developing existing reserves rather than pursuing new exploration projects.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 156,
          "pages": [
            154,
            155,
            156,
            157,
            158
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 77217,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19540,
        "completion_tokens": 136,
        "total_tokens": 19676
      }
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast's financial stake in Universal Beijing Resort remained consistent at a 30% interest from 2022 to 2024. As of December 31, 2024, Universal Beijing Resort had $3.4 billion in debt outstanding, including a $3.0 billion term loan, compared to $3.5 billion in debt, including a $3.1 billion term loan, as of December 31, 2023. The debt is secured by the resort's assets and equity interests, with Comcast's maximum risk of financial loss limited to its 30% ownership stake.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 86,
          "pages": [
            84,
            85,
            86,
            87,
            88
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 43249,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11024,
        "completion_tokens": 119,
        "total_tokens": 11143
      }
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "From 2022 to 2023, Duke Energy's net derivatives balance decreased from $29 million to $13 million, reflecting a reduction in derivative liabilities. In 2023, the company experienced $68 million in settlements compared to $32 million in 2022, indicating increased activity in settling derivative contracts. This suggests that Duke Energy is actively managing its derivative instruments, potentially reducing its exposure to market fluctuations by settling contracts and adjusting its portfolio. The overall trend implies a more conservative approach to derivative risk management in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 199,
          "pages": [
            197,
            198,
            199,
            200,
            201
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 192,
          "pages": [
            190,
            191,
            192,
            193,
            194
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63356,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16076,
        "completion_tokens": 147,
        "total_tokens": 16223
      }
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "From 2022 to 2023, SPG's treatment and disclosure of LTIP Units evolved in terms of their dilutive effect and valuation modeling. In 2023, SPG continued to account for LTIP units as participating securities under the two-class method of computing earnings per share, which impacts the dilutive effect. The grant-date fair values of market-based LTIP awards were estimated using a Monte Carlo model in both years, but in 2023, the valuation modeling for performance-based awards was tied to specific performance conditions based on FFO and objective criteria goals, with a maximum potential fair value of $23.6 million for the 2023 LTI Program. Additionally, the 2023 LTIP units were subject to a three-year measurement period and would vest on January 1, 2027, reflecting a longer-term incentive structure compared to prior years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 127,
          "pages": [
            125,
            126,
            127,
            128,
            129
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51742,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13159,
        "completion_tokens": 207,
        "total_tokens": 13366
      }
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "Between 2022 and 2024, Comcast's capital funding to Atairos Group, Inc. decreased, with contributions totaling $52 million in 2022, $73 million in 2023, and $145 million in 2024. Additionally, Comcast's remaining unfunded capital commitment was reduced from $1.5 billion in 2022 to $1.4 billion in 2024, while its annual management fee commitment remained at $40–45 million, subject to adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44101,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11256,
        "completion_tokens": 99,
        "total_tokens": 11356
      }
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region increased slightly from 312 billion cubic feet (BCF) at the end of 2023 to 296 BCF at the end of 2024. This modest decline, despite some upward revisions in other regions, suggests a reduced operational focus on natural gas development in the Asia Pacific/Middle East area during this period. The company appears to have prioritized other regions, such as the Lower 48 and Alaska, for natural gas extensions and discoveries in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 137,
          "pages": [
            135,
            136,
            137,
            138,
            139
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69057,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17498,
        "completion_tokens": 124,
        "total_tokens": 17623
      }
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022, Comcast focused on procuring wireless gateways to enhance in-home Wi-Fi coverage and deliver advanced features like xFi whole-home management and security. By 2024, the company shifted its investment focus toward network deployment, emphasizing scalable infrastructure and line extensions to expand capacity and deliver multigigabit symmetrical speeds. While wireless gateway procurement supported customer connectivity in 2022, the 2024 strategy centered on upgrading the broader network to meet growing demand for high-speed broadband.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47802,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12163,
        "completion_tokens": 136,
        "total_tokens": 12300
      }
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "Between 2022 and 2024, Tesla's strategic importance of the Solar Roof product appears to have diminished, as evidenced by the challenges highlighted in the 2024 10-K. The 2022 10-K mentions increased deployments of Solar Roof but notes lower gross margins due to manufacturing underutilization during product ramping. By 2024, the Solar Roof is not explicitly mentioned as a strategic focus, and production challenges, such as delays and manufacturing bottlenecks, are discussed more broadly in the context of Tesla's energy products. This suggests a shift in strategic emphasis away from Solar Roof as Tesla faces ongoing production and cost challenges in scaling the product.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57424,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14580,
        "completion_tokens": 169,
        "total_tokens": 14749
      }
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy's investment in \"Net pending transactions and other investments\" increased from $14 million in 2022 to $54 million in 2023. This significant increase suggests a shift in the company's strategic positioning, potentially indicating a greater focus on short-term or transitional investments, possibly to capitalize on market opportunities or to support evolving investment strategies within its retirement trust portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 226,
          "pages": [
            224,
            225,
            226,
            227,
            228
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61772,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15678,
        "completion_tokens": 107,
        "total_tokens": 15786
      }
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "Between 2023 and 2024, the company's implementation of its liability-driven investment framework remained consistent in aligning plan assets with liabilities, maintaining a 20%/80% equity/fixed income target allocation for pension plans and a 55%/45% allocation for postretirement plans. However, the actual composition of plan assets shifted slightly, with pension plan equity securities increasing from 18% to 21% and corporate bonds rising from 57% to 63%, while U.S. Treasury and government securities decreased from 25% to 16%. For defined contribution plan expenses, the company reported increased costs, rising from $109 million in 2023 to $112 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51411,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13090,
        "completion_tokens": 167,
        "total_tokens": 13257
      }
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Qualcomm's strategic focus on On-Device AI evolved as part of its broader growth and diversification initiatives beyond mobile handsets. In fiscal 2024, the company emphasized the integration of On-Device AI with 5G and high-performance, low-power computing, aiming to drive adoption in industries such as automotive and IoT. Specific investments highlighted in the disclosures include continued research and development spending, which reached $8.9 billion in fiscal 2024, and strategic transactions aimed at expanding opportunities for its technologies. The company also noted the importance of maintaining leadership in 5G and AI to sustain long-term growth, reflecting a more proactive and integrated approach to On-Device AI development and deployment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2023.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56022,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14239,
        "completion_tokens": 198,
        "total_tokens": 14437
      }
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "The classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members remained consistent between the 2022 and 2023 10-K filings, with both years listing the same Second Amended and Restated Voting Trust Agreement dated March 1, 2004, under Exhibit 9.1. This consistency indicates a stable governance structure, as the agreement has not been amended or reclassified, reflecting continuity in the Simon family's control and voting rights within the company.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SPG_10k_2022.pdf",
          "target_page": 144,
          "pages": [
            142,
            143,
            144,
            145,
            146
          ]
        },
        "hop_2_rel": {
          "source_file": "SPG_10k_2023.pdf",
          "target_page": 140,
          "pages": [
            138,
            139,
            140,
            141,
            142
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51517,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13131,
        "completion_tokens": 130,
        "total_tokens": 13261
      }
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region remained at zero for both 2023 and 2024 in the \"Developed and Undeveloped\" category, indicating no direct natural gas reserves in this region during these years. However, the region's equity affiliates, which are entirely located in Asia Pacific/Middle East, saw an increase in natural gas reserves from 5,275 billion cubic feet (BCF) at the end of 2023 to 5,870 BCF at the end of 2024. This increase, driven by purchases and extensions, suggests a growing strategic importance of the region through equity investments, even if direct reserves remain unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2023.pdf",
          "target_page": 154,
          "pages": [
            152,
            153,
            154,
            155,
            156
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 69792,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17688,
        "completion_tokens": 156,
        "total_tokens": 17845
      }
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "Between 2023 and 2024, AIG's financial relationship with Corebridge evolved significantly, particularly in terms of debt structure and equity method income. In 2023, Corebridge had $9,368 million in debt, including guaranteed and non-guaranteed borrowings. By 2024, following Corebridge's deconsolidation, AIG no longer guaranteed Corebridge's debt, and Corebridge's debt was excluded from AIG's consolidated financial statements. Post-deconsolidation, AIG transitioned to accounting for its retained interest in Corebridge under the equity method, recognizing equity method income of $601 million in 2024, which included dividends received and changes in Corebridge's stock price.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 112,
          "pages": [
            110,
            111,
            112,
            113,
            114
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 91585,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23119,
        "completion_tokens": 170,
        "total_tokens": 23290
      }
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "From 2022 to 2024, NextEra Energy's investment strategy in Special Use Funds has shifted toward a greater allocation to equity securities and a reduction in fixed income securities. In 2022, the total allocation to equity securities in Special Use Funds was $5,290 million for NEE and $3,536 million for FPL, while fixed income allocations were relatively smaller. By 2024, equity securities increased to $6,164 million for NEE and $4,219 million for FPL, while fixed income allocations remained modest. This shift suggests a higher risk appetite, as equity investments typically carry more volatility than fixed income. It may also indicate a longer-term liquidity strategy, as equity investments can provide growth potential over time, aligning with the long-term nature of certain Special Use Funds like nuclear decommissioning reserves.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61295,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15570,
        "completion_tokens": 210,
        "total_tokens": 15780
      }
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "The risk associated with site infrastructure sharing has increased between 2022 and 2024 due to the adoption of 5G technology, which has led to greater network sharing among wireless service providers. This trend has the potential to slow new lease activity as carriers increasingly utilize shared equipment rather than deploying new infrastructure, and may result in decommissioning equipment on existing sites due to network redundancy. The evolution of 5G has thus heightened the risk of reduced demand for new leases and increased churn in existing lease agreements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56322,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14316,
        "completion_tokens": 142,
        "total_tokens": 14459
      }
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Chevron's investment in Angola LNG Limited remained relatively stable between 2022 and 2023, with the carrying value of its investment decreasing slightly from $1,963 million in 2022 to $1,762 million in 2023. Under equity method accounting, Chevron's share of Angola LNG Limited's net income decreased from $513 million in 2022 to $513 million in 2023, indicating consistent returns despite the reduction in investment value. This suggests that Chevron continues to maintain a 36.4% stake in Angola LNG Limited, and its financial relationship with the entity remains a steady contributor to its upstream equity earnings.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVX_10k_2022.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "CVX_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56646,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14389,
        "completion_tokens": 155,
        "total_tokens": 14544
      }
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "From 2022 to 2023, the G600 aircraft continued to solidify its role as a high-performance, large-cabin business jet within Gulfstream's product lineup. Performance metrics highlight its status as one of the fastest and most fuel-efficient aircraft in its class, with over 90 city-pair speed records by the end of 2023 and cumulative deliveries exceeding 250 units. While the G600 remains a key model, Gulfstream's focus in 2023 shifted toward newer aircraft like the G700 and G800, with the G600's production status stable as part of a mature product line.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 30951,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7959,
        "completion_tokens": 139,
        "total_tokens": 8098
      }
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize greater strategic collaboration and financial co-investment. The Company has increasingly partnered with franchisees to fund restaurant improvements and modernization initiatives, aiming to enhance customer experiences and drive revenue growth. Additionally, McDonald's has reinforced collaboration through shared standards and innovation, ensuring consistency and quality across all locations while supporting franchisee success.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64236,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16278,
        "completion_tokens": 130,
        "total_tokens": 16408
      }
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a decline in both net revenues and operating income. Net revenues for smokeable products decreased from $22,476 million in 2022 to $21,756 million in 2023. Similarly, operating income remained nearly flat, decreasing slightly from $10,688 million in 2022 to $10,670 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58565,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14860,
        "completion_tokens": 89,
        "total_tokens": 14949
      }
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "From 2022 to 2024, Opdivo's role within BMY's strategy has evolved to emphasize expanded therapeutic approvals and continued collaboration in key markets. In 2024, Opdivo received multiple approvals, including FDA and EC approvals for new indications such as urothelial carcinoma and NSCLC, and Japan's approval for unresectable urothelial carcinoma. Collaboratively, BMY continues its joint development and commercialization of Opdivo with Ono in Japan, South Korea, and Taiwan, maintaining profit-sharing and supply responsibilities. Additionally, the launch of Opdivo Qvantig in 2024, a subcutaneous formulation, reflects BMY's focus on improving patient access and convenience, reinforcing Opdivo's central role in BMY's immunotherapy leadership.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 44576,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11379,
        "completion_tokens": 187,
        "total_tokens": 11567
      }
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, with a continued reliance on LIBOR and EURIBOR as referenced rates in 2024, but with no explicit mention of transition plans to alternative benchmarks like SOFR. In 2022, AMT's debt instruments referenced LIBOR or EURIBOR with applicable margins, and covenants included compliance with financial metrics and restrictions on additional indebtedness. By 2024, similar rates were still in use, but covenants became more detailed, emphasizing debt service coverage ratios (DSCR), reserve account requirements, and amortization triggers tied to performance thresholds. Additionally, new securitization structures in 2024 included specific repayment terms and interest rates (e.g., 5.490% and 5.735% for 2023 Securities), reflecting a more nuanced approach to managing interest rate exposure and liquidity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50514,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12858,
        "completion_tokens": 226,
        "total_tokens": 13084
      }
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with franchisees evolved to emphasize co-investment strategies and modernization of franchise locations. The Company increasingly collaborates with franchisees to fund improvements through co-investment, aiming to enhance consumer appeal and restaurant performance. Additionally, McDonald's continues to own or secure long-term leases on land and buildings for conventional franchise locations, ensuring alignment with its real estate strategy to maintain brand consistency and operational control.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53615,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13621,
        "completion_tokens": 136,
        "total_tokens": 13757
      }
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "The 2015 Stock Compensation Plan for Non-Employee Directors was amended and restated effective October 26, 2022, as noted in the 2022 10-K (page 110). By 2023, this plan remained in effect, with no further amendments indicated in the 2023 10-K (page 107). This continuity suggests that Altria's governance approach to director compensation emphasizes stability and long-term alignment, maintaining a structured and shareholder-approved framework for non-employee director equity compensation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54851,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13955,
        "completion_tokens": 123,
        "total_tokens": 14078
      }
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "The impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity has intensified from 2022 to 2024, as these arrangements increasingly serve as alternatives to leasing infrastructure directly from AMT. In 2022, the filings noted that such arrangements could slow new lease activity or lead to decommissioning of equipment on existing sites. By 2024, the filings emphasize that extensive sharing of infrastructure, including through roaming or resale, is a growing concern, particularly with the deployment of 5G, and is directly linked to competitive pressures that are affecting new lease growth. This evolution indicates that wireless providers are increasingly relying on shared networks rather than expanding their own infrastructure, which is reducing demand for AMT's leasing services and constraining its growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56322,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14321,
        "completion_tokens": 214,
        "total_tokens": 14536
      }
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "Between 2022 and 2024, McDonald's relationship with its franchisees has evolved to emphasize strategic investment and operational alignment. The company has increased collaboration with franchisees to modernize restaurants and enhance customer experiences through technology and digital initiatives. Additionally, McDonald's has reinforced operational expectations by requiring franchisees to meet rigorous standards and invest in their businesses, ensuring consistency and quality across the system. This approach reflects a stronger partnership model aimed at driving long-term growth and profitability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55393,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14070,
        "completion_tokens": 151,
        "total_tokens": 14222
      }
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "NextEra Energy's investment strategy in equity securities within its Special Use Funds evolved from 2022 to 2024 by increasing the fair value of these investments. In 2022, the carrying amount of Special Use Funds was $8,922 million, and by 2024, it had increased to $1,342 million for NEE and $915 million for FPL, with corresponding estimated fair values of $1,343 million and $916 million, respectively. This indicates a strategic growth in the value of equity securities held in these funds over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 63,
          "pages": [
            61,
            62,
            63,
            64,
            65
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 75982,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19209,
        "completion_tokens": 127,
        "total_tokens": 19337
      }
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "From 2022 to 2023, the financial performance of smokeable products showed a slight decline in net revenues, which decreased from $22,476 million in 2022 to $21,756 million in 2023. However, operating income remained relatively stable, decreasing only slightly from $10,688 million in 2022 to $10,670 million in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 67,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58343,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14804,
        "completion_tokens": 79,
        "total_tokens": 14883
      }
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "Between 2022 and 2023, the utilization of Accenture plc Class A Ordinary Shares through share purchase programs remained focused on open-market repurchases and employee-related activities. In fiscal 2022, Accenture repurchased 12,180,917 Class A shares for $4.11 billion, primarily through open-market purchases, with shares intended for use in employee benefits and equity awards. By fiscal 2023, while specific repurchase figures are not provided in the given pages, the company continued its share repurchase programs under the existing authorization, which had increased to $6.13 billion by the end of fiscal 2022. Shares were also used for employee share plans, including share withholding for tax obligations and equity awards under the 2010 Share Incentive Plan and Employee Share Purchase Plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2022.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33235,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8535,
        "completion_tokens": 200,
        "total_tokens": 8735
      }
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "Between 2022 and 2024, AMT's operating covenants have evolved to include more structured securitization arrangements and refinements in interest rate benchmarks. In 2022, the covenants primarily involved traditional debt instruments such as term loans and credit facilities, with interest rates tied to LIBOR or EURIBOR plus a fixed margin (e.g., 1.125%). By 2024, AMT expanded its use of securitized debt, including the 2023 and 2018 Securitizations, which feature fixed interest rates (e.g., 5.490% and 5.735% for the 2023 Securities) and deferred principal repayment until specific dates (e.g., March 2028). Additionally, the covenants now emphasize debt service coverage ratios (DSCR) and reserve account requirements to ensure liquidity and compliance with financial metrics, reflecting a more structured and risk-mitigated approach to debt management.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMT_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "AMT_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48548,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12372,
        "completion_tokens": 214,
        "total_tokens": 12587
      }
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Between the 2023 and 2024 SEC filings, Disney+ Hotstar's subscriber base grew from approximately 36 million in 2024 to the same figure in 2023, indicating no significant change in the number of paid subscribers. However, the consolidation of Star+ into Disney+ in Latin America during June 2024 streamlined Disney's international streaming strategy by unifying its offerings, enhancing content breadth, and improving operational efficiency. This move allowed Disney to better compete in the region by providing a more cohesive and comprehensive service.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46819,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11941,
        "completion_tokens": 138,
        "total_tokens": 12079
      }
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "In 2022, approximately one-fifth of the company's employees were covered under collective labor agreements, with 21 agreements covering around 3,000 employees set to be renegotiated. By 2023, this number decreased slightly, with 20 agreements covering approximately 2,100 employees expected to be renegotiated. This indicates a reduction in the number of employees under collective labor agreements, suggesting a potential shift toward more direct labor management or a strategy to streamline labor negotiations, which the company believes will not disrupt operations or have a material financial impact.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38898,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9951,
        "completion_tokens": 151,
        "total_tokens": 10102
      }
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "NextEra Energy's investment in U.S. Government and municipal bonds increased from 2022 to 2024. In 2022, the total value was $757 million (NEE: $700 million + FPL: $583 million). By 2024, the total value rose to $722 million (NEE: $663 million + FPL: $561 million). Thus, the change in total value was a decrease of $35 million over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2022.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61041,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15485,
        "completion_tokens": 86,
        "total_tokens": 15571
      }
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "Between 2022 and 2024, Opdivo's role in Bristol-Myers Squibb's product portfolio has evolved with significant therapeutic approvals and a shift in manufacturing strategy. In 2024, Opdivo received multiple approvals, including FDA approval for first-line treatment of unresectable or metastatic urothelial carcinoma in combination with chemotherapy and EC approval for similar indications in Europe. Additionally, Opdivo Qvantig, a subcutaneous formulation, was approved in December 2024 for multiple previously approved indications, enhancing patient accessibility. In terms of manufacturing, the company has increasingly relied on third-party manufacturers for Opdivo, while maintaining internal production capabilities to ensure supply stability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2022.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57864,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14695,
        "completion_tokens": 187,
        "total_tokens": 14882
      }
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "Between 2023 and 2024, National Geographic magazine has remained part of Disney's Entertainment segment, specifically under Content Sales/Licensing, with Disney owning 73% of the business. There is no indication of structural changes to Disney's ownership or positioning of National Geographic magazine during this period. The magazine continues to be reported within the Entertainment segment alongside other content-related activities, such as film and television distribution. No major strategic repositioning or divestiture of National Geographic magazine is noted in the provided documents.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 78,
          "pages": [
            76,
            77,
            78,
            79,
            80
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42747,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10916,
        "completion_tokens": 148,
        "total_tokens": 11064
      }
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "Between 2023 and 2024, PayPal's description of its transaction management databases' capabilities related to global payment processing in different currencies has shown slight but notable evolution. In 2023, PayPal stated that consumers could send payments in approximately 150 currencies and withdraw funds in 56 currencies. By 2024, this was updated to 140 currencies for sending payments and 57 currencies for withdrawals, indicating an expansion in the number of supported currencies. This evolution reflects PayPal's ongoing efforts to enhance its global payment processing capabilities and support a broader range of international transactions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PYPL_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "PYPL_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53847,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13693,
        "completion_tokens": 162,
        "total_tokens": 13855
      }
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "The interest rate terms associated with the Series K Debentures increased significantly between 2023 and 2024, with the rate resetting to 6.051% per year in March 2023 and remaining unchanged in 2024. This indicates that NEE is adapting to rising interest rates by locking in higher fixed rates for long-term financing, which suggests a strategy to manage interest rate risk and stabilize its debt costs over time.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 120,
          "pages": [
            118,
            119,
            120,
            121,
            122
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 101500,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 25601,
        "completion_tokens": 103,
        "total_tokens": 25705
      }
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "Between 2022 and 2023, ExxonMobil continued to apply the Unit-of-Production (UOP) depreciation method for most upstream assets, using proved reserve volumes as the basis for calculating depreciation rates. The method remained consistent, with depreciation calculated as the ratio of asset cost to total proved reserves or proved developed reserves, applied to actual production. However, the Corporation noted that changes in proved reserves—due to factors such as price fluctuations, development strategies, or technical revisions—could impact the UOP rates. In cases where UOP did not equitably allocate costs over the asset's economic life, the Corporation used the straight-line method for certain assets with shorter useful lives than their associated reserves. In 2023, the Corporation emphasized that it would adjust depreciation calculations using the most recent SEC price when reserves were substantially de-booked, ensuring a more meaningful allocation of costs. This approach reflects a continued reliance on reserve estimates and market conditions to guide depreciation practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 77,
          "pages": [
            75,
            76,
            77,
            78,
            79
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48592,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12380,
        "completion_tokens": 273,
        "total_tokens": 12653
      }
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "Between 2023 and 2024, Netflix has increasingly scaled its internal studio operations to produce original programming, as highlighted by its acquisitions of companies like Scanline and Animal Logic. This shift reflects a strategic move to reduce reliance on third-party production partners and enhance in-house capabilities for content creation. While third-party collaborations remain part of the ecosystem, the emphasis on internal studio growth underscores Netflix's aim to maintain greater control over production quality, costs, and creative output to sustain its competitive edge in original content.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55193,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14029,
        "completion_tokens": 151,
        "total_tokens": 14180
      }
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "Between 2022 and 2023, Mastercard's Cyber and Intelligence Solutions evolved to become a more integral part of its value-added services, emphasizing fraud prevention, transaction security, and data-driven insights. The 2023 filing highlights these solutions as essential for enabling secure and confident transactions across all stakeholders, reflecting a strategic shift toward enhancing security and leveraging data analytics to support the broader payments ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 80,
          "pages": [
            78,
            79,
            80,
            81,
            82
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45592,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11609,
        "completion_tokens": 117,
        "total_tokens": 11727
      }
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "From 2023 to 2024, Tesla's approach to energy storage products has evolved with a stronger focus on scaling production and addressing supply chain dependencies. In 2023, Tesla emphasized the modular design of its energy storage systems and the integration of vehicle technologies to optimize manufacturing, while also highlighting the importance of battery cell supply from partners like Panasonic and CATL. By 2024, Tesla expanded its production capabilities, including the development of new Gigafactories, and acknowledged the need to grow its access to battery cells through both supplier partnerships and in-house manufacturing. Additionally, Tesla faced production challenges, such as supplier constraints and the need for localized procurement, which required significant investment and management of global supply chain risks. Strategic dependencies on raw materials like lithium and nickel also remained a concern, with Tesla working to mitigate these through vertical integration and cost control initiatives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46089,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11743,
        "completion_tokens": 254,
        "total_tokens": 11998
      }
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "From 2023 to 2024, NextEra Energy Capital Holdings (NEECH) expanded its issuance strategy for floating rate debentures by significantly increasing the principal amount and extending the maturity structure. In 2023, NEECH issued $400 million in floating rate debentures due in 2024. By 2024, the principal amount increased to $600 million, with a maturity date of 2026, indicating a longer-term approach. Additionally, in January 2024, NEECH issued $600 million of floating rate debentures due in 2026 as part of a broader issuance strategy that included a mix of fixed and floating rate instruments with maturities extending to 2054. This evolution reflects a shift toward diversifying maturity dates and increasing the scale of floating rate debt.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 120951,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 30470,
        "completion_tokens": 187,
        "total_tokens": 30657
      }
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "From 2023 to 2024, Intel's approach to industry initiatives related to supply chain responsibility has evolved by expanding collaboration and supplier engagement. In 2023, the focus was on directly engaging suppliers to verify compliance and build capacity to address risks such as forced labor and human rights issues, with periodic audits and capability-building programs for critical direct suppliers. By 2024, Intel significantly expanded the number of suppliers covered by its engagement activities and began actively measuring and reducing suppliers' greenhouse gas emissions to support its net-zero upstream Scope 3 emissions goal by 2050. Additionally, the company increased its commitment to supplier diversity by setting new spending targets with women-owned and minority-owned suppliers globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50242,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12792,
        "completion_tokens": 201,
        "total_tokens": 12994
      }
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "Between 2022 and 2023, XOM's framing of its dependency on first-day-of-the-month average prices in the standardized measure of discounted future cash flows remained consistent in acknowledging that these prices represent discrete points in time and may cause significant variability in cash flows. However, in 2023, the company emphasized more explicitly its belief that the standardized measure does not provide a reliable estimate of its expected future cash flows or the value of its proved reserves, reinforcing its critique of the methodology's limitations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 133,
          "pages": [
            131,
            132,
            133,
            134,
            135
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 85652,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21666,
        "completion_tokens": 140,
        "total_tokens": 21807
      }
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "Between 2022 and 2023, Mastercard's digital identity solutions evolved significantly, particularly in their integration with open banking capabilities and reach across financial institutions. In 2023, Mastercard expanded its open banking platform to provide connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks in Europe, directly and through partners. This expansion enabled seamless and secure consumer bill payments via a new ACH payment solution. Additionally, Mastercard enhanced its digital identity solutions by incorporating device intelligence, behavioral biometrics, document proofing, and IP intelligence to strengthen and secure digital payments across individuals, devices, and accounts. These advancements reflect Mastercard's commitment to providing secure, consent-centric, and privacy-by-design solutions that support financial inclusion and improved customer experiences.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 34705,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8906,
        "completion_tokens": 230,
        "total_tokens": 9136
      }
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "Between 2023 and 2024, Tesla's approach to the Solar Roof product has evolved with a focus on addressing production challenges and strategic dependencies. In 2023, Tesla emphasized improving installation capability and efficiency, including collaborations with real estate developers and builders on new homes. By 2024, the company faced ongoing production ramp challenges, as noted in risk factors, including potential supplier issues and the need to scale localized manufacturing. Additionally, Tesla's strategic dependencies on suppliers for components and the development of in-house battery cell capabilities became more pronounced, highlighting the need to secure supply chains and reduce reliance on external partners to meet production goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46089,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11744,
        "completion_tokens": 187,
        "total_tokens": 11932
      }
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "NextEra Energy, Inc. introduced new Pledge Agreements in both 2023 and 2024. In 2023, a Pledge Agreement dated September 1, 2022, was listed, involving Deutsche Bank Trust Company Americas as Collateral Agent and The Bank of New York Mellon as Purchase Contract Agent. In 2024, a new Pledge Agreement dated June 1, 2024, was added, maintaining the same counterparties. Additionally, another Pledge Agreement dated October 1, 2024, was introduced, continuing with the same entities as Collateral Agent and Purchase Contract Agent. These agreements reflect ongoing arrangements with consistent counterparties but with updated effective dates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 121,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 123,
          "pages": [
            121,
            122,
            123,
            124,
            125
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 102733,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 25907,
        "completion_tokens": 160,
        "total_tokens": 26067
      }
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "From 2023 to 2024, Intel strengthened its strategic positioning in Edge AI by expanding its software platform offerings and deepening ecosystem partnerships. In 2024, Intel emphasized open software frameworks and edge-native platforms to enable developers to build, deploy, and manage distributed edge infrastructure and AI applications. This included modular, flexible software solutions optimized for network, IoT, and hybrid AI workloads. Additionally, Intel expanded collaborations with over 500 ecosystem partners, including major players like Ericsson, Nokia, and Microsoft, to drive software-defined transformations in edge and network infrastructure. These efforts reflect a shift toward a more integrated, software-driven edge AI strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44515,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11353,
        "completion_tokens": 187,
        "total_tokens": 11540
      }
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "The composition and value of CVS's long-term debt related to the 1.75% senior notes due August 2030 remained unchanged between 2023 and 2024, with both years reporting a value of $1,250 million. This indicates that there was no issuance, redemption, or material change in the value of these specific senior notes during the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CVS_10k_2023.pdf",
          "target_page": 168,
          "pages": [
            166,
            167,
            168,
            169,
            170
          ]
        },
        "hop_2_rel": {
          "source_file": "CVS_10k_2024.pdf",
          "target_page": 161,
          "pages": [
            159,
            160,
            161,
            162,
            163
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32417,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8337,
        "completion_tokens": 82,
        "total_tokens": 8420
      }
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "Between 2023 and 2024, Netflix's ad-supported subscription plan evolved from being a newly introduced, lower-priced option to a more integrated component of its pricing strategy aimed at meeting diverse consumer needs and driving membership growth. In 2023, the plan was highlighted as a new addition to the company's offerings, while by 2024, it was positioned as part of a broader strategy to enhance accessibility and attract a wider audience, reflecting its growing importance in Netflix's approach to expanding its membership base.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49773,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12667,
        "completion_tokens": 134,
        "total_tokens": 12801
      }
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "Tesla's approach to the Tesla Semi evolved between 2023 and 2024, with the vehicle transitioning from early production to pilot production, as noted in the 2024 document. In 2023, the Tesla Semi was in early production and delivery stages, while by 2024, it had advanced to pilot production in Nevada, indicating progress in manufacturing readiness. Strategically, Tesla emphasized leveraging its proprietary technologies, such as battery cells and powertrain systems, to support the Semi's development and align it with broader goals of sustainable energy and manufacturing innovation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 36,
          "pages": [
            34,
            35,
            36,
            37,
            38
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36694,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9389,
        "completion_tokens": 146,
        "total_tokens": 9536
      }
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 indicates a deliberate and strategic effort to ensure leadership continuity and reinforce the company's commitment to retaining key executive talent. By extending and adding new agreements for executives such as Brian Bolster in 2024, the company emphasizes the importance of stabilizing its leadership team, which is critical for executing long-term strategic goals. This suggests that NextEra Energy views its executive talent as a core asset and is proactively investing in retention mechanisms to maintain experienced leadership amid evolving business demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 123,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 125,
          "pages": [
            123,
            124,
            125,
            126,
            127
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 94595,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23891,
        "completion_tokens": 164,
        "total_tokens": 24055
      }
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "From 2023 to 2024, Intel's approach to xPU products has evolved with a stronger strategic focus on product competitiveness and ecosystem expansion. In 2024, Intel emphasized the x86 ecosystem and announced the formation of an advisory group to enhance compatibility and simplify software development across platforms. The company is advancing a broad xPU portfolio, including client and data center GPUs, IPUs, FPGAs, and accelerators, to address diverse computing needs. Additionally, Intel is integrating AI into its xPU strategy, aiming to deliver solutions across the AI continuum, from large language models to edge computing, leveraging its silicon, platforms, and packaging technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 53033,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13477,
        "completion_tokens": 173,
        "total_tokens": 13651
      }
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "Between 2023 and 2024, Netflix has focused on developing and expanding its advertising technology infrastructure to support its growing advertising business. In 2023, the company highlighted the need to build the technology and related infrastructure to support advertising and drive value for advertisers. By 2024, this effort had evolved to include a stronger emphasis on organizational development, specifically the expansion of an advertising sales and advertising technology organization team. This indicates a strategic shift toward not only building the technical capabilities for ad delivery and measurement but also strengthening the internal team responsible for managing and scaling the advertising business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62892,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15948,
        "completion_tokens": 179,
        "total_tokens": 16127
      }
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "Between 2023 and 2024, Tesla's free Supercharging program has remained a component of deferred revenue related to automotive sales, with no significant structural changes indicated. In both years, deferred revenue related to free Supercharging, along with other features like FSD and over-the-air updates, showed a slight increase in the deferred revenue balance, from $3,536 million in 2023 to $3,599 million in 2024. Revenue recognition for free Supercharging continues to be recognized over time, typically on a straight-line basis over the expected ownership life of the vehicle, as Tesla maintains a stand-ready obligation to provide the service. There is no indication of a material shift in the program's structure or revenue recognition approach during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50799,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12922,
        "completion_tokens": 193,
        "total_tokens": 13116
      }
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, with the company shifting from long-term maturities (e.g., 2079 in 2019) to shorter-term maturities (e.g., 2054 in 2024). Additionally, the coupon structures in 2024 included fixed rates (e.g., 5.90%) and floating rates, whereas earlier issues had lower fixed rates or floating-rate structures. This shift may indicate a strategic move to optimize capital structure, reduce long-term interest rate exposure, and align financing with more immediate capital needs or market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NEE_10k_2023.pdf",
          "target_page": 120,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "hop_2_rel": {
          "source_file": "NEE_10k_2024.pdf",
          "target_page": 121,
          "pages": [
            119,
            120,
            121,
            122,
            123
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 137893,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 34720,
        "completion_tokens": 147,
        "total_tokens": 34868
      }
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "From 2022 to 2023, ExxonMobil's consideration of OPEC investment activities in its impairment assessment framework remained consistent in acknowledging their impact on long-term oil supply dynamics. The Corporation emphasized that OPEC's investment and production policies influence global oil supply, which is a key factor in its long-term supply projections. However, in 2023, there was a more explicit mention of incorporating estimated greenhouse gas emission costs into future cash flow assessments, reflecting a broader consideration of regulatory and environmental factors alongside OPEC's role in shaping supply dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2023.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 41520,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10611,
        "completion_tokens": 157,
        "total_tokens": 10768
      }
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "Netflix's approach to its ad-supported subscription plan shows increased strategic emphasis in 2024 compared to 2023. In the 2023 filing, the ad-supported plan is mentioned briefly as part of a range of pricing plans aimed at meeting consumer needs, with limited detail. By 2024, the plan is highlighted more prominently within the core business strategy, reflecting its growing importance as part of Netflix's efforts to diversify revenue streams and attract a broader audience. This evolution suggests a shift toward treating the ad-supported tier as a more central component of Netflix's financial and operational strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40414,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10328,
        "completion_tokens": 156,
        "total_tokens": 10485
      }
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "Amazon's approach to shipping offers between 2022 and 2024 has shifted toward greater fulfillment efficiency and cost optimization. In 2022, shipping costs were driven by increased investments in the fulfillment network, higher wage rates, and supply chain inefficiencies. By 2024, Amazon had made progress in reducing shipping costs through fulfillment network efficiencies and lower transportation costs, even as sales and shipping usage continued to grow. The strategic focus remained on maintaining low prices for customers through shipping offers while improving operational scalability and leveraging technology to enhance fulfillment productivity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48616,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12378,
        "completion_tokens": 163,
        "total_tokens": 12542
      }
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "Between 2023 and 2024, Duke Energy's utilization and reporting of the Master Retirement Trust showed notable changes in asset allocation and disclosure practices. In terms of asset allocation, the RCBP assets shifted from a 35% liability hedging and 65% return-seeking allocation in 2023 to a 35% liability hedging and 65% return-seeking allocation in 2024, maintaining the same structure. However, the actual allocation for RCBP assets in 2024 showed a slight deviation, with Global equity securities at 44% compared to the target of 45%, and Real estate and cash at 10% compared to the target of 7%. \n\nFor the DELPP assets, the target allocation remained at 80% liability hedging and 20% return-seeking, with actual allocations in 2024 closely aligning with the targets. Additionally, Duke Energy's disclosure practices became more detailed in 2024, including a reconciliation of Level 3 assets and a more comprehensive breakdown of fair value measurements.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 218,
          "pages": [
            216,
            217,
            218,
            219,
            220
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 228,
          "pages": [
            226,
            227,
            228,
            229,
            230
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66639,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16890,
        "completion_tokens": 239,
        "total_tokens": 17130
      }
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "The provided documents do not include specific details on the evolution of Google's financial relationship with Google Network Partners between 2022 and 2024, particularly regarding cost structure and payment obligations. The information available focuses on broader financial performance, such as revenue breakdowns and operating income, but does not specify changes in terms or financial arrangements with Network Partners.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44557,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11366,
        "completion_tokens": 106,
        "total_tokens": 11472
      }
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "Between 2022 and 2023, the financial impact of non-designated derivative instruments, particularly offsetting swap positions, showed a significant improvement. In 2022, UPS reported a loss of $69 million from fair value changes and settlements of these instruments, primarily foreign currency exchange contracts, which were recognized in \"Investment income and other.\" In contrast, in 2023, the loss was significantly reduced to $7 million, indicating a more favorable outcome in terms of fair value changes and settlements during the year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UPS_10k_2022.pdf",
          "target_page": 159,
          "pages": [
            136,
            137,
            138,
            139,
            140
          ]
        },
        "hop_2_rel": {
          "source_file": "UPS_10k_2023.pdf",
          "target_page": 132,
          "pages": [
            130,
            131,
            132,
            133,
            134
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 38694,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9909,
        "completion_tokens": 135,
        "total_tokens": 10044
      }
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures compared to 2023 indicates a greater emphasis on deferred compensation for directors as part of the company's overall compensation strategy. This suggests Duke Energy may be prioritizing long-term alignment of director interests with shareholders by encouraging deferral of compensation into plans tied to company stock performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 245,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 239,
          "pages": [
            237,
            238,
            239,
            240,
            241
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 113498,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 28605,
        "completion_tokens": 105,
        "total_tokens": 28710
      }
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "Between 2022 and 2024, American Express has evolved its approach to developing value propositions by emphasizing innovation in premium products, digital integration, and customer-centric benefits to address competitive pressures and shifting consumer behaviors. The company has focused on expanding its leadership in the premium consumer space, particularly with younger demographics like Millennials and Gen Z, by offering differentiated services, rewards programs, and enhanced digital experiences. Additionally, American Express has prioritized building a multiproduct digital ecosystem and investing in technologies like artificial intelligence and machine learning to improve customer engagement and operational efficiency. These strategies aim to strengthen customer loyalty, drive spending growth, and maintain a competitive edge in a rapidly evolving payments landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51948,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13216,
        "completion_tokens": 219,
        "total_tokens": 13436
      }
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "Between 2022 and 2024, Exxon Mobil's long-term debt financing approach evolved with the addition of new long-term notes issued as part of its acquisition of Pioneer Natural Resources Company in May 2024. Specifically, the 2024 10-K indicates that ExxonMobil issued 545 million shares of common stock and assumed $5 billion in debt as part of the $63 billion fair value transaction. While the exact composition of long-term notes is not detailed in the provided pages, the 2024 filing lists several long-term notes, including 0.524% Notes due 2028, 0.835% Notes due 2032, and 1.408% Notes due 2039, suggesting a continued focus on low-interest, long-term debt instruments to finance operations and strategic acquisitions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "XOM_10k_2022.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "XOM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48848,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12431,
        "completion_tokens": 180,
        "total_tokens": 12611
      }
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "Between 2022 and 2024, American Express has evolved its approach to corporate card solutions by emphasizing innovation and differentiation in commercial payments. The company has focused on enhancing its corporate card and accounts payable expense management solutions, designing innovative products and features such as financing, banking, and payment solutions tailored for business customers. This strategic emphasis reflects a broader goal to strengthen its position in the commercial payments space by delivering more value and flexibility to corporate clients.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 30737,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7908,
        "completion_tokens": 141,
        "total_tokens": 8049
      }
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "Amazon's financial relationship with AWS Services has strengthened significantly between 2022 and 2024, with AWS contributing 16% of total net sales in 2022 and increasing to 17% in 2024. AWS demonstrated robust growth, with a 13% increase in 2022 and a 19% increase in 2024, outpacing growth in other segments. In terms of cash flow generation, AWS supported Amazon's overall operating cash flow, which rose from $84.9 billion in 2023 to $115.9 billion in 2024. The strategic emphasis on AWS is evident in Amazon's capital expenditures, with significant investments in technology infrastructure to support AWS business growth, reflecting its critical role in the company's long-term financial strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56707,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14399,
        "completion_tokens": 175,
        "total_tokens": 14575
      }
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "Between 2023 and 2024, the scope and focus of trend analyses used in evaluating the historical consistency of regulatory asset balances expanded. In 2023, trend analyses were mentioned as part of procedures to evaluate the historical consistency of regulatory asset balances. By 2024, the focus broadened to include not only trend analyses but also comparisons of recorded balances to independently developed expectations, assessments of regulatory developments, and detailed testing of deferred costs, indicating a more comprehensive and forward-looking approach to evaluating regulatory asset recoverability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2023.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54932,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13955,
        "completion_tokens": 152,
        "total_tokens": 14108
      }
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "Between 2022 and 2023, Costco increased the penetration of private-label items as part of its strategy to manage cost and pricing pressures. In response to higher merchandise costs and inflation, Costco adjusted its merchandising and pricing strategies, which included increasing the share of private-label items to maintain competitive pricing and preserve member value. This approach helped Costco balance cost challenges while maintaining its pricing authority and member perception of value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 83157,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 21010,
        "completion_tokens": 123,
        "total_tokens": 21134
      }
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "The financial outlook for Paxlovid has significantly declined between 2023 and 2024 based on Pfizer's remaining performance obligations. As of December 31, 2024, the remaining performance obligations for Paxlovid totaled approximately $1 billion, compared to $2.5 billion in deferred revenues (noncurrent liabilities) as of December 31, 2023. This decrease reflects the transition of Paxlovid from government contracts to commercial markets and reduced demand, as well as the recognition of $2.9 billion in revenue from prior deferred balances in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 98857,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 24929,
        "completion_tokens": 138,
        "total_tokens": 25067
      }
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "Between 2022 and 2024, American Express has maintained a structured and data-driven approach to estimating credit loss reserves, with the R&S Period remaining a central assumption in its models. In 2022, the reserves for credit losses on Card Member loans were $3.3 billion, while in 2024, they increased to $5.7 billion, reflecting a more cautious stance amid evolving economic conditions. The company continues to incorporate historical loss experience, current economic trends, and future projections within the R&S Period, reverting to long-term average loss rates beyond it. This evolution indicates a proactive and adaptive approach to financial risk management, emphasizing transparency, model validation, and the inclusion of qualitative reserves to address uncertainties not captured by quantitative models.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 95,
          "pages": [
            93,
            94,
            95,
            96,
            97
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42279,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10816,
        "completion_tokens": 204,
        "total_tokens": 11020
      }
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "Amazon issued the 0.800% Note due 2025 as part of its debt financing strategy, as disclosed in its 2024 10-K. Specifically, this note was issued under an Officers' Certificate dated June 3, 2020, and is part of Amazon's broader approach to managing its capital structure through a variety of debt instruments with varying maturities and interest rates. Between 2022 and 2024, Amazon continued to issue and manage multiple debt instruments, including the 0.800% Note due 2025, to support its financial operations and investment needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 75,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45117,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11496,
        "completion_tokens": 133,
        "total_tokens": 11629
      }
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "The Twenty-third Supplemental Indenture, dated June 1, 1978, is consistently referenced in both the 2022 and 2024 SEC filings, indicating its historical inclusion as part of Duke Energy Progress' mortgage and deed of trust documentation. However, there is no new disclosure or amendment related to this specific indenture in the 2024 filing, suggesting it has remained unchanged and is no longer the subject of active updates. This implies that the indenture is part of the historical record and is not currently relevant to ongoing operations or recent corporate actions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 249,
          "pages": [
            247,
            248,
            249,
            250,
            251
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 252,
          "pages": [
            250,
            251,
            252,
            253,
            254
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 78426,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19841,
        "completion_tokens": 143,
        "total_tokens": 19984
      }
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "From 2022 to 2024, the total value of Class C Capital Stock repurchases increased slightly. In 2022, $52.868 billion worth of Class C shares were repurchased, in 2023 it was $50.192 billion, and in 2024, $50.192 billion as well. The number of shares repurchased also decreased from 450 million in 2022 to 306 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2024.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58675,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14890,
        "completion_tokens": 81,
        "total_tokens": 14972
      }
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "The American Express Company Salary/Bonus Deferral Plan is referenced in both the 2022 and 2024 SEC filings, but there is no indication of any substantive amendments or changes to the plan itself between these years. The 2022 filing includes references to the plan and its amendments up to 1997, while the 2024 filing does not list the plan explicitly, suggesting it may have been superseded or integrated into broader deferred compensation or incentive plans, such as the 2016 Incentive Compensation Plan. No new amendments or restatements specific to the Salary/Bonus Deferral Plan are disclosed in the 2024 filing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AXP_10k_2022.pdf",
          "target_page": 165,
          "pages": [
            163,
            164,
            165,
            166,
            167
          ]
        },
        "hop_2_rel": {
          "source_file": "AXP_10k_2024.pdf",
          "target_page": 171,
          "pages": [
            169,
            170,
            171,
            172,
            173
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 42705,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10901,
        "completion_tokens": 154,
        "total_tokens": 11055
      }
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "Starbucks' exposure to interest rate swaps between 2022 and 2024 has shifted in both magnitude and classification. In 2022, the interest rate swap liability was $34.0 million, classified under \"Other long-term liabilities,\" while by 2024, the liability had decreased to $19.2 million, still classified under \"Other long-term liabilities.\" Additionally, the carrying amount of the hedged item related to interest rate swaps dropped significantly from $1,047.7 million in 2022 to $332.2 million in 2024, indicating a reduction in the scale of these hedging activities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 74231,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18784,
        "completion_tokens": 141,
        "total_tokens": 18926
      }
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "Between 2022 and 2024, the Directors' Savings Plan at Duke Energy has remained a key component of director compensation governance, allowing outside directors to defer all or a portion of their annual compensation, typically in the form of retainers. The plan continues to credit deferred amounts to an unfunded account adjusted for the performance of phantom investment options, including Duke Energy Common Stock Fund. This suggests a consistent approach to deferral mechanisms, emphasizing long-term alignment with shareholder interests and flexibility for directors to manage compensation timing. The lack of material changes to the plan's structure indicates a stable governance strategy focused on deferral and non-cash compensation mechanisms for directors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DUK_10k_2022.pdf",
          "target_page": 258,
          "pages": [
            256,
            257,
            258,
            259,
            260
          ]
        },
        "hop_2_rel": {
          "source_file": "DUK_10k_2024.pdf",
          "target_page": 239,
          "pages": [
            237,
            238,
            239,
            240,
            241
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 72655,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18400,
        "completion_tokens": 191,
        "total_tokens": 18591
      }
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "Between 2022 and 2023, Costco's Kirkland Signature brand has maintained its positioning as a high-quality, cost-effective private-label offering, but with a heightened focus on navigating evolving market and operational risks. The 2022 filing emphasizes Kirkland Signature's role in differentiating merchandise offerings and earning higher margins, while the 2023 filing reflects increased attention to risks such as supply chain disruptions, inflation, and supplier reliability, which could impact the brand's ability to maintain quality and pricing advantages. This suggests a more cautious risk profile in 2023, as Costco seeks to balance growth and member value against external uncertainties.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45085,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11484,
        "completion_tokens": 174,
        "total_tokens": 11658
      }
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "COP's natural gas reserves in the Asia Pacific/Middle East region declined from 764 BCF at the end of 2021 to 326 BCF at the end of 2022, then further decreased to 312 BCF by the end of 2023, before slightly increasing to 296 BCF by the end of 2024. Key changes in 2022 included downward revisions of 2 BCF and sales of 385 BCF, primarily from the disposition of Indonesia assets. In 2023, the region saw minor upward revisions of 9 BCF and downward adjustments due to production and sales. In 2024, there were small upward revisions of 6 BCF and minor additions from extensions and discoveries in the Middle East and Australia, but overall volumes remained low due to ongoing production and limited new additions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 167,
          "pages": [
            165,
            166,
            167,
            168,
            169
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 79259,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20044,
        "completion_tokens": 178,
        "total_tokens": 20223
      }
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "Between 2022 and 2024, FedEx's strategic relationship with the Boeing 767F has evolved with a focus on fleet modernization. As of May 31, 2022, FedEx owned 114 Boeing 767F aircraft and had committed to purchasing 38 more through 2027. By May 31, 2024, the company had adjusted its commitments, with 14 Boeing 767F aircraft scheduled for delivery in 2025 and 3 in 2026, totaling 17 planned purchases. This shift reflects a continued emphasis on modernizing the fleet with more fuel-efficient aircraft, as the 767F is part of FedEx's broader modernization programs aimed at achieving long-term operating savings and replacing older aircraft.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 116,
          "pages": [
            114,
            115,
            116,
            117,
            118
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40801,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10424,
        "completion_tokens": 159,
        "total_tokens": 10584
      }
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "From 2022 to 2024, Starbucks' inventory value for roasted coffee increased from $310.3 million to $310.3 million (no change in the provided data), while unroasted coffee inventory rose from $1,018.6 million to $1,018.6 million. In terms of production infrastructure, Starbucks maintained and expanded its roasting facilities globally, including locations in the U.S., China, and other key markets, ensuring capacity for roasting, warehousing, and distribution to support its operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42777,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10912,
        "completion_tokens": 121,
        "total_tokens": 11033
      }
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "Based on the provided document pages, PepsiCo's utilization of the 2.750% Senior Notes due 2025 remained consistent between 2023 and 2024. In both years, the notes were referenced in the context of authorizations for issuance, with no indication of changes in their terms or redemption status. Specifically, the 2.750% Senior Notes due 2025 were included in the list of authorized notes in 2023 (PEP_10k_2023.pdf) and similarly referenced in 2024 (PEP_10k_2024.pdf), suggesting no material change in their utilization during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65856,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16691,
        "completion_tokens": 134,
        "total_tokens": 16825
      }
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "FedEx's planned utilization of the B777F aircraft decreased from 2022 to 2024, with deliveries dropping from 8 aircraft in 2022 to just 2 in 2024. This reduction indicates a diminished strategic role for the B777F in the fleet during this period, likely reflecting a shift in focus to other aircraft types such as the B767F and regional freighters like the Cessna SkyCourier 408 and ATR 72-600F, which are more aligned with FedEx's long-term modernization and fuel efficiency goals.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39648,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10136,
        "completion_tokens": 120,
        "total_tokens": 10256
      }
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI decreased from $55.3 million in 2022 to $11.5 million in 2023 and further to a net gain of $9.5 million in 2024. This decline suggests a reduced exposure to foreign currency fluctuations or more effective hedging strategies over the period. The trend indicates that Starbucks may have improved its risk management practices or experienced a more stable foreign exchange environment, leading to smaller swings in gains and losses related to foreign currency exposures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65991,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16742,
        "completion_tokens": 145,
        "total_tokens": 16887
      }
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 2.625% Senior Notes due 2026 remained consistent in terms of broader debt instrument disclosures. In both years, the notes were referenced as part of PepsiCo's extensive list of senior notes, with the 2024 disclosures including the 2.625% Senior Notes due 2026 among newly authorized and issued debt instruments. Notably, in 2024, PepsiCo expanded its debt disclosures to include additional senior notes issued in 2024, such as the 4.500% Senior Notes due 2029 and the 4.800% Senior Notes due 2034, indicating a broader diversification of its debt portfolio while maintaining the 2.625% Senior Notes due 2026 as part of its ongoing obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65856,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16691,
        "completion_tokens": 174,
        "total_tokens": 16865
      }
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "Cisco's exposure to and reliance on overcoming technical hurdles from 2022 to 2024 has increased, particularly as the company has intensified strategic investments in key priority areas such as AI, cloud, cybersecurity, and observability. In 2022, the focus was on realigning resources and addressing challenges in product development timelines, with risks tied to market transitions and the need to develop programmable and virtual networks. By 2024, the company emphasized the acceleration of software subscription offerings and the integration of acquired technologies, such as Splunk, which added complexity to its product development and technical execution. The evolution reflects a greater emphasis on timely innovation and overcoming technical challenges to maintain competitiveness in rapidly evolving markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 55658,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14146,
        "completion_tokens": 204,
        "total_tokens": 14350
      }
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "Based on the provided information, Google Ad Manager played a significant role in driving growth for Google Network revenues in 2021, as it was highlighted as a key contributor to the $8.6 billion increase from 2020 to 2021, along with AdMob and AdSense. However, in the 2023 10-K filing, there is no direct mention of Google Ad Manager's performance or contribution to Google Network revenues, suggesting that its specific role or impact may have diminished or become less emphasized compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45061,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11497,
        "completion_tokens": 125,
        "total_tokens": 11622
      }
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks' derivative liabilities related to foreign currency - other increased from $8.3 million in 2022 to $4.7 million in 2024 under accrued liabilities, and from $8.2 million in 2022 to $4.1 million in 2024 under other long-term liabilities. The total magnitude of change was a decrease of $10.1 million from 2022 to 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SBUX_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "SBUX_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 74231,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18777,
        "completion_tokens": 81,
        "total_tokens": 18859
      }
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "PepsiCo issued the 4.600% Senior Notes due 2045 as part of its broader debt issuance strategy, with no new issuance of these specific notes between 2023 and 2024. However, in 2024, PepsiCo expanded its debt portfolio by issuing new notes such as the 4.650% Senior Notes due 2027 and 4.700% Senior Notes due 2034 through its Singapore subsidiary. This evolution indicates a strategic shift toward diversifying its long-term debt structure, extending maturities, and leveraging international financing platforms to manage interest costs and liquidity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65856,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16692,
        "completion_tokens": 137,
        "total_tokens": 16829
      }
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP's natural gas position in the Asia Pacific/Middle East region remained relatively stable between 2022 and 2024, with slight fluctuations in proved natural gas reserves. In 2022, the region experienced upward revisions due to higher prices and improved LNG market dynamics, while in 2024, the region saw minimal changes, with only minor upward revisions in equity affiliates. This suggests that COP's strategic focus in the region has shifted toward maintaining and optimizing existing reserves rather than pursuing significant new developments or acquisitions, indicating a more conservative approach to its Asia Pacific/Middle East operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 173,
          "pages": [
            171,
            172,
            173,
            174,
            175
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 145,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 74435,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18838,
        "completion_tokens": 162,
        "total_tokens": 19000
      }
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "From 2022 to 2023, Google Play's role in Google's non-advertising revenue strategy remained consistent as a key contributor, generating revenue primarily from the sales of apps, in-app purchases, and digital content through the Google Play store. However, in 2023, there was a slight shift in emphasis, with increased attention to the broader ecosystem of non-advertising revenue sources such as YouTube subscriptions and hardware, suggesting that while Google Play remained important, it was part of a more diversified strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GOOGL_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "GOOGL_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49258,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12537,
        "completion_tokens": 132,
        "total_tokens": 12670
      }
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "From 2022 to 2024, the projected utilization of the Cessna SkyCourier 408 by FedEx has decreased, with planned deliveries shifting from 49 aircraft through 2027 in 2022 to only 31 aircraft by 2025 in 2024. This reduction suggests a diminished strategic reliance on the Cessna SkyCourier 408, as FedEx appears to be prioritizing other aircraft models such as the ATR 72-600F, B767F, and B777F for its fleet modernization and operational needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39648,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10142,
        "completion_tokens": 110,
        "total_tokens": 10252
      }
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "AIG's use of expected loss ratio methods between 2022 and 2023 evolved with a greater emphasis on segmentation and analysis of specific casualty lines. In 2022, the focus was on using expected loss ratio methods for at least the three latest accident years due to low credibility of reported losses, with segmentation by attachment point bands and between automobile and non-automobile claims. By 2023, the methodology expanded further, with more detailed segmentation of non-automobile claims into subsets like construction defects and mass torts, which have unique emergence patterns. Additionally, the analysis for excess casualty lines incorporated more nuanced adjustments for rate changes, loss trends, inflation, and market conditions, reflecting a more refined approach to capturing the impact of external factors and underwriting strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 263,
          "pages": [
            261,
            262,
            263,
            264,
            265
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2023.pdf",
          "target_page": 202,
          "pages": [
            200,
            201,
            202,
            203,
            204
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 260515,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 65355,
        "completion_tokens": 212,
        "total_tokens": 65567
      }
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "Between fiscal years 2022 and 2024, the classification of unallocated products within Nike's consumer construct evolved as part of the Consumer Direct Acceleration strategy. Beginning in fiscal 2022, unisex products were classified within Men's, and the Jordan Brand was separately reported. By fiscal 2024, the \"Others\" category included products not allocated to Men's, Women's, Kids', and Jordan Brand, reflecting a more refined consumer-focused structure. This shift aimed to align reporting with consumer segments, enhancing transparency and strategic decision-making.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43463,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11097,
        "completion_tokens": 143,
        "total_tokens": 11240
      }
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "Between 2023 and 2024, PepsiCo's engagement with the 3.500% Senior Notes due 2025 remained consistent, as these notes were issued in 2020 and are set to mature in 2025. No new issuance or refinancing of these specific notes occurred during this period. This indicates that PepsiCo is managing its debt maturity schedule by maintaining existing obligations while potentially preparing for refinancing or repayment closer to the maturity date, reflecting a strategy of disciplined debt management and maturity alignment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PEP_10k_2023.pdf",
          "target_page": 129,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "PEP_10k_2024.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65856,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16693,
        "completion_tokens": 129,
        "total_tokens": 16822
      }
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "Between 2022 and 2024, COP's financial disclosures for the Lower 48 region showed significant changes in capital expenditures and future cash inflow revisions. In 2022, capital expenditures for the Lower 48 were $3,129 million, increasing to $29,952 million in 2024, primarily driven by higher investments in development and proved property acquisitions. Future cash inflows for the Lower 48 also increased from $195,605 million in 2022 to $164,264 million in 2024, reflecting revised estimates based on updated pricing and production assumptions. These changes highlight a strategic shift toward higher capital allocation and updated reserve valuations in the Lower 48 region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COP_10k_2022.pdf",
          "target_page": 149,
          "pages": [
            147,
            148,
            149,
            150,
            151
          ]
        },
        "hop_2_rel": {
          "source_file": "COP_10k_2024.pdf",
          "target_page": 158,
          "pages": [
            156,
            157,
            158,
            159,
            160
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60387,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15327,
        "completion_tokens": 169,
        "total_tokens": 15496
      }
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "Between 2023 and 2024, Comcast's financial commitments and governance arrangements with Atairos Group remained largely consistent, with a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. Comcast accounts for its investment in Atairos using the equity method, as it does not have the power to direct the activities that most significantly impact Atairos' economic performance due to lacking voting rights. Comcast's economic interests entitle it to approximately 86% of residual returns but obligate it to absorb about 99% of losses. In 2024, Comcast contributed $73 million in cash capital to Atairos, and its total investment, including advances, was $5.1 billion as of December 31, 2024, compared to $5.5 billion in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 100,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57363,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14572,
        "completion_tokens": 188,
        "total_tokens": 14760
      }
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "FedEx's projected utilization of the Cessna SkyCourier 408 decreased between 2022 and 2023, with the total number of aircraft to be purchased dropping from 49 to 31. This reduction indicates a diminished strategic role for the Cessna SkyCourier 408 in FedEx's fleet compared to other aircraft, such as the ATR 72-600F, B767F, and B777F, which also saw changes in their projected utilization but retained a more prominent position in the company's future fleet planning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40006,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10236,
        "completion_tokens": 117,
        "total_tokens": 10353
      }
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "Nike's approach to the Air Max product line from 2022 to 2024 shows a shift in both revenue transparency and technological innovation emphasis. In 2022, Air Max is listed among other technologies like Zoom, Flyknit, and React in the context of leveraging innovations across product categories, but there is no specific revenue breakdown for Air Max. By 2024, while Air Max is still highlighted as a key technology, there is a stronger emphasis on innovation in product design and consumer experiences, particularly with a focus on sustainability and performance. However, no specific revenue figures or transparency for Air Max are disclosed in 2024, indicating that Nike continues to aggregate such data within broader product lines or categories.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56662,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14389,
        "completion_tokens": 187,
        "total_tokens": 14576
      }
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "In 2023, Comcast's capital expenditures for Epic Universe focused on acquiring land for potential theme park expansion opportunities. By 2024, the strategy shifted to direct investment in theme park attractions, with increased spending on the construction of Epic Universe in Orlando. Specific 2024 expenditures included costs associated with developing this new attraction, reflecting a prioritization of advancing the project's physical development over land acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CMCSA_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "hop_2_rel": {
          "source_file": "CMCSA_10k_2024.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41643,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10643,
        "completion_tokens": 118,
        "total_tokens": 10761
      }
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "Between 2022 and 2023, FedEx's utilization of the ATR 72-600F aircraft in its fleet projections decreased. In 2022, FedEx was committed to purchasing 24 ATR 72-600F aircraft, with deliveries scheduled from 2023 to 2026. By 2023, this commitment was reduced to 10 ATR 72-600F aircraft, with deliveries planned for 2023 and 2024 only. This indicates a significant reduction in the planned acquisition of this aircraft type in 2023 compared to the prior year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 40006,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10225,
        "completion_tokens": 114,
        "total_tokens": 10339
      }
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "Between fiscal 2022 and fiscal 2024, Nike's approach to estimating product return reserves remained consistent in its methodology, which involves using historical rates, specific identification of outstanding returns, and estimates of future returns. However, the reserve balances decreased from $1,015 million in 2022 to $53 million in 2024, indicating a significant reduction in anticipated returns. This suggests a potential improvement in customer satisfaction, stronger demand for products, or a shift in sales mix toward lower-return channels like Direct to Consumer, reflecting a more optimistic revenue recognition outlook.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 66,
          "pages": [
            64,
            65,
            66,
            67,
            68
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53809,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13683,
        "completion_tokens": 157,
        "total_tokens": 13841
      }
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "In 2022, FedEx was committed to purchasing 49 Cessna SkyCourier 408 aircraft in total, with 12 planned for delivery in 2025. By 2023, the total number of planned purchases was reduced to 31, with no deliveries scheduled for 2025. This indicates a significant reduction in the company's strategic reliance on the Cessna SkyCourier 408 model for its fleet composition beyond 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39546,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10127,
        "completion_tokens": 94,
        "total_tokens": 10221
      }
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "Mastercard expanded its real-time account-based payments infrastructure from 2023 to 2024 by increasing its operational scale, implementing real-time clearing and settlement infrastructure in 13 markets by December 31, 2023, and enhancing integrated security capabilities through a multi-layered approach. This includes robust programs to protect against cyber and information security threats, incorporating multiple layers of protection, third-party assessments, and collaboration with industry stakeholders to establish secure transaction standards.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54533,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13860,
        "completion_tokens": 138,
        "total_tokens": 13998
      }
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Between 2022 and 2024, Nike's use of foreign exchange forwards and options saw a reduction in both derivative assets and liabilities, reflecting adjustments in their hedging strategy. In 2024, total derivative assets related to these instruments dropped to $343 million from $557 million in 2023, while total derivative liabilities decreased to $151 million from $180 million. This decline suggests a more conservative approach to hedging, potentially due to reduced exposure or improved currency stability. Additionally, the notional amounts of cash flow hedges decreased from $18.2 billion in 2023 to $16.2 billion in 2024, indicating a slight reduction in the scale of hedged transactions. Nike continued to use these instruments primarily to hedge against foreign currency fluctuations, with a focus on major currency pairs like Euro/U.S. Dollar and Chinese Yuan/U.S. Dollar.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65372,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16570,
        "completion_tokens": 219,
        "total_tokens": 16790
      }
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "The product category classification of Puffs within the Baby, Feminine & Family Care segment remained consistent between 2022 and 2023, as it was listed under the Family Care sub-category in both years. In 2022, Family Care included \"Paper Towels, Tissues, Toilet Paper,\" and in 2023, it was similarly categorized under Family Care with the same description.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51030,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12973,
        "completion_tokens": 89,
        "total_tokens": 13063
      }
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "Between 2022 and 2023, Tampax remained within the Baby, Feminine & Family Care segment of P&G's product portfolio. In 2022, Tampax was listed under the \"Feminine Care\" product category, which also included \"Adult Incontinence\" and \"Family Care.\" By 2023, the categorization was slightly refined, with \"Feminine Care\" explicitly divided into \"Adult Incontinence\" and \"Menstrual Care\" subcategories. Tampax was specifically positioned under the \"Menstrual Care\" subcategory in 2023, reflecting a more detailed classification of the product line.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51030,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12983,
        "completion_tokens": 135,
        "total_tokens": 13119
      }
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "Oracle's strategy for Oracle Engineered Systems shifted between fiscal 2022 and 2023, with a continued de-emphasis on nonstrategic hardware products, leading to a decline in hardware revenue contribution. In fiscal 2022, hardware revenues totaled $3.18 billion, a -5% decrease compared to fiscal 2021, and Oracle anticipated this trend to continue as it focused on cloud-based infrastructure. In fiscal 2023, Oracle reiterated its focus on cloud offerings, with hardware representing 6% of total revenues. Research investment expectations for Oracle Engineered Systems were not explicitly detailed, but Oracle committed to ongoing R&D investments in cloud and license offerings, with research and development expenses expected to grow to support cloud expansion and capacity needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53642,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13644,
        "completion_tokens": 195,
        "total_tokens": 13840
      }
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Between 2022 and 2023, Honeywell's Non-U.S. pension plans saw a significant increase in investments in private funds. In 2022, the fair value of private funds was $115 million, classified as $41 million in Level 2 and $74 million in Level 3. By 2023, this amount rose to $131 million, with $74 million in Level 2 and $57 million in Level 3. The overall allocation to private funds increased, reflecting a shift in strategy or performance within the Non-U.S. pension portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 110,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57819,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14691,
        "completion_tokens": 119,
        "total_tokens": 14810
      }
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "The 2014 USD Notes, which had a principal amount of $1,000 million and a maturity date of April 2024, were fully repaid in April 2024. This repayment marked the conclusion of this debt obligation. No further actions or extensions related to the 2014 USD Notes were taken in 2024, as the debt was fully settled upon maturity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2023.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51141,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13006,
        "completion_tokens": 81,
        "total_tokens": 13087
      }
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "Between 2022 and 2024, Lowe's Officer Indemnification Agreements have been consistently documented in the 10-K filings, with the 2024 filing (page 79) referencing the same form agreement as in 2022 (page 80). This continuity suggests that the company has maintained a stable indemnification framework for its officers, indicating a consistent approach to executive risk management and governance. The lack of material changes in the documentation implies a focus on preserving legal protections for executives, ensuring continuity in corporate governance practices.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 79,
          "pages": [
            77,
            78,
            79,
            80,
            81
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36727,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9419,
        "completion_tokens": 141,
        "total_tokens": 9561
      }
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "Between 2022 and 2023, the market share and category positioning of Always Discreet in the adult incontinence market remained relatively stable. In 2022, Always Discreet held over 10% market share in key markets, while in 2023, it maintained a position with about 15% market share in the markets where it competed. This indicates a slight increase in market share and continued presence as a key player in the adult incontinence sub-category under the Baby, Feminine & Family Care segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2022.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51030,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12982,
        "completion_tokens": 122,
        "total_tokens": 13104
      }
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "Oracle's strategic positioning of Engineered Systems between 2022 and 2023 has evolved to emphasize their role as a foundational element in both cloud and on-premise infrastructure, reinforcing Oracle's cloud transformation narrative. In 2022, Engineered Systems were described as pre-integrated solutions that deliver performance, scalability, and operational efficiency, with flexible deployment options including on-premise, cloud, and hybrid models. By 2023, the focus expanded to highlight their integration with Oracle Cloud Infrastructure (OCI), particularly through offerings like Oracle Exadata Cloud Service, which supports Oracle's push toward hybrid and multi-cloud environments. This evolution underscores Oracle's strategy to position Engineered Systems as a bridge between traditional on-premise infrastructure and cloud adoption, supporting customers' hybrid IT needs and enhancing Oracle's cloud narrative.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47637,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12148,
        "completion_tokens": 230,
        "total_tokens": 12379
      }
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "In the 2022 10-K (page 59), the 2020 Stock Plan is described as the \"successor to the 2011 Stock Plan,\" with 5,530,106 shares from the 2011 Plan available for grants under the 2020 Plan. By the 2023 10-K (page 61), the 2011 Stock Plan is no longer explicitly referenced, and the 2020 Stock Plan is presented as the sole active plan, with no mention of shares from the 2011 Plan being carried over. This indicates that the 2020 Stock Plan fully replaced the 2011 Plan by 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 61,
          "pages": [
            59,
            60,
            61,
            62,
            63
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45262,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11534,
        "completion_tokens": 118,
        "total_tokens": 11653
      }
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell's allocation strategy toward private funds increased between 2022 and 2023, particularly in its U.S. pension plans, where private fund investments rose from $1,258 million in 2022 to $1,265 million in 2023. In non-U.S. plans, private fund allocations also increased from $90 million in 2022 to $115 million in 2023. This suggests a slight shift in capital deployment priorities toward alternative investments, potentially to diversify risk and enhance returns in response to evolving market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HON_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "HON_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62477,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15848,
        "completion_tokens": 128,
        "total_tokens": 15976
      }
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "Between 2023 and 2024, Class B-2 Common Stock emerged as a new class of stock following an exchange offer in May 2024, where 241 million shares of Class B-1 Common Stock were exchanged for approximately 120 million shares of Class B-2 Common Stock and 48 million shares of Class C Common Stock. Prior to this exchange, no shares of Class B-2 Common Stock were outstanding. Class B-2 Common Stock has a conversion rate into Class A Common Stock that is subject to adjustments, with double the impact of adjustments compared to Class B-1 Common Stock. The Class B-2 Common Stock is also subject to transfer restrictions and conversion conditions tied to the resolution of litigation matters.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65546,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16613,
        "completion_tokens": 172,
        "total_tokens": 16785
      }
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The financial obligations related to the Target Circle program significantly decreased between 2022 and 2024, with deferred revenue dropping from $89 million in 2022 to $19 million in 2025. This decline suggests that the program may have evolved to recognize revenue more quickly, possibly due to increased member activity, changes in reward structures, or improved redemption rates. The reduction in deferred liabilities indicates a shift toward more immediate revenue recognition, reflecting a more mature or optimized loyalty program.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41980,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10718,
        "completion_tokens": 134,
        "total_tokens": 10853
      }
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million at December 31, 2022, to $996 million at December 31, 2023, despite a par value of $1,000 million in both periods. This slight increase in fair value suggests a modest improvement in investor perception or more favorable market conditions for Netflix's debt in 2023 compared to 2022.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2023.pdf",
          "target_page": 56,
          "pages": [
            54,
            55,
            56,
            57,
            58
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44329,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11313,
        "completion_tokens": 89,
        "total_tokens": 11403
      }
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "Between 2023 and 2024, the equity structure related to Class C Common Stock remained largely unchanged in terms of share issuance, with 10 shares issued and outstanding in both years. However, equity classification was impacted by adjustments in accumulated other comprehensive income (loss), primarily due to changes in foreign currency translation adjustments and derivative instruments. Additionally, the conversion rates of Class B-1 and B-2 common stock were adjusted under the U.S. retrospective responsibility plan, indirectly affecting the earnings per share calculations for Class A common stock but not directly altering the equity classification of Class C shares.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 58,
          "pages": [
            56,
            57,
            58,
            59,
            60
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58795,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14921,
        "completion_tokens": 168,
        "total_tokens": 15089
      }
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "Lowe's engagement with Rough Plumbing from 2022 to 2024 has remained consistent in terms of business classification, as it is included within the Building Products division, which also encompasses categories like Building Materials, Electrical, Lighting, Lumber, Millwork, and Rough Plumbing. In terms of service offerings, Rough Plumbing is highlighted as one of the key categories for installation services and extended protection plans, indicating that Lowe's continues to provide both product and service support for this category. There is no indication of a significant change in the classification or expansion of service offerings specific to Rough Plumbing during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46115,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11748,
        "completion_tokens": 171,
        "total_tokens": 11919
      }
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "The introduction of Class B-2 common stock occurred in May 2024 through an exchange offer, where 241 million shares of Class B-1 common stock were exchanged for 120 million shares of Class B-2 common stock and 48 million shares of Class C common stock. This indicates that Class B-2 common stock was created as part of a restructuring initiative to release transfer restrictions and facilitate liquidity for certain shareholders. The Class B-2 common stock has a similar per-share earnings allocation as Class B-1 common stock but with conversion rate adjustments that have double the impact compared to Class B-1. This suggests that Class B-2 plays a specialized role in the capital structure, likely tied to litigation and conversion mechanics, while still providing higher earnings per share compared to Class A but lower than Class C.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 91,
          "pages": [
            89,
            90,
            91,
            92,
            93
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 68082,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17248,
        "completion_tokens": 209,
        "total_tokens": 17458
      }
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The financial liability associated with the Target Circle program decreased significantly from $117 million in 2022 to $19 million in 2024. This decline suggests that the program may have evolved to a point where more revenue is being recognized in line with customer activity, potentially indicating improved predictability or changes in how rewards and benefits are structured and deferred.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34503,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8851,
        "completion_tokens": 98,
        "total_tokens": 8949
      }
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "NVDA's exposure to and concern about pollution limits and their regulatory impact on operations and customer data center expansion evolved between 2023 and 2024, with increased emphasis on climate-related risks and sustainability. In 2023, the company highlighted the potential for new regulations on pollution limits, carbon taxes, and energy taxes to increase compliance costs and alter operations. By 2024, the discussion expanded to include the direct and indirect financial impacts of such regulations, including higher capital expenditures for facilities and equipment, increased energy costs, and potential supply chain disruptions. Additionally, in 2024, NVDA noted that data centers depend on access to clean water and predictable energy, and that regulations limiting energy or water availability could impair customers' ability to expand data centers, which in turn could negatively impact NVDA's business.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NVDA_10k_2023.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "NVDA_10k_2024.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 65042,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16491,
        "completion_tokens": 229,
        "total_tokens": 16720
      }
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "Between 2023 and 2024, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary totaled $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120% and maturities from 2033 to 2043. In July 2024, $77 of these Guaranteed Senior Notes were repaid. These notes are valued using Level 3 inputs, indicating they rely on unobservable inputs and internal assumptions for valuation. No further issuances or repayments of these specific Guaranteed Senior Notes were reported in 2024 beyond the initial issuance and partial repayment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 31704,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8154,
        "completion_tokens": 138,
        "total_tokens": 8293
      }
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "From 2022 to 2024, Netflix increased its investment in streaming service improvements, as reflected in higher personnel-related costs and cybersecurity measures. In 2022, technology and development expenses rose by 24% due to increased headcount supporting production and streaming improvements. By 2024, the company had strengthened its cybersecurity program, appointing a Vice President of Security and Privacy Engineering with extensive experience and implementing regular risk assessments, penetration testing, and third-party security programs. These efforts indicate a more proactive approach to managing cybersecurity risks and supporting operational resilience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58633,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14895,
        "completion_tokens": 167,
        "total_tokens": 15062
      }
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "Between 2023 and 2024, The Bank of New York Mellon Corporation updated its restricted stock unit (RSU) agreements by introducing the 2024 Form of RSU Agreement, as noted in the 2024 filing (Exhibit 10.29). This reflects a continued evolution in the lifecycle management of equity instruments, with a focus on aligning executive compensation with long-term performance and governance standards. The amendments and restatements to related executive compensation plans, such as the Executive Severance Plan (Exhibit 10.30), indicate a strategic effort to refine and standardize equity award structures and post-employment terms for executives.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44969,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11494,
        "completion_tokens": 160,
        "total_tokens": 11654
      }
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90% Senior Notes due April 15, 2029 were issued in November 2023 with a carrying amount of $750 million as of January 28, 2024. By February 2, 2025, the carrying amount remained unchanged at $743 million. The maturity timeline remains consistent, with the notes maturing in fiscal 2029. No repayments or redemptions of these notes occurred between 2023 and 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 60,
          "pages": [
            58,
            59,
            60,
            61,
            62
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52423,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13328,
        "completion_tokens": 92,
        "total_tokens": 13420
      }
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "Between 2023 and 2024, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 in November 2023 at fixed interest rates ranging from 1.400% to 2.120%. In July 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. No further repayments of these notes were mentioned for the remainder of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33469,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8582,
        "completion_tokens": 85,
        "total_tokens": 8667
      }
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "The risk associated with competitors developing after-market parts for DHR's products is mentioned in both the 2022 and 2023 filings, but there is no explicit indication of a significant evolution in this risk from 2022 to 2023. In both years, the risk is described as a potential factor that may detract from DHR's sales. However, in the 2023 filing, the mention of the Inflation Reduction Act of 2022 and its potential impact on pricing and government-established pricing for certain products suggests a broader regulatory context that could indirectly influence the competitive landscape, including the development of after-market parts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45502,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11611,
        "completion_tokens": 160,
        "total_tokens": 11771
      }
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "From 2022 to 2024, Netflix's membership plans evolved with a focus on pricing adjustments and introducing new service features to address business challenges such as slowing membership growth and increasing competition. The company implemented price increases across various regions to boost average monthly revenue per paying membership, which rose from $9.56 in 2021 to $11.67 by 2024. Additionally, Netflix introduced an ad-supported subscription plan to attract price-sensitive consumers while generating additional revenue through ads. These changes aimed to enhance profitability, retain existing members, and compete more effectively in a crowded entertainment market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NFLX_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "NFLX_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 58566,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14876,
        "completion_tokens": 168,
        "total_tokens": 15045
      }
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "Between 2022 and 2023, Boeing's approach to in-orbit incentive payments has shown increased risk exposure and financial recognition challenges. In 2023, the company highlighted that in-orbit incentive payments, tied to satellite performance for up to 15 years post-acceptance, expose it to financial risks if satellites fail to meet contractual criteria. This is particularly relevant for commercial and government satellite contracts, where failure could lead to loss of incentive payments, refund obligations, and significant charges. In contrast, the 2022 disclosures did not explicitly address in-orbit incentives, focusing instead on general development program risks. Thus, Boeing's 2023 disclosures reflect a more explicit recognition of the long-term financial risks associated with in-orbit performance obligations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 32036,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8230,
        "completion_tokens": 206,
        "total_tokens": 8436
      }
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "Between 2023 and 2024, the Directors' Code of Conduct for The Bank of New York Mellon Corporation remained accessible on the company's website, as disclosed in both years. In 2023, the Code was referenced in the 10-K on page 13 under \"ITEM 10,\" and in 2024, it was similarly referenced on page 3 under \"Available Information.\" There is no indication of substantive changes to the Code's content or accessibility during this period, suggesting continuity in its disclosure and availability to stakeholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35385,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9054,
        "completion_tokens": 126,
        "total_tokens": 9181
      }
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "Between 2022 and 2023, Mobileye Drive™ evolved from being primarily a Level 4 self-driving system for fleet deployment to a more scalable and commercially advanced autonomous driving solution. In 2022, Mobileye positioned Mobileye Drive as part of its dual business model, targeting both Robotaxi services and Vehicle-as-a-Service (MaaS) partnerships. By 2023, Mobileye expanded its deployment strategy by launching Mobileye SuperVision, which provided highway Navigate-on-Pilot capabilities and was deployed in 22 cities, up from two at its launch. Additionally, Mobileye secured production design wins for its consumer-focused Chauffeur product and further integrated its self-driving system with Moovit's mobility platform to enhance MaaS offerings. This reflects a shift toward broader commercialization and integration into both fleet and consumer markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "INTC_10k_2022.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "hop_2_rel": {
          "source_file": "INTC_10k_2023.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 31976,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8201,
        "completion_tokens": 215,
        "total_tokens": 8416
      }
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "From 2022 to 2024, the structure and distribution rate of the Tower Preferred Interests evolved as follows: In 2022, Tower Holdings had two series of preferred interests—Class A-1 (5.0%) and Class A-2 (4.75%)—with distributions resetting every five years. In 2024, the 2019 Tower preferred interests were amended to restructure them into Fixed Rate and Floating Rate Class A Limited Membership Interests. The Fixed Rate Interests carry a 5.90% distribution, while the Floating Rate Interests pay SOFR plus 250 basis points, with a portion transitioning to floating rates annually over five years. This restructuring reflects an adjustment to market conditions and provides more flexibility in distribution terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50171,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12752,
        "completion_tokens": 178,
        "total_tokens": 12930
      }
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "From 2022 to 2023, the investment approach for Level 3 assets related to the Balanced Index Fund remained consistent, as the majority of OPB plan assets continued to be invested in a balanced index fund comprising approximately 60% equities and 40% debt securities, valued using a market approach based on quoted prices. However, the unrealized gains/(losses) for Level 3 assets showed improvement, with a total of $14 in 2023 compared to a significant loss of ($90) in 2022. This indicates a positive shift in the performance of these assets during 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 115,
          "pages": [
            113,
            114,
            115,
            116,
            117
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 96,
          "pages": [
            94,
            95,
            96,
            97,
            98
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44369,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11312,
        "completion_tokens": 138,
        "total_tokens": 11451
      }
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "Between 2023 and 2024, BNY Mellon's emphasis on accounting developments in its forward-looking statements has shifted to reflect a more explicit acknowledgment of their strategic and operational impact. In 2023, accounting developments were mentioned as one of several external factors that could influence the company's business. By 2024, the discussion expanded to highlight how changes in accounting standards could have a \"material impact\" on reported financial metrics, including financial condition, results of operations, and capital planning. This evolution suggests that accounting standards are increasingly being integrated into BNY Mellon's strategic considerations, indicating a growing recognition of their influence on financial reporting and decision-making.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 34970,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8980,
        "completion_tokens": 193,
        "total_tokens": 9174
      }
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "In 2023, the evolution of risks related to store safety and cybersecurity introduced challenges that could negatively impact the associate experience by increasing operational costs, reducing margins, and potentially diminishing associate morale and retention due to unsafe environments or data security concerns. This contrasts with the engagement-focused initiatives in 2022, which emphasized creating an inclusive and supportive workplace through programs like the Voice of the Associate survey, diversity and inclusion efforts, and competitive compensation and benefits to foster emotional commitment and engagement among associates.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53705,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13658,
        "completion_tokens": 159,
        "total_tokens": 13818
      }
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "The role of the 'learning curve' in influencing cost and production estimates between 2022 and 2023 has remained a critical factor in program profitability and risk management, particularly for complex programs like the 777X, 787, and KC-46A Tanker. In 2022, the learning curve was explicitly mentioned as a factor affecting production costs, change incorporation, and achieving anticipated cost reductions. By 2023, the learning curve continued to play a key role in estimating program costs and gross margins, with ongoing challenges in production stability, supplier performance, and regulatory requirements impacting profitability. The evolution reflects a heightened focus on managing these variables to mitigate risks and improve long-term program outcomes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BA_10k_2022.pdf",
          "target_page": 42,
          "pages": [
            40,
            41,
            42,
            43,
            44
          ]
        },
        "hop_2_rel": {
          "source_file": "BA_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 38801,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9930,
        "completion_tokens": 190,
        "total_tokens": 10121
      }
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "Between the 2023 and 2024 SEC filings, the disclosure regarding the Dividend Reinvestment Plan remains consistent in acknowledging that certain officers or directors participate in the plan. However, in the 2024 filing, there is a more specific reference to these arrangements in **ITEM 9B**, where it clarifies that such transactions may either be structured under Rule 10b5-1 or constitute non-Rule 10b5-1 trading arrangements, as defined in Regulation S-K. This added specificity in 2024 provides greater transparency about the nature of the trading arrangements associated with officer and director participation in the plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35796,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9186,
        "completion_tokens": 157,
        "total_tokens": 9343
      }
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "The Home Depot's investment in creating an interconnected shopping experience increased from $2.6 billion in fiscal 2021 to $3.2 billion in fiscal 2023. Specific changes to tailor this experience to customers included enhancing digital capabilities for a seamless blend of online and in-store interactions, introducing mobile app features like store-specific maps, implementing self-service tools such as lockers and curbside pickup, and leveraging data-driven merchandising tools to personalize product offerings based on customer intent and location. Additionally, the company focused on improving store navigation, checkout efficiency, and associate engagement to enhance the in-store experience.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "HD_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "HD_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44475,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11353,
        "completion_tokens": 174,
        "total_tokens": 11528
      }
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "Between 2022 and 2023, DHR's financial relationship with Aldevron primarily involved acquisition-related expenditures. In 2021, DHR acquired Aldevron for approximately $9.6 billion, financing the acquisition using cash on hand and proceeds from commercial paper. The acquisition added approximately $6.1 billion in goodwill to DHR's balance sheet. In 2023, DHR incurred $27 million in transaction-related costs associated with the Abcam Acquisition, but no further material capital investments or acquisition expenditures related to Aldevron were reported. Thus, the financial relationship remained static post-acquisition, with no new capital investments or acquisition activities involving Aldevron in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DHR_10k_2022.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "DHR_10k_2023.pdf",
          "target_page": 74,
          "pages": [
            72,
            73,
            74,
            75,
            76
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 47138,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12011,
        "completion_tokens": 177,
        "total_tokens": 12188
      }
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "From 2022 to 2024, the total value of Telco LLC's preferred interests increased from $7,250 million as of December 31, 2023, to $9,500 million by October 2024, following the planned issuance of an additional $2,250 million in Telco Class A-4 preferred interests in early 2025. The structure evolved with the introduction of the Telco Class A-4 interests, which carry an initial distribution rate of 5.94% annually, subject to a reset on November 1, 2028, and every four years thereafter. The earlier classes (A-1, A-2, and A-3) had initial distribution rates of 4.25% and 6.85%, with reset schedules every seven years. The new Class A-4 interests have a shorter reset interval and a higher initial rate compared to the older classes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 130,
          "pages": [
            128,
            129,
            130,
            131,
            132
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50171,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12775,
        "completion_tokens": 183,
        "total_tokens": 12958
      }
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "Between 2022 and 2024, AIG's use of Expected Loss Ratio Methods has evolved in terms of application and rationale. In 2022, the Expected Loss Ratio method was primarily used for short-tail classes like U.S. Property and for the latest accident year in aviation exposures, where claim severity and variability made frequency/severity methods less effective. By 2024, the Expected Loss Ratio method was still applied to short-tail and long-tail lines, including U.S. Workers' Compensation, where loss emergence is long-term and historical data may be inconsistent. The rationale for its use expanded to include adjusting for rate changes, loss trends, and market conditions, particularly in recent accident years. Additionally, it was weighted more heavily in business written in excess of deductibles, reflecting its reliability in scenarios with limited loss history or inconsistent development patterns.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 273,
          "pages": [
            271,
            272,
            273,
            274,
            275
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 289160,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 72520,
        "completion_tokens": 226,
        "total_tokens": 72746
      }
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "Target's approach to its owned brands evolved from 2023 to 2024 by placing a stronger strategic emphasis on expanding and strengthening its owned brands portfolio as a key element of its overall strategy to delight customers with newness, style, and value. In 2023, the focus was on leveraging owned brands to differentiate its offerings and provide value, while in 2024, the strategy explicitly highlighted strengthening the owned brands portfolio alongside curating national brands and expanding signature partnerships. Additionally, the 2024 document provides a more detailed list of owned brands and emphasizes the importance of global sourcing operations in developing and procuring these brands, indicating a more structured and expanded approach to product portfolio development.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 25426,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6575,
        "completion_tokens": 196,
        "total_tokens": 6772
      }
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggests a strategic approach to diversify its long-term debt structure and potentially access more favorable borrowing conditions. The issuance of the higher-yield 2.900% Notes may indicate that IBM is capitalizing on current market conditions to secure additional financing at a relatively attractive rate, while retaining the lower-yield 0.875% Notes to maintain a balanced maturity profile and manage interest costs over time. This reflects confidence in stable long-term borrowing markets and IBM's proactive management of its debt portfolio to optimize financial flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53151,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13520,
        "completion_tokens": 170,
        "total_tokens": 13690
      }
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "The 4.000% Global Notes due June 1, 2049 (T 49A) were listed in both the 2022 and 2024 filings, indicating continuity in this long-term debt instrument. Between 2022 and 2024, AT&T added new long-term notes, including the 3.950% Global Notes due April 30, 2031 (T 31F) in 2024, reflecting a shift toward issuing notes with shorter maturities and varying coupon rates to manage its debt portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 2,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42322,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10809,
        "completion_tokens": 99,
        "total_tokens": 10908
      }
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The financial impact of the Heritage AspenTech acquisition evolved between 2023 and 2024, with intangibles amortization increasing from $258 million in 2023 to $560 million in 2024, primarily due to the full-year impact of the acquisition and the addition of the National Instruments acquisition in 2024. Restructuring costs related to the Heritage AspenTech acquisition were minimal, at $1 million in 2023 and $8 million in 2024, reflecting ongoing integration and operational adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37481,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9597,
        "completion_tokens": 122,
        "total_tokens": 9719
      }
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG's use of expected loss ratio methods for workers' compensation between 2022 and 2024 has evolved with a greater emphasis on segmentation by business types and the impact of large deductible accounts. In 2022, the proportion of large deductible business continued to increase, which slowed claim reporting patterns. By 2024, AIG further refined its segmentation, analyzing subsets of the portfolio with unique characteristics and segmenting excess of deductible business by deductible size and claim handling (AIG vs. third-party administrators). Additionally, expected loss ratio methods for excess of deductible business were given significant weight in the most recent five accident years, reflecting the evolving approach to account for the delayed emergence of claims in this structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 260,
          "pages": [
            258,
            259,
            260,
            261,
            262
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 259551,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 65127,
        "completion_tokens": 198,
        "total_tokens": 65326
      }
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "From 2023 to 2024, Target enhanced its Cyber Fusion Center operations by strengthening threat investigation and response capabilities, leveraging industry-leading tools and in-house technologies. In 2024, the company emphasized deeper integration of cybersecurity into its enterprise risk management and expanded collaboration with external organizations across industries to share threat intelligence, best practices, and regulatory insights. Additionally, Target continued to invest in developing in-house cybersecurity expertise and training programs, such as the Cyber Plus Institute, to further bolster its response strategies and preparedness.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43494,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11110,
        "completion_tokens": 162,
        "total_tokens": 11272
      }
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "Eli Lilly recognized $677.6 million in revenue from Baqsimi in 2023, a significant increase from $139.3 million in 2022, as noted in the 2023 10-K. By 2024, the 10-K indicates that Baqsimi was included in the revenue from the sale of product rights, though specific figures for 2024 are not provided. This suggests that the contractual arrangement involving Baqsimi likely concluded in 2023, with the majority of revenue recognized during that year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48167,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12265,
        "completion_tokens": 112,
        "total_tokens": 12378
      }
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "From 2023 to 2024, AT&T repurchased all outstanding Mobility Preferred Interests, completing the process in April 2023 by repurchasing the remaining 213 million interests for $5,414, which was primarily funded through the issuance of Telco LLC preferred interests. In terms of expansion, AT&T restructured and reset the Tower Holdings preferred interests in August 2024, transitioning them to Fixed and Floating Rate Class A Limited Membership Interests, with distributions of 5.90% and SOFR + 250 basis points, respectively. Additionally, in October 2024, AT&T agreed to issue $2,250 of new Telco Class A-4 preferred interests in 2025, paying an initial distribution of 5.94%, to fund the redemption of preferred equity securities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 38,
          "pages": [
            36,
            37,
            38,
            39,
            40
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56243,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14306,
        "completion_tokens": 183,
        "total_tokens": 14489
      }
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "From 2023 to 2024, Emerson's relationship with AspenTech evolved significantly, culminating in a proposal to acquire the remaining shares of AspenTech not already owned by Emerson for $240 per share in cash. By 2024, Emerson already owned approximately 57% of AspenTech's outstanding shares. This transformation had notable financial impacts: Emerson's gross margin increased by 1.8 percentage points to 50.8% in 2024, primarily due to the Test & Measurement acquisition (which included AspenTech), despite a negative impact from acquisition-related inventory step-up amortization. Additionally, Emerson's ownership structure was affected, with the proposed acquisition aiming to consolidate full control over AspenTech, enhancing Emerson's position as a global automation leader.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46981,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11973,
        "completion_tokens": 195,
        "total_tokens": 12168
      }
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "Between 2022 and 2024, AIG's Japan pension plans contributed approximately 50-67% of the total non-U.S. pension obligations. The weighted average discount rate for these plans increased from 0.52% at December 31, 2021, to 1.81% at December 31, 2024, reflecting a significant upward shift in the interest rate environment during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 311,
          "pages": [
            309,
            310,
            311,
            312,
            313
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 183,
          "pages": [
            181,
            182,
            183,
            184,
            185
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 70966,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17982,
        "completion_tokens": 85,
        "total_tokens": 18067
      }
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "Between 2022 and 2023, Amazon's framing of the impact of competitive stores on its business evolved to emphasize the intensifying competition in international markets and the challenges posed by evolving business models. In 2022, the disclosure highlighted that local companies had a competitive advantage due to their understanding of local customers and established brand names. By 2023, the framing expanded to include the broader context of geopolitical events and economic conditions, reflecting a more global and dynamic view of external market pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50015,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12736,
        "completion_tokens": 140,
        "total_tokens": 12876
      }
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "Between 2023 and 2024, Target's exposure to port security risks remained a concern, particularly due to its reliance on global supply chains and sourcing a significant portion of merchandise from outside the U.S., with China as its largest source. In 2023, the company highlighted disruptions at major U.S. ports, including closures, ship diversions, labor disputes, and congestion, which could increase costs and affect inventory availability. By 2024, the company reiterated these risks, emphasizing that geopolitical conflicts, labor unrest, and port security issues continued to pose threats to its supply chain. Operationally, Target has made alternative arrangements to mitigate disruptions, but recurring events could still lead to higher costs and inventory challenges. The geographic focus remained on U.S. ports, especially California ports, and the operational impact centered on potential delays, increased costs, and inventory shortages.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51387,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13067,
        "completion_tokens": 237,
        "total_tokens": 13304
      }
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "Between 2023 and 2024, Emerson's financial relationship with Heritage AspenTech evolved in terms of acquisition-related amortization and restructuring costs as follows: \n\nAmortization of intangibles related to the Heritage AspenTech acquisition increased from $258 million in 2023 to $560 million in 2024, reflecting the ongoing amortization of intangible assets from the 2022 business combination. Restructuring costs attributed to AspenTech rose from $1 million in 2023 to $8 million in 2024, indicating incremental restructuring activities within the AspenTech segment during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "EMR_10k_2023.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "hop_2_rel": {
          "source_file": "EMR_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39265,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10044,
        "completion_tokens": 147,
        "total_tokens": 10192
      }
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "AIG's use of Expected Loss Ratio methods between 2022 and 2024 has evolved to place increased weight on these methods for recent accident years, particularly in lines of business characterized by long-tail exposures and low-frequency, high-severity losses. In 2022, the Expected Loss Ratio method was emphasized for newer accident years due to inconsistent loss development patterns and limited historical data. By 2024, this approach was further refined, with significant weight given to Expected Loss Ratio methods for the most recent five accident years across U.S. Workers' Compensation and U.S. Excess Casualty lines. This shift reflects a strategic adaptation to evolving underwriting practices, including higher deductible structures and risk-sharing features, which delay claim emergence and increase reliance on forward-looking assumptions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AIG_10k_2022.pdf",
          "target_page": 270,
          "pages": [
            268,
            269,
            270,
            271,
            272
          ]
        },
        "hop_2_rel": {
          "source_file": "AIG_10k_2024.pdf",
          "target_page": 151,
          "pages": [
            149,
            150,
            151,
            152,
            153
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 273896,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 68708,
        "completion_tokens": 212,
        "total_tokens": 68920
      }
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Between 2022 and 2023, Amazon's monetization strategy for its film groups evolved with an increase in capitalized video and music content costs and associated expenses. The total capitalized costs of video and music content rose from $16.7 billion in 2022 to $17.4 billion in 2023, while total video and music expenses increased from $16.6 billion in 2022 to $18.9 billion in 2023. This suggests a continued investment in content production and licensing to enhance the value proposition of Amazon Prime memberships, with a focus on monetizing these film groups as integrated units across major geographies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48826,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12435,
        "completion_tokens": 151,
        "total_tokens": 12586
      }
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "Between 2022 and 2024, Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges (RBH) evolved significantly, particularly in terms of its stake and associated impairment. In 2024, PMI recorded a non-cash impairment charge of $2,316 million (diluted EPS charge of $1.49 per share) due to the proposed CAD 32.5 billion settlement in Canadian tobacco litigation, which raised concerns about the allocation of the settlement amount among RBH and other parties. This impairment reflected a decline in the estimated fair value of PMI's investment in RBH below its carrying value, indicating a substantial financial impact on PMI's stake in RBH.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 30023,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7729,
        "completion_tokens": 167,
        "total_tokens": 7897
      }
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "The sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities remained relatively stable between 2023 and 2024. In both years, a 5 percent change in these liabilities would result in a change in revenue of approximately $600 million in 2024 and $615 million in 2023. Additionally, the portion of these liabilities attributable to U.S. sales remained consistent at approximately 90 percent for both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2023.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 53,
          "pages": [
            51,
            52,
            53,
            54,
            55
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43899,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11208,
        "completion_tokens": 112,
        "total_tokens": 11320
      }
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "Based on Union Pacific's disclosures, the role and revenue contribution of Bulk shipments evolved from 2022 to 2024 as follows: In 2022, Bulk shipments contributed to freight revenue growth due to increased volume and pricing gains, recovering from the 2020 pandemic impact. By 2024, Bulk shipments accounted for 32% of the company's freight revenues, reflecting continued demand for commodities like grain, fertilizer, and coal, supported by the railroad's extensive network connecting key production and export areas.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2022.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43385,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11060,
        "completion_tokens": 129,
        "total_tokens": 11189
      }
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "The interest rate for IBM's Notes due 2028 remained at 0.300% in both 2023 and 2024. This consistency in the interest rate suggests that IBM has maintained a stable debt strategy for this particular bond issue, likely locking in a low rate to manage financing costs over the long term. It also indicates that IBM did not issue new Notes due 2028 during this period, and the existing issuance continued under the same terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2023.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 1,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53151,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13502,
        "completion_tokens": 105,
        "total_tokens": 13608
      }
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "From 2023 to 2024, AT&T's capital structure strategy regarding preferred interests evolved by retiring the Mobility Preferred Interests, which were fully repurchased by April 2023, and introducing new preferred instruments such as the Tower Holdings and Telco LLC preferred interests. The Tower Holdings preferred interests were restructured in August 2024, transitioning to a mix of fixed and floating rate distributions, while the Telco LLC expanded its preferred interests with the planned issuance of additional Telco Class A-4 interests in early 2025. These changes reflect a shift toward more structured, long-term preferred instruments with flexible redemption and distribution terms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62011,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15738,
        "completion_tokens": 172,
        "total_tokens": 15910
      }
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Between 2022 and 2023, Amazon's characterization of the competitive threat from websites evolved to reflect a more nuanced and dynamic landscape. In 2022, the focus was primarily on traditional competitive pressures, such as the introduction of competitive stores, websites, products, and services. By 2023, the language expanded to emphasize evolving business models and intensified competition, particularly in international markets, as well as the growing influence of local companies with deeper market understanding and established brand presence. This shift in language indicates a recognition of the increasing complexity and localized nature of the competitive environment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 50015,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12735,
        "completion_tokens": 170,
        "total_tokens": 12905
      }
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "PMI's relationship with KT&G has evolved from 2022 to 2024, with increased strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free portfolio. In 2022, PMI announced a global collaboration agreement with KT&G to commercialize KT&G's smoke-free products outside South Korea, and by 2024, PMI had launched commercial initiatives for these products in select markets. KT&G's heat-not-burn products, such as LIL Mini and LIL Plus, are now included in PMI's smoke-free product offerings, reflecting a growing integration of KT&G's innovations into PMI's broader strategy to expand its heat-not-burn product portfolio globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43765,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11171,
        "completion_tokens": 160,
        "total_tokens": 11331
      }
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "Between 2022 and 2024, IBM's use of the PWCC Plan remained consistent in terms of administration and scope. The PWCC Plan continued to be used solely to fund awards for employees of PricewaterhouseCoopers Consulting (PwCC) who became IBM employees following the 2002 acquisition. It did not fund awards for senior executives, and its terms and conditions remained substantively identical to those of the 2001 Plan. No significant changes in administration or scope were noted during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 36175,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9264,
        "completion_tokens": 123,
        "total_tokens": 9388
      }
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "Between 2023 and 2024, AT&T fully repurchased its Mobility Preferred Interests, which were outstanding as of December 31, 2022, with the final redemption occurring in April 2023. This marked a significant shift in AT&T's capital structure management, as the company eliminated a liability that had previously been reclassified from equity to a liability at fair value. In 2024, AT&T focused on restructuring and issuing new preferred interests in its Tower Holdings and Telco LLC subsidiaries, including resetting rates and introducing floating-rate components to align with market conditions. These actions indicate a strategic approach to optimizing capital structure by managing debt obligations, enhancing flexibility, and aligning long-term financing with evolving market dynamics.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51480,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13103,
        "completion_tokens": 196,
        "total_tokens": 13300
      }
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "Between 2022 and 2024, IBM's regulatory exposure for its debt securities remained largely consistent, with exposure stemming from factors such as interest rates, exchange rates, governmental and stock exchange regulations, and credit ratings. However, the 2024 filing highlights an increasingly complex global regulatory environment, particularly around cybersecurity, data privacy, and AI, which could indirectly affect the company's compliance obligations and, consequently, the value and liquidity of its debt securities. There is no indication of a material change in the direct regulatory exposure for debt securities during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "IBM_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "IBM_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 38003,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9720,
        "completion_tokens": 160,
        "total_tokens": 9881
      }
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "Disney's equity income contribution from A+E declined significantly from 2022 to 2024. In 2022, A+E was a major equity investment with 50% ownership, generating income through its cable channels. By 2024, equity income from investees, including A+E, dropped by 26% to $575 million from $782 million in 2023, primarily due to lower income from A+E. This decline reflects a worsening financial contribution from A+E to Disney's consolidated results over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 35,
          "pages": [
            33,
            34,
            35,
            36,
            37
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 32800,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8415,
        "completion_tokens": 115,
        "total_tokens": 8531
      }
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations increased from $16,973 million in 2022 to $18,043 million in 2023. This increase indicates that the company is actively utilizing securitized debt as a long-term funding strategy to support its operations and manage liquidity needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COF_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "COF_10k_2023.pdf",
          "target_page": 210,
          "pages": [
            208,
            209,
            210,
            211,
            212
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48210,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12279,
        "completion_tokens": 70,
        "total_tokens": 12349
      }
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "Between 2022 and 2024, Disney has shifted its focus from international general entertainment channels to prioritize its Direct-to-Consumer (DTC) platforms. The company has consolidated services, such as merging Star+ into Disney+ in Latin America, and plans to launch an ESPN tile on Disney+ in the U.S. This shift reflects a strategic move to monetize content primarily through DTC services rather than licensing linear channels, which is expected to negatively impact the International Channels business. Additionally, Disney has expanded its DTC offerings, including Disney+, Disney+ Hotstar, and ESPN+, with a focus on localized and sports content to drive subscriber growth in key international markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39439,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10092,
        "completion_tokens": 177,
        "total_tokens": 10269
      }
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "From 2022 to 2023, Tesla faced evolving financial and operational challenges related to energy storage products, particularly in accounts receivable and production scaling. In 2022, accounts receivable were impacted by fluctuations in customer payments and government rebate collection timelines, with long-term government rebates reaching $627 million by year-end. By 2023, production scaling dependencies remained a key concern, as Tesla highlighted ongoing challenges in securing sufficient battery cell supply and managing raw material costs and availability, which could hinder production ramping for energy storage products. Additionally, delays in launching and scaling new manufacturing processes and dependencies on suppliers for components continued to pose risks to production efficiency and cost control.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 49458,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12597,
        "completion_tokens": 204,
        "total_tokens": 12801
      }
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "The role of syrups in Coca-Cola's business model remained central in 2022 and 2023, primarily serving as a key component of its concentrate operations. Syrups, including fountain syrups, are sold to bottling partners who then produce finished beverages or sell them directly to fountain retailers. In 2023, concentrate operations accounted for 58% of net operating revenues, up from 56% in 2022, indicating a slight increase in the importance of syrups and concentrates relative to finished product operations. This reflects Coca-Cola's continued focus on leveraging its bottling partners and fountain retailers to distribute its products efficiently, particularly in the foodservice and retail channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 44,
          "pages": [
            42,
            43,
            44,
            45,
            46
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48649,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12386,
        "completion_tokens": 176,
        "total_tokens": 12562
      }
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) decreased from fiscal year 2022 to fiscal year 2024. In fiscal 2022, the fair value of Other MBS & ABS was $84 million (1% of total plan assets), while in fiscal 2024, it was $166 million (1% of total plan assets). Despite the slight increase in absolute value, the proportion relative to the overall fair value hierarchy remained consistent at 1% for both years.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 104,
          "pages": [
            102,
            103,
            104,
            105,
            106
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2024.pdf",
          "target_page": 107,
          "pages": [
            105,
            106,
            107,
            108,
            109
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 55006,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13993,
        "completion_tokens": 110,
        "total_tokens": 14104
      }
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Between 2022 and 2023, Skunk Works' advanced development programs (ADP) at Lockheed Martin expanded their focus on next-generation military aircraft capabilities, emphasizing unmanned and manned aerial systems, air dominance, hypersonics, intelligence, surveillance, reconnaissance (ISR), situational awareness, and air mobility. The evolution highlighted a stronger emphasis on integrating network-enabled technologies and advancing hypersonic capabilities, reflecting the growing importance of speed, agility, and interconnected systems in modern military operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48582,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12367,
        "completion_tokens": 142,
        "total_tokens": 12509
      }
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "From 2022 to 2023, Tesla's approach to the Powerwall product evolved by emphasizing integration with residential solar energy systems and increasing cross-selling efforts. In 2022, the company noted growing customer interest in Powerwall driven by better availability and grid stability concerns, while also highlighting the importance of maintaining adequate battery cell supply. By 2023, Tesla explicitly stated its focus on emphasizing cross-selling with residential solar energy products and improving installation capabilities for Solar Roof, which suggests a more integrated strategy to bundle Powerwall with solar offerings. This shift reflects a stronger emphasis on leveraging synergies between energy generation and storage solutions to drive adoption and scale.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 42301,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10795,
        "completion_tokens": 193,
        "total_tokens": 10988
      }
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "Between 2022 and 2024, Gilead has maintained Biktarvy as a cornerstone of its HIV portfolio, emphasizing its role as a once-daily, single-tablet regimen for the treatment of HIV-1 infection. However, the company faces increasing commercial risks, including competition from generic and branded alternatives, pricing pressures due to legislative actions such as the Inflation Reduction Act (IRA), and reimbursement challenges from government and third-party payers. These factors could impact Biktarvy's market share and profitability, necessitating ongoing strategic adaptations to sustain its position in the HIV treatment landscape.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47959,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12219,
        "completion_tokens": 158,
        "total_tokens": 12378
      }
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "Between 2022 and 2023, the U.S. Retrospective Responsibility Plan saw notable changes in the U.S. Litigation Escrow Agreement. In 2022, the balance in the U.S. litigation escrow account was $1,449 million, with $850 million in deposits and $295 million in payments. By 2023, the balance increased to $1,764 million at the beginning of the period, with $1,000 million in deposits and $685 million in payments, resulting in an end-of-period balance of $3,089 million in 2023. Additionally, the 2023 disclosures introduced new mechanisms such as makewhole agreements, which were not mentioned in 2022, adding complexity to the plan's structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 71,
          "pages": [
            69,
            70,
            71,
            72,
            73
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52426,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13339,
        "completion_tokens": 160,
        "total_tokens": 13500
      }
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "The strategic importance of Biktarvy for GILD has increased from 2022 to 2024, as it remains a key HIV treatment with robust patent protection through 2033 in both the U.S. and the European Union, providing long-term exclusivity. This extended patent life helps mitigate the risk of generic competition, which is a critical concern given GILD's heavy reliance on HIV products for revenue. The 2024 filing emphasizes the continued importance of maintaining market leadership in HIV therapies, particularly as patent protections for other HIV products have started to expire or face litigation, making Biktarvy a central asset for sustaining revenue and competitive positioning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GILD_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "GILD_10k_2024.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 41956,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10719,
        "completion_tokens": 169,
        "total_tokens": 10888
      }
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "Based on the provided document pages, there have been no modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023. The referenced guarantees, including the guarantee of certain obligations of Illinois Bell Telephone Company, are detailed in Exhibit 4-c of the 2023 10-K filing, and there is no indication of structural changes or updated documentation for these guarantees during the specified period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "T_10k_2022.pdf",
          "target_page": 141,
          "pages": [
            133,
            134,
            135,
            136,
            137
          ]
        },
        "hop_2_rel": {
          "source_file": "T_10k_2023.pdf",
          "target_page": 103,
          "pages": [
            101,
            102,
            103,
            104,
            105
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41260,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10553,
        "completion_tokens": 115,
        "total_tokens": 10668
      }
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggests that there has been no dilutive adjustment during this period, which implies stability in the potential voting power of Class A common stockholders in significant corporate transactions. Since the conversion rate remains unchanged, the number of Class A shares that would be issued upon conversion of Class C shares has not increased, preserving the relative voting power of existing Class A common stockholders.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44619,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11391,
        "completion_tokens": 126,
        "total_tokens": 11517
      }
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "From 2022 to 2023, Tesla's relationship with the Solar Roof shifted in production focus and strategic dependencies. In 2022, the Solar Roof was explicitly mentioned as a product developed and produced at Gigafactory New York, indicating a dedicated manufacturing focus. By 2023, however, there was no direct mention of Solar Roof production at Gigafactory New York, suggesting a potential reallocation of resources or reduced emphasis on the product. Additionally, strategic dependencies on Gigafactory New York's operations were noted in 2022, but by 2023, the company's focus appeared to shift toward scaling vehicle production and battery cell development, indicating a reduced strategic reliance on the Solar Roof in favor of core automotive growth.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TSLA_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "TSLA_10k_2023.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 45773,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11659,
        "completion_tokens": 188,
        "total_tokens": 11847
      }
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "Between 2022 and 2023, syrups remained a core component of Coca-Cola's business model, primarily serving as intermediate products in the beverage manufacturing process. Syrups are produced by combining concentrates with water and sweeteners and are sold to bottling partners and fountain retailers, who use them to create finished beverages for retail or immediate consumption. In 2023, concentrate operations (which include syrups) accounted for 58% of net operating revenues, up from 56% in 2022, while finished product operations decreased slightly to 42% from 44%. This suggests a continued emphasis on syrups and concentrate sales as a revenue driver. Distribution channels remained largely consistent, with bottling partners and fountain retailers playing key roles in delivering Coca-Cola's products to consumers globally.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2023.pdf",
          "target_page": 37,
          "pages": [
            35,
            36,
            37,
            38,
            39
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44791,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11427,
        "completion_tokens": 207,
        "total_tokens": 11634
      }
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "Between 2022 and 2024, the company's operational focus on Africa/Eurasia remained relatively stable in terms of geographic reporting structure, as it continued to be a reportable operating segment under the Oral, Personal and Home Care product segment. However, its financial contribution showed a slight increase in operating profit, rising from $228 million in 2022 to $253 million in 2024. Additionally, net sales for Africa/Eurasia grew from $1,082 million in 2022 to $1,095 million in 2024, indicating modest growth in the region's financial performance over the period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36181,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9275,
        "completion_tokens": 143,
        "total_tokens": 9419
      }
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "Between 2023 and 2024, Johnson & Johnson's Orthopaedics business, under the MedTech segment, showed modest global sales growth, with a 4.1% increase in worldwide sales in 2023 compared to 2022. The U.S. market saw a 3.8% growth, while international sales increased by 4.6%. The strategic emphasis on enabling technologies is evident in the expansion of the Orthopaedics portfolio, which includes products and technologies supporting hips, knees, trauma, spine, sports, and other areas. This reflects a continued focus on innovation and advanced solutions to address patient needs across various orthopaedic applications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JNJ_10k_2023.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "JNJ_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50571,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12875,
        "completion_tokens": 155,
        "total_tokens": 13030
      }
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "Between 2022 and 2023, Visa's approach to managing litigation liabilities through loss sharing agreements remained consistent in terms of liability allocation, with the scope of U.S. covered litigation expanding to include actions brought by merchants that opted out of the Rule 23(b)(3) settlement class in MDL 1720. The liability allocation mechanism under the loss sharing agreement continued to distribute obligations based on each bank's membership proportion as defined in Visa U.S.A.'s certificate of incorporation. Additionally, the U.S. litigation escrow account balance increased significantly in 2023, reflecting larger deposits ($1,500 million in 2023 vs. $1,000 million in 2022) and reduced payments to opt-out merchants, indicating a more active management of funds to address potential liabilities.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2023.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53500,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13610,
        "completion_tokens": 203,
        "total_tokens": 13813
      }
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "Between 2022 and 2024, CL's investment in Guaranteed Investment Contracts (GICs) within its pension plans shifted from $34 million in 2023 to $30 million in 2024, indicating a slight reduction in allocation to GICs. This shift suggests a potential diversification or reallocation of pension plan assets toward other investment categories, such as fixed income or multi-asset funds, as part of the company's strategy to manage risk and optimize returns in its defined benefit plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 39712,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10156,
        "completion_tokens": 120,
        "total_tokens": 10276
      }
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "Between 2022 and 2024, the Mastercard Developer Platform evolved from a tool for simplifying access to digital assets and APIs into a more strategic enabler of integration for digital assets and new technologies. In 2022, the platform focused on providing a single access point for customers and partners to leverage digital assets and services. By 2024, it had expanded its role to support blockchain-based business models, programmable payments via the Mastercard Multi-Token Network™, and enabling consumers to buy and spend cryptocurrencies seamlessly. The platform also facilitated integration with emerging technologies and fintech innovations, reinforcing Mastercard’s commitment to a future-ready payments ecosystem.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46049,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11750,
        "completion_tokens": 181,
        "total_tokens": 11931
      }
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "The company's investment in U.S. common stocks within its pension plans remained minimal between 2022 and 2024, with only $1 million in U.S. common stocks reported in 2024 and none in 2022 and 2023. This indicates that the company's strategic asset allocation continues to prioritize fixed income securities and other investments over direct holdings in U.S. common stocks, aligning with its target allocation of 21% equity securities for U.S. plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2024.pdf",
          "target_page": 100,
          "pages": [
            98,
            99,
            100,
            101,
            102
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 33481,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8599,
        "completion_tokens": 112,
        "total_tokens": 8711
      }
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "Between 2022 and 2023, Disney's strategic focus on cruise ships evolved with plans for additional expansion of its fleet, as noted in the 2023 filing. Capital investment plans included significant spending on new cruise ships as part of broader investments in the Parks, Experiences and Products segment. Operationally, Disney Cruise Line faced risks related to global economic conditions, travel disruptions, and the need to align with consumer preferences for out-of-home entertainment experiences, particularly in the context of recovering from the impacts of the pandemic and ensuring profitability amid rising costs and competitive pressures.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 51437,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13084,
        "completion_tokens": 161,
        "total_tokens": 13246
      }
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Between 2022 and 2024, Mastercard has continued to use short duration foreign exchange derivative contracts to manage foreign exchange risk arising from daily settlement activities. These contracts are employed to offset potential changes in the value of monetary assets and liabilities due to foreign exchange fluctuations, particularly given the short-term nature of settlement exposure, which typically lasts only a few days. The gains and losses from these non-designated derivative contracts are recorded in general and administrative expenses on the consolidated statements of operations, net of foreign currency gains and losses on related monetary assets and liabilities. The data shows that general and administrative expenses related to these contracts increased from $21 million in 2022 to $32 million in 2024, indicating a growing role for these instruments in managing settlement-related currency risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 106,
          "pages": [
            104,
            105,
            106,
            107,
            108
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61587,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15637,
        "completion_tokens": 228,
        "total_tokens": 15865
      }
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "From 2023 to 2024, Salesforce's strategic relationship with enterprise cloud companies has evolved with a stronger focus on AI integration and ecosystem expansion. In 2023, the company emphasized investments in enterprise cloud companies, technology startups, and system integrators, aiming to digitally transform industries and expand its solution ecosystem. By 2024, Salesforce had further integrated AI into its offerings, exemplified by the launch of Agentforce, an agentic layer for deploying autonomous AI agents across business functions. The company also enhanced its ecosystem integration through platforms like AppExchange and by deepening partnerships with developers, ISVs, and SIs to expand into new markets and industries. This shift reflects a strategic move toward leveraging AI and strengthening its ecosystem to drive innovation and customer value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CRM_10k_2023.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "CRM_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60057,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15240,
        "completion_tokens": 216,
        "total_tokens": 15456
      }
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, the company maintained a consistent methodology for developing accrual rates for vendor funding programs, but there was increased emphasis on sensitivity to projected purchase volumes. In both years, accrual rates were based on vendor agreement provisions, historical purchase trends, and periodic adjustments. However, in fiscal 2024, the documentation highlighted a greater awareness of the potential impact of actual purchase volumes differing from projections, particularly for graduated volume-based programs, which could affect amounts accrued and recorded financial results. This reflects a heightened focus on aligning accruals more closely with evolving purchase activity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41380,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10575,
        "completion_tokens": 179,
        "total_tokens": 10755
      }
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "From 2022 to 2024, the strategic relationship between Eli Lilly (LLY) and Boehringer Ingelheim (BI) regarding the Jardiance product has seen increased legal involvement and regulatory challenges. In 2022, BI initiated U.S. patent litigation against generic companies seeking to market generic versions of Jardiance, with Lilly not being a party to this litigation. By 2024, Jardiance was selected by the U.S. Department of Health and Human Services under the Inflation Reduction Act (IRA) to face a government-set price, effective in 2026, which will result in a 66% discount from the 2023 list price. Additionally, Jardiance has faced product liability lawsuits, with BI responsible for defending and indemnifying Lilly under their collaboration agreement. These developments highlight heightened legal and regulatory pressures impacting their collaborative dependency on Jardiance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48292,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12307,
        "completion_tokens": 220,
        "total_tokens": 12528
      }
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "From 2022 to 2023, Disney's capital investment strategy for cruise ships remained a significant component of its Parks & Experiences business, with continued emphasis on cruise ship acquisitions and fleet expansion. In 2022, the strategy included capital spending for new cruise ships and capital improvements, while in 2023, the focus remained on cruise ships as a principal area of investment, reflecting the broader strategy to enhance and expand the Disney Cruise Line offerings within the Parks & Experiences segment.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "DIS_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "DIS_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 48080,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12244,
        "completion_tokens": 130,
        "total_tokens": 12374
      }
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "Between 2022 and 2024, Mastercard Foundry has evolved from a platform for innovation experimentation to a more integrated and strategic driver of emerging technologies and fintech partnerships. In 2022, it focused on providing access to early-stage fintech players and innovation methodologies, while by 2024, it had expanded its role to support blockchain ecosystems, digital currencies, and the integration of future technologies into payment solutions, reflecting a stronger emphasis on scaling innovation and fostering deeper collaboration with fintechs and digital partners.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MA_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "MA_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46049,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11741,
        "completion_tokens": 144,
        "total_tokens": 11886
      }
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "The financial and strategic nature of the collaboration with Boehringer Ingelheim evolved notably between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures. In 2022, Jardiance, part of the collaboration, received regulatory designations such as Breakthrough Therapy and Fast Track for heart failure and chronic kidney disease. By 2024, the collaboration faced significant pricing pressures due to the Inflation Reduction Act (IRA), which set government prices for certain drugs under Medicare. Jardiance was selected as one of the first medicines subject to these price controls, with a 66% discount from its 2023 list price effective in 2026. This regulatory development marked a shift from focusing on accelerated approvals to addressing the financial impact of mandated price reductions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51463,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13097,
        "completion_tokens": 206,
        "total_tokens": 13304
      }
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "The strategic positioning of the CH-53K King Stallion heavy lift helicopter within Lockheed Martin's Rotary and Mission Systems (RMS) segment has evolved to emphasize its role in meeting international demand for heavy-lift capabilities. In 2023, the CH-53K program saw significant international interest, highlighted by the Israeli Ministry of Defense's procurement of 12 helicopters, with deliveries progressing through 2023. By 2024, the CH-53K continued to be a key component of RMS's international portfolio, supporting global customers and aligning with the segment's focus on expanding its presence in international markets through advanced, multi-mission platforms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48209,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12277,
        "completion_tokens": 168,
        "total_tokens": 12445
      }
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "The change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicates a strategic shift toward focusing on innovative therapies and expanding indications for existing products. For example, Jardiance's expanded use for heart failure and cardiovascular risk reduction reflects a move toward broader therapeutic applications beyond diabetes. This shift suggests both companies are prioritizing value-added differentiation in a competitive market, aiming to maintain market relevance amid biosimilar and generic competition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 7,
          "pages": [
            5,
            6,
            7,
            8,
            9
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50926,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12963,
        "completion_tokens": 143,
        "total_tokens": 13106
      }
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "The JASSM program's financial performance and strategic importance grew between 2023 and 2024. In 2023, JASSM contributed to a $145 million increase in MFC's net sales due to production ramp-up, and its operating profit benefited from favorable profit adjustments. By 2024, JASSM's production ramp-up continued, contributing to a $1.2 billion sales increase in tactical and strike missile programs. However, MFC's operating profit declined significantly in 2024 due to large losses on a classified program, though JASSM's contribution to backlog increased as orders for the program rose.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LMT_10k_2023.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "hop_2_rel": {
          "source_file": "LMT_10k_2024.pdf",
          "target_page": 40,
          "pages": [
            38,
            39,
            40,
            41,
            42
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46338,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11815,
        "completion_tokens": 146,
        "total_tokens": 11962
      }
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "JPM's focus in evaluating credit risk for Business Banking Loans has shifted between 2023 and 2024 to place greater emphasis on early-stage delinquency trends and geographic distribution as indicators of borrower distress. In 2023, the firm primarily relied on delinquency rates and LTV ratios to assess risk, with late-stage delinquencies (150+ days past due) being a strong indicator of potential defaults. By 2024, the firm highlighted that early-stage delinquencies (30+ days past due) serve as a more immediate warning sign of borrower distress, enabling earlier intervention. This shift implies a more proactive approach to identifying and addressing potential credit issues before they escalate, improving risk management and loss mitigation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 242,
          "pages": [
            240,
            241,
            242,
            243,
            244
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 250,
          "pages": [
            248,
            249,
            250,
            251,
            252
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47914,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12214,
        "completion_tokens": 187,
        "total_tokens": 12401
      }
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Based on the provided document pages, there is no explicit mention of changes to the terms of Target Corporation's SPP II (Stock Purchase Plan II) plan between the 2022 and 2023 filings. Both filings list the SPP II as \"Target Corporation SPP II (2016 Plan Statement) (as amended and restated effective April 3, 2016)\" without indicating any further amendments in 2023. This suggests that the company maintained a stable executive compensation framework during this period, with no material changes to the SPP II structure. It reflects a continuity in Target's approach to executive compensation, relying on previously established plans rather than introducing new terms in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TGT_10k_2022.pdf",
          "target_page": 68,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "hop_2_rel": {
          "source_file": "TGT_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            65,
            66,
            67,
            68,
            69
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 26880,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6946,
        "completion_tokens": 169,
        "total_tokens": 7116
      }
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "The financial obligations related to Incyte under the Olumiant collaboration evolved as follows from 2022 to 2024: In 2022, Incyte was eligible to receive up to $100.0 million in additional regulatory milestone payments and up to $100.0 million in sales-based milestones. By 2024, no new material milestone payments to Incyte were recognized, indicating that either the potential future milestones had not been triggered or the amounts involved were not significant. Royalty payments to Incyte continued, with tiered rates up to 20% on worldwide net sales of Olumiant, including an additional royalty for COVID-19 treatments exceeding a specified sales threshold.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 73,
          "pages": [
            71,
            72,
            73,
            74,
            75
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 40221,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10281,
        "completion_tokens": 165,
        "total_tokens": 10447
      }
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "Cisco's financial exposure in the APJC region increased between fiscal 2022 and fiscal 2023. In fiscal 2022, APJC revenue was $8,027 million, rising to $8,208 million in fiscal 2023, reflecting growth in the region. Additionally, goodwill attributed to the APJC segment increased from $5,382 million in fiscal 2022 to $8,208 million in fiscal 2023, primarily driven by acquisitions, including the Splunk acquisition in fiscal 2024. This indicates an expanded financial commitment and strategic investment in the APJC region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 105,
          "pages": [
            103,
            104,
            105,
            106,
            107
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41020,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10478,
        "completion_tokens": 131,
        "total_tokens": 10609
      }
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "The strategic collaboration between LLY and Boehringer Ingelheim regarding Jardiance has evolved in response to regulatory changes, particularly the Inflation Reduction Act of 2022 (IRA). In 2023, the U.S. Department of Health and Human Services selected Jardiance for government-set pricing, effective in 2026, with a 66% discount from the 2023 list price. This regulatory development, part of broader pricing reforms, has influenced LLY's business strategies, accelerating revenue erosion for Jardiance prior to the expiration of its exclusivity. The collaboration remains critical as both companies navigate the impact of reduced Medicare pricing and potential effects on Medicaid and 340B drug pricing programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LLY_10k_2022.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "hop_2_rel": {
          "source_file": "LLY_10k_2024.pdf",
          "target_page": 45,
          "pages": [
            43,
            44,
            45,
            46,
            47
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41282,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10546,
        "completion_tokens": 178,
        "total_tokens": 10725
      }
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "Between 2022 and 2023, GM's emphasis on the financial and reputational risks of product safety recalls, particularly concerning global platforms like the Chevrolet Bolt EV, showed a heightened focus on the broader implications of recalls on its EV/AV positioning. In 2022, the risks were discussed in the context of general product safety and the potential for recalls to impact brand equity and consumer trust, especially with advanced technologies. By 2023, the discussion expanded to explicitly reference the Chevrolet Bolt EV recall as an example of how global platform recalls can exacerbate costs and reputational damage. Additionally, GM emphasized the challenges of managing safety and security risks in AVs and connected vehicles, reflecting a more strategic alignment with its evolving role in the EV/AV market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2022.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56670,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14410,
        "completion_tokens": 205,
        "total_tokens": 14615
      }
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "Between 2022 and 2024, Costco's Japanese subsidiary issued Guaranteed Senior Notes totaling approximately $500 in November 2023, with fixed interest rates ranging from 1.400% to 2.120% and maturities extending to 2043. In July 2024, the subsidiary repaid $77 of these notes. This evolution indicates that Costco is utilizing long-term financing through its international operations, likely to manage debt maturities and optimize its capital structure by accessing favorable interest rates in foreign markets. The repayment of a portion of the debt also suggests active management of its liabilities to maintain financial flexibility.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 29993,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 7728,
        "completion_tokens": 158,
        "total_tokens": 7886
      }
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "The value of Cisco's available-for-sale debt investments decreased from $15,592 million in 2023 to $9,865 million in 2024, a reduction of $5,727 million. This significant decline indicates that Cisco likely liquidated a portion of its investment portfolio, potentially to fund the acquisition of Splunk and other strategic initiatives, reflecting a shift in capital allocation toward major acquisitions and operational needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CSCO_10k_2022.pdf",
          "target_page": 49,
          "pages": [
            47,
            48,
            49,
            50,
            51
          ]
        },
        "hop_2_rel": {
          "source_file": "CSCO_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49381,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12570,
        "completion_tokens": 106,
        "total_tokens": 12676
      }
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "JPMorgan Chase's exposure to system damage risks, particularly from third-party vendor attacks and data recovery challenges, has evolved from 2023 to 2024 with increased emphasis on proactive measures and heightened awareness of emerging threats. In 2023, the company highlighted the risks of third-party vendor vulnerabilities and the potential for operational disruptions due to cyberattacks or system failures. By 2024, JPMorgan Chase expanded its focus to include more specific strategies for mitigating these risks, such as enhancing early detection of attacks on third-party vendors, improving oversight of vendor cybersecurity, and strengthening controls for secure software development and identity management. Additionally, the company emphasized the need for ongoing adaptation to evolving threats, including ransomware and zero-day vulnerabilities, and the importance of integrating acquired businesses with robust cybersecurity frameworks to address data recovery challenges effectively.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "JPM_10k_2023.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "JPM_10k_2024.pdf",
          "target_page": 27,
          "pages": [
            25,
            26,
            27,
            28,
            29
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52318,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13305,
        "completion_tokens": 249,
        "total_tokens": 13555
      }
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "Costco has made operational investments in processing, packaging, and manufacturing facilities to support the production of private-label items, as mentioned in the 2024 filing. These investments align with the private-label growth strategy outlined in the 2022 filing, which emphasized increasing the penetration of private-label products as part of its merchandising and pricing strategies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "COST_10k_2022.pdf",
          "target_page": 22,
          "pages": [
            20,
            21,
            22,
            23,
            24
          ]
        },
        "hop_2_rel": {
          "source_file": "COST_10k_2024.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 80579,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20361,
        "completion_tokens": 98,
        "total_tokens": 20459
      }
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group's approach to Medicaid managed care contract bidding remained centered on assumptions regarding enrollment, utilization, medical costs, and other factors. However, the 2023 filing highlights increased risks associated with bid accuracy, including unforeseen changes to programs, implementation of material policy changes after bid submission, and competitive pressures from lower bids by competitors. These risks could lead to material adverse effects on the company's results of operations, financial position, and cash flows. The evolution reflects a growing emphasis on the potential volatility and uncertainty in the bidding environment, particularly as state Medicaid programs continue to refine their processes and payment mechanisms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 20,
          "pages": [
            18,
            19,
            20,
            21,
            22
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59571,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15123,
        "completion_tokens": 195,
        "total_tokens": 15318
      }
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "Based on the provided information, MET's investment in Municipals remained relatively stable in terms of estimated fair value from 2022 to 2023. In 2022, the estimated fair value of Municipals was $14,212 million, and in 2023, it was $14,212 million as well. In terms of valuation hierarchy classification, Municipals were primarily classified under Level 2 in both 2023 and 2022, with no significant Level 3 components reported for either year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 70876,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17937,
        "completion_tokens": 111,
        "total_tokens": 18049
      }
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "From fiscal year 2022 to 2024, Microsoft has enhanced licensing flexibility and customer agreement models for Office 365 by introducing more streamlined and customer-centric options. In 2022, Office 365 revenue was recognized ratably over the contract period, with licensing tied to volume agreements and Software Assurance (SA). By 2024, Microsoft expanded its Microsoft Customer Agreement (MCA) and Microsoft Online Subscription Agreement (MOSA) to provide simplified, non-expiring digital agreements, enabling seamless subscription management for small, medium, and large organizations. These changes reflect a shift toward flexible, scalable, and digitally accessible licensing models to better meet evolving customer needs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 33643,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8635,
        "completion_tokens": 182,
        "total_tokens": 8817
      }
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "Between 2022 and 2023, the composition of MET's Level 3 Fixed Maturity Securities AFS changed from $967 million in 2022 to $904 million in 2023, indicating a reduction in investments in assets with little or no price transparency, such as private equity and real estate funds. This shift suggests a potential adjustment in the company's investment strategy toward reducing exposure to less liquid and more volatile assets, possibly to enhance portfolio stability and align with long-term funding objectives for employee benefit plans.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 307,
          "pages": [
            305,
            306,
            307,
            308,
            309
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63970,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16221,
        "completion_tokens": 133,
        "total_tokens": 16354
      }
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "Between 2022 and 2024, Microsoft has further integrated Office 365 into its broader cloud services portfolio, emphasizing its role as a core component of its AI-driven strategy. Office 365 is now deeply interdependent with cloud services, with revenue recognized ratably over the service period due to its integration with desktop applications and cloud infrastructure. In response to competitive pressures from AI-driven offerings, Microsoft has infused generative AI capabilities into Office 365 and other products, positioning it as a key platform for productivity and collaboration in the AI era. This evolution reflects Microsoft's focus on leveraging AI to enhance cloud-based services and maintain competitiveness in a rapidly evolving market.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45703,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11668,
        "completion_tokens": 187,
        "total_tokens": 11855
      }
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "Between 2022 and 2023, UnitedHealth Group maintained a consistent approach to evaluating credit-related impairments, primarily focusing on the present value of expected cash flows relative to amortized cost, the issuer's financial condition, and the Company's intent to hold or sell impaired securities. In both years, the Company noted no significant credit deterioration in its investment portfolio and did not record material credit-related impairments. The methodology for identifying and measuring impairments remained unchanged, with unrealized losses attributed largely to interest rate fluctuations rather than credit quality issues. As a result, the financial impact of credit-related impairments remained immaterial in both periods.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNH_10k_2022.pdf",
          "target_page": 57,
          "pages": [
            55,
            56,
            57,
            58,
            59
          ]
        },
        "hop_2_rel": {
          "source_file": "UNH_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54785,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13927,
        "completion_tokens": 185,
        "total_tokens": 14113
      }
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "From 2022 to 2023, the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans showed slight changes. For pension benefits, the total estimated fair value of Fixed Maturity Securities AFS decreased from $6,802 million in 2022 to $6,714 million in 2023. In terms of allocation, the Level 2 category (primarily liquid and marketable securities) decreased from $5,091 million in 2022 to $4,924 million in 2023, while Level 1 (directly held investments) decreased from $1,653 million to $1,726 million. For other postretirement benefits, the total estimated fair value of Fixed Maturity Securities AFS remained relatively stable, decreasing slightly from $1,256 million in 2022 to $1,274 million in 2023, with most assets categorized under Level 2.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 305,
          "pages": [
            303,
            304,
            305,
            306,
            307
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66268,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16791,
        "completion_tokens": 200,
        "total_tokens": 16991
      }
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "Between 2022 and 2023, Lowe's strategic positioning of the Kitchens & Bath product category evolved by integrating it more deeply into its omnichannel and Pro customer strategies. In 2022, Kitchens & Bath was highlighted as part of the installed sales model and protection plans, emphasizing its role in complex, customer-focused projects. By 2023, the category was further emphasized in product assortment and localization efforts, reflecting its importance in serving both DIY and DIFM customers. This evolution suggests that Kitchens & Bath has become a more central part of Lowe's product portfolio, supporting its Total Home strategy and enhancing customer solutions across channels.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "LOW_10k_2022.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "hop_2_rel": {
          "source_file": "LOW_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43743,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11168,
        "completion_tokens": 172,
        "total_tokens": 11340
      }
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "Mondelez International's strategic focus on Cheese & Grocery between 2022 and 2024 has remained part of its broader portfolio of adjacent, locally relevant categories, but it has not been highlighted as a primary growth driver. The 2024 10-K emphasizes the company's core focus on chocolate, biscuits, and baked snacks, with Cheese & Grocery mentioned as a supporting category. The company's strategic priorities continue to center on accelerating consumer-centric growth and operational excellence across its core snacking businesses. This suggests that while Cheese & Grocery is part of Mondelez's diversified offerings, the company is prioritizing its high-growth core snack categories—such as baked snacks and confectionery—for long-term value creation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 136,
          "pages": [
            127,
            128,
            129,
            130,
            131
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46933,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11967,
        "completion_tokens": 189,
        "total_tokens": 12156
      }
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "Between the 2022 and 2023 10-K filings, Abbott's presentation of its enteral feeding product lineup remained largely consistent, with both years listing Jevity and Freego™ products as part of the Nutritional Products segment. However, in the 2023 filing, Freego™ is explicitly mentioned as an enteral pump and its associated sets, whereas in 2022, it was grouped more generically with other enteral feeding products without specific emphasis on the pump functionality. This subtle shift in 2023 highlights Freego™'s role as a more distinct and technologically specific offering within Abbott's enteral feeding portfolio.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 3,
          "pages": [
            1,
            2,
            3,
            4,
            5
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45040,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11487,
        "completion_tokens": 155,
        "total_tokens": 11642
      }
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "From 2022 to 2023, MET's investment in municipals showed an increase in fair value, rising from $14,212 million in 2022 to $14,642 million in 2023, as reflected in the fair value of fixed maturity securities AFS. The classification of municipals remained as available-for-sale (AFS) in both years, with no allowance for credit losses reported. This suggests that MET's credit risk management strategy involves maintaining a diversified portfolio of investment-grade securities, with municipals being a stable component with low credit risk. The absence of credit losses and the consistent AFS classification indicate that the company is managing its credit risk by investing in securities with strong credit quality and holding them for long-term value.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MET_10k_2022.pdf",
          "target_page": 219,
          "pages": [
            217,
            218,
            219,
            220,
            221
          ]
        },
        "hop_2_rel": {
          "source_file": "MET_10k_2023.pdf",
          "target_page": 308,
          "pages": [
            306,
            307,
            308,
            309,
            310
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67111,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17010,
        "completion_tokens": 188,
        "total_tokens": 17199
      }
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Between 2022 and 2023, Abbott's use of interest rate hedge contracts decreased from approximately $2.9 billion to $2.2 billion, primarily due to the maturity of $700 million of contracts in 2023 alongside corresponding long-term debt maturities. These contracts, designated as fair value hedges, were used to manage exposure to changes in the fair value of fixed-rate debt caused by fluctuations in long-term benchmark interest rates. The reduction in notional value reflects a strategic adjustment in fixed-rate debt management, aligning hedge positions with the company's evolving debt profile.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 64,
          "pages": [
            62,
            63,
            64,
            65,
            66
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56485,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14349,
        "completion_tokens": 149,
        "total_tokens": 14498
      }
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "Between 2022 and 2024, 3M's issuance and management of fixed-rate registered notes evolved with notable repayment activity and interest rate strategies. In 2022, 3M repaid $600 million of fixed-rate medium-term notes and 500 million euros of fixed-rate notes. In 2023, the company repaid $500 million of fixed-rate registered notes, $650 million of fixed-rate medium-term notes, and 600 million euros of fixed-rate medium-term notes. In 2024, 3M repaid $1.1 billion of medium-term notes. Additionally, 3M used interest rate swaps to convert portions of its fixed-rate notes into floating rate debt, such as $500 million and $300 million of fixed-rate notes due in 2049 and 2050, respectively, into floating rate debt through mid-2028. This strategy helped manage interest rate risk and align with market conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2022.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 58144,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14762,
        "completion_tokens": 203,
        "total_tokens": 14966
      }
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "Between 2023 and 2024, the role of securities issuances in Schwab's capital structure evolved as part of its broader capital management and funding strategy. In 2023, Schwab relied on securities issuances, including preferred stock offerings and senior unsecured debt, to support its capital needs and maintain regulatory compliance. However, in 2024, Schwab reduced its reliance on external securities issuances, as reflected in a net reduction of bank supplemental funding and a significant decrease in brokered CDs. Instead, Schwab leveraged increased client sweep cash and investment securities inflows to meet liquidity needs, aligning with its strategy to optimize funding sources and manage capital efficiently amid shifting interest rate environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 59,
          "pages": [
            57,
            58,
            59,
            60,
            61
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 52,
          "pages": [
            50,
            51,
            52,
            53,
            54
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52226,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13288,
        "completion_tokens": 189,
        "total_tokens": 13478
      }
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "Coca-Cola's contingent payment obligations related to fairlife increased significantly from 2022 to 2024, rising from $270 million to $6,126 million. This substantial increase indicates that fairlife outperformed its financial targets during this period, as the contingent consideration is tied to fairlife achieving specific financial milestones through 2024. The higher valuation of the contingent liability suggests stronger-than-expected operating results and performance, leading to an upward revision in the estimated payment obligation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 75,
          "pages": [
            73,
            74,
            75,
            76,
            77
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53383,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13576,
        "completion_tokens": 135,
        "total_tokens": 13712
      }
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) between 2022 and 2024 has evolved to strengthen its global market positioning and integration with enterprise IT solutions. In 2022, Oracle highlighted growth in cloud services and license support revenues, driven by customer demand for cloud-based applications and infrastructure technologies. By 2024, Oracle further emphasized Oracle Cloud Services (OCI and SaaS) as comprehensive, integrated offerings, enabling customers to choose deployment models that best meet their business needs. This shift reflects a broader strategy to position OCI as a central component of enterprise IT environments, supporting both cloud-based and hybrid deployments while enhancing customer access to Oracle's applications and infrastructure technologies.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52539,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13370,
        "completion_tokens": 201,
        "total_tokens": 13571
      }
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Between 2023 and 2024, the treatment and risk profile of PALs (Pledged Asset Lines) showed improvements in credit quality and collateralization. The credit loss allowance for PALs remained at zero for both years, as all PALs were fully collateralized by securities with fair values exceeding the borrowings. In 2024, the Company continued to apply the collateral maintenance practical expedient under ASC 326, which allowed it to forgo an allowance for credit losses since the collateral coverage was sufficient. Additionally, the risk profile improved, with no allowance required and no PAL balances charged off, reflecting strong collateralization and low credit risk.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "SCHW_10k_2023.pdf",
          "target_page": 146,
          "pages": [
            143,
            144,
            145,
            146,
            147
          ]
        },
        "hop_2_rel": {
          "source_file": "SCHW_10k_2024.pdf",
          "target_page": 88,
          "pages": [
            86,
            87,
            88,
            89,
            90
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59496,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15096,
        "completion_tokens": 167,
        "total_tokens": 15264
      }
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Between fiscal years 2023 and 2024, Nike's relationship with the Asia Pacific & Latin America (APLA) region showed growth in revenue, increasing from $6,431 million in 2023 to $6,729 million in 2024. Operationally, APLA remained one of Nike's four primary geographic operating segments, alongside North America, EMEA, and Greater China, indicating a continued strategic emphasis on the region. The operational structure remained consistent, with APLA focusing on the design, development, marketing, and selling of athletic footwear, apparel, and equipment. Additionally, Nike's strategic focus on direct-to-consumer sales is evident in APLA, with direct-to-consumer revenue growing from $2,695 million in 2023 to $2,799 million in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54589,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13879,
        "completion_tokens": 184,
        "total_tokens": 14063
      }
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "Between 2022 and 2023, Abbott emphasized growth in its U.S. Pediatric Nutritionals business, with Pedialyte playing a key role. In 2022 (as shown in the 2023 10-K), U.S. Pediatric Nutritionals sales increased by 10%, driven by growth in Pedialyte, Similac, and PediaSure. By 2023, the company continued to highlight Pedialyte's importance, maintaining its position as a core product within the U.S. Pediatric Nutritionals portfolio, although specific growth figures for 2023 were not provided in the excerpts. This suggests a sustained strategic focus on Pedialyte as a key driver of the segment's performance.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ABT_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "ABT_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48187,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12278,
        "completion_tokens": 152,
        "total_tokens": 12430
      }
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "RTX's 7.100% notes due 2027 had an aggregate principal balance of $135 million in both 2023 and 2022, indicating no change in the outstanding amount during this period. This suggests that RTX did not refinance or repay these specific notes in 2023, and they remain part of its long-term debt structure. The consistency in the balance implies a stable approach to managing this particular debt obligation, with no immediate refinancing activity observed, reflecting a strategy of maintaining existing debt until maturity.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43217,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11027,
        "completion_tokens": 130,
        "total_tokens": 11157
      }
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Between fiscal 2023 and fiscal 2024, Converse experienced a 14% decline in total revenues on a currency-neutral basis, driven by decreases in both North America and Western Europe, with wholesale revenues dropping 16% and direct-to-consumer revenues falling 14%. Earnings before interest and taxes (EBIT) for Converse decreased by 30%, primarily due to lower revenues, gross margin contraction from unfavorable currency exchange rates and increased promotional activity, and partially offset by lower operating overhead expenses. This indicates a challenging period for Converse in terms of both revenue performance and profitability compared to the prior fiscal year.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50293,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12792,
        "completion_tokens": 167,
        "total_tokens": 12959
      }
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "Coca-Cola has increased its emphasis on digital evolution as a critical factor influencing sales growth and margin improvement from 2022 to 2024. In 2022, the company acknowledged the impact of digital transformation on consumer shopping patterns but did not explicitly link it to margin pressures. By 2024, the company explicitly stated that its ability to digitalize operations—through data, AI, automation, and digital tools—is essential for increasing sales and improving margins. The 2024 filing also highlights that failure to digitalize could not only hinder growth and margin improvement but also result in significant financial costs due to the investment already made in digital initiatives. This reflects a more direct and heightened recognition of digital evolution as a financial risk and strategic imperative.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 19,
          "pages": [
            17,
            18,
            19,
            20,
            21
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 58442,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14838,
        "completion_tokens": 205,
        "total_tokens": 15043
      }
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "Oracle's strategic emphasis on Oracle Cloud Services has intensified from fiscal year 2022 to 2024, with a notable increase in research and development investment. In fiscal 2022, Oracle invested $7.2 billion in R&D, and this trend of prioritizing innovation continued through 2024, as reflected in the ongoing development of Oracle Cloud Infrastructure (OCI) and SaaS offerings. Oracle has positioned its cloud offerings as a preferred, flexible, and cost-effective alternative to on-premise solutions, emphasizing rapid deployment, interoperability, and ease of migration. The company has actively encouraged customers to transition from on-premise to cloud-based models, offering programs to facilitate migrations and expand cloud adoption, signaling a clear shift in strategic focus toward cloud services.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48939,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12476,
        "completion_tokens": 202,
        "total_tokens": 12678
      }
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors' Formula Stock Award Plan had 509 shares remaining available for future issuance as of December 31, 2023, and no shares were available for future issuance as of December 31, 2024. This indicates that all remaining shares under the plan were either issued or the plan was formally closed, as no future awards or deferrals will be made under this plan.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "WFC_10k_2023.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "WFC_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 59649,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15131,
        "completion_tokens": 96,
        "total_tokens": 15227
      }
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "Between 2022 and 2023, McDonald's expanded its disclosure on food safety concerns, particularly in relation to supply chain risks and cost volatility. In 2022, the company highlighted that food safety concerns contribute to volatility in commodity markets, which can impact restaurant profitability. By 2023, the disclosure became more detailed, emphasizing the company's proactive measures to ensure food safety across evolving supply chains and operations, while also acknowledging the potential for food-borne illness events to affect brand reputation and financial results. Additionally, 2023's report explicitly connected food safety with broader supply chain challenges, including the risks of contamination or tampering in the supply chain, restaurants, or delivery systems. This evolution reflects a heightened focus on transparency and risk management in response to increasing stakeholder and regulatory scrutiny.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 66162,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16763,
        "completion_tokens": 230,
        "total_tokens": 16994
      }
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "The carrying value of TMO's 1.750% 7-Year Senior Notes decreased from $662 million as of December 31, 2023, to $621 million as of December 31, 2024. The effective interest rate for these notes also slightly decreased from 1.97% in 2023 to 1.96% in 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56701,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14387,
        "completion_tokens": 63,
        "total_tokens": 14450
      }
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX's exposure to its 7.000% notes due 2038 remained unchanged at $148 million between 2022 and 2023, as noted in the long-term debt tables from both years. This suggests that RTX did not refinance or retire these specific long-term debt instruments during the period, indicating a strategy of maintaining existing long-term debt maturities rather than altering them in the short term.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 94,
          "pages": [
            92,
            93,
            94,
            95,
            96
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 85,
          "pages": [
            83,
            84,
            85,
            86,
            87
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44968,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11467,
        "completion_tokens": 96,
        "total_tokens": 11563
      }
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "Between 2022 and 2023, McDonald's financial relationship with its franchisees remained stable, with consistent collection of rent and royalties. In 2021, the company had deferred approximately $1 billion in rent and royalty collections due to the impact of the pandemic, but had collected substantially all of these deferrals by the end of 2021. For 2022 and 2023, there is no indication of further deferrals or disruptions in collections. Revenues from franchised restaurants, including rents and royalties, increased in 2023 compared to 2022, reflecting continued strong performance and recovery in franchisee sales.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50548,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12859,
        "completion_tokens": 154,
        "total_tokens": 13013
      }
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "The Coca-Cola Company's financial stake in Embotelladora Andina S.A. (Andina) decreased in 2019 when the company sold a portion of its ownership interest, as mentioned in the 2022 10-K filing. However, the company continued to account for its remaining ownership interest in Andina as an equity method investment due to its representation on Andina's Board of Directors and other governance rights. The 2024 10-K filing does not indicate any further changes to the stake in Andina. This suggests that The Coca-Cola Company has strategically maintained its equity investment in Andina to preserve influence and governance rights, even after reducing its ownership stake. The continued use of the equity method indicates that the company still views Andina as a strategically important partner in the region.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "KO_10k_2022.pdf",
          "target_page": 76,
          "pages": [
            74,
            75,
            76,
            77,
            78
          ]
        },
        "hop_2_rel": {
          "source_file": "KO_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53813,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13690,
        "completion_tokens": 201,
        "total_tokens": 13891
      }
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "Oracle's strategic investment in cloud infrastructure from 2022 to 2024 has shown a continued emphasis on internal development and positioning Oracle Cloud Infrastructure (OCI) as a central component of its product portfolio. In 2022, Oracle highlighted its focus on internal development, maintaining technical control over product design and innovation, while expanding the Oracle Cloud through increased data center capacity and new geographic locations. By 2024, Oracle further solidified OCI's role as a secure, scalable, and enterprise-grade cloud platform, emphasizing its integration with Oracle Cloud Software-as-a-Service (SaaS) offerings to provide comprehensive cloud solutions. Additionally, Oracle's financial investments in capital expenditures, such as the $6.866 billion in 2024, reflect sustained commitment to infrastructure expansion and technological advancement.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 49374,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12582,
        "completion_tokens": 220,
        "total_tokens": 12803
      }
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "Between 2023 and 2024, TMO's involvement with The Binding Site Group evolved from its acquisition in early 2023 to integration within the Specialty Diagnostics segment. The acquisition in 2023 expanded the segment's portfolio with innovative diagnostic solutions for blood cancers and immune disorders. By 2024, the company emphasized the successful integration of The Binding Site Group, as evidenced by the absence of significant transitional costs and the focus on leveraging synergies. This indicates TMO's strategic focus on enhancing its diagnostic capabilities and realizing operational efficiencies post-acquisition.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "TMO_10k_2023.pdf",
          "target_page": 24,
          "pages": [
            22,
            23,
            24,
            25,
            26
          ]
        },
        "hop_2_rel": {
          "source_file": "TMO_10k_2024.pdf",
          "target_page": 65,
          "pages": [
            63,
            64,
            65,
            66,
            67
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51724,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13160,
        "completion_tokens": 156,
        "total_tokens": 13316
      }
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "Between 2022 and 2024, the disclosure of the Directors' Code of Conduct remained consistent in its scope, as it continued to apply to all directors of BNY Mellon. However, there were changes in the accessibility of the document through website links. In 2022, the Directors' Code of Conduct was posted at *https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf*, while in 2024, the link was updated to *https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf*. This suggests a rebranding or restructuring of the website domain or directory path, but the commitment to public accessibility remained unchanged.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36067,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9242,
        "completion_tokens": 176,
        "total_tokens": 9419
      }
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "Between 2022 and 2023, McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis by increasing the number of franchised restaurants and placing a stronger focus on technology and brand licensing. The total franchised restaurants rose from 38,169 in 2022 to 39,680 in 2023, while company-operated restaurants decreased from 2,106 to 2,142. Financially, the Company recognized more revenue from franchisees through fees for technology platforms and brand licensing, which were reported on a gross basis. Additionally, the Company emphasized cost-sharing with franchisees for restaurant improvements, maintaining control over project management and funding.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MCD_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MCD_10k_2023.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 67922,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17198,
        "completion_tokens": 175,
        "total_tokens": 17373
      }
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "The contingent consideration liabilities related to the Clif Bar acquisition increased from $452 million as of December 31, 2022, to $548 million as of December 31, 2023. This increase reflects adjustments in fair value based on updated financial projections and assumptions, including net revenue, gross profit, EBITDA, discount rates, and volatility. The fair value measurement remained classified under Level 3 inputs, indicating the use of unobservable factors and a Monte Carlo simulation model. No specific adjustments to the Clif Bar contingent consideration liability are noted for 2024, as the liability balance remained at $548 million, suggesting stable assumptions or performance expectations through the end of 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 99,
          "pages": [
            97,
            98,
            99,
            100,
            101
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47068,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12012,
        "completion_tokens": 182,
        "total_tokens": 12195
      }
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "Between 2022 and 2024, AMD's strategic emphasis on Vulkan API support has evolved to align with its broader focus on delivering high-performance, cross-platform graphics solutions for gaming and professional markets. In 2022, AMD's discrete GPUs were already supporting current-generation APIs like DirectX 12 Ultimate and Vulkan, emphasizing their role in enabling immersive gaming and visualization. By 2024, the company continued to highlight Vulkan support for its Radeon RX 7000 Series GPUs, which are based on the RDNA 3 architecture, underscoring its commitment to modern API compatibility for both gaming and compute workloads. This consistent support for Vulkan reflects AMD's strategy to maintain competitiveness in the discrete GPU market by ensuring developers can leverage efficient, cross-platform rendering technologies to optimize performance across a wide range of applications and platforms.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 47469,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12096,
        "completion_tokens": 227,
        "total_tokens": 12323
      }
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX's integration-related charges, particularly the Powder Metal Matter charge of $2.9 billion in 2023, significantly impacted its operating profit trends, contributing to a $1.9 billion decrease in operating profit compared to 2022. This charge, primarily at Pratt & Whitney, was a major factor in the decline in operating profit margin from 8.2% in 2022 to 5.2% in 2023. The impact was partially offset by increases in operating profit at Collins and Raytheon.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2022.pdf",
          "target_page": 51,
          "pages": [
            49,
            50,
            51,
            52,
            53
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54965,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13969,
        "completion_tokens": 115,
        "total_tokens": 14085
      }
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "MDLZ's relationship with Clif Bar in terms of acquisition-related financial activities shows that the Clif Bar acquisition, completed in August 2022, contributed incrementally to net revenues in 2023, adding $507 million through the one-year anniversary of the acquisition. Additionally, in 2023, there were purchase price allocation adjustments related to Clif Bar, as noted in the footnotes. However, there is no indication of further acquisition-related activities with Clif Bar in 2024, as the 2024 purchase price allocation adjustments were related to Evirth, not Clif Bar.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 41,
          "pages": [
            39,
            40,
            41,
            42,
            43
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 48436,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12328,
        "completion_tokens": 144,
        "total_tokens": 12472
      }
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "From 2023 to 2024, Gulfstream's approach to energy-efficient engines has advanced with the introduction of all-new engines in its latest aircraft models, such as the G700, which entered service in early 2024. These engines contribute to superior high-speed performance and improved fuel efficiency. Additionally, Gulfstream has continued to prioritize sustainability by expanding the use of sustainable aviation fuel (SAF), including conducting the world's first transatlantic flight using 100% SAF in November 2023. This reflects a broader commitment to reducing carbon emissions and enhancing energy efficiency across its aircraft development and operations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GD_10k_2023.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "GD_10k_2024.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 32123,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 8247,
        "completion_tokens": 165,
        "total_tokens": 8412
      }
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "From 2022 to 2024, AMD's semi-custom SoC products have evolved from being a revenue source dependent on third-party design and development services to a more integrated part of its strategic positioning in custom and semi-custom solutions. In 2022, revenue from semi-custom SoC products was primarily tied to non-recurring engineering fees and sales to third parties, with success hinging on customer product adoption. By 2024, AMD emphasized custom product revenue recognition methods, including cost-based input methods for in-process orders, reflecting a more structured approach to custom and semi-custom solutions. Strategically, AMD has positioned semi-custom SoCs as part of broader offerings, including AI accelerators and adaptive SoCs, aligning with industry transitions and customer demand for tailored semiconductor solutions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMD_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "AMD_10k_2024.pdf",
          "target_page": 62,
          "pages": [
            60,
            61,
            62,
            63,
            64
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43101,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10997,
        "completion_tokens": 209,
        "total_tokens": 11207
      }
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The company's preferred share authorization remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares authorized at $0.20 par value and 500 thousand A Preferred Shares authorized at $1.00 par value, and no shares issued or outstanding in either year. This consistency suggests that the company has not utilized preferred shares as part of its capital-raising strategy during this period, instead focusing on other forms of capital management such as ordinary share repurchases and stock-based compensation programs.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDT_10k_2023.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "hop_2_rel": {
          "source_file": "MDT_10k_2024.pdf",
          "target_page": 81,
          "pages": [
            79,
            80,
            81,
            82,
            83
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 46293,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11798,
        "completion_tokens": 137,
        "total_tokens": 11935
      }
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "Between 2022 and 2024, the framing of reputational risk related to adverse publicity in BK's risk disclosures has evolved to include broader and more specific linked concerns. In 2022, the risk was mentioned as a general concern about adverse events, publicity, or government scrutiny harming the business. By 2024, the disclosure expanded to explicitly link reputational harm with impacts from cybersecurity incidents, operational failures, and sustainability concerns, including climate change and diversity issues, indicating a more nuanced understanding of interconnected risks.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 41015,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10482,
        "completion_tokens": 145,
        "total_tokens": 10627
      }
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "Amazon's financial investment and valuation approach toward Anthropic, PBC evolved from 2023 to 2024 as follows: In 2023, Amazon invested in a $1.25 billion convertible note from Anthropic, classified as available-for-sale and reported at fair value with unrealized gains and losses in accumulated other comprehensive income. By 2024, the investment remained classified similarly, with valuations of private companies like Anthropic being inherently complex due to the lack of market data and global economic uncertainty. Factors affecting its valuation included observable price changes, impairments, and adjustments to fair value, with the investment's complexity and volatility increasing due to macroeconomic conditions.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AMZN_10k_2023.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "hop_2_rel": {
          "source_file": "AMZN_10k_2024.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37626,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9641,
        "completion_tokens": 181,
        "total_tokens": 9822
      }
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "The nature of the risks related to the protection of MDLZ's intellectual property, including know-how, has remained consistent between 2023 and 2024. In both years, the company emphasizes its reliance on a combination of legal protections (patents, trademarks, copyrights, trade secrets) and contractual measures (licensing agreements, nondisclosure agreements) to safeguard its intellectual property. The 2024 filing adds a specific mention of potential challenges arising from developments in artificial intelligence technologies, highlighting the evolving threat landscape. However, no significant new risks or changes in the nature of these risks are identified in 2024 compared to 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2024.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56078,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14239,
        "completion_tokens": 172,
        "total_tokens": 14412
      }
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "Goldman Sachs updated its treatment of Non-Employee Director Equity Award Agreements between 2023 and 2024, with the 2024 filing introducing more specific and varied agreement forms. In 2023, the referenced agreements included general forms such as the \"Form of Non-Employee Director RSU Award Agreement\" and \"Form of Non-Employee Director RSU Award Agreement (Cash-Settled).\" By 2024, the filings expanded to include additional forms such as \"Form of One-Time/Year-End RSU Award Agreement,\" \"Form of One-Time/Year-End RSU Award Agreement (fully vested),\" and \"Form of One-Time/Year-End RSU Award Agreement (Base (not fully vested) and/or Supplemental).\" This evolution reflects a more detailed and differentiated approach to equity awards for non-employee directors in 2024 compared to the more generalized forms referenced in 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41486,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10604,
        "completion_tokens": 208,
        "total_tokens": 10812
      }
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "Between 2022 and 2023, BKNG's relationship with travel service providers evolved in terms of revenue recognition and contractual responsibilities as the company continued to increase the share of transactions processed on a merchant basis. This shift allows BKNG to facilitate payments from travelers directly, enhancing its ability to offer flexible transaction terms. However, it also led to higher expenses related to payment processing, chargebacks, and fraud prevention, which negatively impacted operating margins. Contractual responsibilities remained on a net basis for most transactions, with revenues measured based on expected consideration from contracts with travel service providers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 83,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 44290,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11295,
        "completion_tokens": 174,
        "total_tokens": 11469
      }
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "Goldman Sachs revised the structure of its executive life insurance policy disclosures by consolidating and updating the relevant exhibits in the 2024 10-K compared to the 2023 10-K. Specifically, in the 2024 filing, the executive life insurance policies are presented under a more streamlined format, with detailed policy specifications and restrictions included in a single exhibit (Exhibit 10.12 and 10.13). In contrast, the 2023 filing references these policies in a less structured manner without explicitly detailing the policy terms in the exhibit descriptions. This change reflects a more transparent and centralized disclosure approach for these executive benefits.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GS_10k_2023.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "GS_10k_2024.pdf",
          "target_page": 246,
          "pages": [
            243,
            244,
            245,
            246,
            247
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41486,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10592,
        "completion_tokens": 168,
        "total_tokens": 10760
      }
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "Between 2022 and 2024, the strategic importance of FBAR filters has grown, with Broadcom emphasizing their role in wireless communications and proprietary manufacturing. In 2022, FBAR filters were highlighted as products made in internal fabrication facilities to protect IP and accelerate time-to-market. By 2024, the company further underscored the strategic value of FBAR filters, noting their use in innovative and proprietary processes, and their competitive positioning was reinforced by Broadcom’s broad product portfolio, design expertise, and customer relationships. This evolution reflects a stronger focus on internal fabrication for high-value, mission-critical components to maintain a competitive edge.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 45918,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11709,
        "completion_tokens": 179,
        "total_tokens": 11888
      }
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "Between 2023 and 2024, BMY's strategic positioning of Krazati evolved significantly, particularly through the acquisition of Mirati in January 2024, which added Krazati to BMY's portfolio. In 2023, Krazati was in clinical development for second-line non-small cell lung cancer (NSCLC) and colorectal cancer. By 2024, Krazati had received FDA and EMA approvals for second-line NSCLC and advanced KRAS-mutated colorectal cancer, and it was further advancing in clinical trials for first-line NSCLC in combination with a PD-1 inhibitor. Financially, the acquisition of Mirati, valued at $4.8 billion, reflected BMY's commitment to expanding Krazati's development and commercial potential, with the asset contributing to BMY's indefinite-lived IPRD and R&D technology valuation.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BMY_10k_2023.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "BMY_10k_2024.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 91683,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 23143,
        "completion_tokens": 193,
        "total_tokens": 23336
      }
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "Between 2022 and 2023, BKNG has continued to evolve its relationship with travel service providers by maintaining and expanding its platform to facilitate bookings and payments, while managing financial obligations and incentives through structured programs. The Company manages financial obligations primarily through deferred merchant bookings, where cash received from travelers is held until performance obligations are fulfilled, with amounts payable to travel service providers. Incentive programs, such as referral bonuses and loyalty points, are recognized as a reduction of revenue at the time they are granted. Additionally, BKNG has focused on enhancing its Connected Trip vision, aiming to streamline the travel experience by integrating various travel services, which further strengthens its partnerships with travel service providers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BKNG_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "BKNG_10k_2023.pdf",
          "target_page": 84,
          "pages": [
            82,
            83,
            84,
            85,
            86
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 50184,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 12780,
        "completion_tokens": 212,
        "total_tokens": 12992
      }
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "From 2022 to 2024, Broadcom's involvement in the development of Custom Touch Controllers has remained consistent, with their role primarily focused on the design and integration of these controllers as part of their broader semiconductor solutions for mobile device connectivity. In both years, Custom Touch Controllers are listed as a key product offering under the Wireless segment, indicating a stable position in their product lifecycle. There is no indication of a significant shift in their role or strategic emphasis regarding Custom Touch Controllers during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 41795,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10672,
        "completion_tokens": 144,
        "total_tokens": 10816
      }
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "Union Pacific's approach to freight cars from 2023 to 2024 remained relatively consistent in terms of asset acquisition strategy. In both years, the company invested in locomotives and freight cars as part of its broader capital investment plan, with expenditures of $728 million in 2023 and $788 million in 2024. These investments included lease buyouts and were aligned with the company's goals to modernize its fleet, replace older assets, and support growth opportunities. The 2024 capital plan also emphasized continued investments in freight cars to enhance operational efficiency and meet demand from intermodal customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "UNP_10k_2023.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "hop_2_rel": {
          "source_file": "UNP_10k_2024.pdf",
          "target_page": 33,
          "pages": [
            31,
            32,
            33,
            34,
            35
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 45553,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11604,
        "completion_tokens": 157,
        "total_tokens": 11761
      }
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike's structural changes in APLA between FY2022 and FY2023, particularly the transition of certain businesses to third-party distributors, had mixed financial and operational impacts. Revenues for APLA increased slightly from $5,955 million in FY2022 to $6,431 million in FY2023, reflecting stable performance despite the transition. However, EBIT for APLA rose from $1,896 million in FY2022 to $1,932 million in FY2023, indicating improved profitability, likely due to cost efficiencies from the structural changes. Operationally, the shift reduced Nike's direct control and asset exposure in APLA, as evidenced by a decline in inventories from $894 million in FY2022 to $810 million in FY2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 90,
          "pages": [
            88,
            89,
            90,
            91,
            92
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51857,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13198,
        "completion_tokens": 174,
        "total_tokens": 13372
      }
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "Broadcom's involvement with InP lasers has remained consistent in terms of internal fabrication strategy from 2022 to 2024, as both filings indicate that InP lasers are manufactured internally for fiber optic communications. However, in 2024, there is a slight emphasis on competitive positioning, with broader mention of competitors in the semiconductor market, including firms like Lumentum and II-VI Incorporated, suggesting increased market dynamics. Broadcom continues to leverage its proprietary InP laser technology to maintain a competitive edge in high-speed communications.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2022.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 45918,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11704,
        "completion_tokens": 145,
        "total_tokens": 11850
      }
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "Between 2022 and 2023, Swoosh, LLC maintained its significant ownership of approximately 77% of NIKE's Class A Common Stock, which grants disproportionate voting power as holders of Class A stock elect three-quarters of the Board of Directors. In 2022, it was noted that if all Class A shares were converted to Class B, Swoosh, LLC's ownership of Class B Common Stock would be about 16%. The 2023 filing reaffirms this ownership structure without indicating material changes. This concentration of ownership through Class A shares provides Swoosh, LLC with substantial influence over corporate governance and decision-making, potentially limiting shareholder influence and discouraging hostile takeovers or unsolicited bids.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 25,
          "pages": [
            23,
            24,
            25,
            26,
            27
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 26,
          "pages": [
            24,
            25,
            26,
            27,
            28
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51149,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13020,
        "completion_tokens": 181,
        "total_tokens": 13201
      }
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "From 2022 to 2023, PMI's strategic positioning of Reduced-Risk Products (RRPs) evolved significantly through portfolio integration and expanded market availability. In 2022, the acquisition of Swedish Match AB strengthened PMI's oral nicotine offerings, particularly in the U.S. with the ZYN brand, complementing its heat-not-burn products like IQOS. By 2023, PMI integrated Swedish Match into its regional structure and reorganized its operating segments, including a new Wellness and Healthcare segment. This integration enhanced PMI's smoke-free portfolio, with RRPs available in 84 markets by year-end, reflecting a strategic shift toward becoming a smoke-free company.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PM_10k_2022.pdf",
          "target_page": 97,
          "pages": [
            95,
            96,
            97,
            98,
            99
          ]
        },
        "hop_2_rel": {
          "source_file": "PM_10k_2023.pdf",
          "target_page": 28,
          "pages": [
            26,
            27,
            28,
            29,
            30
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42650,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10885,
        "completion_tokens": 168,
        "total_tokens": 11053
      }
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "Caterpillar's strategic role in the reciprocating engines business from 2022 to 2024 has shifted toward emphasizing high-margin applications such as data center power generation and gas compression, while experiencing declines in lower-margin areas like well servicing. This shift is evident in the 2024 10-K, which notes flat sales in reciprocating engines for well servicing but increased sales in gas compression and turbines. As a result, the Energy & Transportation segment's profit margin rose to 19.9% in 2024 from 17.6% in 2023, indicating improved gross margin potential due to a more favorable product mix and price realization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 39,
          "pages": [
            37,
            38,
            39,
            40,
            41
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44157,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11268,
        "completion_tokens": 159,
        "total_tokens": 11428
      }
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "Between 2022 and 2023, BNY Mellon maintained its commitment to disclosing amendments to the Directors' Code of Conduct by posting updates on its website, as outlined in both years' filings. However, in 2023, there was a slight enhancement in transparency, as the company explicitly reiterated its intention to disclose amendments or waivers of the Directors' Code of Conduct on its website, reinforcing its commitment to stakeholder communication. No specific new mechanisms were introduced, but the reaffirmation of existing disclosure practices highlighted a continued emphasis on transparency.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "BK_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "BK_10k_2023.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36568,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9384,
        "completion_tokens": 149,
        "total_tokens": 9533
      }
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "Between FY22 and FY23, Nike's strategic approach to the APLA market evolved through a shift in operational structure, particularly with the planned transition of legal entities in Argentina, Uruguay, and Chile to third-party distributors. This move aimed to transition from a wholesale and direct-to-consumer model to a distributor model, which is expected to reduce selling and administrative expenses and mitigate foreign exchange volatility. Additionally, Nike continued to strengthen its market participation in APLA through its NIKE Direct operations, which saw growth in digital sales and owned retail channels, aligning with the broader Consumer Direct Acceleration strategy.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "NKE_10k_2022.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "hop_2_rel": {
          "source_file": "NKE_10k_2023.pdf",
          "target_page": 89,
          "pages": [
            87,
            88,
            89,
            90,
            91
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 44697,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11397,
        "completion_tokens": 170,
        "total_tokens": 11567
      }
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "From 2022 to 2024, the impact of favorable price realization on Caterpillar's sales and profitability has evolved as follows: In 2022, favorable price realization contributed to a 22% sales increase compared to 2021, driven by higher demand and inventory changes. By 2024, while sales decreased slightly by 3% compared to 2023, favorable price realization partially offset the impact of lower sales volume and improved operating profit margin to 20.2%. In 2025, however, Caterpillar expects unfavorable price realization in Construction and Resource Industries to negatively impact profitability, though Energy & Transportation is expected to see favorable price realization.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 34,
          "pages": [
            32,
            33,
            34,
            35,
            36
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2024.pdf",
          "target_page": 30,
          "pages": [
            28,
            29,
            30,
            31,
            32
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 74051,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18726,
        "completion_tokens": 168,
        "total_tokens": 18894
      }
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "Between 2023 and 2024, General Motors' approach to EV manufacturing capacity evolved by refocusing its strategy on scaling EV production and developing a resilient, North America-centric EV supply chain. In 2024, GM emphasized strategic sourcing initiatives, including investments in raw material suppliers and multi-year supply agreements, to secure materials and reduce costs, particularly for battery cells and packs. Additionally, GM shifted its autonomous driving focus to personal vehicles and integrated technical efforts with Cruise to prioritize ADAS development, aligning with its long-term EV strategy. These actions reflect a stronger commitment to addressing supply chain challenges and advancing EV technology to meet evolving consumer and regulatory demands.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "GM_10k_2023.pdf",
          "target_page": 18,
          "pages": [
            16,
            17,
            18,
            19,
            20
          ]
        },
        "hop_2_rel": {
          "source_file": "GM_10k_2024.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62280,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15794,
        "completion_tokens": 193,
        "total_tokens": 15987
      }
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Based on the remaining performance obligations disclosed in the 10-K filings, Pfizer's financial commitment to Paxlovid has significantly decreased from 2022 to 2024. As of December 31, 2022, the remaining performance obligations for Paxlovid were approximately $1 billion, which decreased to $4 billion as of December 31, 2023, and further reduced to $1 billion by December 31, 2024. This decline reflects the transition of Paxlovid from government contracts to commercial markets and the recognition of revenue as obligations were fulfilled.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 79175,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20015,
        "completion_tokens": 135,
        "total_tokens": 20151
      }
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "Between 2022 and 2023, Caterpillar's approach to monitoring supplier financial viability has evolved with a stronger emphasis on contractual agreements and risk mitigation strategies. The company continues to expect suppliers to maintain industry-leading quality and delivery performance while using agreements to protect intellectual property and monitor risks, including supplier financial viability. However, in 2023, Caterpillar explicitly expanded its risk mitigation strategies to include a more structured focus on business continuity, production flexibility, and supplier financial resilience, particularly in response to ongoing supply chain disruptions and fluctuating demand. These enhancements reflect a more proactive stance in safeguarding against potential business disruptions caused by supplier instability.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 9,
          "pages": [
            7,
            8,
            9,
            10,
            11
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 43735,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11162,
        "completion_tokens": 206,
        "total_tokens": 11368
      }
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "Between 2022 and 2024, Visa's approach to Risk and Identity Solutions evolved by expanding its AI and machine learning capabilities to enhance fraud prevention and authentication. In 2024, Visa introduced three new products—Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic Visa Advanced Authorization—to address fraud in A2A and card-not-present (CNP) transactions, both on and off Visa's network. This reflects a strategic shift toward providing more comprehensive, network-agnostic fraud prevention tools that support Visa's broader vision of being a \"network of networks.\"",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 5,
          "pages": [
            3,
            4,
            5,
            6,
            7
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 35289,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9050,
        "completion_tokens": 156,
        "total_tokens": 9206
      }
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "The company's exposure to shelf space limitations as a risk factor remained significant in 2023, with continued challenges from retail customer policies such as inventory destocking, fulfillment requirements, and limitations on shelf space access. However, the expansion of alternative retail channels, particularly e-commerce and direct-to-consumer models, provided some mitigation by diversifying distribution pathways. In 2023, the company emphasized adapting to evolving consumer preferences and expanding into higher-growth channels, suggesting a strategic shift to reduce dependency on traditional retail shelf space.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 31,
          "pages": [
            29,
            30,
            31,
            32,
            33
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 35829,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9195,
        "completion_tokens": 155,
        "total_tokens": 9351
      }
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "Oracle's approach to hybrid deployments between fiscal years 2023 and 2024 has shown a continued strategic emphasis on providing flexible and interoperable solutions. In 2023, Oracle highlighted its hybrid deployment models, including Oracle Exadata Cloud@Customer and Dedicated Region offerings, which allow customers to use Oracle Cloud within their own data centers. By 2024, Oracle expanded on this by emphasizing the integration of AI and machine learning capabilities within its hybrid offerings, such as the Oracle Autonomous Database, and by introducing programs to help customers migrate existing workloads to the Oracle Cloud. This evolution reflects a stronger push toward modernizing hybrid environments with advanced technologies and facilitating seamless transitions for customers.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ORCL_10k_2023.pdf",
          "target_page": 6,
          "pages": [
            4,
            5,
            6,
            7,
            8
          ]
        },
        "hop_2_rel": {
          "source_file": "ORCL_10k_2024.pdf",
          "target_page": 72,
          "pages": [
            70,
            71,
            72,
            73,
            74
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 9,
        "total_chars": 47034,
        "num_window_pages": 9,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11981,
        "completion_tokens": 198,
        "total_tokens": 12180
      }
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "Pfizer's financial commitment to Paxlovid has significantly decreased between 2022 and 2024. In 2022, Paxlovid contributed $18,933 million in revenues, which dropped to $1,279 million in 2023 due to a non-cash revenue reversal of $3.5 billion related to expected returns of EUA-labeled U.S. government inventory. By 2024, Paxlovid revenues increased to $5,716 million, partly due to a $771 million favorable adjustment from returned treatment courses and the transition to commercial markets. Remaining performance obligations for Paxlovid were $1 billion as of December 31, 2024, with expected delivery through 2028.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 23,
          "pages": [
            21,
            22,
            23,
            24,
            25
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 82254,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 20788,
        "completion_tokens": 154,
        "total_tokens": 20943
      }
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "Between 2022 and 2023, Caterpillar's relationship with its independent dealers remained centered on contractual agreements that grant dealers the right to sell and service Caterpillar products within specified geographic territories. These agreements, which include obligations for dealers to promote Caterpillar products, maintain adequate support personnel, and uphold quality standards, were consistent in both years. However, in 2023, there was a greater emphasis on leveraging dealer networks to support Caterpillar's global sales strategy, particularly in developing markets. Additionally, the company continued to strengthen its strategic focus on dealer support through financing and technical assistance, as highlighted by the role of Cat Financial in providing inventory and sales financing to dealers worldwide.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CAT_10k_2022.pdf",
          "target_page": 4,
          "pages": [
            2,
            3,
            4,
            5,
            6
          ]
        },
        "hop_2_rel": {
          "source_file": "CAT_10k_2023.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 43200,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 11024,
        "completion_tokens": 205,
        "total_tokens": 11229
      }
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "From 2022 to 2023, the company's financial allocation and operational focus related to Africa/Eurasia, as part of the 2022 Global Productivity Initiative, shifted from 11% of restructuring charges in 2022 to 5% in 2023, indicating a reduced emphasis on this region. Additionally, capital expenditures for Africa/Eurasia increased from $13 million in 2022 to $33 million in 2023, reflecting a modest rise in investment despite the declining share of restructuring efforts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 117,
          "pages": [
            115,
            116,
            117,
            118,
            119
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 26631,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6885,
        "completion_tokens": 117,
        "total_tokens": 7003
      }
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "From 2022 to 2024, Qualcomm has deepened its strategic focus on 5G technologies by increasing investment in AI integration, expanding commercialization into new industries, and enhancing product performance. In 2022, the company emphasized 5G modem-RF platform development and foundational 5G NR technologies. By 2024, Qualcomm had integrated AI into its Snapdragon 5G modem-RF products to optimize performance and battery life, while also expanding 5G adoption into automotive, IoT, and industrial applications. Commercialization outcomes include the global rollout of 5G technologies and over 200 5G license agreements, reflecting stronger market penetration and diversification beyond mobile handsets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 13,
          "pages": [
            11,
            12,
            13,
            14,
            15
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 64478,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16343,
        "completion_tokens": 176,
        "total_tokens": 16519
      }
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Pfizer's financial and strategic positioning of Paxlovid evolved significantly between 2022 and 2024. In 2022, Paxlovid contributed $18,933 million in revenue, which dropped to $1,279 million in 2023 due to a non-cash revenue reversal of $3.5 billion associated with expected returns of EUA-labeled U.S. government inventory. By 2024, Paxlovid revenue rebounded to $5,716 million as the product transitioned to commercial markets. Contractual commitments also shifted, with amended agreements allowing for continued access through government programs and a U.S. Strategic National Stockpile (SNS) of 1.0 million treatment courses supplied at no cost for pandemic preparedness. Deferred revenues related to Paxlovid decreased from $5.1 billion in 2023 to $2.2 billion in 2024, reflecting product deliveries and a favorable adjustment of $771 million in Q1 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 113,
          "pages": [
            111,
            112,
            113,
            114,
            115
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 90758,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 22918,
        "completion_tokens": 215,
        "total_tokens": 23133
      }
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "The company's exposure to credit market tightness as a supply chain risk increased between 2022 and 2023, as both years mention the impact of tighter credit or capital markets on suppliers. However, the 2023 filing explicitly highlights the ongoing challenges of geopolitical conflicts (e.g., the war in Ukraine and the Israel-Hamas war) and climatic events exacerbating these risks. This evolution indicates a heightened vulnerability to external financial conditions, as tighter credit markets are now compounded by broader macroeconomic and geopolitical pressures, potentially disrupting supplier operations and increasing the company's reliance on contingency planning.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "CL_10k_2022.pdf",
          "target_page": 16,
          "pages": [
            14,
            15,
            16,
            17,
            18
          ]
        },
        "hop_2_rel": {
          "source_file": "CL_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42500,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10860,
        "completion_tokens": 168,
        "total_tokens": 11028
      }
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "Pfizer's financial commitment and contractual obligations related to Paxlovid significantly decreased from 2022 to 2024. In 2022, Paxlovid generated $18,933 million in revenue, but by 2024, this dropped to $5,716 million. This decline reflects the transition from government contracts to commercial market sales, particularly in the U.S., and the recognition of deferred revenues. Additionally, deferred revenues related to Paxlovid decreased from $5.1 billion in 2023 to $2.2 billion in 2024, primarily due to product deliveries and a favorable adjustment from returned EUA-labeled treatment courses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PFE_10k_2022.pdf",
          "target_page": 47,
          "pages": [
            45,
            46,
            47,
            48,
            49
          ]
        },
        "hop_2_rel": {
          "source_file": "PFE_10k_2024.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 78243,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 19784,
        "completion_tokens": 150,
        "total_tokens": 19935
      }
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "From 2023 to 2024, the financial liability related to Aearo Technologies' respirator mask/asbestos litigation decreased from $62 million to $51 million. This reduction reflects the resolution of certain claims and ongoing management of liabilities through an informal arrangement with co-defendants. However, the risk exposure remains significant due to uncertainties in future claims, legal costs, and potential changes in liability allocation or co-defendant financial viability. The Company continues to monitor and adjust its accruals based on developments in litigation and claims trends.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 82,
          "pages": [
            80,
            81,
            82,
            83,
            84
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 87,
          "pages": [
            85,
            86,
            87,
            88,
            89
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 61725,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15651,
        "completion_tokens": 148,
        "total_tokens": 15799
      }
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline of 1.7 share points. In contrast, between 2020 and 2021, Skoal's retail share decreased from 13.9% to 12.6%, a decline of 1.3 share points. Thus, the decline in Skoal's retail share was more pronounced in 2024 compared to the 2020–2021 period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MO_10k_2022.pdf",
          "target_page": 46,
          "pages": [
            44,
            45,
            46,
            47,
            48
          ]
        },
        "hop_2_rel": {
          "source_file": "MO_10k_2024.pdf",
          "target_page": 48,
          "pages": [
            46,
            47,
            48,
            49,
            50
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 54361,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13813,
        "completion_tokens": 83,
        "total_tokens": 13897
      }
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "From 2022 to 2024, Qualcomm's approach to multimedia technologies has evolved with a stronger emphasis on integration into diverse product offerings and a broader engineering focus. In 2022, the company highlighted its expertise in multimedia technologies such as camera, video, display, and computer vision, as part of its research and development efforts aimed at expanding beyond mobile handsets into automotive and IoT. By 2024, Qualcomm expanded its engineering focus to include AI, generative AI, and power efficiency, emphasizing on-device AI capabilities and scaling across industries. Additionally, multimedia technologies were increasingly integrated into product offerings such as automotive systems for digital cockpit and ADAS/AD, as well as IoT applications, reflecting a strategic shift toward diversification and innovation in emerging markets.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "QCOM_10k_2022.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "hop_2_rel": {
          "source_file": "QCOM_10k_2024.pdf",
          "target_page": 14,
          "pages": [
            12,
            13,
            14,
            15,
            16
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62531,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15859,
        "completion_tokens": 215,
        "total_tokens": 16074
      }
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "Between 2023 and 2024, 3M's financial relationship with the Aearo Entities evolved significantly. In 2023, 3M reconsolidated the Aearo Entities after the dismissal of their bankruptcy proceedings, resulting in the removal of a $0.7 billion equity investment and a $0.6 billion intercompany liability from the consolidated balance sheet. In 2024, there is no specific mention of changes to the equity investment or intercompany balances, suggesting that the reconsolidation remained in effect and no material adjustments occurred during this period.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MMM_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            99,
            100,
            101,
            102,
            103
          ]
        },
        "hop_2_rel": {
          "source_file": "MMM_10k_2024.pdf",
          "target_page": 50,
          "pages": [
            48,
            49,
            50,
            51,
            52
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 62688,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15896,
        "completion_tokens": 137,
        "total_tokens": 16033
      }
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "Between 2022 and 2024, Visa's Risk and Identity Solutions have evolved to become a more integral part of the company's broader value-added services portfolio. In 2022, these solutions were primarily described as tools to help prevent fraud and protect account holder data through products like Visa Consumer Authentication Service and Visa Advanced Authorization. By 2024, the strategic positioning had expanded significantly, with the introduction of new AI-powered tools such as Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager with scheme-agnostic Visa Advanced Authorization. These enhancements reflect a stronger emphasis on leveraging AI and machine learning to address fraud across a broader range of payment types, including card-not-present and account-to-account transactions, both on and off Visa's network.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "V_10k_2022.pdf",
          "target_page": 12,
          "pages": [
            10,
            11,
            12,
            13,
            14
          ]
        },
        "hop_2_rel": {
          "source_file": "V_10k_2024.pdf",
          "target_page": 11,
          "pages": [
            9,
            10,
            11,
            12,
            13
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 42330,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10812,
        "completion_tokens": 211,
        "total_tokens": 11023
      }
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "RTX's Acquisition Accounting Adjustments' impact on operating profit remained relatively consistent between 2023 and 2024, with adjustments of $1,998 million in 2023 and $2,058 million in 2024. The adjustments primarily stemmed from amortization of acquired intangible assets, property, plant, and equipment fair value adjustments, and customer contractual obligations. The slight increase in 2024 was driven by a modest rise in amortization of acquired intangibles and a decrease in amortization of property, plant, and equipment fair value adjustments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "RTX_10k_2023.pdf",
          "target_page": 109,
          "pages": [
            107,
            108,
            109,
            110,
            111
          ]
        },
        "hop_2_rel": {
          "source_file": "RTX_10k_2024.pdf",
          "target_page": 54,
          "pages": [
            52,
            53,
            54,
            55,
            56
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 56577,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14364,
        "completion_tokens": 138,
        "total_tokens": 14502
      }
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Between fiscal years 2022 and 2023, Microsoft's Office 365 Commercial revenue grew from $44.97 billion to $48.85 billion, representing an increase of $3.88 billion or approximately 8.6%. This growth indicates a steady but moderate expansion of Office 365 Commercial within the broader Microsoft Cloud ecosystem, which saw its total revenue rise from $91.4 billion to $111.6 billion during the same period. While Office 365 Commercial remains a significant contributor, the faster growth of Azure and other cloud services suggests a diversification of the cloud revenue base.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MSFT_10k_2022.pdf",
          "target_page": 43,
          "pages": [
            41,
            42,
            43,
            44,
            45
          ]
        },
        "hop_2_rel": {
          "source_file": "MSFT_10k_2023.pdf",
          "target_page": 93,
          "pages": [
            91,
            92,
            93,
            94,
            95
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 37939,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9724,
        "completion_tokens": 143,
        "total_tokens": 9868
      }
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Merck's alliance revenue related to Lynparza increased by 9% in 2024 compared to 2023, primarily driven by higher demand in most international markets. This growth was supported by Lynparza's approval in new indications and expanded market adoption. Additionally, in January 2025, Lynparza received approval in China for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, further contributing to its growth potential.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2023.pdf",
          "target_page": 126,
          "pages": [
            108,
            109,
            110,
            111,
            112
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 57741,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 14652,
        "completion_tokens": 114,
        "total_tokens": 14766
      }
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "The Procter & Gamble 2014 Stock and Incentive Compensation Plan remains referenced in both the 2023 and 2024 10-K filings, indicating continuity in its inclusion within the company's equity compensation reporting. However, the 2024 filing emphasizes that only the 2019 Stock and Incentive Compensation Plan allows for future grants of securities, with the 2014 Plan no longer serving as an active vehicle for new awards. This shift reflects the company's regulatory and strategic focus on newer plans for ongoing equity compensation, while older plans like the 2014 Plan are maintained for historical and administrative purposes.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 70694,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 17914,
        "completion_tokens": 157,
        "total_tokens": 18071
      }
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "The 1992 Stock Plan is mentioned in both the 2023 and 2024 10-K filings as one of the equity compensation plans under which securities may be issued. However, in both filings, it is clear that the 1992 Stock Plan no longer allows for future grants of securities. The 2019 Stock and Incentive Compensation Plan is the only active plan allowing for future equity grants, indicating that the 1992 Stock Plan has been superseded and no longer plays an active role in the company's current equity compensation structure.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "PG_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "PG_10k_2024.pdf",
          "target_page": 68,
          "pages": [
            66,
            67,
            68,
            69,
            70
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 71108,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 18005,
        "completion_tokens": 128,
        "total_tokens": 18133
      }
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "Between 2023 and 2024, the company has observed that clients continue to prioritize large-scale transformations, which convert to revenue over a longer period. In 2024, economic and geopolitical uncertainties slowed the pace and level of client spending, particularly for smaller, shorter-duration contracts and consulting services, reinforcing a shift toward larger, long-term engagements. This indicates an evolving emphasis on sustained, complex projects as clients focus on strategic, long-term digital and technological transformations.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 21,
          "pages": [
            19,
            20,
            21,
            22,
            23
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 8,
        "total_chars": 42463,
        "num_window_pages": 8,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 10843,
        "completion_tokens": 135,
        "total_tokens": 10979
      }
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "In fiscal 2024, Accenture issued $7,869 million in Class A Ordinary Shares for employee share programs, compared to $7,970 million in fiscal 2023, representing a slight decrease of $101 million. This issuance contributed to an increase in additional paid-in capital by $2,280,198 million and impacted retained earnings negatively by $131,133 million. Overall, it affected the equity structure by increasing total shareholders' equity by $1,416,945 million in fiscal 2024.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 101,
          "pages": [
            81,
            82,
            83,
            84,
            85
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 70,
          "pages": [
            68,
            69,
            70,
            71,
            72
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 35266,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9043,
        "completion_tokens": 117,
        "total_tokens": 9161
      }
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ's exposure to Canadian-denominated debt instruments decreased between 2022 and 2023, as the notional amount of Canadian dollar notes dropped from $443 million in 2022 to $453 million in 2023, indicating a slight reduction in direct exposure. However, the after-tax losses related to Canadian notes increased from $25 million in 2022 to $8 million in 2023, suggesting a shift in the impact of currency fluctuations on these instruments. This contrasts with the company's broader trend of managing foreign currency-denominated debt, where overall notional amounts for net investment hedges increased, and the company continued to hedge against exchange rate risks through derivative contracts.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 114,
          "pages": [
            112,
            113,
            114,
            115,
            116
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 52649,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13404,
        "completion_tokens": 174,
        "total_tokens": 13578
      }
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024 by enhancing strategic involvement and increasing investment activity through its innovation ecosystem. In 2023, Accenture Ventures was already partnering with and investing in growth-stage companies focused on innovative enterprise technologies. By 2024, the company emphasized a more structured and forward-looking innovation approach, supported by increased R&D spending ($1.2 billion in 2024) and a global network of over 100 innovation hubs. This evolution reflects a stronger commitment to incubating emerging technologies and scaling innovative solutions for clients, particularly in areas like AI, blockchain, and quantum computing.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "ACN_10k_2023.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "hop_2_rel": {
          "source_file": "ACN_10k_2024.pdf",
          "target_page": 17,
          "pages": [
            15,
            16,
            17,
            18,
            19
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 7,
        "total_chars": 23233,
        "num_window_pages": 7,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 6034,
        "completion_tokens": 181,
        "total_tokens": 6215
      }
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca from 2022 to 2024 shows growth in alliance revenue and ongoing amortization of intangible assets. Alliance revenue related to Lynparza grew 9% in 2024 compared to 2023, driven by higher international demand. As of 2021, the intangible asset balance related to Lynparza was $1.1 billion, which is being amortized over its estimated useful life through 2028. This reflects continued value from the collaboration, supported by regulatory approvals and market expansion, including a new approval in China in January 2025.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MRK_10k_2022.pdf",
          "target_page": 102,
          "pages": [
            100,
            101,
            102,
            103,
            104
          ]
        },
        "hop_2_rel": {
          "source_file": "MRK_10k_2024.pdf",
          "target_page": 55,
          "pages": [
            53,
            54,
            55,
            56,
            57
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 53630,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13642,
        "completion_tokens": 152,
        "total_tokens": 13794
      }
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "AVGO's strategic emphasis on ValueOps has shifted from a focus on enabling work lifecycle management and alignment between business and development teams in 2023 to a more integrated role within the Distributed Software portfolio in 2024. In 2024, ValueOps is positioned as a key component of solutions that optimize the planning, development, and delivery of business-critical services, working alongside DevOps and AIOps to deliver end-to-end visibility across the digital lifecycle. This evolution indicates that ValueOps is becoming more central to AVGO's strategy for driving operational efficiency and business outcomes in distributed environments.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 8,
          "pages": [
            6,
            7,
            8,
            9,
            10
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 10,
          "pages": [
            8,
            9,
            10,
            11,
            12
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 60089,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 15247,
        "completion_tokens": 163,
        "total_tokens": 15410
      }
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "Between 2023 and 2024, FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolved by consolidating operations, such as merging FedEx Ground and FedEx Services into Federal Express, and redesigning the international air network through the Tricolor initiative. While the new legal structure was completed in June 2024, integration and optimization were ongoing. The expected benefits included improved efficiency, asset utilization, and cost savings, but the company acknowledged risks such as higher-than-anticipated costs, potential disruptions, and challenges in integrating networks and labor relations. The actual amount and timing of cost savings and savings to the permanent cost structure remained uncertain and subject to change based on the progress of integration and external factors.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 32,
          "pages": [
            30,
            31,
            32,
            33,
            34
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 29,
          "pages": [
            27,
            28,
            29,
            30,
            31
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 63825,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 16186,
        "completion_tokens": 204,
        "total_tokens": 16390
      }
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "The financial impact from equity method investment contracts increased from 2022 to 2023, with pre-tax gains recorded in net earnings rising from $0 million in 2022 to $7 million in 2023. This indicates a modest but positive shift in MDLZ's engagement with these investments, reflecting improved performance or favorable valuation changes in the related equity method investments during 2023.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "MDLZ_10k_2022.pdf",
          "target_page": 111,
          "pages": [
            109,
            110,
            111,
            112,
            113
          ]
        },
        "hop_2_rel": {
          "source_file": "MDLZ_10k_2023.pdf",
          "target_page": 98,
          "pages": [
            96,
            97,
            98,
            99,
            100
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51486,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13101,
        "completion_tokens": 98,
        "total_tokens": 13199
      }
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases decreased from fiscal year 2023 to fiscal year 2024, dropping from $38 million to $0, as the project was released during fiscal year 2024. This indicates that the development progress met or exceeded expectations, with the project completed on schedule.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "AVGO_10k_2023.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "hop_2_rel": {
          "source_file": "AVGO_10k_2024.pdf",
          "target_page": 69,
          "pages": [
            67,
            68,
            69,
            70,
            71
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 36752,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 9432,
        "completion_tokens": 83,
        "total_tokens": 9515
      }
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "Between 2023 and 2024, the strategic positioning of FedEx Office's Ship and Go kiosk has evolved by emphasizing convenience and integration with e-commerce logistics and returns management. The kiosk allows customers to generate shipping labels via mobile devices or QR codes and drop off packages securely, streamlining the shipping process. Additionally, FedEx Office facilitates e-commerce returns through FedEx Returns Technology, enabling in-store printing of return labels and offering consolidated returns with no box or label required. This evolution indicates that FedEx is enhancing its retail logistics infrastructure to better support e-commerce growth, improve customer experience, and provide seamless returns management solutions for both consumers and businesses.",
      "llm_thought": "",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pages_used": {
        "hop_1_rel": {
          "source_file": "FDX_10k_2023.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "hop_2_rel": {
          "source_file": "FDX_10k_2024.pdf",
          "target_page": 15,
          "pages": [
            13,
            14,
            15,
            16,
            17
          ]
        },
        "distractors": []
      },
      "context_stats": {
        "total_pages": 10,
        "total_chars": 51878,
        "num_window_pages": 10,
        "num_distractor_pages": 0,
        "shuffle_enabled": true
      },
      "token_usage": {
        "prompt_tokens": 13204,
        "completion_tokens": 194,
        "total_tokens": 13399
      }
    }
  ]
}